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Evidence-based medicine (EBM) was introduced to the best benefit of the patient. 
It has transformed the pathophysiological approach to the outcome approach of 
today’s treatments. Disease-oriented to patient-oriented medicine. And, for some, 
daily medical practice from patient oriented to case oriented medicine. Evidence has 
changed the paternalistic way of medical practice. And gave room to patients, who 
show a tendency towards partnership. Although EBM has introduced a different 
way of thinking in the day to day medical practice, there is plenty of space for 
implementation and improvement. This book is meant to provoke the thinker towards 
the unlimited borders of caring for the patient.
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Evidence-based, in general, is the term that characterizes many decision making 
processes in modern society and science. From justice to politics. To medicine.  
Evidence-based medicine (EBM) was introduced to the best benefit of the patient. It has 
transformed the pathophysiological approach to the outcome approach of today’s 
treatments. Disease- oriented to patient- oriented   medicine. And, for some, daily medical 
practice from patient oriented to case oriented  medicine. Evidence has changed the 
paternalistic way of medical practice. And gave room to patients, who show a 
tendency towards partnership.  
The only certain in medical science is uncertainty. Therefore, medicine relies more and 
more to statistics. But the significant does not always dignify the essential. As William 
Osler quoted, “if it was not for differences among individuals, the Art of Medicine 
could be Science in addition”. 
Statistical significance is not enough. Importance is hidden under the clinical influence 
of evidence. And according to Gertrude Stein, “for a difference to be different it must 
make a difference”. 
Although EBM has introduced a different way of thinking in the day to day medical 
practice, there is plenty of space for implementation and improvement.  And the 
dispute remains: should “Evidence-based Medicine” be the new “Faith-based 
Medicine”? 
 
Dr Nikolaos M. Sitaras 
Athens University, Medical School,  
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1. Introduction  
Randomized Controlled Trials (RCTs) are the most valuable study which play an important 
role in the field of medicine. Other study types including descriptive studies (e.g. case 
reports, case series, cross-sectional studies) and certain analytical studies (e.g. case control 
studies, cohort studies) are also important pieces of evidence but RCTs which are designed 
for evaluation of the interventions in clinical practice are probably the highest level of 
evidence in the pyramid of Evidence Based Medicine. It is simple, yet the most powerful 
tool in modern clinical research.  
2. RCTs: Top of the evidence-pyramid  
RCTs are considered the most powerful evidence that exists. This is most probably due to 
the fact that ‘randomizing’ people into two different groups probably takes care of all the 
confounding factors and equals out all the causes which may affect the final result of the 
study. 
This is mostly because of their accurate design. This reduces any possibility of bias in the 
result. Every year, the numbers of RCTs that are published in Medical Journals are 
increasing and thus, they have a great effect on changing the way medical science is 
practiced all over the world. Evidence-Based Medicine is highly dependent on the RCTs. 
Therefore designing, conducting and reporting RCTs is an important aspect of medical 
science and all medical professionals should learn these skills. Critical appraisal of RCTs is 
probably as important as conducting them. All medical professionals need to understand 
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directly into changing clinical practice. Hence, it is important that they are free of bias and 
are strong in their design and execution. 
3. RCTs: The other side of the coin 
However, RCTs are not far from their fair share of disadvantages. They may be the most 
powerful tool in the world of research but many ethical and practical concerns limit their 
use.  
3.1. Not all randomized trials are unethical. However, a RCT may be ethical but infeasible. 
This may be due to difficulties in randomization or recruitment. For example, interventions 
like cancer screening at an early age might have an extremely long follow up with not may 
positive outcomes.  
3.2. Once a convention is set in the community or a particular intervention gains popularity, 
it is tough convincing the subjects to “experiment” with their alternative options. A recent 
attempt to conduct a trial of counselling in general practice failed when practitioners 
declined to recruit patients to be allocated at random. 
3.3. Certain populations of people may have certain strong ideologies and preferences. This 
may also limit recruitment and result in bias outcomes if not accounted for and 
accommodated within the study design. 
3.4. Randomised trials are not always practical for evaluation of rare diseases or rare 
outcomes or even outcomes which take a long time to develop.  
3.5. A successful and valid RCT requires a large sample size because the outcomes generally 
have smaller effects and a large measurable difference is required when comparing two 
groups of interventions. So, the larger the sample size, the better the randomized trial but 
the larger the financial constraints as well as the time required for the trial to be completed. 
3.6. They also have a fairly large drop-out rates and a huge population of the sample size is 
often lost to follow up making it even harder to assess the final results.  
3.7. Even with the people who do follow up, not all religiously adhere to the regimen 
prescribed to them and some may even be totally non-compliant.  
3.8. Since they require a lot of time and manpower, they are fairly expensive to conduct. 
Financial constraints are probably the most common reason for a trial to be shelved. 
3.9. Randomized trials have a huge ethical dilemma. If an intervention is considered inferior 
to the current treatment modality, exposing some patients to it and not others (or exposing 
one group to placebo and the other to the treatment) is often thought unethical. For 
example, a non-random study suggested that multivitamin supplementation during 
pregnancy could prevent neural tube defects in children. Even though the study was 
seriously flawed, ethics committees were unwilling to deprive patients of this potentially 
useful treatment, making it difficult to carry out the trial which later showed that folic acid 
was the effective part of the multivitamin cocktail. 
Thus, these randomized trials should only be undertaken if there is an important question 
which needs to be answered by the physician and other small scale observational or 
analytical studies justify its conduction. 
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4. Justification of your trial: Ask two keys questions 
A simple way of knowing if you should go through the trouble of conducting the 
randomized trial is to ask yourself these two simple questions: 
4.1. Is the intervention well enough developed to permit evaluation? 
This can be especially difficult to decide when new interventions are heavily dependent on 
clinicians’ skills (surgical procedures7 or “talk” therapies). 
4.2. Is there preliminary evidence that the intervention is likely to be beneficial (from 
observational studies), including some appreciation of the size of the likely treatment effect?  
Such information is needed to estimate sample sizes and justify the expense of a trial. 
However, there is another side of the story. Failure to perform these important trials which 
should have been conducted may sometimes result in harmful treatments being used 
continuously without validation and evaluation. For example, neonates were widely treated 
with high concentrations of oxygen until randomized trials identified oxygen as a risk factor 
for retinopathy of prematurity. 
Other study designs, including non-randomised controlled trials, can detect associations 
between an intervention and an outcome. But they cannot rule out the possibility that the 
association was caused by a third factor linked to both intervention and outcome. Double 
blinding ensures that the preconceived views of subjects and clinicians cannot 
systematically bias the assessment of outcomes.   
5. History of randomised controlled trials 
Daniel Judah has been thought to have conducted the first and earliest recorded clinical trial 
which dates back to approximately 600 B.C. He compared the health effects of the 
vegetarian diet with those of a royal Babylonian diet over a 10-day period. The trial was 
obviously not even close to the current modern standards set for trials and was majorly 
flawed with allocation bias, ascertainment bias, and confounding by divine intervention, but 
the report has influenced medical decision for now over two millennia. 
The 19th century saw a steep development curve in the history of clinical trials. In 1836, the 
editor of the American Journal of Medical Sciences wrote an introduction to an article that he 
considered “one of the most important medical works of the present century, marking the 
start of a new era of science,” and stated that the article was “the first formal exposition of 
the results of the only true method of investigation in regard to the therapeutic value of 
remedial agents.” This article was the French study on bloodletting in treatment of 
pneumonia by P. C. A. Louis. Sir Austin Bradford Hill takes all the credit for the modern 
concepts of randomization trials. The Medical Research Council trials on streptomycin for 
pulmonary tuberculosis are rightly regarded as a landmark that ushered in a new era of 
medicine. Since Hill’s pioneering achievement, the methodology of the randomized 
controlled trial has been increasingly accepted and the number of randomized controlled 
trials reported has grown exponentially. The Cochrane Library already lists more than 
150,000 such trials, and they have become the underlying basis for what is currently called 
“evidence-based medicine”  
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6. Evidence supporting randomised trials 
Enough evidence exists that a successful RCT is one which is well-designed. These RCTs are 
superior to other study designs in estimating an intervention’s true effect. Meta-analysis of 
controlled trials shows that failure to conceal random allocation and the absence of double 
blinding yield exaggerated estimates of treatment effects. 
It is also well known that well-matched comparison-group designs may be a good 
alternative when an RCT is not feasible.  
7. Issues in designing and conducting RCTs 
As, mentioned before RCTs are conducted to evaluate the importance of an intervention of 
any sorts. They can be used to understand the effectiveness of a screening test or the effect of 
any surgical or medical intervention by comparing the outcomes like mortality or disease 
recurrence. 
Let’s discuss several important issues in designing and conducting of RCTs. 
7.1 Inclusion and exclusion criteria 
In all study types the researchers need to define their target population and the criteria for 
inclusion and exclusion of every individual in the study. This forms an important aspect of 
the trial which needs to be decided before starting the trial. 
Accurate definition of the study population in RCTs is extremely important and some key 
pointers are: 
7.1.1. In RCTs, the researcher needs to make an intervention on the study population and it 
is required that these candidates in the study are eligible for receiving the intervention 
according to the current guidelines.  
7.1.2. If the intervention is contraindicated in a population, then that population meets the 
exclusion criteria of the study target. 
7.1.3. Sometimes it is difficult to assess the effect of an intervention in a large population 
because that needs a large sample size. So the researcher intervenes on a specific portion of 
the population (for example a specific sex or age group). 
7.1.4. Case selection bias is one of the most important bias in RCTs which can be prevented 
by using appropriate inclusion and exclusion criteria.  
Sometimes, the same criteria can be used as either for inclusion or exclusion from the study. 
For example, a specific drug reaction can serve as both depending on what the researcher 
wants to study. It can be an inclusion criterion if the study is about a particular drug and the 
associated adverse reaction. It can also be an exclusion criterion in case the investigator 
wants to analyze the efficacy of the drug. 
The researchers need to report the exact number of the individuals assessed intending to 
meet the inclusion criteria, the exact number of individuals included in the study after 
fulfilling all inclusion and exclusion criteria, the exact number of individuals excluded from 
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the study at the end along with the reasons for the same. It is useful to note that 
unwillingness of an individual to receive the intervention is an exclusion criterion. 
7.2 Study designs  
All randomized trials usually have similar study design. However, still some differences 
exist. If classified according to the patient exposure and the response to the intervention, the 
following styles exist: 
7.2.1 Parallel design 
This is the most popular design and is based on the comparison of the effects of the 
intervention in the case group with the control group or another intervention group. The 
two groups receive a maximum of one intervention. Normally two parallel groups with 
equal sample size will be selected through a randomized selection. However, at times the 
number of the two groups isn’t equal. It is important that the researcher reports this as well 
as the ratio of the individuals in the two groups at the time of reporting the trial.  
Randomized trials can also be done by involving more than two groups. It is then known as 
a multi-arm parallel RCT. 
7.2.2 Cross-over design 
Each participant receives all the interventions involved in the trial. The sequential order in 
which they receive them is decided randomly. This study design however should be limited 
to stable chronic conditions where the disease profile doesn’t fluctuate over time as well as 
short interventions. Also a key concern in these trials is the adequate washout period 
between the two therapies in order to avoid the carry-on effect. 
7.2.3 Factorial design 
This is a complex design where more answers can be found in a single trial. The two or more 
interventions are compared between themselves as well as a control group. Since RCTs are 
expensive to conduct, it’s better that we get more answers in a single trial. 
Due to such differences, it is important that the study design is described in detail at the 
time of reporting the trial. This helps the reader a much better understanding of the research 
conducted. All the study designs must be considered and the best one chosen at the time of 
designing one’s RCT. 
Usually the study design is fixed once the protocol is submitted and the researchers don’t 
change it till end of the study. However, sometimes there is need to modify the study due to 
various reasons. It is important that researchers explain the cause of the same and also the 
outline the changes in the RCT design in detail. 
7.3 Intervention 
One of the most important issues in RCTs is the intervention. Researchers need to answer 
several questions about this aspect before even starting their trial. 
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expensive to conduct, it’s better that we get more answers in a single trial. 
Due to such differences, it is important that the study design is described in detail at the 
time of reporting the trial. This helps the reader a much better understanding of the research 
conducted. All the study designs must be considered and the best one chosen at the time of 
designing one’s RCT. 
Usually the study design is fixed once the protocol is submitted and the researchers don’t 
change it till end of the study. However, sometimes there is need to modify the study due to 
various reasons. It is important that researchers explain the cause of the same and also the 
outline the changes in the RCT design in detail. 
7.3 Intervention 
One of the most important issues in RCTs is the intervention. Researchers need to answer 
several questions about this aspect before even starting their trial. 
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An intervention can be a drug or device. It can be used for prevention or treatment. For 
drugs it is important to carefully determine the dosage, timing, duration and administration 
route. All information about the drug needs to be provided to the reader at the time of 
reporting. Even the manufacturer of the drug or device can be mentioned for the sake of 
complete reporting and easy reproducibility of the trial if required. 
Even very small differences either in the type, dosage, duration or the route of 
administration may lead to a significant difference in the outcomes. The intervention should 
be obvious in order to give the possibility of comparison to other study to the researchers as 
well as a chance to reproduce the results if required.  
7.4 Outcome/ Results 
Probably the most important think we are looking for in a randomized trial article are the 
outcomes or the results. These can be divided into primary and secondary outcomes. They 
should have been determined before even starting the study.  
Primary outcome is the main intervention outcome. Other study outcomes aer put in the 
category of secondary outcomes. For example the drug side effects are usually put in that 
category.  
Another important issue in the outcomes is the ‘measures’ used to measure these outcomes. 
The outcomes may be laboratory test results. For these outcomes, it is important to list the 
methodology for the measurement, kits used for the same as well as the manufacturer 
where they are produced.  
Other type of outcome is the clinical outcome. For this, it is important to mention the 
guidelines used by the researcher for the determination of the variable as well as the name 
of that person (e.g. General physician, specialists or medical students). 
It is recommended that before selection of the primary and secondary outcomes the 
researchers reviews the literature thoroughly and chooses the similar outcomes in similar 
studies. This is important for comparing the results of the evidence already out there with 
their study. 
An advantage of designing a trial with clearly pre-determined inclusion criteria/exclusion 
criteria, intervention and outcomes which are similar to other studies, is the possibility of 
collecting these data to form a meta-analysis which gives us even more clarity and 
consolidates all the evidence to give a final conclusion. 
7.5 Sample size  
A small sample size is unable to show all differences between case and control group. As 
we mentioned before, the effects are usually small and thus, we need to demonstrate large 
results to show sizable difference and this is why we need a large sample size. However, 
large sample sizes need more time and budget. There are also issues with recruitment and 
reaching out to large populations. Sample size should be determined after a thorough 
literature review and full access to previous studies in populations similar to the current 
study and also after determination of the power of the study. The sample size is the 
answer to the power of the study and simply answers the question: how many 
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participants are needed in order to show the difference in a particular outcome in a 
certain statistical significance? 
Sample size should be determined using sample size calculator software or the standard 
formula. It is recommended to consult a statistician for calculation of the study sample 
size. 
7.6 Randomization 
Randomization is what gives the RCTs its strength. In RCTs patients are randomly assigned 
into the two or more study groups and each individual has an equal chance to be assigned 
to any group. The clinician, the investigators or the patient have no choice in the allocation. 
This prevents the selection bias. Random allocation ensures no systematic differences 
between intervention groups in factors, known and unknown, that may affect outcome. No 
other study design allows this kind of a balance. It is crucial that the investigators pre define 
the allocation guidelines and stick by it till the end of the trial. It is extremely important that 
the guidelines are not modified at any point in the trial. Randomization can be done in 
several different methods. 
The easiest method to do randomization of the sample is ‘simple randomization’. In this 
method, individuals are assigned equally to the groups using a random process, for example, a 
computer generated list of random numbers. Other methods like blocked randomization and 
stratified randomization are more complex, less common and are usually used for very 
specific trials. Blocked randomization aims to numerical balance between groups and stratified 
randomization aims to balance characteristics between the groups. 
7.7 Blinding 
Blinding means that the person is not aware of what group he/she is in and what treatment 
or placebo he/she is receiving. According to the various levels of blinding like blinding the 
participants, researchers, outcome assessors and statisticians, RCTs are divided into four 
types: open label, single blinded, double blinded and triple blinded RCTs. Due to confusions 
and discrepancies about who exactly was blinded in the single and double and triple 
blinded studies, The 2010 CONSORT guidelines specify that authors should not use these 
terms. It is required to report the details of the blinding like "If done, who was blinded after 
assignment to interventions (for example, participants, care providers, those assessing 
outcomes) and how." 
Blinding obviously helps to prevent personal bias in the study which is a huge concern in 
conducting a RCT. Every effort should be made to reduce any bias as much as possible. In 
case the study population is neonates, researchers may decide not to use blinding because of 
the differences in interventions like oral or IV feeds. The most prevalent type of blinding is 
the double blinded design where the investigator and the patient are both unaware of the 
details of who is in which group. 
7.8 Statistical analysis 
The most common statistical tests used for all type of papers are descriptive. These tests 
include mean and standard deviation for quantitative variables and frequency and 
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percentage for qualitative variables. They also use Chi-square test or Exact fisher test for 
comparison and the T tests are also commonly used. Other descriptive statistical tests are 
less commonly used. However, researchers may need other statistical tests for subgroup 
analysis and adjusted analysis. 
Two main ways to analyze RCTs are per protocol analysis and intent to treat analysis. In per 
protocol analysis, analysis will be done based on the groups which the patients are assigned 
into, but in intent to treat analysis the analysis is based on receiving treatment or not. 
Some RCTs need large sample sizes and may continue for a long time. The researchers may 
decide to cease the study if significant difference was observed in important study 
outcomes. For example if a specific drug be associated with significant increase in a side 
effect, then the study should be stopped. Also if a significant improvement be observed 
during the study, the researchers can stop the study. To reach this aim interim analysis can 
be done. But the number of interim analysis, the time, the individuals who will do it and the 
conditions in which the study will stop should be clear. 
8. Clinical trial registry 
All RCTs need to be registered in international clinical trial registry databases before starting 
enrolment of study participants. Once the researchers register their clinical trial in a clinical 
trial registry database they will receive a unique trial registry number. 
Almost all medical journals request their authors mention their trial registry number in the 
abstract of their paper. The editors of these journals avoid publication of RCTs without trial 
registry number even if they have high quality in study design and writing. 
According to the registry database where the researchers register their clinical trial, detailed 
information about the trial is needed by them. 
This information includes: Title, purpose, condition which the study is studying in detail, 
type, name and dosage and all other information about the intervention, study type, 
allocation, endpoints and outcomes, intervention model, masking (Blinding), the number of 
patient enrolled in the study, study start and completion dates, inclusion and exclusion 
criteria etc. 
RCT registration has several benefits. They are a good source of previous trials and it is 
possible to search and reach the content of the registered RCTs easily. 
During the registration the researchers needs to review all important issues in the study 
design and methodology of the research. This helps them to reduce bias in their design and 
consider all aspect of the RCT design. 
All RCTs need to obtain the ethics approval of the committee of the institute or the hospital 
where they want to conduct the trial. This practice will guarantee that all the RCTs 
published in the top-notch high impact medical journals are validated and ethically correct. 
The International Clinical Trial Registry Platform (ICTRP) has introduced ten primary 
registries in its registry network which can register the clinical trial with their profile and the 
link to their website 
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 Australasian New Zealand Clinical Trial Registry 
 Brazilian Clinical Trial Registry 
 Chinese Clinical Trial Registry 
 Clinical Research Information Service (CRIS) , Republic of Korea 
 Clinical Trial Registry – India 
 Cuban Public Registry of Clinical Trials 
 EU Clinical Trial Registry 
 German Clinical Trial Registry 
 Iranian Registry of Clinical Trials 
 Japan Primary Registries Network 
9. Summary 
Randomised controlled trials are the most rigorous way of determining whether a cause-
effect relation exists between treatment and outcome and for assessing the cost effectiveness 
of a treatment. Some key pointers at a glance are: 
9.1. Random allocation to intervention groups 
9.2. Patients and trialists should remain unaware of which treatment was given until the 
study is completed-although such double blind studies are not always feasible or 
appropriate 
9.3. All intervention groups are treated identically except for the experimental treatment 
9.4. Patients are normally analysed within the group to which they were allocated, 
irrespective of whether they experienced the intended intervention (intention to treat 
analysis) 
9.5. The analysis is focused on estimating the size of the difference in predefined outcomes 
between intervention groups. 
Given that poor design may lead to biased outcomes, investigators should strive for 
methodological rigour and report their work in enough detail for others to assess its 
quality. 
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1. Introduction 
Because few would object to evidence-based medicine’s (EBM) principal task of basing 
medical decisionmaking on the most judicious and up-to-date evidence, the debate over this 
prolific movement may seem puzzling. Who, one may ask, could be against evidence (Carr-
Hill, 2006)? Yet this question belies the sophistication of the evidence-based movement. This 
chapter presents the evidence-based approach as a socio-medical phenomenon and seeks to 
explain and negotiate the points of disagreement between supporters and detractors. This is 
done by casting EBM as more than the simple application of research findings to clinical 
care and improved health outcomes, but rather an umbrella term that harnesses a specific 
set of pedagogical objectives (some rather radical) under a name that makes it difficult to 
argue against.  
EBM is most popularly defined as the “conscientious and judicious use of current best 
evidence in the healthcare of individuals and populations” (Sackett et al., 1996b). EBM’s 
influential doctrine first appeared in the Journal of the American Medical Association as a brief 
polemic authored by the Evidence Based Medicine Working Group: 
A new paradigm for medical practice is emerging. Evidence based medicine de-emphasizes 
intuition, unsystematic clinical experience, and pathophysiologic rationale as sufficient grounds 
for clinical decision-making and stresses the examination of evidence from clinical research. 
EBM requires new skills of the physician, including efficient literature searching and the 
application of the formal rules of evidence (Evidence Based Medicine Working Group 
[EBMWG], 1992). 
EBM rose quickly into prominence in medicine, with virtually every area of healthcare now 
subscribing to the evidence based mantra. This is a considerable feat for a discipline that is 
described in the EBM manifesto as largely reliant on conventions and habits of thought and 
practice. 
Yet amidst the hubris, there is a sort of obviousness to EBM that has prompted critics to 
charge EBM with offering “nothing new” (Benitez-Bribiesca, 1999): 
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“Evidence based medicine,” one chemist said to me, “What other kind of medicine could there 
possibly be?” and a consultant physician said gruffly: “We have always practiced evidence based 
medicine” (Hope, 1995).1 
The EBM pioneers equivocated on the movement’s innovation and conservatism. It was 
described as both a “new paradigm” (EBMWG, 1992) and a historically-supported approach 
“whose philosophical origins extend back to mid-19th century Paris and earlier” (Sackett et 
al., 1996b). Yet it will be demonstrated in this chapter that although EBM is not best 
understood as a new “paradigm” or a radical departure from biomedicine, it offers 
methodological innovation that has shifted how we pursue, collect, and evaluate medical 
knowledge. 
Beginning with a historical account of the origins of EBM, a focus on three key 
methodological innovations employed by EBM will be used to advance the argument that 
EBM’s original contribution to medicine, or what separates EBM from other approaches, is 
the priority it gives to certain forms of evidence, specifically evidence from randomized 
controlled trials. EBM offers a shift in the sort of evidence that is most highly valued for 
diagnosis, therapy, and prognosis questions, as heavy emphasis is placed on experimental 
controls and quantified measures, thus diminishing the previous status of clinical 
experience and observational studies significantly. This commitment represents not only 
methodological change, but also a novel regard of the reliability of various forms of medical 
knowledge. EBM offers a new answer to medicine’s fundamental normative question: how 
ought we to practice medicine? 
2. The origins of evidence-based medicine 
The origins of the evidence-based medicine movement are traceable back to a series of 
lectures given by epidemiologist Archie Cochrane in the early 1970s, where he argued that 
many popularly used medical practices were of unknown or questionable safety and 
efficacy (Ashcroft, 2004). In these lectures, which were later compiled in Effectiveness and 
Efficiency: Random Reflections on Health Services (Cochrane, 1972), he detailed the injury, 
waste, and failure to improve care that ensued from widespread acceptance and use of 
unestablished medical interventions. He maintained that treatments should be evaluated 
using unbiased methods like the randomized controlled trial, and that health care 
professionals should regularly update their knowledge base (Ashcroft, 2004). Aschcroft has 
noted the strong ethical imperative behind Cochrane’s recommendations, as they were 
rooted in concern to do no harm, to do one’s best for one’s patients, and to do so justly by 
eliminating waste (Ashcroft, 2004).  
Cochrane’s programmatic outline was revitalized in 1990 by a group of professors of clinical 
epidemiology, medical informatics, and biostatistics at McMaster University in Canada, 
who called themselves the “Evidence Based Medicine Working Group”. They introduced 
the phrase “Evidence Based Medicine” in a ubiquitous 1992 manifesto as a “new paradigm” 
in medical education and practice (EBMWG, 1992). In the document, the ethical promise 
was made that the virtuous clinician “whose practice is based on an understanding of the 
                                                 
1 Hope is a supporter of EBM who maintains that one sign of a movement being important is when its 
detractors indignantly maintain that it is nothing new.  
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underlying evidence will provide superior patient care” (EBMWG, 1992). While the ethical 
imperative to improve patient care remained central, the promise to decrease medical 
uncertainty by systematic evaluation of the efficacy of current practices was particularly 
appealing to health care administrators and policy analysts facing a crisis situation with 
respect to escalating healthcare costs and spending. Added to the gamut of methodologies 
for data collection and analysis first recommended by Cochrane was the use of emerging 
information technologies to synthesize the large quantities of published studies, proliferate 
information, and increase accessibility. The combined picture of EBM as ethically driven to 
improve patient care, fiscally responsible, and technologically up-to-date likely drove the 
rapid integration of the movement into medicine, where just over twenty years since the 
Evidence Based Medicine Working Group formed, EBM is now common parlance within 
health care. Academic centres and journals dedicated to EBM’s advancement have been 
established with much fanfare, and the evidence-based movement has stretched beyond the 
health sciences to business management (Kovner et al., 2000; Kovner & Rundall, 2006), 
public health (McGuire, 2005), speech pathology (Reilly et al., 2004), occupational therapy 
(Von Zweck, 1999) social work (Cournoyer, 2004; Howard et al., 2003; Grinnell & Unrau, 
2010), education (Council for Exceptional Children, 2011; Horner et al., 2005; Slavin, 2002), 
and other social science disciplines. It is even generating attention as a promising new 
approach to bioethics (“evidence-based ethics”) (Roberts, 2000; Strech, 2008; the rare 
criticism is found in Goldenberg, 2005). The term “evidence-based everything” has been 
used to describe the enthusiasm for this movement (Mykhalovskiy & Weir, 2004). 
3. What’s new about EBM?  
Despite the fanfare, it is not immediately obvious that EBM offers something new to medical 
practice. In response to EBM’s demand that medical decisions ought to be based on 
stringent empirical evidence, critics ask, hasn’t modern medicine always been evidence-
based? Quite surely, by being founded on natural science, biomedicine has always been 
grounded in the empirical sciences, which bases its claims on observational evidence. 
The critics are correct to think that EBM’s empirical commitments are not new to medicine’s 
ideal practices (regardless of whether or not they are actually practiced). However, 
proponents have denied the charge that EBM is “old hat” (Sackett et al., 1996b), and have 
even been grandiose in their descriptions of EBM as being a “new paradigm” promising to 
“revolutionize” medicine (EBMWG, 1992). This description suggests the evidence based 
approach to offer something radically different from previous approaches, and so it is worth 
investigating this alleged paradigm change.  
3.1 Is EBM a new paradigm? 
To illustrate the unique workings of EBM, the new paradigm of medicine, the Evidence 
Based Medicine Working Group presented the following clinical scenario: 
A junior medical resident working in a teaching hospital admits a 43-year old previously well 
man who experiences a witnessed grand mal seizure. He had never had a seizure before and had 
not had any recent head trauma…Findings on physical examination are normal. The patient is 
given a loading dose of phenytoin intravenously and the drug is continued orally. A computed 
tomographic head scan is completely normal, and an electroencephalogram shows only non-
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“Evidence based medicine,” one chemist said to me, “What other kind of medicine could there 
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1 Hope is a supporter of EBM who maintains that one sign of a movement being important is when its 
detractors indignantly maintain that it is nothing new.  
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specific findings. The patient is very concerned about his risk of seizure recurrence. How might 
the resident proceed (EBMWG, 1992)? 
The Working Group explain that the resident practicing “the way of the past” (pre-EBM) would 
consult the senior resident, who, supported in his view by the attending physician, informs her 
that the risk of seizure recurrence is high, although its precise risk factor is unknown to him. 
He instructs the resident to relay this information and the related precautions to the patient. 
The resident does as she is told and the patient, still fearful, is discharged (EBMWG, 1992). In 
“the way of the future”, however, the EBM-trained resident asks herself whether she knows the 
prognosis of a first seizure and, realizing that she does not, proceeds to the library and 
conducts a literature search on the Grateful Med (now PubMed) search engine. Her search on 
the medical subject headings “epilepsy”, “prognosis”, and “recurrence” retrieves twenty-five 
titles, of which one is deemed by the resident to be directly relevant. Exercising the critical 
appraisal skills that she learned in medical school, she reviews the paper, deems the study and 
its conclusions to be valid, and returns to her patient after only thirty minutes. She conveys the 
risk of recurrence over time post-incident, and recommends follow-up with his family 
physician. The patient leaves “with a clear idea of his likely prognosis” (EBMWG, 1992). 
In their comparative analysis of EBM and its biomedical predecessor, Sehon and Stanley 
argue that the EBM programmatic literature’s likening of its approach to a Kuhnian 
paradigm shift is a gross exaggeration (Sehon & Stanley, 2003). The authors contend that 
EBM is not a new paradigm because Kuhn described such a large-scale scientific revolution 
as involving dramatic changes of worldview and even a different world in which scientists 
must operate (Kuhn, 1996). A Kuhnian paradigm is an “entire constellation of beliefs, 
values, techniques, and so on shared by the members of a given community” (Kuhn, 1996). 
The new paradigm will be incommensurable, to some extent, with the previous paradigm, a 
condition that is not met with the evidence based approach in comparison to biomedicine’s 
“basic science approach”, which involves “studying the physiological mechanisms of the 
body and the biochemical properties of drugs” (Sehon & Stanley, 2003).  
When EBM is suggested to be a new paradigm, this fosters the impression that an entire set 
of beliefs, values, and techniques are being discarded, “and that the whole world of medical 
research and clinical practice is completely different than it was in the days before EBM” 
(Sehon & Stanley, 2003). This impression is certainly false. Furthermore, the language of 
paradigms suggests that health care practitioners must make a “stark choice” between EBM 
and “traditional” biomedicine, where one can “accept the new regime and completely reject 
the old, or defensively hold onto the old and dismiss EBM entirely” (Sehon & Stanley, 2003). 
Aside from not being a productive atmosphere in which to hold a critical debate about EBM, 
this polarization exaggerates the merits, demerits, and differences between EBM and its 
biomedical “predecessor”. 
Numerous commentators have characterized the EBM debate as dredging up the hoary “art 
versus science” dispute regarding the nature of modern clinical medicine. The critics worry 
that EBM overemphasizes the latter at the expense of the former. Sullivan and 
MacNaughton, for example, comment that  
the doctor does not deal with illnesses alone but with people who are ill, and for each individual 
the illness is unique in terms of his or her experience of it and in its presentation to the doctor 
(Sullivan & MacNaughton, 1996). 
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Understanding the unique circumstances of the individual case is thought to involve a form of 
practical knowledge or judgment quite different from the technical knowledge offered by EBM. 
The “grey zones” of practice (Naylor, 1995), that is, areas where the evidence from randomized 
trials about risk-benefit ratios of competing clinical options is incomplete, inconclusive, or 
contradictory and so clinical judgment must be relied on,2 are repeatedly argued to be missing 
from EBM’s formulaic knowledge base (Tanenbaum, 1993). Indeed, EBM struggles to account 
for the interpretive dimensions of clinical care, as evidence-based decisionmaking is largely an 
effort to standardize and rationalize the application of evidence to clinical care. It is no wonder 
that critics fail to be persuaded by EBM’s conciliatory efforts, such as making the first principle 
of EBM “evidence is never enough” in the authoritative Users’ Guides to the Medical Literature 
textbook (Guyatt & Rennie, 2002). It is also worth asking: if evidence is not the fundamental 
base of medicine, are we still practicing evidence based medicine? 
In light of these grey zones, EBM is charged with creating and sustaining the idea that 
evidence and practice are opposing concepts (Pope 2003; Wood et al., 1998). Other dualisms 
reinforced in the EBM literature include technical vs. experiential/intuitive knowledge, 
empirical vs. theoretical knowledge, evidence based vs. patient-centred care, and, of course, 
EBM vs. its biomedical predecessor, which is inappropriately referred to as “traditional 
medicine”.3 Adherence to these artificial bifurcations seems to misdirect the EBM debate, as 
they promote undue polarization between EBM and its biomedical alternatives. For 
instance, the references to pre-EBM as “traditional medicine” in some of the early EBM 
programmatic literature (EBMWG, 1992; Sackett et al, 1996b) is an obvious misnomer, as the 
term typically refers to folk and alternative healing practices. The selection of this 
inappropriate term was presumably deliberate, as it permitted the EBM originators to 
emphasize what they alleged to be the widespread tendency of clinical medicine to operate 
without sufficient evidentiary support to establish the efficacy of their practices. Pre-EBM 
biomedicine was therefore “traditional” insofar as it is unscientific or at least insufficiently 
scientific. Some support for this claim has been found in the phenomenon of small area 
variations of healthcare practice among different geographical regions (Parchman, 1995). 
However invoking “traditional medicine” is polemical (and distracting) in its 
misrepresentation of biomedicine, as it cannot account for biomedicine’s modern scientific 
framework, its significant technological advances and achievements, and, of course, EBM’s 
ties to the biomedical tradition. 
Despite not invoking revolution (or comparable large-scale upheaval) in medical practice, it 
will now be demonstrated that EBM brings something new to medicine. The critics who 
deny this claim likely do so because they misunderstand EBM to be asking for no more than 
rigorous empirical research in medicine. But the term “evidence based” amounts to much 
more. While the evidence based approach certainly does call for rigorous empirical research 
in medicine, this call is accompanied by novel accounts of what counts as valid evidence 
                                                 
2 Among the procedures cited by Naylor to be in the “grey zone” are: carotid endarterectomy, upper 
gastrointestinal (GI) endoscopy, hysterectomy, and percutaneous transluminal coronary angioplasty. 
Randomized controlled trials have been done in these areas, but the results have not produced 
unequivocal conclusions. 
3 Accompanying these imposed bifurcations are, of course, efforts at integration, such as “evidence-
based patient centred care” (Borgmeyer, 2005), and “evidence-based patient choice” (Hope, 1996; 
Edwards & Elwyn, 2001; Parker, 2001). The literature also includes an effort to overcome (or possibly 
deny) the evidence/judgment divide (Downie et al., 2000). 
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and what qualifies as the most rigorous methods of empirical research. Rather than a 
revolution or paradigm change, EBM represents an important shift in biomedical thinking 
and practice that is a significant alternative to its biomedical predecessor. Specifically, EBM 
offers a shift in the sort of evidence that is most highly valued for diagnostics, prognostics, 
and therapeutics, in its emphasis on experimental controls and quantitative research, which 
undermines previous regard of clinical experience and observational studies significantly 
(Sehon & Stanley, 2003). At minimum, this shift is signified by a change from a medical 
model grounded in basic science to a novel statistically-based medicine (Henry, 2006). 
EBM’s hierarchy of evidence is at the service of outcomes research, which uses a cluster of 
statistical and epidemiological methods for analyzing the therapeutic effectiveness of 
clinical interventions (Gifford, 1996). This commitment to highly controlled data and 
methods of statistical analysis that were previously used only for population-based research 
(such as public health) represents not only methodological change, but also a novel regard 
of the reliability of various forms of medical knowledge.  
4. The novel contents of EBM 
The unique content offered to medicine by EBM remains difficult for many to grasp. Hardly 
anyone can disagree with the goal of getting clinicians to make “conscientious, explicit, and 
judicious use of current best evidence” for decisions in patient care. Any expressions of 
doubt about EBM activities are usually greeted with vigorous accusations of disregarding 
“today’s harsh realities”, or ignoring “what happens in clinical medicine” (Sackett et al., 
1996a). Furthermore, critics are frequently denounced for erroneous beliefs that EBM only 
uses evidence from randomized controlled trials, that it involves “merely the mindless 
application of the results of megatrials”, and that “other forms of evidence are heavily 
discounted” (Rosenberg & Donald, 1995). Feinstein and Horwitz have wisely suggested that 
much of the confusion surrounding what EBM actually stands for lies in the distinction 
between the contents of EBM itself and its application in clinical practice. It is only when this 
distinction is blurred that many clinicians claim EBM to offer “nothing new” (Feinstein & 
Horwitz, 1997). Many practitioners have seen little novelty in EBM because they regularly 
assemble evidence, develop clinical judgment, read medical literature, attend medical 
meetings, and have discussions with one another. These activities seem entirely compatible 
with the statement that the practice of EBM consists of “integrating individual clinical 
expertise with the best available external clinical evidence from systematic research” 
(Sackett et al., 1996b). The activities surrounding the practice of EBM also seems fairly 
standard, as the data informing evidence-based practice “is not restricted to randomized 
trials and meta-analyses” (Sackett et al., 1996b). It contains “clinically relevant research, 
often from the basic sciences of medicine” and it includes studies of diagnostic tests, 
prognostic markers, and “the efficacy and safety of the therapeutic, rehabilitative and 
preventive regimes” (Sackett et al., 1996b). With this description of what is done when EBM 
is practiced and with the overt acknowledgement by the EBM originators that EBM is rooted 
in the medical thought of mid-nineteenth century France, specifically “the call for external 
evidence expressed in Paris 150 years ago by Louis, Bichat and Magendie” (Sackett et al., 
1997), clinicians can easily conclude that EBM is not particularly novel, and may wonder 
why it has stirred so much fuss and controversy (Feinstein & Horwitz, 1997). 
The novelty lies, however, in the organization and privileging of information. While a wide 
range of evidentiary sources are permitted in evidence-based practice, the evidence 
collected for EBM itself is confined almost exclusively to RCTs and meta-analyses of those 
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trials. The RCT is consistently ranked at the top of the hierarchy of evidence, thus 
confirming the former’s privileged position (Feinstein & Horwitz, 1997). For instance, 
Sackett et al. maintain that for questions of therapy,  
we should try to avoid the nonexperimental approaches, since they routinely lead to false-positive 
conclusions about efficacy…The randomized trial, and especially the systematic review of several 
randomized trials…has become the “gold standard” (Sackett et al, 1996b, as cited in Feinstein & 
Horwitz, 1997).  
The analysis in the next three sections will further examine the novel contents of EBM 
captured in its methodological privileging of (1) the hierarchy of evidence, (2) the 
randomized controlled trial, and (3) outcomes measures.  
4.1 The hierarchy of evidence 
The hierarchy of evidence captures EBM’s basic methodological and epistemic commitments 
in a fairly straightforward ranking of methods. EBM proponents strongly hold that the 
trustworthiness or validity of evidence is a function of the design of the study from which 
the evidence is obtained (Sackett, 1989, 1997; Sackett et al., 1991; Solomon & McLeod, with 
the Canadian Task Force on the Periodic Health Examination, 1994), and so the desire to use 
only the “best evidence from clinical research” in the management of individual patients 
(Sackett et al, 1996b, 1997) has resulted in intricate classificatory schemes for ranking the 
value of different types of studies. Among the numerous published formulations, there is a 
consistent placement of randomized controlled trials or the systematic review of these trials 
at the top, retrospective studies well down the list, and clinical anecdotes are seen as 
providing little if any evidence for the value of intervention (see Fig. 1).  
A Hierarchy of Strength of Evidence for Treatment Decisions 
 N of 1 randomized controlled trial 
 Systematic reviews of randomized controlled trials 
 Single randomized trial 
 Systematic review of observational studies addressing patient-important outcomes 
 Single observational study addressing patient-important outcomes 
  Physiologic studies (studies addressing blood pressure, cardiac output, exercise 
capacity, bone density, and so forth) 
  Unsystematic clinical observations 
Fig. 1. Users’ Guide to Medical Literature hierarchy of evidence (Rennie & Guyatt, 2002) 
While EBM has evolved over time, most notably in its self-regard from a (polemical) “new 
paradigm” to a more tempered technique for clinicians to manage vast quantities of 
research information (for example, Haynes, 2002), the core belief that evidence belongs in 
fixed hierarchical order with the systematic review of randomized controlled trials always 
on top remains unshaken (Upshur et al., 2001). In the evaluation of treatment effects, for 
example, a large, well-designed, randomized trial is considered more reliable than those 
findings from non-randomized prospective or retrospective studies (Sackett, 1997). 
Similar schemes have been developed for the ranking of evidence in other clinical 
categories such as prognosis, aetiology, and diagnosis (Centre for Evidence-Based 
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trials. The RCT is consistently ranked at the top of the hierarchy of evidence, thus 
confirming the former’s privileged position (Feinstein & Horwitz, 1997). For instance, 
Sackett et al. maintain that for questions of therapy,  
we should try to avoid the nonexperimental approaches, since they routinely lead to false-positive 
conclusions about efficacy…The randomized trial, and especially the systematic review of several 
randomized trials…has become the “gold standard” (Sackett et al, 1996b, as cited in Feinstein & 
Horwitz, 1997).  
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randomized controlled trial, and (3) outcomes measures.  
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the evidence is obtained (Sackett, 1989, 1997; Sackett et al., 1991; Solomon & McLeod, with 
the Canadian Task Force on the Periodic Health Examination, 1994), and so the desire to use 
only the “best evidence from clinical research” in the management of individual patients 
(Sackett et al, 1996b, 1997) has resulted in intricate classificatory schemes for ranking the 
value of different types of studies. Among the numerous published formulations, there is a 
consistent placement of randomized controlled trials or the systematic review of these trials 
at the top, retrospective studies well down the list, and clinical anecdotes are seen as 
providing little if any evidence for the value of intervention (see Fig. 1).  
A Hierarchy of Strength of Evidence for Treatment Decisions 
 N of 1 randomized controlled trial 
 Systematic reviews of randomized controlled trials 
 Single randomized trial 
 Systematic review of observational studies addressing patient-important outcomes 
 Single observational study addressing patient-important outcomes 
  Physiologic studies (studies addressing blood pressure, cardiac output, exercise 
capacity, bone density, and so forth) 
  Unsystematic clinical observations 
Fig. 1. Users’ Guide to Medical Literature hierarchy of evidence (Rennie & Guyatt, 2002) 
While EBM has evolved over time, most notably in its self-regard from a (polemical) “new 
paradigm” to a more tempered technique for clinicians to manage vast quantities of 
research information (for example, Haynes, 2002), the core belief that evidence belongs in 
fixed hierarchical order with the systematic review of randomized controlled trials always 
on top remains unshaken (Upshur et al., 2001). In the evaluation of treatment effects, for 
example, a large, well-designed, randomized trial is considered more reliable than those 
findings from non-randomized prospective or retrospective studies (Sackett, 1997). 
Similar schemes have been developed for the ranking of evidence in other clinical 
categories such as prognosis, aetiology, and diagnosis (Centre for Evidence-Based 
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Medicine, 2006; Sackett et al., 1997). At the bottom of each of these clinical scales is 
evidence obtained from case reports and personal experience.  
The logic behind the ranking of evidence is simple: randomization is the best method for 
distinguishing between the effects of active treatment from the effects of known and 
unknown potentially biasing influences (Peto & Baigent, 1988). It follows that we should 
make every effort to identify and catalogue these studies. And this is exactly what is 
happening. EBM proponents initially endorsed the teaching of critical analysis skills in 
medical schools so that physicians could properly assess the quality of a study (EBMWG, 
1992). The hierarchy of evidence is one of the tools used in this task. It was quickly 
realized, however, that more advanced informatics were needed in order for clinicians to 
manage the massive amount of research data available. The Cochrane Collaboration has 
undertaken the monumental task of identifying and evaluating well over a million 
randomized controlled trials (U.S. Cochrane Center, 2002). Systematic reviews and meta-
analyses of randomized trials in specific areas of medicine are now widely available on 
EBM databases and in EBM journals.  
The privileging of “hard” evidence—the quantified data generated by randomized controlled 
trials—over knowledge generated from clinical experience (EBMWG, 1992) and qualitative 
measures (Gray, 1997) speaks to an epistemic distrust of subjective or personal experience, 
which cannot guard against biasing influences. Methodologies like blinding, randomization, 
placebo-control, the use of large subject populations, and replication of results serve to abstract 
from values to reveal empirical facts. Of the types of trials available, clinical trials offer the 
strongest and clearest support for any claim that a treatment is effective because they allow 
scientists to control extraneous variables and test one factor at a time (Schick & Vaughn, 2002). 
The hierarchy of evidence is, by the founders’ own admission, based on levels of certainty, 
where the quantified and the scientific forms of evidence are placed on top because they are 
understood to be most resistant to sceptical refutation (Sackett et al., 1991). 
The central goal behind the EBM movement is quality of care, and this goal serves as the 
grounds for encouraging medical practice that utilizes the latest and best evidence. 
Evidence-based practices, including the ranking of evidence, are thought to enhance 
effective and efficient clinical decision-making. But, critics argue, “effectiveness” need not be 
limited to clinical- or cost-effectiveness. It could also refer to patient-based outcomes 
indicating satisfaction with the treatment provided. The hierarchy prioritizes evidence of 
clinical effectiveness and necessarily excludes subjective perceptions (Malterud, 1995, 2001; 
Rogers 2002). Yet patient narratives and the interpretive features of clinical practice are 
thought by many to be crucial features of quality healthcare (Greenhalgh & Hurwitz, 1998; 
Greenhalgh, 1999; Malterud 2001; Silva et al., 2011). 
4.2 Randomized controlled trials: The “gold standard” of medical research 
The methodological debates that make up the bulk of the EBM literature revolve around the 
general question whether or not the refined focus on clinical evidence (as prioritized in the 
EBM hierarchy of knowledge), or the search for secure knowledge in general, improves our 
ability to decipher best practices and therefore prescribe the most effective treatments. 
Alternatively, the methods may leave out too many important features of clinical care that 
are not readily measurable through evidence-based approaches. This leads to the important 
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further question of whether the randomized controlled trial rightfully deserves the title of 
“gold standard”.  
Regarded as a maverick among his peers, Cochrane strongly promoted the controversial view 
that randomized controlled trials offer the best test for the effects of medical interventions and 
could thereby correct ineffectiveness and even harms perpetrated by contemporary medical 
practice (this was another heretical claim) (Pope, 2003). With time, this view came to be 
accepted and randomized trials became “a yardstick by which other sources of information 
were judged and ranked within a hierarchy of evidence” (Pope, 2003). The introduction of 
randomized trials to medical research has been credited by Iain Chalmers, one of the original 
founders of the Cochrane Collaboration who was knighted in 2000 for his activism in 
cumulating evidence in medical research, and others for revolutionizing therapeutic 
development and increasing the life expectancy of patients from three to seven years over the 
past half century (Chalmers, 1998). When substantial uncertainty exists about treatment 
effects, it is widely thought to be not only scientifically correct to answer it in a study with the 
smallest amount of built-in bias, but also most ethical to expose patients to alternative 
treatment options based on chance only and not upon the biased opinion of a physician 
(Edwards et al., 1998; Frazier & Mosteller, 1995; Freedman, 1997; Lilford & Jackson, 1995).  
Many EBM critics point to the “experiential nature” of medical practice for being not only 
inextricable from but also inappropriately maligned by the evidence based approach 
(Tanenbaum 1993; Williams & Garner, 2002). However, supporters of EBM insist that 
experiential knowledge is worth minimizing because experience allows for the repetition of 
mistakes. EBM proponents point to the data available suggesting human fallibility and bias 
in drawing conclusions based on uncontrolled experience (Dawson & Arkes, 1987; 
MacCoun, 1998). Others argue that investigators with relationships or experience with a 
subject form expectations with respect to treatment outcomes that make them less able to 
produce objective reviews of scientific evidence than non-experts trained in critical appraisal 
of evidence (Oxman & Guyatt, 1993). A logical deductive framework for interpretation of 
evidence is therefore argued to be needed if we are to avoid practicing medicine based on 
uncontrolled experience, which may do more harm than good (Sackett, 1989). The nature of 
research is meant to reduce uncertainty, even if it cannot be completely eliminated. Yet what 
randomized controlled trials gain in experimental certainty (internal validity), they lose in 
applicability to the clinical context (external validity) (Cartwright, 2007). The EBM hierarchy 
indicates a strong presumption in favour of internal validity in experimental design. 
The randomized controlled trial design is better geared for certain kinds of intervention 
questions than others. These trials are ideal for the direct comparison between simple 
treatments such as two single drugs, and so the pronounced “hegemony of the double-blind 
randomized controlled trial” (Charlton, 1991) can both undermine research into the use of 
complex interventions and result in a failure to meet the complex needs of individual 
patients. Regarding the former, the critics worry that because randomized controlled trial 
design is increasingly favoured, and because the expectation to provide “best evidence” of 
effectiveness before implementing interventions is growing, complex interventions are by 
default less likely to be supported over time (DeVries & Lemmens, 2006). As a result, 
behavioural, psychosocial, community based, and multiple-component interventions lose 
out in favour of individual patient-based treatments (Dieppe, 1998; Tallon et al., 2000) and 
resultant public health policy-setting increasingly focuses on individuals rather than on 
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further question of whether the randomized controlled trial rightfully deserves the title of 
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groups (Davey-Smith et al., 2001). Speaking more abstractly, numerous philosophers of 
science deny that there is any universal method in science, randomized trial or otherwise 
(Cartwright, 2007; Urbach, 1993; Worrall, 2002).  
In the arena of individual patient care, critics argue that because EBM guidelines are derived 
from controlled trials of simplified clinical situations using criteria that often exclude other 
complicating serious conditions, the evidence may not be applicable to complex clinical 
situations. The “gold standard” of clinical research is widely thought to have a problem of 
generalizability of its results to individual patient care (Britton et al., 1998; Culpepper & 
Gilbert, 1999; Feinstein & Horwitz, 1997). Even Cochrane recognized that while the RCT can 
measure effectiveness, its results may not be directly replicable in clinical practice (Cochrane, 
1972), and so Dingwall et al. seem correct in their suggestion that Cochrane’s ideas have been 
used somewhat selectively in EBM (Dingwall et al., 1988, as cited in Pope, 2003). The problem 
of generalizability begins with the narrow eligibility criteria for randomized trials, which limit 
conclusions about a treatment’s effectiveness to patients who fulfill those criteria (Feinstein & 
Horwitz, 1997). To demonstrate optimal efficacy, randomized controlled trials often use 
relatively homogenous subject populations (Djulbegovic et al., 2000). Patients excluded from 
such trials can differ substantially from study patients in a variety of ways that could influence 
treatment outcomes (i.e. disease severity, comorbid conditions, gender, race) (Britton et al., 
1998; Tanenbaum, 1995). Furthermore, the time periods covered in clinical trials and the 
measures used to assess outcomes frequently differ from those used to assess the success of a 
therapy in actual practice. In an effort to be efficient, clinical trials typically use the shortest 
time possible for determining valid results, employing surrogate endpoints rather than 
clinically relevant outcomes. Surrogate endpoints are physiological or biochemical markers 
that can be ascertained quickly and taken to be predictive of clinically meaningful endpoints—
such as how a patient feels, functions, or survives—that take much longer to observe. They are 
“surrogate” insofar as they are outcome measures that are not of direct practical importance 
but are believed to reflect outcomes that are clinically relevant. For example, cholesterol 
studies frequently use cholesterol reduction as a surrogate for reduced mortality. Direct 
demonstration of mortality reduction requires lengthy trials using large subject populations, 
while cholesterol reduction is known to be strongly associated with mortality benefits, and can 
be measured easily in smaller numbers of patients. Similarly, blood pressure is not directly 
important to patients but it is often used as an outcome in clinical trials because it is a risk 
factor for stroke and heart attacks (Bandolier, n.d.).  
Yet the requirement that surrogate endpoints reliably predict the overall effect of the clinical 
outcome frequently fails in practice (Fleming & DeMets, 1996). The disease process can 
affect the clinical outcome through several causal pathways that are not mediated by the 
surrogate. Therefore the effect of the intervention on these pathways will be different from 
the effect on the surrogate (Fleming & DeMets, 1996). It is more likely, however, that “the 
intervention affects the clinical outcome by unintended, unanticipated, and unrecognized 
mechanisms of action that operate independently of the disease process” (Fleming & 
DeMets, 1996). Fleming and DeMets argue that surrogate endpoints frequently mislead 
regarding the actual effects that treatments have on health outcomes. For instance, although 
lipid levels are widely seen to be important predictors of cardiovascular-related mortality, 
there is debate over the relationship between lipid lowering and reduction in overall 
mortality. The Coronary Drug Project in the 1970’s showed clofibrate and niacin to decrease 
cholesterol levels, however neither agent reduced total mortality (Fleming & DeMets, 1996). 
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Taken together, the numerous controls utilized to guard against bias and promote efficiency 
in medical research limits the relevancy of, and may even distort, the “best evidence from 
clinical research” in the management of individual patients. While there are differences of 
opinion regarding the challenges posed in making clinical evidence applicable, EBM fails to 
engage significantly with this problem. EBM’s penchant for methodological rigour may be 
at odds with the ad hoc nature of clinical practice. Tanenbaum has suggested that the 
precision of “best evidence” is fundamentally irreconcilable with its clinical relevance, given 
the particularity of patients and the significant improvisational dimensions of clinical 
practice (Tanenbaum, 1995). Shaughnessy et al. refer to this improvisational feature as 
“clinical jazz” (Shaughnessy et al., 1998). The debate over randomized controlled trials 
highlight that the problem of evidence in EBM does not only concern what knowledge is 
missing from the evidence based decisionmaking framework, but also the nature of the 
knowledge that does enter into consideration. 
4.3 Outcomes measures: Clinical effectiveness and the quality movement in medicine 
EBM was introduced to healthcare in the wake of what has been famously described as 
the “third revolution” in health care (Relman, 1988),4 a turn toward assessment and 
accountability in light of escalating health care costs creating a “crisis” situation in health 
care spending throughout the industrialized world. Patients and payers widely 
subscribed to a “waste theory” that described physicians wasting healthcare money on 
poorly performing diagnostics and treatments (Tanenbaum, 1994a). Furthermore, the 
documentation of notable geographical variations in practice that could not be explained 
by local organizational and financial arrangements caused alarm (Clancy & Eisenberg, 
1988). Health care advocates wanted the consistent practice of only the best health care 
interventions. The “best” was determined by the “end results” or “outcomes” of medical 
practice. The urgency with which the public demanded that physicians pay attention to 
medical outcomes led to what soon became known as the “outcomes movement” in health 
policy (Epstein, 1990). Evaluating clinical effectiveness was seen as a fiscally responsible 
means of only financing the most promising therapies and research. EBM facilitated the 
clinical data that outcomes research requires in order to evaluate best practices.  
Outcomes research refers to all activity directed towards the assessment of outcomes, 
analysis of effectiveness, and quality assurance (Epstein, 1990). It uses statistical analysis of 
clinical data to determine associations between particular therapeutic interventions and 
particular results (Tanenbaum, 1994a). Unlike laboratory research which measures definable 
clinical events like lipid lowering or blood pressure, outcomes research can employ patient-
derived endpoints, the outcomes that patients care about (Clancy & Eisenberg, 1988). 
Common themes in outcomes research are: safety, effectiveness, equity, efficiency, 
timeliness, and patient centeredness (Institute of Medicine, 2001). The benefits of outcomes 
research to healthcare include better informed patients and providers, the development of 
clinical guidelines that reflect those assessments, and wiser purchasing of health care 
technologies (Agency for Health Care Research and Quality, n.d.). This move towards 
                                                 
4 Relman later lamented that this “third revolution” was never realized due to lack of government 
initiative by any of the US governmental administrations elected since the 1988 writing of his editorial 
(Relman, 2009).  
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technologies (Agency for Health Care Research and Quality, n.d.). This move towards 
                                                 
4 Relman later lamented that this “third revolution” was never realized due to lack of government 
initiative by any of the US governmental administrations elected since the 1988 writing of his editorial 
(Relman, 2009).  
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accountability is supposed to serve as a rational basis for decision making and, by extension, 
make medical care more efficient. 
The outcomes movement argues for the primacy of probabilistic knowledge derived from 
statistical studies for medical practice and the vigorous adoption of this position within health 
care indicates a radical shift in medical rationality (Tanenbaum, 1994a). Polychronis et al., for 
example, regard the ascendancy of EBM as the triumph of statistics over clinical common 
sense based on deterministic reasoning (Polychronis et al., 1996). Clinical epidemiology, the 
application of epidemiologic and biometric methods to direct patient care (Sackett, 1969), is 
now held by some to be a basic medical science (Sackett et al., 1991). EBM distinguishes itself 
from pre-evidence based biomedicine by its orientation toward outcomes research, while 
biomedicine is more dependent on bench science. Biomedical research employs laboratory 
science that aims to understand the causal relationship between an intervention and a desired 
effect, whereby therapeutic efficacy can then be inferred. EBM seeks to generate probabilistic 
knowledge regarding what is likely to work for whatever reason (Tanenbaum, 1994a). John 
Wennberg, director of the Centre for Evaluative Clinical Science at Dartmouth Medical School, 
regards biomedical science to be at the service of evaluative science in treatment 
decisionmaking. He argues that biomedicine generates new technologies, while evaluative 
science provides the crucial data linking treatments to outcomes (Wennberg, 1992).  
The consistent placement of the randomized controlled trial at the top of the EBM hierarchy of 
evidence is better understood in light of the biomedical versus evidence-based distinction, as 
this research method serves the objectives of outcomes research by appearing to bracket out a 
whole range of scientifically and epistemologically difficult questions about why treatments 
do or not work (Ashcroft, 2002). For instance, rather than determining the properties that 
enable or hinder an intervention’s success, randomized controlled trials establish efficacy by 
comparing the outcomes of the experimental arm with those found in a similar subject 
population receiving a comparator intervention. Eliminating bench science’s focus on 
determining why a treatment works or not through appeal to deeper biological theory has 
certain advantages for healthcare decision-making (Ashcroft 2002; Gifford 1996).5 Definitive 
biological explanation has not always led to safe or beneficial treatment of actual patients. The 
randomized trial “acts as a practical filter permitting the calibration of scientific good ideas 
against clinical reality (however that is constructed)” (Ashcroft, 2002). By comparing two or 
more competing courses of treatment (including placebo), the RCT “offers a technique for 
dispute resolution within medicine: where there is discord, let a trial be” (Ashcroft, 2002). 
Because EBM and outcomes research are closely allied, the concerns regarding the latter are 
similar to those launched against the former. The task of outcomes research, to solve the 
problems of quality and cost that beset the healthcare system and to do so by scientific 
rather than political means, raises the concern about the tenability of value-free measures 
(Goldenberg 2006). Furthermore, Tanenbaum’s account of the “epistemological politics” of 
the US outcomes movement (Tanenbaum, 1994a) brings into question whether this research 
can ever be so benign that it merely informs decision makers and helps them make better 
decisions (Sage, 1994). The championing of probabilistic knowledge to improve clinical 
practice is argued to replace subjective professional judgment with micromanagement by 
insurance companies and government (Tanenbaum 1993, 1995). 
                                                 
5 Of course there are several ways in which “does it work?” can be construed (Ashcroft et al., 1997).   
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While Tanenbaum is accused of pandering to the fears of physicians and other professionals 
who perceive outcomes research to be a threat to autonomous practice (Cangialose, 1994), 
her criticisms are not against outcomes research per se, as she recognizes the usefulness of 
statistical analysis in evaluating medical care. Her target is rather the outcomes movement, 
the “organized effort of one research community and its champions to gain special privilege 
for statistical evidence, to consider it the only true evidence of medical effectiveness, and to 
predicate an accountable health care system on physicians’ adherence to norms of practice 
derived from outcomes studies” (Tanenbaum, 1994b). Similar to EBM, the critics find utility 
in outcomes research for improving patient care, but they question its near-hegemonic 
status in influential health policy and administrative circles.  
5. Conclusion 
While this analysis dampens some of the hubris surrounding the evidence-based movement, 
it highlights the significant methodological innovation that EBM has brought to medicine. 
The evidence based approach is marked by the flourishing relationship that the evaluative 
sciences and informatics, once solely the domain of business and managerial studies, now 
have with medicine. Eliciting EBM’s place within the “quality movement” (Bodenheimer, 
1999) captures a shift in medical rationality and knowledge away from previous 
incarnations of biomedicine by way of EBM’s insistent epistemological privileging of 
standardized information over judgment, quantified measurement over experience, and 
epidemiology over bench science.  
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1. Introduction  
Evidence-based medicine (EBM) is a new paradigm for the health-care system involving 
using the current evidence (results of the medical research studies) in the medical literature 
to provide the best possible care to patients.1 It has encouraged the rapid and transparent 
translation of the latest scientific knowledge in the day to day practice of medical 
professionals. EBM has given new direction in all the fundament responsibilities of medical 
professionals like care of the patient, research, teaching and learning, and public health. 
There is need to move from opinion-based education to evidence-based education. Best 
Evidence Medical Education (BEME) is the implementation of methods and approaches to 
education based on the best evidence available.2 The evidence available may be in a wide 
variety of formats for example: the results of the controlled experimental studies, 
description of case studies, and opinions of experts. Studies alone are not the evidence.3 As 
Hart and Harden have suggested evidence is defined in the American Heritage Dictionary 
of the English Language as a thing or things helpful in forming a conclusion or judgement.4,5 
The current practices in different regions and institutions in the world will be a form of 
evidences to consider. Similarly the available evidences in the clinical medicine, or indeed in 
any other field like airlines industry, need to be correlated with the areas to give focus in the 
medical education. The text is discussed in four sections, viz. planning of medical education 
and the community need and service; training and assessment; teachers’ criteria and 
training; and finally individual’s mistake, system‘s error, health safety and trainees. To 
highlight the key areas of medical education and training requiring attention, the learnings 
are presented in the form of twenty lessons to consider.  
2. Planning of medical education and the community need and service 
2.1 Undergraduate medical education  
Since seventeen century, different curricular models have been considered which have 
catalyzed significant changes in the medical education: the apprenticeship model, the 
discipline-based model, the organ-system-based model, the problem-based-learning model, 
and the clinical-presentation-based model.6 These curricula differ to a varying extent in the 
organization of course content, controllers of content, relationship of clinical to basic 
sciences, organization of concept formation, teaching methods, timing of patient/case, 
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exposure, cognitive skills emphasized, primary learning guides and problem-solving 
model.6 Each has advantages and disadvantages as per the context and mixtures of models 
are used now in the medical education. In developing countries, the departments in general 
tend to control the content of the undergraduate medical education as per the discipline-
based model, but principles of other models are increasingly being applied.  
2.2 Educational strategies  
The focus on the undergraduate medical education in the industrialized countries is 
increasingly on the newer approaches of educational strategy, as opposed to the traditional 
ones. The newer approaches are highlighted by the SPICES model, consisting of Student-
centered, Problem-base, Integrated, Community-based, Electives with a core and 
Systematic.7 These are in contrast to the traditional approaches like Teacher-centered, 
Information gathering, Discipline-based, Hospital-based, Uniform and Apprenticeship. 
These approaches are self-explanatory, as their names indicate, to some extent and need to 
be considered and balanced in their spectrums wherever applicable. The problem-based 
learning approach uses problem-based learning as a vehicle to develop a usable body of 
integrated knowledge and develop problem-solving skills. A student-centered approach 
emphasizes on the student, increases motivation and prepares for continuing education.7 
But teachers, students and staff need to adopt and prepare for it. Various approaches 
depend on the context and situation. However the teaching and learning experiences of 
students should not be left to chance and it should be planned and recorded and assessed in 
a systematic manner. Electives allow students to focus as per their need or choice.  
2.3 Integrated approach 
A number of methods are used to integrate the curriculum, like spiral curriculum and multi-
professional learning.7,8 There is rapid growth of medical colleges in the developing 
countries leading to dearth of teachers in basic science. A few available basic science 
teachers may go to different medical colleges and there is tendency of medical colleges even 
to lure such teachers from other colleges, hampering the teaching of medical students. The 
acute shortage of basic science teachers in the developing countries has also indirectly raised  
the need to widen discipline-based approach to integrate the curriculum in the possible 
ways. The related clinical faculty can undertake the required extra training and then they 
can be certified for the training of students in the related basic science, for example general 
surgeons in anatomy, internist in pharmacology, internist and anesthetist in physiology and 
pathologist in forensic medicine. The teaching by such adjunct clinical faculty will 
automatically expose the students to the clinical implication of the basic science, making it a 
sort of applied basic science. The concerned department may be run by the regular faculty 
and the concerned subject or curriculum committee may be formed by including both the 
regular and well trained certified adjunct faculties. The regular and the adjunct faculties can 
learn from each other. The increased interaction will help to develop organ-system-based 
teaching learning. The exposure and inclusion of the adjunct faculties in the subject 
committee will also help to arrange early clinical exposure of the students and the vertical 
integration of the curriculum. In this way, the discipline-based models of the undergraduate 
medical education will move towards the newer models incorporating the advantages of 
both discipline-based and integrated approaches. 
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2.4 Community-based education 
In community-based education students are taught in a community setting in contrast to 
community-oriented education where the focus for teaching is the needs of the community.8 
But in the name of community-based education there may not be much benefit to the 
student or the community by just posting the students in the community, e.g. for family 
data collection. The postings of the students covering the overcrowded curriculum should 
also fulfill the need of the students. If the required and relevant areas, like general practice, 
internal medicine, pediatric, surgery or obstetrics and gynecology, of the posting for the 
students are actually practiced in the community, it would be useful to all. For this, the 
medical institutes should have their own or have affiliation with peripheral institutes 
providing service to the community in the urban and rural areas. The faculty of the medical 
institutes can be posted there on rotation and the students will be able to utilize most the 
posting under their own teacher in the community. It will also directly benefit the 
community especially in the developing countries, where health-coverage of the general 
population is inadequate.  
2.5 Incorporation of learning theories in the residential training 
The learning is not easy to define.9 The learning theories are also equally, or more complex, 
to explain. Just knowing something does not complete the definition of learning. From the 
educational point of view it may broadly be called a process which brings relatively 
permanent changes in the way of thinking about and/or feeling about and/or looking at the 
reality and/or behavior of a learner through experience, education, training, or practice. The 
change may be temporary or permanent.  
The concept about teaching and learning has changed dramatically over the several 
decades. “Teaching by pouring in” refers to a medieval belief that we teach people by 
drilling holes in the human head and, with a funnel, pour information into the brain. Then 
came the era of behaviorism where the issue was not how new knowledge is acquired, but 
how is new behavior acquired. Behavior can change as a result of extrinsic motivators 
such as incentives, rewards and punishments, which are utilized in different ways in the 
training and education in all the fields. Behaviorism is also seen further flourishing with 
the competency and learning outcomes movement, which focuses exclusively on 
observable behavior.10 During the late 1960s and early 1970s cognitivism became popular 
to understand learning.10 Cognitivism was closer to a common sense view of how people 
learned, attempting to map individual thinking processes. The cognitive perspective 
recognizes the need to build rich, interconnecting knowledge structures, based on existing 
knowledge, that allows continuing incorporation of new learning. Social cognitive theory 
(formerly social learning theory) acknowledges the social (interactive) aspect of learning 
and unites two approaches, behaviorist and cognitive, to understanding knowledge. It 
posits that our actions, learning and functioning are the result of a continuous, dynamic 
reciprocal interaction among the three sets of determinants: personal, environmental 
(situational) and behavioral.11 Similarly constructivism is based on the premise that the 
learners construct their own perspective of the world through individual experience and 
schema.  
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exposure, cognitive skills emphasized, primary learning guides and problem-solving 
model.6 Each has advantages and disadvantages as per the context and mixtures of models 
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Information gathering, Discipline-based, Hospital-based, Uniform and Apprenticeship. 
These approaches are self-explanatory, as their names indicate, to some extent and need to 
be considered and balanced in their spectrums wherever applicable. The problem-based 
learning approach uses problem-based learning as a vehicle to develop a usable body of 
integrated knowledge and develop problem-solving skills. A student-centered approach 
emphasizes on the student, increases motivation and prepares for continuing education.7 
But teachers, students and staff need to adopt and prepare for it. Various approaches 
depend on the context and situation. However the teaching and learning experiences of 
students should not be left to chance and it should be planned and recorded and assessed in 
a systematic manner. Electives allow students to focus as per their need or choice.  
2.3 Integrated approach 
A number of methods are used to integrate the curriculum, like spiral curriculum and multi-
professional learning.7,8 There is rapid growth of medical colleges in the developing 
countries leading to dearth of teachers in basic science. A few available basic science 
teachers may go to different medical colleges and there is tendency of medical colleges even 
to lure such teachers from other colleges, hampering the teaching of medical students. The 
acute shortage of basic science teachers in the developing countries has also indirectly raised  
the need to widen discipline-based approach to integrate the curriculum in the possible 
ways. The related clinical faculty can undertake the required extra training and then they 
can be certified for the training of students in the related basic science, for example general 
surgeons in anatomy, internist in pharmacology, internist and anesthetist in physiology and 
pathologist in forensic medicine. The teaching by such adjunct clinical faculty will 
automatically expose the students to the clinical implication of the basic science, making it a 
sort of applied basic science. The concerned department may be run by the regular faculty 
and the concerned subject or curriculum committee may be formed by including both the 
regular and well trained certified adjunct faculties. The regular and the adjunct faculties can 
learn from each other. The increased interaction will help to develop organ-system-based 
teaching learning. The exposure and inclusion of the adjunct faculties in the subject 
committee will also help to arrange early clinical exposure of the students and the vertical 
integration of the curriculum. In this way, the discipline-based models of the undergraduate 
medical education will move towards the newer models incorporating the advantages of 
both discipline-based and integrated approaches. 
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In community-based education students are taught in a community setting in contrast to 
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data collection. The postings of the students covering the overcrowded curriculum should 
also fulfill the need of the students. If the required and relevant areas, like general practice, 
internal medicine, pediatric, surgery or obstetrics and gynecology, of the posting for the 
students are actually practiced in the community, it would be useful to all. For this, the 
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providing service to the community in the urban and rural areas. The faculty of the medical 
institutes can be posted there on rotation and the students will be able to utilize most the 
posting under their own teacher in the community. It will also directly benefit the 
community especially in the developing countries, where health-coverage of the general 
population is inadequate.  
2.5 Incorporation of learning theories in the residential training 
The learning is not easy to define.9 The learning theories are also equally, or more complex, 
to explain. Just knowing something does not complete the definition of learning. From the 
educational point of view it may broadly be called a process which brings relatively 
permanent changes in the way of thinking about and/or feeling about and/or looking at the 
reality and/or behavior of a learner through experience, education, training, or practice. The 
change may be temporary or permanent.  
The concept about teaching and learning has changed dramatically over the several 
decades. “Teaching by pouring in” refers to a medieval belief that we teach people by 
drilling holes in the human head and, with a funnel, pour information into the brain. Then 
came the era of behaviorism where the issue was not how new knowledge is acquired, but 
how is new behavior acquired. Behavior can change as a result of extrinsic motivators 
such as incentives, rewards and punishments, which are utilized in different ways in the 
training and education in all the fields. Behaviorism is also seen further flourishing with 
the competency and learning outcomes movement, which focuses exclusively on 
observable behavior.10 During the late 1960s and early 1970s cognitivism became popular 
to understand learning.10 Cognitivism was closer to a common sense view of how people 
learned, attempting to map individual thinking processes. The cognitive perspective 
recognizes the need to build rich, interconnecting knowledge structures, based on existing 
knowledge, that allows continuing incorporation of new learning. Social cognitive theory 
(formerly social learning theory) acknowledges the social (interactive) aspect of learning 
and unites two approaches, behaviorist and cognitive, to understanding knowledge. It 
posits that our actions, learning and functioning are the result of a continuous, dynamic 
reciprocal interaction among the three sets of determinants: personal, environmental 
(situational) and behavioral.11 Similarly constructivism is based on the premise that the 
learners construct their own perspective of the world through individual experience and 
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The ability to reflect on one’s practice or performance is critical to lifelong, self-directed 
learning. At the heart of various learning theories is the belief that we can learn from 
experience, incorporating it into our existing knowledge and skills. This opportunity for 
reflection must be actively incorporated and a systematic approach to facilitate reflection 
must be introduced early. Reflection is not merely description of experience, but analysis of 
it; it is not a natural and intuitive ability, but must be developed through practice. It is 
critical to becoming an effective lifelong learner, as it also enables learners to develop and 
apply standards to their performance, decide what further learning needs to occur, and to 
continue their learning over a professional lifetime.11 The concept of the reflective 
practitioner incorporates all five stages that professionals use in problem solving: knowing-
in-action, surprise, reflection-in-action, experimentation, and reflection-on-action. 
Reflectivity in practice is a learned skill of critical thinking and situational analysis.11 
Self-directed learning is an aspect of several theoretical approaches, including the cognitive, 
social learning, humanist and constructivist. Humanist approach views self-direction as 
evidence of higher level of individual development. Self-directed learning elements can also 
be seen in the ability to learn from experience, through critical reflection, which allows 
learners to identify their personal learning needs, and to be aware of, monitor and direct the 
growth of their knowledge, skills and expertise.11 
Experiential learning theory considers that learning is best achieved in an environment that 
considers both concrete experience and conceptual models. There is the necessity of 
integrating the process of actual experience and education in learning.11 Learners along the 
medical educational continuum use various experiential learning methods. These may 
include: apprentice, internship or practicum, mentoring, clinical supervision, on-the-job 
training, clinics, case study research.11 There is a shift away from the older apprenticeship 
system towards more formal structured training. Structured training focuses on formal skills 
training, evidence-based accountability, objective evaluation, and competence-based 
assessment.12 Old apprenticeship models stressed ‘immersion’ – the learning by experience 
simply through exposure. New apprenticeship or ‘cognitive apprenticeship’ models stress 
that novices do not simply learn how to ‘do’ the job as they gain expertise – they also learn 
how to ‘think’ and to ‘recount’ the job.10 Doing, thinking and recounting are intimately 
linked as a ground for learning. Medicine is a complex professional practice in which the 
separation of cognition (thinking), conation (will), affect (feeling), and skill (doing) is 
impossible and unnecessary and in which individual cognition is secondary to social and 
other similar effects, i.e. context in learning. Learning implies connections between thinking, 
sensing, doing, feeling, willing, imagining, intuiting and thinking about thinking 
(metacognition).10 After the undergraduate medical education, the medical doctors undergo 
the structured training programme, commonly called residential training or simply 
residency, when they work under supervision in the specialty concerned. Most of the 
theories of learning are incorporated in various forms in the structured residential training 
at different stages. The focus is on active learning, rather than on passive teaching.13 
Teaching is the process or the ‘means’ and learning is the outcome or the ‘end’. The concept 
of the structured training programme of residency with actual working in the field under 
supervision with various teaching-learning and communication activities is to make the 
learners learn actively and reflectively.  
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2.6 Continuum of medical education as per the community need 
There is continuum of medical education: undergraduate medical education, residential 
training, and continuing medical education. After undergraduate education, medical 
doctors have to undergo the structured residential training and accredited appropriately in 
a specialty before they are allowed to practice. What or where they will practice will depend 
on the service available in the community. The whole medical education is planned as the 
need of the community.14 The service and need of the curriculum decides the medical 
curriculum. The continuum of medical education and the need of structured training 
programme of residency are evident by the successful absorption in the US residential 
programme of thousands of medical graduates taught in different undergraduate 
curriculums from the developing countries. The structured residential training is obviously 
important. The undergraduate medical education of whatever curriculum is incomplete 
without further residential training.  
2.7 Lessons learned 
Lesson 1: Graduation like MBBS alone not sufficient to allow doctors to practice 
independently  
In the past after graduation the doctors were expected to practice independently with or 
without having some experience in hospitals. But with increasing vastness of medicine and 
changing concept of learning and medical education and increasing focus on safety and 
rights of patients, such independent practice for any medical graduate is not possible now in 
the industrialized countries. Many lessons could also be learnt from the evidences of the 
background and implementations of series of health and educational reports and reforms, 
like Tomorrow’s Doctors, Modernizing Medical Careers and others in different parts of the 
world.15-18 With the rapid and massive growth of diagnostic and therapeutic interventions 
and specializations, the need of structured residency programmes for medical training is 
more now. Without even the basic training of the medical profession of vast majority of 
medical doctors, it will be difficult, if not impossible, to implement evidence-based 
medicine. Thus every medical graduate now needs to undertake structured-residential 
training to practice clinical medicine.  
Lesson 2: Structured training programme of residency is a ‘must’ in postgraduate medical 
education  
As discussed above, after graduation, medical professionals need to undergo supervised, 
structured residential training of actual working to fulfill the required evidences to be fit to 
practice in any field. In developing countries, many postgraduate degrees are awarded 
without residential programme. Evidences are clear that such ‘theoretical’ or ‘library’ 
degrees, either for national or foreign students, are not valid for any clinical practice on 
human beings. Training and learning would not be acquired without working as residents. 
Teaching and learning basically occur while managing cases in the units. The focus is on 
developing skills of reflexivity, not just remembering. The residents have to manage patients 
and face different situations, so the materials to be learned are personally relevant and 
responsibilities to learn fall on the learners themselves as well. This is an example of task-
based learning, the strategy that focuses student learning around real cases that the students 
meet in the wards, out-patient departments and emergency.19 The meaningfully learned 
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2.6 Continuum of medical education as per the community need 
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training, and continuing medical education. After undergraduate education, medical 
doctors have to undergo the structured residential training and accredited appropriately in 
a specialty before they are allowed to practice. What or where they will practice will depend 
on the service available in the community. The whole medical education is planned as the 
need of the community.14 The service and need of the curriculum decides the medical 
curriculum. The continuum of medical education and the need of structured training 
programme of residency are evident by the successful absorption in the US residential 
programme of thousands of medical graduates taught in different undergraduate 
curriculums from the developing countries. The structured residential training is obviously 
important. The undergraduate medical education of whatever curriculum is incomplete 
without further residential training.  
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Lesson 1: Graduation like MBBS alone not sufficient to allow doctors to practice 
independently  
In the past after graduation the doctors were expected to practice independently with or 
without having some experience in hospitals. But with increasing vastness of medicine and 
changing concept of learning and medical education and increasing focus on safety and 
rights of patients, such independent practice for any medical graduate is not possible now in 
the industrialized countries. Many lessons could also be learnt from the evidences of the 
background and implementations of series of health and educational reports and reforms, 
like Tomorrow’s Doctors, Modernizing Medical Careers and others in different parts of the 
world.15-18 With the rapid and massive growth of diagnostic and therapeutic interventions 
and specializations, the need of structured residency programmes for medical training is 
more now. Without even the basic training of the medical profession of vast majority of 
medical doctors, it will be difficult, if not impossible, to implement evidence-based 
medicine. Thus every medical graduate now needs to undertake structured-residential 
training to practice clinical medicine.  
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As discussed above, after graduation, medical professionals need to undergo supervised, 
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practice in any field. In developing countries, many postgraduate degrees are awarded 
without residential programme. Evidences are clear that such ‘theoretical’ or ‘library’ 
degrees, either for national or foreign students, are not valid for any clinical practice on 
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Teaching and learning basically occur while managing cases in the units. The focus is on 
developing skills of reflexivity, not just remembering. The residents have to manage patients 
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responsibilities to learn fall on the learners themselves as well. This is an example of task-
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meet in the wards, out-patient departments and emergency.19 The meaningfully learned 
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knowledge is retrievable, durable and generalisable. The students acquire basic science 
knowledge and clinical reasoning skills in the context of actual patient care.11 
Lesson 3: The candidates selection for any Sub-Specialist Training should only be from 
among those who have already completed General Specialist Training 
After the undergraduate medical education, for clinical practice every graduate will have to 
undergo General (or Basic) Specialist Training. After the General Specialist Training, they 
can join the medical practice in the relevant subject or can continue Sub- (or Higher-) 
Specialist Training.16-18 The general outline of the training of the medical professionals is 
shown in the Figure 1.  
 
Fig. 1. The continuum of education of the medical professionals: The medical graduate can 
only practice in any specialty after the necessary accreditation in the relevant field after 
undergoing structured-residential training. 
After graduation, medical professionals need to undergo supervised, structured 
residential training of actual working and get accredited in the General Specialty like 
General Surgery, Internal Medicine, General Practice or others. Then they can either 
practice in the General Specialty or go for Sub-Specialist Training similarly in different 
sub-specialties like cardiology, diabetes, urology and others.16-18 Each step of requirement 
is important to go to the next phase. The ‘experience of working’ alone in any basic 
specialties, medicine or surgery, will not fulfill the requirement to allow the candidates go 
to higher specialties, like gastroenterology or urology, training. But direct enrolment and 
teaching in different sub-specialities is practiced in many ‘postgraduate‘ programmes in 
the developing countries. The candidates for any Sub-Specialist Training should not be 
enrolled before they complete the relevant General Specialist Training. Similarly the 
experts need to consider whether direct orthopedic training, as practiced in many 
countries, should be allowed or not without first undergoing the training in General 
Surgery, particularly if the orthopedicians primarily manage trauma patients, and trauma 
units or centers.   
Lesson 4: Need of structured residential training programme in General Practice 
Evidences are clear that medical professionals need to fulfill the required evidences to be fit 
to practice in any field before they can be allowed to practice independently. Similar 
requirements are required for anyone to practice as Generalist in rural or urban areas. 
General Practitioners have to manage from medicine to surgery, pediatric to geriatric, 
orthopedics to obstetrics, and other. Residential training in General Practice provides the 
necessary medical professionals to serve in the community as practiced in industrialized as 
well as now in some developing countries in the world.16-18,20 Similar program is required in 
other countries before the medical graduates can practice in the rural or urban community. 
Such practitioners will also be the most appropriate personnel to be further trained for some 
months in health administration or public health to take such responsibilities later; this 
would also provide them further career incentive. 
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Lesson 5: Need of structured training programme, with appropriate eligibility criteria, in 
infectious diseases 
Communicable or infectious diseases are major public health burdens in the developing 
countries.21 But there is scarcity of Sub-Specialist Training programmes in Infectious 
Diseases for the medical professionals already qualified with General-Specialist Training in 
Internal Medicine to produce infectious disease specialists.20,22,23 That could be one of major 
reasons of not having adequate service and data of infectious diseases in the developing 
countries. The trend now is to train the medical professionals in the Infectious Diseases after 
the General Specialist Training programme of residency in Internal Medicine.16-18 Similar 
program is required in the developing countries to produce appropriate consultants and 
leaders in this common major problem of infectious diseases, including HIV/AIDS, 
tuberculosis, hepatitis and others.  
Lesson 6: Need of appropriate eligibility criteria for the educational course of public 
health and health-service administration  
Health administration plans and mobilizes the health professional service in any country. 
The service decides the curriculum for the training of health professionals in any 
community.14 So health-service administration is a key point and personnel need to have 
experience and concepts of both the medical education and health problems in the 
community. Medical doctors just with the undergraduate education, like MBBS, may not 
have full concepts of the health problems even with any other administrative training alone. 
Similarly in the public health, training the MBBS, or non-MBBS, graduates only with some 
months of master in public health training program may not now produce appropriate 
experienced professionals to give the required leadership in this vital field. The varied 
eligibility criteria for such course in public health seems to be creating confusion in the 
hierarchy of postings and in the planning and implementation of the necessary programmes 
in the developing countries. General Practitioners or other practitioners who have had 
undergone structured training programme after medical graduation may be the appropriate 
personals to be further trained in health administration or public health for some months to 
take such responsibilities. This would also be a career incentive for General Practitioners in 
the rural and urban community. Thus the training programme in public health and health-
service administration needs to be discussed and planned considering the implications and 
the contexts.  
Lesson 7: Public health institutes have to be involved in the structured training or 
postgraduate programmes 
The opportunity for structured training in the developing countries is severely limited by 
the concept of giving ‘postgraduate degrees’ mostly inside the closed-wall of medical 
colleges,20,22 which are increasingly becoming private and charge exorbitant fees. The mass 
of people in developing countries attend public institutes, which are not given the due 
priority, or even attention, for improvement in the quality, as if EBM is only to be taught by 
the professors in the medical colleges. Whereas the public health institutes itself could also 
be easily included in the structured training of medical graduates improving the quality of 
the public health institutes and increasing the training venues to adequately train the 
medical graduates efficiently, as evident in the industrialized, as well as in some 
developing, countries.16-18,24,25 If the quality of the public hospitals is not taken care of, the 
 
Evidence Based Medicine – Closer to Patients or Scientists? 34
knowledge is retrievable, durable and generalisable. The students acquire basic science 
knowledge and clinical reasoning skills in the context of actual patient care.11 
Lesson 3: The candidates selection for any Sub-Specialist Training should only be from 
among those who have already completed General Specialist Training 
After the undergraduate medical education, for clinical practice every graduate will have to 
undergo General (or Basic) Specialist Training. After the General Specialist Training, they 
can join the medical practice in the relevant subject or can continue Sub- (or Higher-) 
Specialist Training.16-18 The general outline of the training of the medical professionals is 
shown in the Figure 1.  
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After graduation, medical professionals need to undergo supervised, structured 
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experts need to consider whether direct orthopedic training, as practiced in many 
countries, should be allowed or not without first undergoing the training in General 
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to practice in any field before they can be allowed to practice independently. Similar 
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Lesson 5: Need of structured training programme, with appropriate eligibility criteria, in 
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reasons of not having adequate service and data of infectious diseases in the developing 
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developing, countries.16-18,24,25 If the quality of the public hospitals is not taken care of, the 
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situation of the private institutions could become even worse. Considering the rapid and 
massive growth of diagnostic and therapeutic interventions and specializations, it may not 
be possible to keep all the facilities for patient care and residents’ training under one roof or 
closed-wall of a medical institute, especially for the Sub-Specialist Training. Demographic 
and environmental conditions may also lead to variation in the types and cases of patients 
visiting any particular institute. Apart from the private medical colleges, other private 
medical institutes may also be included in the training programme if the facilities and 
patients are available. As the teaching-learning is a part of professionalism of medical 
professionals, the consultants and other specialists can easily be trained to be a supervisor 
and faculty for the training programme. The university and medical colleges can affiliate 
with the public hospitals for teaching-learning and service activities and can also develop 
their own medical centers in the peripheral part of the country. The students and the faculty 
of the medical institutes can be posted there on rotation in their required specialties in the 
peripheral health centers, which will also help the undergraduates and residents to get the 
experience of community-based education (as discussed in 2.4).  
Lesson 8:  Residential training, as well as later revalidation and appraisal, programmes are 
the responsibilities of the State, not of individual medical institutes or trainees 
The structured residential postgraduate programmes need to be planned and supervised by 
the State as in the industrialized countries.16-18 Committee or councils are required to 
accredit institutes, like medical schools and public and private institutes, for training and 
similarly to accredit the structured residential programme.16-18 Subdivisions of the required 
functions for the training and registration of medical professionals and their relation with 
different institutes where structured training programme could be arranged are shown in 
the Figure 2. Relevant experts from different fields can be the members of the committees. 
There can be overlap of representatives from different stakeholders in the committees as per 
the local situation. But the academic requirements and programmes need to be guided by 
the principles and committees of the State. Registration of medical practitioners by the State 
is in general a separate issue (Figure 2). Identification and regulation of separate functions 
helps to promote their appropriate planning and implementation. But in many countries, all 
 
Fig. 2. Subdivisions of the required functions for the training and registration of medical 
professionals and their relation with different institutes where structured training 
programme could be arranged: There can be overlap of representatives from different 
stakeholders in the committees.  
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 the three functions are managed by medical council.20,22 It would not be easy for any single 
organization to plan and manage different types of the functions requiring different 
approaches appropriately, which may, not surprisingly, lead to inefficiency and even 
corruption often heard in the developing countries. In UK, before the Calman reforms 
trainees were expected to organize their own training programmes. After the introduction 
of reforms the control and responsibility for the organization of training shifted to the 
committees.26 Structured residential training, as well as later revalidation and appraisal, 
programmes are the responsibilities of the State for the safety and health of the people.  
Lesson 9: Training of the medical professionals is planned as per the community need 
Medical education and curriculum is guided by the community situation, practice and need.14 
Community need may change as per the population demographics, disease patterns, resources 
and possible services. Specialty and subspecialty service development would be as per the 
local situation including volume of patients to justify the separate service, time of the available 
experts and the duration of training required to develop the expertise. The medical service 
practice in the community based on the available human resources may need to be 
restructured later differently for the effective and safe service delivery to the people 
considering the changing situation and teaching and learning concepts, increasing human 
resources and population as well as demand of the people, and trends in other parts of the 
world. For example, in many developing countries the patients in the emergency and 
observation wards are often managed by other speciality units, including Internal Medicine 
units, of the hospital and in this situation emergency department, simply a patient-entry point 
venue for other specialties to manage the patient, is easily coordinated by the General 
Pracititioners even without any extra training. If the Emergency or Acute Medicine is to be 
practiced independently as in many industrialized countries, then internists may need to be 
further trained for it. Similarly, the intensive care or treatment units (ICU/ITU), especially the 
ventilatory and other related aspects, in the developing countries are managed, along with 
other related units, usually by the anesthetists or by respiratory physicians now in some 
places. But the Critical Care Medicine is itself becoming a separate sub-specialty service and 
training area from the Internal Medicine stream. With increasing number of elderly population 
the need of Geriatric Medicine service and training is also obvious. Thus, the training courses 
for different higher specialties practice are guided by the community service need. The 
community need may be different in affluent or non-affluent and sparse or densely populated 
areas even in the same country whether industrialized or developing one. Some possible 
service, career and training options of Internal Medicine, General Practice and General Surgery 
and their sub-specialties in the community are shown in Figures 3, 4 and 5 respectively. For 
the situation of the scarce human resources or patient-loads, like in rural areas, the trainees 
from the general stream of General Practice could be given extra required training in obstetrics 
and gynaecology and anesthesia to practice as rural general practitioner (Figure 4). There will 
be similar options of services and trainings for other specialties like Paediatrics, Obstetrics and 
Gynaecology, Radiology, Pathology and others. After the General Specialist Training in any 
specialties, a faculty can be fully trained in Medical (Health Professional) Education specialty. 
The proportions of the numbers of the training opportunities for General Practice and other 
General and Sub-Specialty Trainings should be decided as per the requirements of the 
community and the later possible careers. Whether the Dental Surgeons should first undergo 
general medical undergraduate education followed by General Specialist Training in Dental 
field is a matter which can be discussed by the relevant experts, especially for the overlapping 
fields like oral-maxillary-facial surgery.27  
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*The extra service can be continued along with the Internal Medicine as per the volume of workload, 
time of the available experts and training required in the subject.  
Fig. 3. Some possible options of services of Internal Medicine and its sub-specialties in the 
community, according to which the training of the medical professionals need to be arranged. 
 
*The extra service an be continued along with the General Practice as per the volume of workload, time 
of the available experts and training required in the subject.  
Fig. 4. Some possible options of services of General Practice and its sub-specialties in the 
community, according to which the training of the medical professionals need to be 
arranged.  
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Fig. 5. Some possible options of services of General Surgery and its sub-specialties in the 
community, according to which the training of the medical professionals need to be arranged.  
Lesson 10:  Structured-residential programme involves doing the required work entitling 
the full pay and continuation of the service without any extra-training fee  
Every medical graduate needs to undergo residential training before they can serve as a 
medical professional.15-18 Even while they are undergoing structured-training programme, 
they are working in the field of their career and serving the community. Thus residential 
programme, whether General Specialist or Sub-Specialist Training, is like in-service training, 
not requiring any special leave or extra-payment for the training. During the residential 
training, the residents provide efficient and actual service to the people for which they 
should be paid as well as such residential training, unlike undergraduate medical or other 
non-residential non-service providing higher education, should be free not requiring any 
extra-training fee as in many industrialized countries. This is different from educational 
programmes of other service personnel in any institute or national service, where people 
may have to take special leave to study without doing their assigned jobs. The medical 
training and service are interrelated. The formal inclusion of the concept will help the career 
and morale of the trainees which is important for the better service and care of the patients. 
The trainees can thus continue their sub-specialty training as per their choice and service.  
3. Training and assessment 
Optimal training of the residents is a key concern of all the stakeholders. The focus of 
teachers and curriculum planners is to provide appropriate training. But active participation 
of the learners is required. Students may not realize and give full attention to the concept of 
the training. Passing the examination is the major focus of students. Students naturally tailor 
their learning styles to the assessment demands. They are very quick to respond to what 
they perceive as the demands of the assessment system.28 The content of the assessment will 
become in reality the course objective. For example, if it becomes widely known that topic 
‘A’ is never included in any examination, it is difficult, if not impossible, to persuade 
students that mastery of it should be an objective for their studies.28 Thus, assessment 
methods and criteria are the most effective tools we have to help all students achieve 
training criteria and ultimately pass. The curriculum planner and faculty need to 
understand the relation between the training and assessment criteria (Figure 6), and 
especially the fact that assessment is basically for training, not just for certification. The 
educational impact of the assessment on the learning of students is significant and faculty 
must utilize it to the maximum.  
“It is the examination system rather than educational objectives, curriculum organization, or 
educational techniques that had the most profound impact upon student learning. For no matter 
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how appealing the statement of goals, how logical the program organization, how dazzling the 
teaching methods, it is the examination that communicated most vividly to students what was 
expected of them” 
--George E Miller 
“Students work to pass, not to know……They do pass and they don’t know”  
--Thomas Huxley  
“Learning, teaching and assessment must not be viewed as isolated concepts. In the ideal 
scenario effective teaching, effective learning and effective assessment are all part of the same 
educational process. The value of changing assessment to reflect what needs to be learned is 
evident since students learn what they will be tested on” 
--Doyle, 1983 
 
Training criteria          Assessment criteria 
 
Fig. 6. The close relation between training and assessment criteria. 
The assessment criteria should be clearly spelled out as per the outcomes we want of the 
products of the training. While preparing the assessment criteria, the faculty need to 
consider the training need of the students for the specialty in the local community and such 
criteria then should be made known to the students, so that they try to prepare accordingly, 
which in the process helps them to achieve the expected training need. We can, thus, say: 
“Whatever you want your students to do, include it as a part of the assessment first, and 
then only they will learn and do actively!” 
3.1 Criterion-referenced assessment  
The principal objective of medical education is to produce a competent physician. 
Unquestionably, the basic aim and approach for the evaluation process is to assess the 
standard of competency and not the rank order of students.29 The assessment which simply 
ranks the order of performance in terms of their position in the group is norm- or 
normative-referenced assessment. The norm-referenced assessment fails to providea clear 
picture of what the student can or cannot do. It does not provide useful feedback i.e. 
pinpoint strengths and weakness and it cannot discern to what degree an educational 
programme has met these standards.29 Recognising the norm-referenced assessment’s 
limitations, Glasser in 1963 formalised the concept of criterion-referenced assessment.30 
Standards of performance are set using minimal levels of competence before the test is 
applied. The assessor sets the level of performance which is required. It may be the total 
mastery of a task or it may be the minimal acceptable level. The criteria-referenced 
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assessment allows pinpointing students’ capabilities i.e. what they can or cannot do. Thus 
criterion-referenced testing must become the principal method of evaluation within medical 
education. “Meeting the required standards” and “Fitness for purpose” are two notions that 
highlight quality assurance.31 Both are related ideas in that we need to consider the criteria 
against which the achievement of standards is going to be measured, and a major criterion 
must surely be the fitness for purpose. This certification cannot be achieved just by the 
theory or clinical practical examination in the exit examination. A mixture of assessment 
criteria and methods has to be documented. 
3.2 Exit examination and the eligibility criteria for the exit examination  
Apart from the assessment in the exit examination, the eligibility for the exit examination 
has to be defined by the criteria to be fulfilled. Once eligibility is expressed clearly, then it is 
obvious that all candidates have to achieve it before they can appear in exit examination and 
subject committees and examination section have to ensure they are achieved. Passing the 
examination is the major focus of students. Indeed, regulations, like the eligibility for final 
exit examination, and examination are the only ‘languages‘ students try to understand fully 
and take seriously. Each component and criterion of the examination is vital to train the 
students appropriately and needs serious attention.  
3.3 Lessons learned 
Lesson 11:  Spell out the eligibility criteria for the exit examination  
The eligibility criteria for the exit examination will vary as per the level of assessment, 
situation of the service and need in the community where the candidates will later work, 
and the specialty. There is a example of ten criteria of assessment for the exit examination of 
residential-programme in the General Specialist Training.32 In general, the outline of the 
possible eligibility criteria for the exit examination could be considered in the following 
headings:  
 Adequate attendance of actual working as a resident with regular and emergency duties 
 Achievement of the minimum pass-percentage in the required theory and clinical 
examination held earlier 
 Completion of horizontal and vertical, i.e. spiral upward, rotation training posting 
 Completion of minimum numbers of most important, e.g. top 10, procedures and/or 
experiences 
 Completion of relevant mandatory basic courses, like advanced cardiac life support 
(ACLS), communication skills including breaking bad news, learning principles and 
methods, evidence-based medicine, basic surgical skills, trauma-life support, palliative 
care, and others 
 Completion of portfolio focused on communication  
 Completion of minimum numbers of presentations, e.g. journal, case, topic and others 
 Completion of minimum numbers of teaching to juniors and nurses 
Lesson 12: Assess the required basic theory and clinical components in the early part of the 
training programme 
One of the characteristics of the adult learners is that they base their learning upon the 
experiences they have.33 The skills required for patient care depend upon learning in both 
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methods, evidence-based medicine, basic surgical skills, trauma-life support, palliative 
care, and others 
 Completion of portfolio focused on communication  
 Completion of minimum numbers of presentations, e.g. journal, case, topic and others 
 Completion of minimum numbers of teaching to juniors and nurses 
Lesson 12: Assess the required basic theory and clinical components in the early part of the 
training programme 
One of the characteristics of the adult learners is that they base their learning upon the 
experiences they have.33 The skills required for patient care depend upon learning in both 
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the theory and clinical areas.13 A lack of solid base of knowledge foundation, including 
applied basic science, during the clinical training programme will be a serious handicap for 
learning the concepts of the subject. If the students can correlate and apply their knowledge 
to the patient care related to the subject of postgraduation during the context of their 
training, then they are likely to have the full understanding of the concepts and principles of 
the specialty. For this purpose, the students have to acquire the required base of knowledge 
on time during the initial phase of training itself. The students give priority to the 
assessment. If the theory examination, including of the applied basic science, is held at the 
end of the final year, the students will naturally prepare for it at that time only. But the aim 
is not just to assess knowledge of the students at the end, but to train them in their actual 
field of specialization integrating all the required knowledge. Thus the basic or minimum 
theory and clinical components required for the training to be assessed in the early part of 
the training-programme have to be decided and arranged in the required scheduled. The 
training and assessment have to be primarily managed by the faculty of the relevant 
specialty, not by the basice science teachers. Such assessment would help to achieve the aim 
of formative assessment, which is the identification of deficiency during the training period 
in order to correct them. The possible topics, areas and questions to be asked in such 
assessment may be published as a guidebook and given to the students, so that they can 
prepare themselves for the examination. The role of study guides in facilitating and 
managing independent learning is well accepted.34 
Lesson 13:  Plan appropriately the horizontal and vertical, i.e. spiral upward, rotation 
training posting 
In postgraduate residential training, the students are rotated in different units related to 
their subject of post-graduation. During such rotations, the training and exposure in 
different sub-specialties required and the sufficient work load and other learning 
opportunities available should be considered to decide regarding the postings and their 
durations. The specialties for the residents to be rotated need to be correlated with the actual 
responsibilities they will be fulfilling later after the training. For example, in Internal 
Medicine rotation in psychiatry, diabetes, infectious diseases, ICU/ITU and CCU may be 
equally, if not more, relevant that in gastroenterology and cardiology alone if the residents 
later are not going to do any invasive or non-invasive procedures of gastroenterology and 
cardiology. For this, the subject committee may have to consider the types of patients 
managed by the general medicine unit and decide as per the local context. The postings 
planned a few years back will have to be reviewed as per the changing situation. The other 
important point to consider is that the training during the rotation postings is not just 
horizontal; it is also vertical and progressive,i.e. spiral upward. In the beginning of the 
training, the students are posted as junior residents in their subject of post-graduation for 
about some months to a year to get the basic knowledge and skills. Next they will be rotated in 
different subspecialties or related units as rotating residents. Finally they need to be rotated 
back as senior residents to their subject of post-graduation for about a year to assimilate or 
integrate all the learning. During this final posting as senior residents, they work with 
increased experience and responsibility of managing the unit with wider perspective and 
decision making responsibility, including supervision of junior residents, thus, to have the 
overview of the subject. The concept of problem based learning (PBL), i.e. a learning strategy 
characterized by self-directed active learning starting with problems or inquiries that learners 
themselves identify35 is thus inherently incorporated in the third year posting. It is well said 
 
Twenty Lessons to Incorporate EBM Concept and Practices into Medical Education 43 
that a good surgeon knows how to operate, a better surgeon knows when to operate and the 
best surgeon knows when not to operate. The decision making training in the specialty to be 
certified can be given in the final phase of posting in that subject. Approximately 75% of the 
significant events in surgical procedure are linked to decision making and about 25% to 
manual skills.36 Thus appropriate horizontal and vertical rotation training postings need to be 
planned. 
Lesson 14:  Spell out the minimum numbers of most important, e.g. top 10, procedures 
and/or experiences 
Postgraduate residents are required to maintain a record (log) book of the work carried out 
by them.20,22,23 But without the specifications of the minimum numbers of experiences 
required, checking the logbook with details of the entries of so manjy procedures and 
activities will just make it a formality for the residents to get it signed, even at the last hour 
before examination. If the minimum number of the top ten procedures or experience is 
spelled out, the verification of their completion by the subject committee can then be easily 
made as one of the eligibility criteria to be fulfilled before the final exit examination.24,25,32 
The spelling out the minimal number of most important procedures and/or experience in 
the curriculum and logbook will automatically ensure fulfillment of many other necessary 
background experience as well.32 The principle objective of structured residential training 
programme is to produce a competent specialist. At the end of the training programme, it is 
necessary to certify the candidate’s level of knowledge, skill and competence. The clear 
specification of operative skills is particularly vital in surgical specialties. For example to 
certify a medical profession as a trained in General Surgery, it has to be assured that the 
candidate has the necessary experience of working in General Surgery and s/he has achieved 
the necessary competency level to operate the required surgeries like appendicectomy or 
cholecystectomy independently etc. With the documentation of such criteria of important 
procedures, then external examiners and reviewers can also give necessary feedback. The 
experts in the field may also need to discuss the related vital issues, for example “What is the 
domain of General Surgery now in the changing medical and demographic scenario like 
increasing old age and problem of benign prostatic hypertrophy, development of laprascopic 
surgery, the scarcity of urology operation theatre (OT) and redundancy of general surgical 
service with mostly asymptomatic gall stones available to fill the OT list?”; or “Should the 
senior faculty and consultants in the General Surgeon Unit perform transurethral resection of 
prostate with Urologists dealing the area beyond the prostate?” and others.37 
Lesson 15:  Need of skill laboratory for the safe and appropriate training of the residents 
The rapid expansion of medical knowledge and medical procedures, lesser working hours 
available and longer years of training required considering the learning curve for 
appropriate competency and patient safety indicate the value and need of skill lab in clinical 
and procedural training. Simulation-based medical education is now recognized as an 
increasingly powerful complementary teaching methodology in the medical profession. It is 
driven by a combination of the forces; they are: the patient safety movement, objective 
structured clinical examinations, patient rights movements and patient ethical issues, animal 
rights movements, risk management and medicolegal atmosphere, economic forces, and the 
simulation industry.38 Experienced surgeons, if they desire to learn an innovative procedure, 
students and surgical trainees have to pass through a learning curve to acquire any 
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the theory and clinical areas.13 A lack of solid base of knowledge foundation, including 
applied basic science, during the clinical training programme will be a serious handicap for 
learning the concepts of the subject. If the students can correlate and apply their knowledge 
to the patient care related to the subject of postgraduation during the context of their 
training, then they are likely to have the full understanding of the concepts and principles of 
the specialty. For this purpose, the students have to acquire the required base of knowledge 
on time during the initial phase of training itself. The students give priority to the 
assessment. If the theory examination, including of the applied basic science, is held at the 
end of the final year, the students will naturally prepare for it at that time only. But the aim 
is not just to assess knowledge of the students at the end, but to train them in their actual 
field of specialization integrating all the required knowledge. Thus the basic or minimum 
theory and clinical components required for the training to be assessed in the early part of 
the training-programme have to be decided and arranged in the required scheduled. The 
training and assessment have to be primarily managed by the faculty of the relevant 
specialty, not by the basice science teachers. Such assessment would help to achieve the aim 
of formative assessment, which is the identification of deficiency during the training period 
in order to correct them. The possible topics, areas and questions to be asked in such 
assessment may be published as a guidebook and given to the students, so that they can 
prepare themselves for the examination. The role of study guides in facilitating and 
managing independent learning is well accepted.34 
Lesson 13:  Plan appropriately the horizontal and vertical, i.e. spiral upward, rotation 
training posting 
In postgraduate residential training, the students are rotated in different units related to 
their subject of post-graduation. During such rotations, the training and exposure in 
different sub-specialties required and the sufficient work load and other learning 
opportunities available should be considered to decide regarding the postings and their 
durations. The specialties for the residents to be rotated need to be correlated with the actual 
responsibilities they will be fulfilling later after the training. For example, in Internal 
Medicine rotation in psychiatry, diabetes, infectious diseases, ICU/ITU and CCU may be 
equally, if not more, relevant that in gastroenterology and cardiology alone if the residents 
later are not going to do any invasive or non-invasive procedures of gastroenterology and 
cardiology. For this, the subject committee may have to consider the types of patients 
managed by the general medicine unit and decide as per the local context. The postings 
planned a few years back will have to be reviewed as per the changing situation. The other 
important point to consider is that the training during the rotation postings is not just 
horizontal; it is also vertical and progressive,i.e. spiral upward. In the beginning of the 
training, the students are posted as junior residents in their subject of post-graduation for 
about some months to a year to get the basic knowledge and skills. Next they will be rotated in 
different subspecialties or related units as rotating residents. Finally they need to be rotated 
back as senior residents to their subject of post-graduation for about a year to assimilate or 
integrate all the learning. During this final posting as senior residents, they work with 
increased experience and responsibility of managing the unit with wider perspective and 
decision making responsibility, including supervision of junior residents, thus, to have the 
overview of the subject. The concept of problem based learning (PBL), i.e. a learning strategy 
characterized by self-directed active learning starting with problems or inquiries that learners 
themselves identify35 is thus inherently incorporated in the third year posting. It is well said 
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that a good surgeon knows how to operate, a better surgeon knows when to operate and the 
best surgeon knows when not to operate. The decision making training in the specialty to be 
certified can be given in the final phase of posting in that subject. Approximately 75% of the 
significant events in surgical procedure are linked to decision making and about 25% to 
manual skills.36 Thus appropriate horizontal and vertical rotation training postings need to be 
planned. 
Lesson 14:  Spell out the minimum numbers of most important, e.g. top 10, procedures 
and/or experiences 
Postgraduate residents are required to maintain a record (log) book of the work carried out 
by them.20,22,23 But without the specifications of the minimum numbers of experiences 
required, checking the logbook with details of the entries of so manjy procedures and 
activities will just make it a formality for the residents to get it signed, even at the last hour 
before examination. If the minimum number of the top ten procedures or experience is 
spelled out, the verification of their completion by the subject committee can then be easily 
made as one of the eligibility criteria to be fulfilled before the final exit examination.24,25,32 
The spelling out the minimal number of most important procedures and/or experience in 
the curriculum and logbook will automatically ensure fulfillment of many other necessary 
background experience as well.32 The principle objective of structured residential training 
programme is to produce a competent specialist. At the end of the training programme, it is 
necessary to certify the candidate’s level of knowledge, skill and competence. The clear 
specification of operative skills is particularly vital in surgical specialties. For example to 
certify a medical profession as a trained in General Surgery, it has to be assured that the 
candidate has the necessary experience of working in General Surgery and s/he has achieved 
the necessary competency level to operate the required surgeries like appendicectomy or 
cholecystectomy independently etc. With the documentation of such criteria of important 
procedures, then external examiners and reviewers can also give necessary feedback. The 
experts in the field may also need to discuss the related vital issues, for example “What is the 
domain of General Surgery now in the changing medical and demographic scenario like 
increasing old age and problem of benign prostatic hypertrophy, development of laprascopic 
surgery, the scarcity of urology operation theatre (OT) and redundancy of general surgical 
service with mostly asymptomatic gall stones available to fill the OT list?”; or “Should the 
senior faculty and consultants in the General Surgeon Unit perform transurethral resection of 
prostate with Urologists dealing the area beyond the prostate?” and others.37 
Lesson 15:  Need of skill laboratory for the safe and appropriate training of the residents 
The rapid expansion of medical knowledge and medical procedures, lesser working hours 
available and longer years of training required considering the learning curve for 
appropriate competency and patient safety indicate the value and need of skill lab in clinical 
and procedural training. Simulation-based medical education is now recognized as an 
increasingly powerful complementary teaching methodology in the medical profession. It is 
driven by a combination of the forces; they are: the patient safety movement, objective 
structured clinical examinations, patient rights movements and patient ethical issues, animal 
rights movements, risk management and medicolegal atmosphere, economic forces, and the 
simulation industry.38 Experienced surgeons, if they desire to learn an innovative procedure, 
students and surgical trainees have to pass through a learning curve to acquire any 
 
Evidence Based Medicine – Closer to Patients or Scientists? 44
particular new skills. This learning curve is usually constructed in retrospect, rather than 
being applied as a continuous assessment based on predetermined criteria. It is possible to 
predict the extent of a learning curve.39 For example, Yaegashi et al relied upon operating 
time and blood loss when suggesting that gynecology trainees need to perform more than 75 
hysterectomies to achieve competence in the procedure.40 Surgeons can become proficient 
after performing about 25 laparoscopic antireflux procedures.41,42 It would be ideal if the 
learning curve for all the surgical procedures could be measured. Learning by 'service 
saturation' has to change in response to the decrease in hours that surgical trainees can work.39 
Thus it is increasingly crucial to take advantage of the educational value of every experience in 
an effort to shorten the length of the learning curve for new procedures. Teaching and 
development of practical skills is now frequently done in workshops and skills laboratories. It 
requires specialist materials and equipment, smaller class size and longer blocks of time for 
practice.39 The use of simulation has the potential to allow measurement of performance and 
establish objective metrics that can be used for formative and summative assessments. This is 
of crucial importance if we are to consider the development of proficiency-based curricula 
rather than time-based educational programs. Different kinds of tools to teach practical skills 
are available like printed materials, mannekin, video, multimedia, complex manipulation 
simulators, integrated procedure simulators, laprascopic simple box trainers, virtual 
laparoscopic trainers, and others.39 Virtually reality technology have been used widely in 
aviation training and more recently it has been adapted for use in surgery.39 A virtual reality 
simulator can offer the chance for the learner to repeatedly practice a manual skill until it is 
technically perfected. To utilize the resources effectively, especially if scarce, the skill lab can be 
developed with mutual collaboration as a common training venue for trainees from different 
institutes. International agencies and the institutes of industrialized countries should come 
forward to help establishing the skill lab in developing countries. Indeed the institutes in the 
industrialized countries can also be benefited by the mutual collaboration. Low resource 
centers may have volumes of patients and procedures and other varieties of disease patterns 
useful for the appropriate trainees from abroad. Thus both can benefit from cooperation, 
including faculty exchange and discussion forums. The experts from industrialized countries 
can visit low resource centers to help setting-up newer diagnostic and therapeutic modalities 
and units.  
Lesson 16:  The thesis-study not appropriate now for the residential training programme 
Submission and approval of thesis work is a well known pre-requisite to become eligible to 
appear in the final exit examination in postgraduate clinical training programme in the 
developing countries.20,22,23 But in the changing situation of present context it appears to be a 
high-time to consider whether we should continue to keep thesis study as the necessary 
component in the clinical residential training of medical professionals. There is a rapid and 
massive growth of diagnostic and therapeutic interventions and specializations. It could be 
difficult for the residents to cope with the training and learning requirements related to their 
own field and thesis-study on human subjects, including children and pregnant women, 
could hamper the actual training required. Moreover the requirements required to conduct 
research in humans are clear and established now. Medical professionals need separate 
training and certification for conducting research. Both students and their guides, with 
burdens of and primary focus on service and teaching responsibilities, may not have enough 
time for or may not be well trained to conduct research mostly on patients attending health 
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institutes only for seeking treatment. The residents are students in the phase of learning of 
their own field, even leaving aside the research principles. The clinical training itself is 
getting more complex with rapid growth in technology, globalization and increasing 
expectation of the population. The structured residential training is required for all medical 
graduates. With the increasing number of trainees it could be more difficult, if not 
impossible, for the institutional review boards and research councils to make adequate 
supervision of such studies in the developing countries with likelihood of harms to the 
patients. It is, thus, an issue of basic safety and rights of the patients in the developing 
countries where illiteracy and ignorance of rights are also high. Conducting thesis-study is 
not necessary to learn EBM. EBM could be learned by mandatory basic course training on 
EBM, journal club, applying EBM in each patient and learning the development of one’s 
practicing field. Requirement of thesis-study is not there in the clinical training programmes 
of many industrialized countries.16-18 If the thesis-study is not required, the number of 
residents to be enrolled to structured training programme of residency will also not be 
limited by the availability of faculty who can fulfill the criteria to guide the thesis work. The 
residents for the structured-training programme could, then, be admitted or enrolled as per 
the required training possible in the specialty under the supervision of the senior faculties 
who are already as such managing the unit and providing the necessary service to the 
community.  
Lesson 17:  Assessment of history taking, physical examination and communication is 
necessary in the exit examination of residential training programme 
All evidences point the importance of history and communication in the patient 
management. Current evidence suggest that most diagnoses result from findings in the 
history, and to a lesser extent, the physical examination and laboratory testing.43,44 Similarly, 
failures in communication are the most frequent source of patient dissatisfaction. Some 70% 
of lawsuits are a result of poor communication rather than failures of biomedical practice.45 
Thus adequate training of communication and history taking is obviously important. 
Training and assessment of communication, including history taking, done during the 
undergraduate education before the beginning of the structured-residential training alone 
will not be sufficient. Effective history taking and communication depends on the base 
knowledge, experience of actual working in the specialty, and the practice of doing so 
during the residential training. If there is no assessment of the history taking and 
communication in the training programme of the residency, the students may not give much 
attention to it and may not try to gain knowledge about it or adopt practice. But the training 
assessments may be focused just on multiple-choice questions (MCQs) considering its 
reliability.16,17 An instrument may be perfectly reliable but totally invalid. For example, an 
MCQ examination may show high reliability but is it really a valid measure of whether 
students are competent in resuscitation skills or history taking and communication?47 
Existing methods of assessment of history taking and communication, e.g. modified OSCEs, 
multiple long cases, observed long cases, videos, simulated/standardized patients and 
others, may not have that high reliability. But that does not mean a method just because of 
its high reliability can replace a valid method of assessment especially when evidences are 
clear that value of communication is high in diagnosis as well as patient satisfaction and 
reducing medical error. In the criterion-referenced assessment, like for the accreditation of 
medical professional, validity is the priority to give attention particularly when the 
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particular new skills. This learning curve is usually constructed in retrospect, rather than 
being applied as a continuous assessment based on predetermined criteria. It is possible to 
predict the extent of a learning curve.39 For example, Yaegashi et al relied upon operating 
time and blood loss when suggesting that gynecology trainees need to perform more than 75 
hysterectomies to achieve competence in the procedure.40 Surgeons can become proficient 
after performing about 25 laparoscopic antireflux procedures.41,42 It would be ideal if the 
learning curve for all the surgical procedures could be measured. Learning by 'service 
saturation' has to change in response to the decrease in hours that surgical trainees can work.39 
Thus it is increasingly crucial to take advantage of the educational value of every experience in 
an effort to shorten the length of the learning curve for new procedures. Teaching and 
development of practical skills is now frequently done in workshops and skills laboratories. It 
requires specialist materials and equipment, smaller class size and longer blocks of time for 
practice.39 The use of simulation has the potential to allow measurement of performance and 
establish objective metrics that can be used for formative and summative assessments. This is 
of crucial importance if we are to consider the development of proficiency-based curricula 
rather than time-based educational programs. Different kinds of tools to teach practical skills 
are available like printed materials, mannekin, video, multimedia, complex manipulation 
simulators, integrated procedure simulators, laprascopic simple box trainers, virtual 
laparoscopic trainers, and others.39 Virtually reality technology have been used widely in 
aviation training and more recently it has been adapted for use in surgery.39 A virtual reality 
simulator can offer the chance for the learner to repeatedly practice a manual skill until it is 
technically perfected. To utilize the resources effectively, especially if scarce, the skill lab can be 
developed with mutual collaboration as a common training venue for trainees from different 
institutes. International agencies and the institutes of industrialized countries should come 
forward to help establishing the skill lab in developing countries. Indeed the institutes in the 
industrialized countries can also be benefited by the mutual collaboration. Low resource 
centers may have volumes of patients and procedures and other varieties of disease patterns 
useful for the appropriate trainees from abroad. Thus both can benefit from cooperation, 
including faculty exchange and discussion forums. The experts from industrialized countries 
can visit low resource centers to help setting-up newer diagnostic and therapeutic modalities 
and units.  
Lesson 16:  The thesis-study not appropriate now for the residential training programme 
Submission and approval of thesis work is a well known pre-requisite to become eligible to 
appear in the final exit examination in postgraduate clinical training programme in the 
developing countries.20,22,23 But in the changing situation of present context it appears to be a 
high-time to consider whether we should continue to keep thesis study as the necessary 
component in the clinical residential training of medical professionals. There is a rapid and 
massive growth of diagnostic and therapeutic interventions and specializations. It could be 
difficult for the residents to cope with the training and learning requirements related to their 
own field and thesis-study on human subjects, including children and pregnant women, 
could hamper the actual training required. Moreover the requirements required to conduct 
research in humans are clear and established now. Medical professionals need separate 
training and certification for conducting research. Both students and their guides, with 
burdens of and primary focus on service and teaching responsibilities, may not have enough 
time for or may not be well trained to conduct research mostly on patients attending health 
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institutes only for seeking treatment. The residents are students in the phase of learning of 
their own field, even leaving aside the research principles. The clinical training itself is 
getting more complex with rapid growth in technology, globalization and increasing 
expectation of the population. The structured residential training is required for all medical 
graduates. With the increasing number of trainees it could be more difficult, if not 
impossible, for the institutional review boards and research councils to make adequate 
supervision of such studies in the developing countries with likelihood of harms to the 
patients. It is, thus, an issue of basic safety and rights of the patients in the developing 
countries where illiteracy and ignorance of rights are also high. Conducting thesis-study is 
not necessary to learn EBM. EBM could be learned by mandatory basic course training on 
EBM, journal club, applying EBM in each patient and learning the development of one’s 
practicing field. Requirement of thesis-study is not there in the clinical training programmes 
of many industrialized countries.16-18 If the thesis-study is not required, the number of 
residents to be enrolled to structured training programme of residency will also not be 
limited by the availability of faculty who can fulfill the criteria to guide the thesis work. The 
residents for the structured-training programme could, then, be admitted or enrolled as per 
the required training possible in the specialty under the supervision of the senior faculties 
who are already as such managing the unit and providing the necessary service to the 
community.  
Lesson 17:  Assessment of history taking, physical examination and communication is 
necessary in the exit examination of residential training programme 
All evidences point the importance of history and communication in the patient 
management. Current evidence suggest that most diagnoses result from findings in the 
history, and to a lesser extent, the physical examination and laboratory testing.43,44 Similarly, 
failures in communication are the most frequent source of patient dissatisfaction. Some 70% 
of lawsuits are a result of poor communication rather than failures of biomedical practice.45 
Thus adequate training of communication and history taking is obviously important. 
Training and assessment of communication, including history taking, done during the 
undergraduate education before the beginning of the structured-residential training alone 
will not be sufficient. Effective history taking and communication depends on the base 
knowledge, experience of actual working in the specialty, and the practice of doing so 
during the residential training. If there is no assessment of the history taking and 
communication in the training programme of the residency, the students may not give much 
attention to it and may not try to gain knowledge about it or adopt practice. But the training 
assessments may be focused just on multiple-choice questions (MCQs) considering its 
reliability.16,17 An instrument may be perfectly reliable but totally invalid. For example, an 
MCQ examination may show high reliability but is it really a valid measure of whether 
students are competent in resuscitation skills or history taking and communication?47 
Existing methods of assessment of history taking and communication, e.g. modified OSCEs, 
multiple long cases, observed long cases, videos, simulated/standardized patients and 
others, may not have that high reliability. But that does not mean a method just because of 
its high reliability can replace a valid method of assessment especially when evidences are 
clear that value of communication is high in diagnosis as well as patient satisfaction and 
reducing medical error. In the criterion-referenced assessment, like for the accreditation of 
medical professional, validity is the priority to give attention particularly when the 
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assessment is considered along with a mixture of criteria. Whereas in the normative-
referenced assessment, like in entrance examination for any programme or job, reliability 
assumes more importance than validity to remove any selection bias, or even possibility of 
nepotism or corruption (Figure 7). From this point of view reliability appears to support 
rights of the students and validity appears to support rights (and safety) of the patients. 
Using and finding reliable ways to make the valid assessment would be preferred in 
criterion-referenced assessment than using reliable method of assessment which is less 
valid. 
 
Fig. 7. Balancing reliability and validity as the assessment tool 
Lesson 18: Include training in communication and reflection in the General Specialist 
Training programme 
Different methods of teaching like case-based discussion, feedback, directly observed 
history taking, clinical examination and procedure performance are increasingly included 
now in the residential training. Many of these aspects can be efficiently incorporated in the 
ambulatory care setting of outdoor clinics by quick methods of teaching like one-minute 
preceptor model. Training programmes, most importantly, also need to be planned directly 
to cover communication, including breaking bad news and communication in consultation, 
by the communication and medical education experts. Communication training during 
undergraduate medical education without the required base knowledge of the subject of 
specialization and regular exposure during the residential training will not be enough for 
the requirements during the residential training. The communication is a daily, almost 
continuous, affair in the medical world. Valuable learning can be acquired from any 
experience in the medical training by reflection and further learning efforts.11 For this, apart 
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from the other face-to-face training programs on communication, the learning-portfolio in 
the field of communication is of immense help.48-51 Repeated training of all the residents is 
not feasible, but portfolio on communication gives an opportunity to learn from every 
encounter of communication. Learning-portfolio also helps the residents to develop the 
quality of reflective practitioner. Reflection is an essential component for the development of 
a learning cycle and life-long learning required for the professionals. It is essential for 
medical professionals to continue their personal learning plans as per the different 
developments and requirements later in their career. The accreditation process of the 
specialists should of course depend on fulfilment of work-designated responsibilities and 
requirements, not just on achievement of personal learning plans. Learning-portfolio is one 
of the useful approaches to facilitate reflection.49-51 Thus, portfolio focused on 
communication would help the residents to improve their communication as well as the 
habit of reflection. 
4. Teachers’ criteria and training  
The twelve roles of the teacher are well known: clinical or practical teacher and lecturer as 
information provider, on-the-job role model and teaching role model as medical expertise, 
learning facilitator and mentor as facilitator, student assessor and curriculum evaluator as 
assessor, curriculum planner and course organizer as planner, and study guide producer 
and resource material creator as resource developer.52 For the General or Sub-Specialty 
training of the residents the most important roles expected from the vast majority of faculty 
are those of medical expertise and supervision. They can then be easily trained in other 
common responsibilities regularly required for all viz. learning-facilitator and students-
assessment. Some can be trained to coordinate development of resource and organization of 
course. A few will need to focus on curriculum planning and curriculum evaluation. The 
point to note is that in the twelve roles of the teachers, conducting studies and publication of 
paper on clinical aspects are as such not emphasized. But in the teachers criteria the focus is 
only in paper publication in their fields in many parts of the world.20,22,23 The teaching 
faculty designations itself appears to be linked more with the ideas of any research and 
paper publication, rather than with educational activities.20,22 Due to the minimum criteria 
required of the teachers to have done thesis-study previously and publish number  of 
original articles, there is scarcity of teachers, when the need of today is to provide the 
opportunity of residential training to ‘all’ medical graduates, not just a few ones. The 
residents for the structured-training programme should be admitted or enrolled as per the 
required and relevant work available in the specialty, for which they are being trained. Thus 
there is dire need to consider appropriately the definition of the domains of the teachers and 
the criteria required for them which are separate from those of other academic positions. 
The teaching responsibility of the medical professionals deserves appropriate attention, 
priority, and ‘glamorization‘ equal to, if not more than, their role as researcher.32  
4.1 Lesson learned 
Lesson 19:  Make appropriate teachers’ criteria and plan necessary training accordingly 
The teachers’ criteria for the residential training programme should be based on the most 
important role expected from the vast majority of faculty, which is clinical and practical and 
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assessment is considered along with a mixture of criteria. Whereas in the normative-
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nepotism or corruption (Figure 7). From this point of view reliability appears to support 
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valid. 
 
Fig. 7. Balancing reliability and validity as the assessment tool 
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experience in the medical training by reflection and further learning efforts.11 For this, apart 
 
Twenty Lessons to Incorporate EBM Concept and Practices into Medical Education 47 
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there is dire need to consider appropriately the definition of the domains of the teachers and 
the criteria required for them which are separate from those of other academic positions. 
The teaching responsibility of the medical professionals deserves appropriate attention, 
priority, and ‘glamorization‘ equal to, if not more than, their role as researcher.32  
4.1 Lesson learned 
Lesson 19:  Make appropriate teachers’ criteria and plan necessary training accordingly 
The teachers’ criteria for the residential training programme should be based on the most 
important role expected from the vast majority of faculty, which is clinical and practical and 
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patient management skills. Any faculty or consultant are likely to have such expertize 
required for that contexts. Subsequently teachers’ training needs to be planned and other 
requirements to be laid down to continue as teachers. Shorter overview training covering 
the spectrums of teaching-learning activities, lesson-planning, class-room teaching and 
communication skills, feedback method, ambulatory teacher-learning, assessment and other 
similar ones may be required for all. Specific workshops and training will be useful for 
assessment methods, microteaching, lesson-planning and other skills. Constructive feedback 
is an essential responsibility of all teachers for which they should be trained.54 As the focus 
of healthcare provision shifts towards ambulatory care, increasing attention must now be 
given to developing opportunities for clinical teaching in this setting.55 Many specialties like 
dermatology, ophthalmology, general practice, diabetes and others have significant 
ambulatory service. The number of residents in such specialties will not be dependent on 
the indoor works and bed numbers, but will depend on workload and opportunities for 
learning in the ambulatory care settings. Support and training of teachers and supervisors is 
essential in improving the quality of postgraduate medical education. All faculties may not 
have the similar roles. After the initial general training of the junior faculty, portfolio on 
postgraduate training will be useful to remind them regularly the various aspects of 
teaching-learning.56 The portfolio can be for learning or assessment.49-51 Audit, including of 
teaching-learning activities, will also be useful for junior faculty. The value of audit is well 
established and popular in industrialized countries since more than two decades in 
improving patient care as part of an ongoing educational process, basically involving 
change management and quality assurance.57,58 Training on preparation of study guides will 
be useful for majority. The role of study guides in facilitating and managing independent 
learning is well accepted.34 The requirements of research training certification and paper 
publications, including on medical education, will also be applicable to the various 
academic faculty positions, especially the senior ones, but this should not prevent the 
enrolment of the medical graduates for the structured residential training. The criteria for 
teachers for residential training is a separate issue than that for other academic faculty 
positions. Thus the teachers’ criteria, benefits and training need to match the expected 
training of the residents and provide the opportunities for training for all the medical 
graduates in the community.32 The faculty position designations of the teachers may be 
categorized based on different educational activities, involvement or roles like on-the-job 
training and supervision, clinical teaching, small group facilitation, assessment, curriculum 
management and planning, mentoring, audit, portfolio, study guide development, course 
organization, skill laboratory management, course evaluation, extra medical education 
qualification, medical education research and others. The recognition of such roles will help 
the appropriate development of all these required activities, which may otherwise be 
neglected as extra-burden.    
5. Individual’s mistake, system’s error, health safety and trainees 
There is still an unacceptably high level of risk associated with medicine, surgery and 
hospital stays.59 Medicine remains a high-risk activity because it has not yet assimilated the 
necessary values to maintain safety practices.10 A mishap in health setting commonly occurs 
due to various errors like communication, environmental, human, team-work, technical, 
instrumental, decision-making, cross-checking, and others. Improvement of all such 
situation to minimize problems will not adequately occur if the law is to hold individual 
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clinicians responsible for ‘mistakes‘. To err is human; if humans are solely responsible, then 
errors will be there. Humans are fallible but the institute or the State should not be. 
Individual’s mistake, system’s error and medical negligence are separate entities. When 
individual’s mistake causes harm to patients or others, then it becomes system’s error. The 
institute and the State should continuously evolve foolproof cross-checking methods to 
prevent individual’s mistakes and harm to patients and others, i.e. system’s errors. 
Moreover if a trainee who is not adequately trained makes mistake, should the blame be put 
on the individual for making the mistake or on the institute or the State for posting or 
allowing the ‘not-adequately‘ trained personnel to provide such service, i.e. for conducting 
system’s errors? Improvement of any situation and team work requires workshops, training 
and making guidelines and rules by the institute or the State. The onus for safety should be 
on the institution and/or the State, rather than on the individuals. The institute or the State 
then can make enquiry which will also be useful for prevention of such mistakes and errors 
again. For gross, i.e. not expected considering the level of training of the personnel as per 
the existing local norms, situation and data, or deliberate medical negligence by the 
clinicians, the medical council is there to look after. With the responsibility, and the fear, the 
institutes and the State will gear up to follow all the possible safety measures. It took around 
15 years for the modern airline industry to move from being a ‘high-risk’ industry to 
becoming a ‘safety critical’ or ‘high reliability’ culture. The outcome of this is well evidenced 
– it is now very safe to fly.10 The responsibility of airline safety lies with the airline industry 
and the State, not just on individual pilots. There is a need of developing a fundamental 
shift in values and practices of the medical education that would transform the safety 
culture.10  
5.1 Lesson learned 
Lesson 20:  Health safety is a responsibility of the institute and the State 
Delivery of the health care service to the people is the responsibility of the State. Health 
service and training of medical professionals are interrelated.14 Training of medical 
profession is also the responsibility of the State. Similarly safety of the patients in the health 
care service is the responsibility of the State and Institute and it cannot be left on the 
individual health workers or trainees. There are two major safety issues in the health care all 
over the world. One is to provide the expert assessment and planning of the management of 
sick patients as early as possible by the already trained faculty and the other is preventing 
unnecessary procedures, investigations and medications. The medical service in the human 
society should ultimately aim to provice immediate assessment of every new patient 
admitted in the hospitals by the already trained faculty twenty four hours a day seven days 
a week. Such assessment and care could be crucial for the survival of many patients. For the 
safety of the residents as well, the trainees cannot be just exposed to the situation or practice 
for which they are not adequately trained. The training should be supervised, structured and 
graded. Coverage by the trained supervisor and faculty is vital. Residents need also to be 
trained in all the basic safety principles. Health institutes, medical schools and the State are like 
industry. They have all the resources and experts to plan, implement and evaluate the safety 
issues. Service, training, and safety are directly or indirectly dependent on the finance. If 
optimum service, training, and safety are the responsibility of the institute or the State, not of 
the individual clinicians, the economic benefits or loss will also relate to the institute or the 
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patient management skills. Any faculty or consultant are likely to have such expertize 
required for that contexts. Subsequently teachers’ training needs to be planned and other 
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given to developing opportunities for clinical teaching in this setting.55 Many specialties like 
dermatology, ophthalmology, general practice, diabetes and others have significant 
ambulatory service. The number of residents in such specialties will not be dependent on 
the indoor works and bed numbers, but will depend on workload and opportunities for 
learning in the ambulatory care settings. Support and training of teachers and supervisors is 
essential in improving the quality of postgraduate medical education. All faculties may not 
have the similar roles. After the initial general training of the junior faculty, portfolio on 
postgraduate training will be useful to remind them regularly the various aspects of 
teaching-learning.56 The portfolio can be for learning or assessment.49-51 Audit, including of 
teaching-learning activities, will also be useful for junior faculty. The value of audit is well 
established and popular in industrialized countries since more than two decades in 
improving patient care as part of an ongoing educational process, basically involving 
change management and quality assurance.57,58 Training on preparation of study guides will 
be useful for majority. The role of study guides in facilitating and managing independent 
learning is well accepted.34 The requirements of research training certification and paper 
publications, including on medical education, will also be applicable to the various 
academic faculty positions, especially the senior ones, but this should not prevent the 
enrolment of the medical graduates for the structured residential training. The criteria for 
teachers for residential training is a separate issue than that for other academic faculty 
positions. Thus the teachers’ criteria, benefits and training need to match the expected 
training of the residents and provide the opportunities for training for all the medical 
graduates in the community.32 The faculty position designations of the teachers may be 
categorized based on different educational activities, involvement or roles like on-the-job 
training and supervision, clinical teaching, small group facilitation, assessment, curriculum 
management and planning, mentoring, audit, portfolio, study guide development, course 
organization, skill laboratory management, course evaluation, extra medical education 
qualification, medical education research and others. The recognition of such roles will help 
the appropriate development of all these required activities, which may otherwise be 
neglected as extra-burden.    
5. Individual’s mistake, system’s error, health safety and trainees 
There is still an unacceptably high level of risk associated with medicine, surgery and 
hospital stays.59 Medicine remains a high-risk activity because it has not yet assimilated the 
necessary values to maintain safety practices.10 A mishap in health setting commonly occurs 
due to various errors like communication, environmental, human, team-work, technical, 
instrumental, decision-making, cross-checking, and others. Improvement of all such 
situation to minimize problems will not adequately occur if the law is to hold individual 
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clinicians responsible for ‘mistakes‘. To err is human; if humans are solely responsible, then 
errors will be there. Humans are fallible but the institute or the State should not be. 
Individual’s mistake, system’s error and medical negligence are separate entities. When 
individual’s mistake causes harm to patients or others, then it becomes system’s error. The 
institute and the State should continuously evolve foolproof cross-checking methods to 
prevent individual’s mistakes and harm to patients and others, i.e. system’s errors. 
Moreover if a trainee who is not adequately trained makes mistake, should the blame be put 
on the individual for making the mistake or on the institute or the State for posting or 
allowing the ‘not-adequately‘ trained personnel to provide such service, i.e. for conducting 
system’s errors? Improvement of any situation and team work requires workshops, training 
and making guidelines and rules by the institute or the State. The onus for safety should be 
on the institution and/or the State, rather than on the individuals. The institute or the State 
then can make enquiry which will also be useful for prevention of such mistakes and errors 
again. For gross, i.e. not expected considering the level of training of the personnel as per 
the existing local norms, situation and data, or deliberate medical negligence by the 
clinicians, the medical council is there to look after. With the responsibility, and the fear, the 
institutes and the State will gear up to follow all the possible safety measures. It took around 
15 years for the modern airline industry to move from being a ‘high-risk’ industry to 
becoming a ‘safety critical’ or ‘high reliability’ culture. The outcome of this is well evidenced 
– it is now very safe to fly.10 The responsibility of airline safety lies with the airline industry 
and the State, not just on individual pilots. There is a need of developing a fundamental 
shift in values and practices of the medical education that would transform the safety 
culture.10  
5.1 Lesson learned 
Lesson 20:  Health safety is a responsibility of the institute and the State 
Delivery of the health care service to the people is the responsibility of the State. Health 
service and training of medical professionals are interrelated.14 Training of medical 
profession is also the responsibility of the State. Similarly safety of the patients in the health 
care service is the responsibility of the State and Institute and it cannot be left on the 
individual health workers or trainees. There are two major safety issues in the health care all 
over the world. One is to provide the expert assessment and planning of the management of 
sick patients as early as possible by the already trained faculty and the other is preventing 
unnecessary procedures, investigations and medications. The medical service in the human 
society should ultimately aim to provice immediate assessment of every new patient 
admitted in the hospitals by the already trained faculty twenty four hours a day seven days 
a week. Such assessment and care could be crucial for the survival of many patients. For the 
safety of the residents as well, the trainees cannot be just exposed to the situation or practice 
for which they are not adequately trained. The training should be supervised, structured and 
graded. Coverage by the trained supervisor and faculty is vital. Residents need also to be 
trained in all the basic safety principles. Health institutes, medical schools and the State are like 
industry. They have all the resources and experts to plan, implement and evaluate the safety 
issues. Service, training, and safety are directly or indirectly dependent on the finance. If 
optimum service, training, and safety are the responsibility of the institute or the State, not of 
the individual clinicians, the economic benefits or loss will also relate to the institute or the 
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State, not to the individual clinicians. If compensations are to be given by the institute or the 
State, not by the individual practitioners, the benefits, if any!, should also go to the institute or 
the State. The payment to the individual clinicians will then be as per the service hours, 
expenses required to acquire the skills and the training, and other factors, not payment 
according to every procedure. Because outcome of every procedure is also dependent on the 
patient-selection, quality of the instruments, facilities available, support human resources, 
team works and other factors, not just on the skill of operator. As such the skill may be difficult 
to acquire initially. But once acquired, it will be just maintained or improved like driving skill. 
On the other hand it is not easy to maintain ‘knowledge’ in this era of information 
bombardment. The institute or the State has also the responsibility to upgrade the skill and 
knowledge of the medical practitioners for the sake of the safety of the patients. The medical 
professionals decide the indication of any procedures and situations should not be created to 
make them bias in any form. If the operators, surgeons or interventionists are paid for each 
procedure, there will naturally be the increased probability of advising unnecessary surgeries 
and procedures not only to the individual patients but also even in the institutional or national 
guidelines. If the medical professionals who perform the procedures are paid inappropriately 
high as stipend by the institute, even if not directly for each procedure, it can lead to the 
similar situation. If the cost and benefit of the procedures is to be borne by the institute, the 
medical professional can decide the indication without any bias. It is, thus, a very important 
issue of safety, i.e. rights, of the patients. At this point it would be relevant to emphasize that 
all the medical professionals themselves also belong to the patient groups, especially in the old 
age, with consequent liability to the society and the State. The related aspect for the trainee is 
that if the teachers are paid for the procedure and are biased to perform the procedure, the 
learning will be similarly acquired, directly or indirectly. The residents ultimately learn 
considering the actual practice, not just the theoretical teaching or ‘preaching‘, of their 
teachers. The medical students may from beginning be bias even to choose their career 
considering the economic benefit, rather than aptitude. Such tendency is observed both in 
developing and the industrialized countries. In this era of rapid and massive growth of 
diagnostic and therapeutic technology, unnecessary procedures, investigations, and 
medications are the major risks to patients as well as the significant cause of economic burden 
to the insurance companies, the State and ultimately to the people.  
6. Conclusion 
Medical education has evolved from different models and different educational strategies 
have been developed considering the experience and evidences. There is continuum of 
medical education from undergraduate medical education to structured-residential 
programme of specialist training incorporating the various learning theories. The concept of 
the structured training programme of residency with actual working in the field under 
supervision with various teaching-learning and communication activities is to make the 
learners learn actively and reflectively and be able to perform their responsbilities reflexly 
professionally. After graduation, all medical professionals need to undergo supervised, 
structured residential training of actual working and get accredited in the General Specialty 
like General Surgery, Internal Medicine, General Practice or others. Then only they can 
either practice in the General Specialty or go for Sub-Specialist Training similarly in 
different sub-specialties like cardiology, infectious diseases, urology and others. Training in 
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different specialties has to match the community service. The aim of the residential training 
is to make the medical practitioners fit to practice as per the community need. Public health 
institutes fulfilling the requirements have to be involved in the residential training 
programmes. Structured residential training, as well as later revalidation and appraisal, 
programmes are the responsibilities of the State, not of individual medical institutes or 
trainees. Committee or councils are required to accredit institutes, like medical schools and 
public and private institutes, for training and to accredit the structured residential 
programme.  
The educational impact of the assessment on the learning of students is significant and 
faculty must utilize it to the maximum. Training should be planned focusing on the 
criterion-referenced assessment. The assessment criteria, especially the eligibility criteria for 
the exit examination, should be clearly spelled out as per the outcomes we want of the 
products of the training. Inclusion of training and assessment in communication in the 
training programme matches the importance of history taking and communication in the 
actual practice. Establishment of skill lab in developing countries is an urgent responsibility 
to be fulfilled by the national and international agencies. Considering the vast areas of 
training requirements in the short period available, the patients’ safety, need of training of 
all the medical graduates in the community and the dearth of the faculty to fulfill the criteria 
to guide the thesis work, the practice of keeping thesis study of the patients, attending the 
health institutes primarily for the treatment, in the clinical training programme of the 
residents is not appropriate. Appropriate training and education of medical professionals 
are very vital for the safety and care of the patients and the community. Eduction role of 
medical professionals should be given due priority. Teachers’ criteria and training need to 
match the expected training of the residents and provide the opportunities for training for 
all the medical graduates in the community. Then only we can expect the practice of EBM 
from the medical practitioners in every encounter with patients. To achieve such practice of 
EBM in each and every encounter with patients and to move the medical world from being a 
high-risk service to becoming a high reliability culture, there appears a fundamental need to 
acknowledge that health service, medical education and patient safety, and thus the health 
economics, are all interrelated and are the responsibility of the State, not the individuals.  
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match the expected training of the residents and provide the opportunities for training for 
all the medical graduates in the community. Then only we can expect the practice of EBM 
from the medical practitioners in every encounter with patients. To achieve such practice of 
EBM in each and every encounter with patients and to move the medical world from being a 
high-risk service to becoming a high reliability culture, there appears a fundamental need to 
acknowledge that health service, medical education and patient safety, and thus the health 
economics, are all interrelated and are the responsibility of the State, not the individuals.  
7. References 
[1] Mayer D. Essential Evidence-Based Medicine. 2nd Ed. Cambridge: Cambridge University 
Press, 2010.  
[2] Harden RM, Grant J, Buckley G, Hart IR. Best Evidence Medical Education Guide No. 1. 
Dundee: Association for Medical Education in Europe, 1999.  
[3] Hammick M. Interprofessional education: evidence from the past to guide the future. 
Medical Teacher 2000;22(5): 461 
[4] Harden RM. O:1 Issues in Medical Education: Best Evidence Medical Education. 
Dundee: Centre for Medical Education, 2005.  
[5] Hart IR, Harden RM. Best evidence medical education: a plan for action. Medical 
Teacher 2000;22(2):131.  
[6] Papa FJ, Harasym PH. Medical curriculum reform in North America, 1765 to the present: 
A cognitive science perspective. Academic Medicine 1999; 74: 154-164.  
[7] Harden RM, Sowden S, Dunn WR. Some educationl strategies in curriculum 
development: The SPICES model. Medical Education, 1984; 18:284-297.  
 
Evidence Based Medicine – Closer to Patients or Scientists? 52
[8] Harden RM, Davis MH, Crosby JR. The new Dundee medical curriculum: a whole that is 
greater than the sum of the parts. Medical Education 1997;31:264-271,  
[9] Law SAT. TL:17 Personal Development Planning. Dundee: Centre for Medical 
Education, 2008.  
[10] Bleakley A, Bligh J, Browne J. Medical Education for the Future: Identity, Power and 
Location. London: Springer, 2011.  
[11] Kaufman DM, Mann KV, Jennet PA. Teaching and Learning in Medical Education: How 
Theory can Inform Practice. Edinburgh: Association for the Study of Medical 
Education (ASME); 2000. 
[12] Hamdorf JM, Hall C. Acquiring surgical skills. BJS 2000;87:28-37.  
[13] McLeod PJ, Harden RM. Clinical Teaching Strategies for Physicians. Medical Teacher 
1985;7: 173-89. 
[14] Harden RM. Ten questions to ask when planning a course or curriculum. Medical 
Education 1986;20:356-365.  
[15] World Federation for Medical Education. Postgraduate Medical Education: WFME 
Global Standards for Quality Improvement. Copenhagen: World Federation for 
Medical Education, 2003.  
[16] Accreditation Council for Graduate Medical Education. Bylaws. Illinois: Accreditation 
Council for Graduate Medical Education, 2011.  
[17] Liaison Committee on Medical Education. Rules of Procedure. Washington: Liaison 
Committee on Medical Education, 2010. 
[18] 4 UK Health Departments. Modernising Medical Careers – The Next Steps: The Future 
Shape of Foundation, Specialist and General Practice Training Programmes. 
London: Department of Health, 2004.  
[19] Harden RM, Crosby JR, Davis MH, Howie PW, Struthers AD. Tasked-based learning: 
the answer to integration and problem-based learning in the clinical years. Medical 
Education. 2000; 34: 391-7. 
[20] Nepal Medical Council. Regulations for Postgraduate Medical Education (MD/MS 
Programs). Kathmandu: Nepal Medical Council, 2006.  
[21] WHO. World health report 2002: Reducing risks, promoting healthy life. Geneva: WHO, 
2003. 
[22] Medical Council of India. Postgraduate Medical Education Regulations. New Delhi: 
Medical Councils of India, 2000.  
[23] College of Physicians and Surgeons Pakistan. Guidelines for Examiners. Karachi: 
College of Physicians and Surgeons Pakistan, 2003.  
[24] National Academy of Medical Sciences. Curriculum for MD/MS (as per the specialty). 
Kathmandu: National Academy of Medical Sciences, 2008. 
[25] National Academy of Medical Sciences. Curriculum for DM/MCh (as per the specialty). 
Kathmandu: National Academy of Medical Sciences, 2011.  
[26] Patil NG. The postgraduate curriculum. In: Dent JA, Harden RM, eds. A Practical Guide 
for Medical Teachers. 2nd Ed. Edinburgh: Elsevier/Churchill Livingstone, 2005: 28-37 
[27] Bhattarai MD. Dentistry – a medical specialization. British Dental Journal 2003; 194: 466. 
[28] Harden RM. Assess students: An overview. Medical Teacher 1979;1(2): 65-70. 
[29] Turnbull JM. What is … normative versus criterion-referenced assessment? Medical 
Teacher 1989; 11(2): 145-50. 
[30] Glasser R. Instructional technology and the measurement of learning outcomes. Am 
Psychologists. 1963; 18: 519-21. 
[31] Steward A. CD:13 Quality Assurance in Medical Education. Dundee: Centre for Medical 
Education; 2005. 
 
Twenty Lessons to Incorporate EBM Concept and Practices into Medical Education 53 
[32] Bhattarai MD. Ten criteria for criterion-referenced assessment in postgraduate MD/MS 
education. In: Dixit H, Joshi SK. Eds. Modern Trends in Medical Education. 
Kathmandu: Kathmandu Medical College, 2009: 144-158.  
[33] Knowles MS. The Modern Practice of Adult Education: From Pedagogy to Andragogy. 
New York: Cambridge Books; 1980. 
[34] Laidlaw JM, Harden RM. What is ……a study guide? Medical Teacher, 1990;12:7.  
[35] Ananthanarayanan PH. Problem based learning. In: Ananthanarayanan N, Sethuraman 
KR, Kumar S, eds. Pondicherry: Alumni Association of National Teacher Training 
Centre, JIPMER; 2000. 89-98. 
[36] Spencer FC. Teaching and measuring surgical techniques – the technical evaluation of 
competence. Bulletin of the American College of Surgeons 1978;63:9-12.  
[37] Bhattarai MD. General surgery units, asymptomatic gallstones and benign prostatic 
hypertrophy. The Surgeon – Journal of the Royal College of Surgeons and 
Edinburgh and Ireland. 2003; 1: 361. 
[38] Ziv A. Simulators and simulation-based medical education. In: Dent JA, Harden RM, Eds. A 
Practical Guide to Medical Teachers. Edinburgh: Churchill Livingstone, 2009: 217-222.  
[39] Aly EH. S: 4 Teaching Practical Skills. Dundee: Centre for Medical Education, 2009.  
[40] Yaegashi N, Kuramoto M, Nakayama C, Nakano M, Yajma A. Resident gynecologists 
and total hysterectomy. Tohokti J Exp Med 1996;178:299-306.  
[41] Meehan JJ, Georgeson KE. The learning curve associated with laparoscopic antireflux 
surgery in infants and children. J Pediatric Surgery 1997;32:426-429 
[42] Watson DI, Baigrie RJ, Jamieson GG. A learning curve for laparoscopic fundoplication: 
Definable, avoidable, or a waste of tune? Ann Surg 1996;224:198-203. 
[43] Peterson MC, Holbrook JH, Von Hales D, et al. Contributions of the history, physical 
examination, and laboratory investigation in making medical diagnoses. West J 
Med 1992;156:163-165.  
[44] Reilly BM. Physical examination in the care of medical inpatients: an observational 
study. Lancet 2003;362:1100-1105.  
[45] Cushing A, Mallinson C. Communication. In: Kumar P, Clark M, Eds. 7th Edition. 
Kumar & Clark’s Clinical Medicine. Edinburgh: Saunders Elsevier, 2009: 8-17.  
[46] Bhattarai MD. Multiple Choice Questions and Open Ended Questions for Written 
Assessment. Kathmandu: DMDB 2005. 
[47] McAleer S. Choosing assessment instruments. In: Dent JA, Harden RM, eds. A Practical 
Guide for Medical Teachers. 2nd Ed. Edinburgh: Elsevier/Churchill Livingstone, 
2005: 302-310. 
[48] Bhattarai MD. Portfolio: Focused on Communication. Kathmandu: National Academy 
of Medical Sciences, 2007.  
[49] Law S, Davis M. TL:13 Portfolio Building. Dundee: Centre of Medical Education 2005. 
[50] Neades BL. Professional portfolios: all you need to know and were afraid to ask. 
Accident and Emergency Nursing 2003; 11: 49-55. 
[51] Challis M. AMEE Medical Education Guide No.11 (revised): Portfolio-based learning 
and assessment in medical education. Medical Teacher 1999; 21(4): 370-85. 
[52] Harden RM, Crosby JR. Education Guide No. 20 – The Good Teacher is More Than a 
Lecturer: The Twelve Roles of the Teacher. Dundee: Association for Medical 
Education in Europe, 2000.  
[53] Bhattarai MD. Study skills course in medical education for postgraduate residents. 
Kathmandu University Medical Journal 2007; 5(4):561-565.  
[54] Bhattarai MD. ABCDEF IS – The principle of constructive feedback. J Nep Med Assoc 
2007;46 (167):151-156 
 
Evidence Based Medicine – Closer to Patients or Scientists? 52
[8] Harden RM, Davis MH, Crosby JR. The new Dundee medical curriculum: a whole that is 
greater than the sum of the parts. Medical Education 1997;31:264-271,  
[9] Law SAT. TL:17 Personal Development Planning. Dundee: Centre for Medical 
Education, 2008.  
[10] Bleakley A, Bligh J, Browne J. Medical Education for the Future: Identity, Power and 
Location. London: Springer, 2011.  
[11] Kaufman DM, Mann KV, Jennet PA. Teaching and Learning in Medical Education: How 
Theory can Inform Practice. Edinburgh: Association for the Study of Medical 
Education (ASME); 2000. 
[12] Hamdorf JM, Hall C. Acquiring surgical skills. BJS 2000;87:28-37.  
[13] McLeod PJ, Harden RM. Clinical Teaching Strategies for Physicians. Medical Teacher 
1985;7: 173-89. 
[14] Harden RM. Ten questions to ask when planning a course or curriculum. Medical 
Education 1986;20:356-365.  
[15] World Federation for Medical Education. Postgraduate Medical Education: WFME 
Global Standards for Quality Improvement. Copenhagen: World Federation for 
Medical Education, 2003.  
[16] Accreditation Council for Graduate Medical Education. Bylaws. Illinois: Accreditation 
Council for Graduate Medical Education, 2011.  
[17] Liaison Committee on Medical Education. Rules of Procedure. Washington: Liaison 
Committee on Medical Education, 2010. 
[18] 4 UK Health Departments. Modernising Medical Careers – The Next Steps: The Future 
Shape of Foundation, Specialist and General Practice Training Programmes. 
London: Department of Health, 2004.  
[19] Harden RM, Crosby JR, Davis MH, Howie PW, Struthers AD. Tasked-based learning: 
the answer to integration and problem-based learning in the clinical years. Medical 
Education. 2000; 34: 391-7. 
[20] Nepal Medical Council. Regulations for Postgraduate Medical Education (MD/MS 
Programs). Kathmandu: Nepal Medical Council, 2006.  
[21] WHO. World health report 2002: Reducing risks, promoting healthy life. Geneva: WHO, 
2003. 
[22] Medical Council of India. Postgraduate Medical Education Regulations. New Delhi: 
Medical Councils of India, 2000.  
[23] College of Physicians and Surgeons Pakistan. Guidelines for Examiners. Karachi: 
College of Physicians and Surgeons Pakistan, 2003.  
[24] National Academy of Medical Sciences. Curriculum for MD/MS (as per the specialty). 
Kathmandu: National Academy of Medical Sciences, 2008. 
[25] National Academy of Medical Sciences. Curriculum for DM/MCh (as per the specialty). 
Kathmandu: National Academy of Medical Sciences, 2011.  
[26] Patil NG. The postgraduate curriculum. In: Dent JA, Harden RM, eds. A Practical Guide 
for Medical Teachers. 2nd Ed. Edinburgh: Elsevier/Churchill Livingstone, 2005: 28-37 
[27] Bhattarai MD. Dentistry – a medical specialization. British Dental Journal 2003; 194: 466. 
[28] Harden RM. Assess students: An overview. Medical Teacher 1979;1(2): 65-70. 
[29] Turnbull JM. What is … normative versus criterion-referenced assessment? Medical 
Teacher 1989; 11(2): 145-50. 
[30] Glasser R. Instructional technology and the measurement of learning outcomes. Am 
Psychologists. 1963; 18: 519-21. 
[31] Steward A. CD:13 Quality Assurance in Medical Education. Dundee: Centre for Medical 
Education; 2005. 
 
Twenty Lessons to Incorporate EBM Concept and Practices into Medical Education 53 
[32] Bhattarai MD. Ten criteria for criterion-referenced assessment in postgraduate MD/MS 
education. In: Dixit H, Joshi SK. Eds. Modern Trends in Medical Education. 
Kathmandu: Kathmandu Medical College, 2009: 144-158.  
[33] Knowles MS. The Modern Practice of Adult Education: From Pedagogy to Andragogy. 
New York: Cambridge Books; 1980. 
[34] Laidlaw JM, Harden RM. What is ……a study guide? Medical Teacher, 1990;12:7.  
[35] Ananthanarayanan PH. Problem based learning. In: Ananthanarayanan N, Sethuraman 
KR, Kumar S, eds. Pondicherry: Alumni Association of National Teacher Training 
Centre, JIPMER; 2000. 89-98. 
[36] Spencer FC. Teaching and measuring surgical techniques – the technical evaluation of 
competence. Bulletin of the American College of Surgeons 1978;63:9-12.  
[37] Bhattarai MD. General surgery units, asymptomatic gallstones and benign prostatic 
hypertrophy. The Surgeon – Journal of the Royal College of Surgeons and 
Edinburgh and Ireland. 2003; 1: 361. 
[38] Ziv A. Simulators and simulation-based medical education. In: Dent JA, Harden RM, Eds. A 
Practical Guide to Medical Teachers. Edinburgh: Churchill Livingstone, 2009: 217-222.  
[39] Aly EH. S: 4 Teaching Practical Skills. Dundee: Centre for Medical Education, 2009.  
[40] Yaegashi N, Kuramoto M, Nakayama C, Nakano M, Yajma A. Resident gynecologists 
and total hysterectomy. Tohokti J Exp Med 1996;178:299-306.  
[41] Meehan JJ, Georgeson KE. The learning curve associated with laparoscopic antireflux 
surgery in infants and children. J Pediatric Surgery 1997;32:426-429 
[42] Watson DI, Baigrie RJ, Jamieson GG. A learning curve for laparoscopic fundoplication: 
Definable, avoidable, or a waste of tune? Ann Surg 1996;224:198-203. 
[43] Peterson MC, Holbrook JH, Von Hales D, et al. Contributions of the history, physical 
examination, and laboratory investigation in making medical diagnoses. West J 
Med 1992;156:163-165.  
[44] Reilly BM. Physical examination in the care of medical inpatients: an observational 
study. Lancet 2003;362:1100-1105.  
[45] Cushing A, Mallinson C. Communication. In: Kumar P, Clark M, Eds. 7th Edition. 
Kumar & Clark’s Clinical Medicine. Edinburgh: Saunders Elsevier, 2009: 8-17.  
[46] Bhattarai MD. Multiple Choice Questions and Open Ended Questions for Written 
Assessment. Kathmandu: DMDB 2005. 
[47] McAleer S. Choosing assessment instruments. In: Dent JA, Harden RM, eds. A Practical 
Guide for Medical Teachers. 2nd Ed. Edinburgh: Elsevier/Churchill Livingstone, 
2005: 302-310. 
[48] Bhattarai MD. Portfolio: Focused on Communication. Kathmandu: National Academy 
of Medical Sciences, 2007.  
[49] Law S, Davis M. TL:13 Portfolio Building. Dundee: Centre of Medical Education 2005. 
[50] Neades BL. Professional portfolios: all you need to know and were afraid to ask. 
Accident and Emergency Nursing 2003; 11: 49-55. 
[51] Challis M. AMEE Medical Education Guide No.11 (revised): Portfolio-based learning 
and assessment in medical education. Medical Teacher 1999; 21(4): 370-85. 
[52] Harden RM, Crosby JR. Education Guide No. 20 – The Good Teacher is More Than a 
Lecturer: The Twelve Roles of the Teacher. Dundee: Association for Medical 
Education in Europe, 2000.  
[53] Bhattarai MD. Study skills course in medical education for postgraduate residents. 
Kathmandu University Medical Journal 2007; 5(4):561-565.  
[54] Bhattarai MD. ABCDEF IS – The principle of constructive feedback. J Nep Med Assoc 
2007;46 (167):151-156 
 
Evidence Based Medicine – Closer to Patients or Scientists? 54
[55] Dent J. Education Guide No. 26 : Clinical Teaching in Ambulatory Care Settings – 
Making the Most of Learning Opportunities with Outpatients. Dundee: Association 
for Medical Education in Europe, 2006.  
[56] Bhattarai MD. Portfolio: Focused on Postgraduate Training. Kathmandu: National 
Academy of Medical Sciences, 2007. 
[57] Royal College of General Practitioners. Quality and Audit in General Practice: 
Meanings and Definitions. London: Royal College of General Practitioners; 1993.  
[58] Bhattarai MD. Ten PM note of organophosphate poisoning: Successful outcome of a 
medical audit with complete seven steps. J Nep Med Assoc 2010;49(177):76-83.  
[59] Amalberti R, Auroy Y. Five system barriers to achieving ultra safe health care. Annals 
of Internal Medicine, 2005;142:756-764.  
4 
A Post-Structuralist View 
 of Evidence-Based Medicine (EBM)  
Brian Walsh 
University of Otago 
New Zealand 
1. Introduction 
Evidence-based medicine has been praised for its enormous contribution to information 
processing, and for other achievements. Most of the criticism has been directed at its 
conceptual structure. This criticism has been levelled by philosophers and doctors, such as 
Miles, Loughlin and Polychronis. My own approach is to develop a viewpoint on EBM from 
post-structuralism. I have drawn on the work of Foucault, Deleuze and Guattari, a celebration 
of smooth space and nomadic science.  In this chapter I place the doctor with the patient and her 
problems in smooth space, detour into the striated space of the medical (EBM) gaze, then 
back into the smooth space of the patient and her problems. I explain "smooth space", 
"striated space" along with the related concepts of "nomadic science" and "State science", and 
I explain the "medical gaze" which I update to the "EBM gaze."  
1.1 Striated space and smooth space  
Deleuze and Guattari provide an account of their division of the universe into the smooth 
space of the nomad, the war machine and nomadic science, and the striated space instituted 
by the State apparatus. What might appear a straightforward division quickly reveals a 
number of complexities. Smooth space and striated space are mixed together and have a 
moving borderline. The desert becomes mapped, and a city in a declining empire drifts into 
desert. This transfer from smooth to striated space is a different movement from the transfer 
from striated to smooth space. By now we can picture a de jure distinction between smooth 
and striated spaces, and a de facto distinction. The former is abstract. In characterising the 
two kinds of space, Deleuze and Guattari explain that we occupy smooth space without 
counting. By contrast, we count in order to occupy striated space. Thus we structure the city 
before living in it. Taking the distiction to the level of thought and knowledge, an example might 
be the medical thinking of a previous decade in which certain divisions that seemed 
exclusive and fixed are now blurred – living versus non-living – where do you put prions, 
parasite versus inclusion – where should we put the viruses that have incorporated 
themselves into human DNA through the eons of human evolution? 
Deleuze and Guattari explain that nomadic science, the science of smooth space, often 
contributes to major science, renewing it. Even so, minor science would be insipid without 
the rigour of major or State science. The striation of smooth space is a complex issue. It 
cannot be done very well: try striating infinity, or the slightest angle of declination. This 
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means that striation is done by verticals and tangents: these cannot gain control of a very 
small angle. Nor can lamination, the process used in striation, control smooth space at a 
macroscopic level. At the other pole, it escapes them by the spiral or vortex, in other words, 
a figure in which all the points of space are simultaneously occupied according to the laws 
of frequency or of accumulation, distribution; these laws are distinct from the so-called 
laminar distribution corresponding to the striation of parallels.1 Using a mathematical 
model, they tell us that the striation of smooth space EBM, which I depict as an aspect of 
State science, tries to striate the smooth space of medical practice, and I argue that this can 
be done only incompletely. 
...is an operation that undoubtedly consists in subjugating, overcoding, metricising smooth 
space, in neutralising it, but also in giving it a milieu of propagation, extension, refraction, 
renewal, and impulse without which it would perhaps die of its own accord:...”.2  
1.2 State science and nomadic science 
Deleuze and Guattari explain that, from the point of view of the State apparatus, the war 
machine appears in negative form: “stupidity, deformity, madness, illegitimacy, usurpation, 
sin.” The war machine betrays everything. Deleuze and Guattari go on to explain the 
difficulty in conceiving of the war machine. It is everywhere exteriority – the unfamiliar and 
wild or unstructured - , whereas the State apparatus is everywhere interiority, what we are 
accustomed to, and from which we take our point of view. They depict the war machine in 
terms of the expression of feeling which then becomes affect. Projected with velocity, this 
affect of love or hate becomes exterior.  
Deleuze and Guattari introduce epistemology here. There is, they tell us, a scientific dimension 
to the conflict between 1) the State/interiority and 2) the war machine/exteriority. Deleuze 
and Guattari3 distinguish a State science from  nomadic science, or minor science, or at least a 
way of treating science. The former is the traditional science, hallowed by the State, but the 
latter is not supported by history, law, or royal authority. Because nomadic science does not 
develop from a recognized centre, Deleuze and Guattari refer to it as “eccentric science”, and 
set out four characteristics. It posits a fluid model rather than a solid/fluid model--“Flux is 
reality itself”.4 Secondly, the eccentric scientific model depicts becoming and heterogeneity, 
rather than fixed scientifically investigable types with their “homogeneity” within categories 
for the purpose of grouping and generalizing. This contrasts with the stability and constancy 
in the State science model. Thirdly, rather than occupying a rectangular, striated space, the 
eccentric science involves a vortical (like a vortex) movement in open space. There are flows in 
smooth space. This contrasts with State science in striated space, which is set out in matrix 
form before use. Fourthly, the eccentric science is occupied with problems produced by affect – 
the restless desire to be able to do certain things. Working towards their solutions is the task of 
the war machine. The pathway is punctuated by accidents, movements, change, and is typified 
by events, rather than essences. The nomad signifier is essentially disruptive, and is like a 
tent—temporary, shifting, adjusting to local conditions, but providing a kind of shelter within 
                                                 
1 Deleuze and Guattari 1987, p. 489. 
2 Deleuze and Guattari 1987, p. 486. 
3 1987, pp. 361 ff. 
4 Deleuze and Guattari 1987, p. 361. 
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which state-like processes can go on. By contrast, the State science is immersed in rationality – 
like a house or castle or farm with fences.  
The war machine is projected into an abstract knowledge which is developing away from 
the centre of the State science, and which is formalised differently from the State science. 
(For example, this eccentric science relates differently to technology.) The State science has a 
complex relationship with the nomad or minor science.5 The State science partly excludes 
and belittles the minor science, (describing it as a “prescientific, parascientific or 
subscientific agency”6) but otherwise dominates it, siphoning off some of its results and its 
thinkers. These latter are then in a state of imbalance between being 1) energised by the war 
machine and 2) saturated with rationality. The minor science pressurises the State science, 
which sometimes yields, to a degree, incorporating some of the viewpoint of the minor 
science, structuring this new material in its own fashion. Symmetrically, the minor science 
detaches aspects of the State science. The upshot of these gains and losses is that the border 
is always changing, as is the uneasy relationship between EBM, academic medicine, 
dissenters from the dominant paradigm, and real practice.  
One of the discordant differences between State science and minor science lies in the division 
of labour, which is largely determined by the pattern of scientific activity. State science and 
minor science divide their labour differently. For example, there are differences in the type and 
level of skill, and in the numbers of workers, and their geographic distribution. This is one of 
the reasons why State science resists minor science. Any gain in ground made by minor 
science involves a change in the distribution of labour. This can have profound economic and 
social implications, and is likely to be resisted with all the might of capitalism. An example 
would be the promotion of meditation as a substitute for tranquillizers.  
State science has been developed around gravity, seriousness and rectitude. This is related 
to the arborescent form of knowledge and the structuring logos of rectitude. This vertical 
force has led the way to the concepts of “parallel” and “horizontal”. These are derived from 
the vertical force of gravity.  
Homogeneous space is in no way a smooth space; on the contrary, it is the form of striated space. 
The space of pillars. It is striated by the fall of bodies, the verticals of gravity, the distribution of 
matter into parallel layers, the lamellar and laminar movement of flows.7  
Over the centuries scientists and mathematicians have developed a striated space, bringing 
in Euclidian geometry. They have identified the straight line as the shortest path between 
                                                 
5 Nomadic science is science which cannot firmly plant its roots in any particular well structured 
scientific discourse because the ontology or metaphysics of those discourses do not adequately capture 
the things, explanations and phenomena that one needs to be able to understand. Nomadic science 
therefore takes resources where it can and uses them in ways that the contributing disciplines would 
find undisciplined because it asks poorly formed questions that do not properly respect the current 
contours of debate. For instance, when one asks how the legislative context and the political 
emancipation of women affects the biology of the HIV virus this sounds like an illegitimate question. Or 
if one asks how the MAO levels available in the amygdala of the right temporal lobe are influenced by a 
history of colonization, that sounds equally flaky and disruptive or destructive in terms of orderly, 
striated science (“Personal Communication”, Gillett, 2010).  
6 Deleuze and Guattari 1987, p. 367. 
7 Deleuze and Guattari 1987, p. 370.  
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2 Deleuze and Guattari 1987, p. 486. 
3 1987, pp. 361 ff. 
4 Deleuze and Guattari 1987, p. 361. 
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which state-like processes can go on. By contrast, the State science is immersed in rationality – 
like a house or castle or farm with fences.  
The war machine is projected into an abstract knowledge which is developing away from 
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5 Nomadic science is science which cannot firmly plant its roots in any particular well structured 
scientific discourse because the ontology or metaphysics of those discourses do not adequately capture 
the things, explanations and phenomena that one needs to be able to understand. Nomadic science 
therefore takes resources where it can and uses them in ways that the contributing disciplines would 
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striated science (“Personal Communication”, Gillett, 2010).  
6 Deleuze and Guattari 1987, p. 367. 
7 Deleuze and Guattari 1987, p. 370.  
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two points, and the “multiplicities termed metric or arborescent”.8 By now we have a space 
which is homogeneous, and visual. Of great importance is the universal attraction between 
two bodies. With these principles, any part of the world can be a striated space, the striation 
not being tied to any one part of the earth. Whenever a new field of science arises, royal 
science tries to mould the new science into this homogeneous structure. Deleuze and 
Guattari state that chemistry moved forward once the concept of weight had been 
elaborated.9  
Nomadic science is not like this. While it does not refute gravity and its associated 
phenomena, it is not dependent on them, and cannot be reduced to them. It lodges in a 
supplement or excess, over and above gravity and is correlates. A fundamental departure 
was the slightest excess of angle, the slightest deviation from the straight line. Take, for 
example, a body which falls along a curved path. This freedom allows nomadic science to reach 
into unstructured areas. By now we have the space of the smallest deviation, and this is 
smooth space. 
 ...therefore it has no homogeneity, except between infinite proximate points, and the linking of 
proximities is effected independently of any determined path. It is a space of contact, of small 
tactile or manual actions of contact, rather than a visual space like Euclid's striated space.10   
Smooth space is heterogeneous and occupied by different multiplicities. These are acentred 
and rhizomatic. Deleuze and Guattari apply the words rapidity and celerity11 to movement 
which deviates even minimally. As pointed earlier, this movement is vortical (as in a vortex 
or spiral) and actually draws smooth space. “All the points of space are simultaneously 
occupied according to the laws of frequency or of accumulation, distribution; these laws are 
distinct from the so-called laminar distribution corresponding to the striation of parallels”.12 
EBM, so structured, cannot reach into all of smooth space, and so cannot relate adequately 
to the partly disorganized world of human health, with its polyglot forces. In fact, the 
qualitative opposition gravity-celerity, slow-rapid, heavy-light is coextensive with science 
but does not constitute a quantitative part of it. Rather it provides a space for distinguishing 
between striated space and smooth space, and it regulates their interaction, including the 
domination of one by the other.  
Royal science is characterised by reproduction, while nomad science allows thought to get 
away from the traditional base, such as the subject, or humanity, and to wander freely, to 
create new areas.13 In royal science, then, there is enough lattice-work to provide for 
constant relations between variables and continuity between competing representations. 
Deduction and induction are possible. For reproduction to occur, a fixed point of reference 
is available from which to view the process. These are not the processes of itinerant or 
                                                 
8 Deleuze and Guattari 1987, p. 370. 
9 1987, p. 370. 
10 The use of a straight line to limn a curve is well characterized mathematically by means of tangents, 
as Aristotle notes, but the use of a curve to map another curve is not well established and so with 
smooth or nomadic science there may not be striated or well organized relationships of mapping 
between the discourse and its structures of meaning and the phenomenon of interest. 
11 Swiftness. 
12 Deleuze and Guattari 1987, p. 489. 
13 Colebrook 2002, p. xxvii. 
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nomadic science, which moves in smooth space, in search of singularities of matter or 
material, rather than form. The meaning of the world changes. This is because the 
deterritorialization creates the territory. Instead of calculating constants which bind 
variables, nomad science tracks the variations of the variables, as in language.  
The State science is always trying to striate the smooth space. A multiplicity in smooth space 
is at risk of having a grid of parallel vectors superimposed. Then it can be visualised from a 
vantage point. By contrast, nomadic science would have followed the multiplicity “in an 
'exploration by legwork'".14 The nomad science tries to retain or regain its smooth space, 
where it can follow the singularities in vortical flows. State science is often interacting in 
complex ways with the leaders of nomadic science, sometimes conferring a minor position 
in its system upon one of them. 
State science, including experimental science, have considerable conceptual equipment and 
metric power, but ambulant sciences are not able to evolve autonomy. Always in 
problematic mode, they draw, and link up, smooth space. They follow the flow of matter, 
and so stay with reality. However, the modus operandi of State science is to extract 
operations from intuition, setting up categorised structures. Some resources are devoted to 
safety, as in the building of a bridge from diagrams. By contrast, nomadic science's problem-
solving modus operandi often takes it into uncharted territory as it moves from singularity 
to singularity. With regard to the inattention to safety as nomadic science proceeds, it is 
likely to have to sort out the consequences in real life. Deleuze and Guattari15 explain that 
nomadic science works, often intuitively, among problems, but often needs the resources of 
State science to structure and solve these.  
Underlying these considerations is the layer of reality called “thought”. Bear in mind that 
Deleuze and Guattari consider thought to be an active ingredient of life. (So it would be 
more accurate to place thought “within these considerations”.) These authors depict a 
circular relationship between the State and thought. All thought conforms to a model of 
thought produced by the State. But surely we have a way of thinking about the State? But 
we are told how to do that. So which comes first?16 They proceed to describe two heads of 
thought. “There is an imperium of true thinking.....constituting the efficacy of a foundation 
(mythos); a republic of free spirits proceeding by pact or contract...(logos)”.17 For example, 
an organism has a lawlike operation that can be studied within its own boundaries as a 
homeostatic system. (This is related to the episteme of ideal rationality which neglects the 
relationship between power and knowledge.)  
Deleuze and Guattari go on to explain the benefits of this symbiosis. From the State, thought 
gains gravity. Actually, its heaviness takes thought out of the daily arena, to some extent. 
Then it goes unchallenged, and with it the benefits to the State. Perhaps it goes unnoticed 
that the State-form has a consensus. How, without thought, could we fabricate a notion of a 
State possessed of “de jure universality”.18 So the State alone divides subjects into “rebel” 
and “supportive”. Taking advantage of the status of reason, the State characterises itself as 
                                                 
14 Deleuze and Guattari 1987, p. 373. 
15 1987, p. 374. 
16 Deleuze and Guattari 1987, p. 374. 
17 Deleuze and Guattari 1987, p. 375. 
18 p. 375. 
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“the rational and reasonable organization of the community”.19 Drawing on the power of 
the State, reason is fleshed out as the State. “It was all over the moment the State-form 
inspired an image of thought. With full reciprocity”.20  
Deleuze and Guattari21 amalgamate exterior thought and the war machine, in their model. 
Describing noology as the study of thought images, they explain that “outside thought can 
disturb the results of this endeavour. They explain that relating these nomadic, scattered 
thoughts to forces, is not straightforward. For example, Nietzsche's aphorisms, as distinct 
from maxims, await being operationalized by forces (people). The are calculatedly 
disruptive and challenging.  
You shall be such for me that your eye is always seeking an enemy―your enemy. And with some 
of you there is hate at first sight.  
You shall seek your enemy, you shall wage your war―and for your own thoughts!22  
Certain forces (people) will convert these thoughts into a war machine. Thus Deleuze and 
Guattari introduce a diachronic dimension to the amalgamation of nomadic thought into a 
war machine. Occupying smooth space, these outside thoughts do not function in a method, 
as in striated space. The arrow (thought) does not move from point to point. It is taken up at 
any point to be sent to any other point. The points are determined by the change in direction 
of the thought, or the creation of one thought from another, not vice versa. The thoughts are 
primary, the points secondary. This resembles the movement of nomads. 
States must gain control of smooth space, if possible. For example, they set up systems to control 
the movement of ships on the sea, especially the Suez canal, because that is a vital junction 
that controls movement among major domains of opportunity and they police the airways. 
During the cold war, it was unacceptable for a Russian fighter plane to fly through the air 
above the USA. As part of this process of extending its communication channels safely 
through smooth space, the State acts against nomadic movements. This is all part of their 
aim to control all flows, everywhere. Those movements which are allowed are assessed on 
several parameters, such as proximity to striated space, speed and direction. These are 
relativized to the striated space. Here Deleuze and Guattari write of deterritorialization of 
the earth: when States acquire control over smooth space, they pay little attention to the 
details of the subordinated nomads, who may themselves be attuned to the reality of the 
smooth space. An example would be the use of intravenous Vitamin C in the critical zone of 
the Intensive Care Unit (ICU).23 
In section one I have given a post-structuralist account of smooth space/striated space and 
of nomadic science/State science. I have taken the view that EBM is an aspect of State 
science which provides no account of nomadic science or smooth space. As far as possible 
these should be supplanted. I place the doctor and patient with her problems in this smooth 
space, starting this chapter. I now proceed to the medical gaze/EBM gaze which I depict as 
striated and striating.  
                                                 
19 p. 375. 
20 An example of this reciprocity would be between funding and the biomedical model such that more 
wild and singular explorations are marginalised. 
21 1987, pp. 376-7. 
22 Nietzsche 2005, p 41. 
23 Gillett 2011, p. 8. 
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2. The medical gaze 
2.1 The configuration of disease: The space of pathology  
Once pathological anatomy had attained high status in the nineteenth century, the space of 
configuration of disease became superimposed on the body (where it remains). The medical 
gaze superimposes pathology on anatomy: for instance, a histopathologist looks down a 
microscope and “recognises” a tubercle, a lesion pathognomonic for tuberculosis. With her 
training in pathology, she extrapolates from the tubercle under the lens to the disease 
configuration called “tuberculosis”. Foucault says of the sovereign moment of diagnosis, 
The “glance” has simply to exercise its right of origin over truth.  
But how did this supposedly natural, immemorial right come about? How was this locus, in 
which disease indicated its presence, able to determine in so sovereign a way the figure that 
groups its elements together?24 
The space of the configuration of disease has several principles. The knowledge is historical. 
This means that over, say, two days, a range of symptoms and signs manifests itself to the 
clinical gaze. Secondly, the cause is in the same space as effect but Foucault depicts this space 
without a temporal dimension so that time does not figure in this model. In this model of 
the configuration of the disease, “There is only one plane and one moment”.25 (Bear in mind 
that “disease” is an abstraction, like a map. “Disease” is a conceptual system, a reification of 
a dynamic process which may or may not share some core features, across individuals--one 
that we happen to be good at picking up.) A third principle is: “It is a space in which 
analogies define essences”.26 This means that the differences between two diseases, such as 
pneumonia and influenza, is established by analogy through the extent to which their 
surface pictures resemble each other (both exhibit fever and cough, but sputum or the 
presence of basal crepitations27 characterise only pneumonia). Lastly, Foucault explains how 
patient and doctor are interlopers in the disease process or space. Each specific patient 
distorts the ideal picture of the disease because the patient both reveals and conceals the 
disease, and the doctor is in a strange situation using her knowledge of disease as a guide, in 
that she never experiences the disease in ideal form. The doctor chases the disease through 
her patient who distorts the ideal form. In order to know the truth of the pathological fact 
the doctor must abstract the patient.28 What is more, as soon as the doctor begins treatment, 
she further distorts the disease, if the treatment is effective.  
If Foucault is correct, then it is very difficult to practise “patient-centered care” (PCC), which 
has been defined as “quality healthcare achieved through a partnership between informed 
and respected patients and their families, and a co-ordinated healthcare team”.29 The 
practice of PCC is difficult because of the nature and complexity of the diagnostic process. 
Using her knowledge of pathology as a map or guide, the doctor goes on a hunt for one or 
another disease or map defined in relation to others by comparison and contrast. But, as 
                                                 
24 1994, p. 4. 
25 1994, p. 6. 
26 1994, p. 6. 
27 These are fine crackles heard, often at the lowest part of a lung.  
28 Foucault 1994, p. 8. 
29 In a 2004 study of patient-centred care, the American National Health Council defined PCC 
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explained in the previous paragraph, the patient a) obscures and b) distorts the ideal picture 
the doctor is trying to bring into bold relief, although the patient also, perhaps reluctantly, 
reveals the disease. Using shingles (Herpes Zoster) as an example, the patient may obscure the 
disease by presenting with pain in the renal area. Many doctors make the wrong diagnosis 
before the characteristic rash arrives on about the fourth day. With regard to the distortion 
each patient makes, a doctor may be accustomed to seeing shingles in elderly patients. But if 
the patient with a painful rash is ten 10 years old, the diagnosis is difficult. (Of course, if the 
correct diagnosis is made, then the patient has revealed the disease.) Continuing with my 
assertion that the diagnostic process makes it hard to practise patient-centered care, Foucault 
explains that the doctor is constantly seeking lacunae. She thinks in the space between true and 
false (for example, hyperventilation due to anxiety or metabolic acidosis), and in the space 
between viral and bacterial, and in the space between benign and malignant, and in other 
spaces. This difficult thinking, which surely distracts from thinking about the patient only or 
the patient at the centre of the process, can be pictured in a space between obscurity and clarity 
of the disease. In this space is the interaction between the body and the disease. It does not fit 
the ideal forms captured in the canonical texts and treated with canonical methods. Thus I 
have postulated a tension between the primary space of pathology and the secondary space of 
the individual person, as set out by Foucault in The Birth of the Clinic. 
2.2 The medical gaze in more detail 
2.2.1 History  
Canguilhem30 and Foucault extensively develop the space of perception. The term used here 
is “gaze”. The gaze is the perception of the doctor, perceiving the patient, and is scopic or 
visual. This is because, since the end of the eighteenth century, the post-mortem 
examination--which is visual--has fundamentally determined how doctors view the 
diseased patient. Doctors look back from death, in which medical truth is revealed, to life. 
Secondarily, Foucault allows both auditory and tactile modes of perception to intertwine 
with vision in the gaze so that a doctor examining a patient's chest might look at the 
breathing rate, touch the pulsation of the lowermost, leftmost point of distinct cardiac 
pulsation, and listen to the breath sounds, the three forms of perception functioning 
together. However, the sight--hearing--touch perception system is subject to the absolute 
gaze of knowledge. This latter is dominated by death, in that, as previously explained, the 
post-mortem examination is the foundation stone of medical epistemology.  
2.2.2 Pathology dominates the gaze. A new role for death. Medical epistemology 
modernised  
Foucault makes three very interesting points about this imperious, death-infiltrated, gaze. 
The first is that “The 'glance' has become a complex organization with a view to a spatial 
assignation of the invisible".31 “The structure, at once perceptual and epistemological, that 
commands clinical anatomy, and all medicine that derives from it, is that of invisible 
visibility”.32 A doctor (and this is the second point) is drawing a 3D picture, not learning, 
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when she steadies her gaze on the patient. Obviously, the doctor detects from the 2D surface 
(usually: sometimes the doctor conducts an internal examination, for example of the rectum, 
after which she is no longer limited to a 2D assessment) of the body a few clues, through 
sight, hearing and touch. (When a doctor hears a certain type of murmur between the first 
and second heart sounds, she may visualise a narrowed space between the cusps of the 
mitral valve. When she palpates the lowermost, leftmost point of distinct cardiac pulsation 
and finds it is further to the left than normal, she visualises an enlarged heart.) The gaze 
uses knowledge of human life, derived from post-mortem examination, to build a 3D 
(functional) model of the body's disease. This aspect of the Foucaldian gaze is important 
with regard to EBM because its epistemology assumes that the 3D picture is objective. But it 
implicitly undermines EBM evidence in that EBM evidence provides a truth, rather than the 
truth. After all, each doctor might build a different 3D model. A third interesting point made 
by Foucault about the gaze is that it medicalises the human world. This means that people 
are now viewed in a dichotomy of diseased--healthy whereby “....one did not think first of 
the internal structure of the organized being, but of the medical bipolarity of the normal and the 
pathological”.33 EBM has inherited this powerful bias, this binary thinking, not that of life and 
health and normal living.  
I have indicated that the post-mortem examination laid the foundation of the medical gaze 
which henceforth would establish disease as individual and require a nuanced use of the old 
language to express the newly perceived realities of pathological anatomy in combination 
with the age-old symptoms. However, Foucault explains two other developments arising 
from the use of the post-mortem examination. One is that death, as well as being 
individualised, was also concretised. It moved into the space previously occupied by the 
gods and immortality. There was a decrease in theory and systems that had befuddled 
earlier generations of doctors.  
Early in the nineteenth century in France, the belief that disease had an essence which “was 
both nature and counter-nature”,34 was removed from the medical gaze. To constitute the 
new gaze then, the post-mortem examination had to form or inform the foundation of 
medical epistemology--  
In anatomical perception, death was the point of view from the height of which disease opened up 
onto truth; the life/disease/death trinity was articulated in a triangle whose summit culminated 
in death; perception could grasp life and disease in a single unity only insofar as it invested 
death in its own gaze.35 
From early in the nineteenth century, death built into the gaze a better understanding of life 
and disease, using the anatomical--clinical model. Death also built into the gaze the 
dissolution of disease, and the limited nature of disease as that which enabled death, rather 
than death being the consequence of disease. Thus the medical gaze is henceforth structured 
to regard death as more fundamental than disease, which death elucidates (through post-
mortem examination) and terminates (hence it is basilisk-like). 
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The epistemological foundation stone for this view of disease is, by now, the post-mortem 
examination and from that origin the gaze proceeds to construct the individual. Previously, 
clinical medicine had dealt with cases. But the new gaze is to be different. The post-mortem 
examination provides information about the individual so disease is primarily the disease of 
an individual. It is no longer the case that each individual presents a variation on a general 
phenomenon. Thus the idea that the individual is an exemplar of a general phenomenon is 
now problematised.  
2.2.3 The gaze is multifaceted  
The gaze is “not content to observe what was self-evident”.36 
Foucault explains that the gaze involves possibilities and probabilities, risks--and experience. 
He reminds us that society confers authority on the doctor, so that the doctor from her gaze, 
announces the truth (The doctor says she has cancer: so she has cancer).  
In the clinic, it was a question of a much more subtle and complex structure in which the 
integration of experience occurred in a gaze that was at the same time knowledge, a gaze that 
exists, that was master of its truth .... . . At this level there was no distinction to be made 
between theory and experience, method and results; one had to read the deep structures of 
visibility in which field and gaze are bound together by codes of knowledge;...the linguistic 
structure of the sign and the aleatory structure of the case.37  
2.2.4 Disease is now visible, but needs to be articulated 
Here Foucault draws attention to the need for a language that relates the signs and 
symptoms of diseases to human understanding and communication. This matter belongs in 
linguistic and semiological spaces. Bear in mind that the gaze includes questioning the 
patient, in language. The patient answers verbally and non-verbally. Foucault explains that 
language needed to adapt to the new knowledge so that the disease of the individual could 
be seen. Doctors who conducted the post-mortem examinations needed to clothe the new 
knowledge in words that would convey it to absent clinicians:- 
It is no longer a question of correlating a perceptual sector and a semantic element, but of 
bending language back entirely towards that region in which the perceived, in its singularity, 
runs the risk of eluding the form of the word and of becoming finally imperceptible because 
incapable of being said.38 
Foucault tells us how the language was adapted to express the new perceptions “to 
introduce language into that penumbra where the gaze is bereft of words”.39 He mentions 
the use of colour, metaphor, empirical comparisons, the value of intersensorial qualities, and 
references to the normal and everyday. Many of these ways of making the perceived 
expressible were deployed by Laennec, whose early description of one cirrhotic liver, 
quoted by Foucault, exemplifies these linguistic developments.  
                                                 
36 Foucault 1994, p. 89. 
37 pps. 81, 90. 
38 Foucault 1994, p. 169. 
39 1994, p. 169. 
 
A Post-Structuralist View of Evidence-Based Medicine (EBM) 
 
65 
The liver...when cut, it seemed to be made up entirely of a mass of small seeds, round or oval in 
shape, varying in size from a millet seed to a hemp seed. These seeds, which can be easily 
separated, left almost no gap between them in which one might be able to make out some 
remaining part of the real tissue of the liver; they were fawn or reddish-yellow in colour, verging 
in parts on the greenish; their fairly moist, opaque tissue was slack, rather than soft, to touch, 
and when one squeezed the grains between one's fingers only a small part was crushed, the rest 
feeling like a piece of soft leather.40 
I have alluded obscurely to an issue which needs clarifying. In Foucault, a distinction is 
made between a statement and the visible. I have explained that when the post-mortem 
examinations were first used to provide knowledge, it was necessary to develop a language-
-statements--to match the visible. Foucault provides an account of the difference in the 
nature of these two, the visible and the articulable. Read what Deleuze explains regarding 
Foucaldian theory:  
...there is a difference in nature between the form of content and the form of expression, between 
the visible and the articulable (although they continually overlap and spill into one another in 
order to compose each stratum or form of knowledge). ...Between the two there is no isomorphism 
or conformity, in spite of a mutual presupposition and the primacy of the statement. ...there is 
neither causality from one to the other nor symbolization between the two, and that if the 
statement has an object, it is a discursive object which is unique to the statement and is not 
isomorphic with the visible object. Of course we dream of isomoprhism, ….”41 
I consider that all this eludes EBM. Does this matter? I argue that EBM rides rapidly over 
some deep and obscure issues yet urges us to change the way we treat sick people. EBM 
moves the articulable around from paper to paper and book to book to guidelines, but I 
suspect that these writers assume that the object of the statement is the visible object: I am 
sure that EBM protagonists assume that what we are saying matches what we are seeing. In 
simple terms, then, I am arguing that such complex, underlying issues make the strident 
assertions of EBM protagonists seem too strident.  
2.2.5 Reconfiguration of the doctor, patient, consultation and epistemology 
The other consequence of the new perceptual structure was that this visual system rested on 
an opaque base. This means that what lay beyond the base was not available for the 
constitution of knowledge. This is of enormous importance for EBM. Foucault postulates 
that a change in doctor/patient relationship has occurred over recent centuries in which the 
key element is epistemology. He uses the metaphor of a grid. By now doctor, patient and 
their interaction take place in this new grid. This is like children moving their game to a 
jungle gym. However, no analogy is complete, and, in fact, the children are newly configured 
(their bodies can go through different sequences), as well as playing by different rules which 
have resulted from a fundamentally different knowledge that the jungle gym prescribes. This 
is like a discipline that introduces a new habitas, like the posture associated with ballet.  
Previously the doctor and patient were taken as given, not as problematic, although this is 
an exaggeration. Medical progress was considered to have occurred between the two 
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“givens”. For example, early in the twentieth century it became possible for a doctor to 
arrange for the patient's chest to be X-Rayed. But against this given-ness of the doctor and 
patient, both were constructions in flux. Late-twentieth-century patients began to manage 
their own asthma and diabetes, and the doctors also changed. Early in the twentieth century 
a chest physician had skills to map out the tuberculous cavities in the chest, with whispering 
pectoriloquy, percussion, and auscultation for bronchial breathing. The late-twentieth-
century chest physician had lost some of these skills, but become expert in reading a chest X-
Ray film. The chest physician had become subject--in turn--to the gaze. This applies with more 
force to the cardiologist and neurologist with electrocardiograms, ectroencephalograms, ultra-
sound, magnetic resonance imaging and computerised axial tomography.  
The space between doctor and patient changed to further complexify the shifting relationships. 
The physician moved closer to the patient, beginning to examine the rectum and vagina, and 
to pass a sigmoidoscope into the colon. These procedures brought the interior more directly 
under the scopic gaze.42 But further even again to these profound changes from a more subtle 
and profound level, Foucault challenges this “given”, unproblematic nature of the doctor, 
patient, and consultation space. In the last two decades, EBM has further reconstructed the 
patient, doctor and intervening space reconstructing the smooth and striated yet again:--43 
A more precise historical analysis reveals a quite different principle of adjustment beyond these 
adjustments: it bears jointly on the type of objects to be known, on the grid that makes it appear, 
isolates it, and carves up the elements relevant to a possible epistemic knowledge (savoir), on the 
position that the subject must occupy in order to map them, on the instrumental mediations that 
enables it to grasp them, on the modalities of registration and memory that it must put into 
operation, and on the forms of conceptualization that it must practice and that qualify it as a 
subject of legitimate knowledge. What is modified in giving place to anatomo-clinical medicine is 
not, therefore, the mere surface contact between the knowing subject and the known object; it is the 
more general arrangement of knowledge that determines the reciprocal positions and connexion 
between the one who must know and that which is to be known. The access of the medical gaze into 
the sick body was not... it was the result of a recasting at the level of epistemic knowledge (savoir) 
itself, and not at the level of accumulated, refined, deepened, adjusted knowledge (connaissances).44 
The EBM clinician makes little use of herself as a person.45 Although her reality is with her 
patient, she quickly sets out on a conceptual trajectory which distances her from her patient. 
She first asks what group of Patients or experimental subjects her patient can be placed in. 
Then her mind continues to function at a distance from her patient by asking what 
Intervention she should consider. Third, her mind continues at a distance by asking what 
intervention is probably less suitable, for Comparison. Lastly, she projects herself out of the 
here and now by asking what Outcome, in the future, she is planning. This is the scheme for 
the PICO question, the start of the EBM process. 
The modern (EBM) patient is biomedical, hopefully has one acute disease, depictable though 
the science of pathology, and is viewed against a background of one or more groups of 
similar patients whose disease has been investigated through one or more RCTs and/or 
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observational studies. Suitable treatment is available, and affordable. The modern (EBM) 
doctor is steeped in the studies and/or their downstream proliferations. She sees her patient 
against a background of groups of experimental subjects whose similarity to her patient she 
is assessing. Where possible, she is applying clinical guidelines. The space between doctor 
and patient is infiltrated with research/statistics, and the computer/internet. This is how the 
grid is constructed. Doctor and patient have moved towards the model of experimenter and 
experimental subject.  
All parties work in a grid of knowledge that has been, or should have been, reconceived, not 
just increased. The legitimated knowledge is computerised biomedicine, connecting a 
biomedical patient with a guidelined doctor. This legitimated knowledge has been produced 
by biomedicine's emblematic group, the protagonists of EBM―a group that has determined 
what counts as knowledge, who speaks authoritatively, and in particular, what counts as 
evidence, and what does not. Critically important are the reliability of evidence, the strength of 
the recomendations flowing from the evidence, and the power/knowledge supporting these. 
Foucault makes the point that the sciences of Man and the notion of the uniqueness of Man 
and his individual qualities, separating him from nature and so on, were not so-called ground-
breaking “discoveries”. The “Enlightenment” did not “roll back the frontiers of ignorance” 
and provide a means of knowing the “truth”. The “truth” was the product of discourse. 
Discourses may be understood as bodies of knowledge or disciplines, in themselves the form 
of disciplinary practices.46 A discourse enables and limits what can be thought, said and 
written during a period of time. Discourses produce knowledges and knowledge is made 
known historically. The historical constitution of knowledge undermines any claim that 
knowledge is impartial or better than previous knowledge. Foucault does not see an extra-
discourse point from which we can assess the correctness of any discourse. Thus the truth 
about “Man” is not a pale reflection of a real, natural man, idealised in form and content but 
the actual, engaged, situated human beings described in social sciences and works of art.  
It is my contention that EBM does not acknowledge the Foucaldian insight that EBM does 
not investigate and treat an objective patient, through an objective doctor. Foucault would 
argue that EBM has constructed the patient, the doctor, and the consultation space. As 
stated above, EBM has not just added to our knowledge, EBM has set up a new knowledge. 
And not only that. EBM has established itself as the creator of knowledge, has decided how 
knowledge is legitimated (through RCTs and observational studies leading on to an 
hierarchy of evidence and the strength of recommendations flowing from the evidence). It is 
my contention that all this floats free of evidence, and that the medical profession has not 
debated it to an agreed conclusion.47 You could say that EBM has not just altered the 
goalposts. It has moved us to a new football field and reconfigured the teams and the rules. 
And yet in some ways EBM plays as if we were on the old field (realistically or mind-
independently construed). It's proponents do not acknowledge the constructed status of the 
patient, the doctor and the consultation space. They do not acknowledge that the patient is 
set up in terms of variables and mechanisms which EBM can investigate and treat. The 
investigating gaze of the EBM doctor takes itself to be dividing even to the joints and 
marrow of nature itself (“cutting nature at the joints”), armed with the spirit of truth.  
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“givens”. For example, early in the twentieth century it became possible for a doctor to 
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43 Of course, Foucault is writing of the early nineteenth century in France. 
44 Foucault 1994, p. 137. 
45 I draw on Wifstad 2008 for this line of thinking.  
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observational studies. Suitable treatment is available, and affordable. The modern (EBM) 
doctor is steeped in the studies and/or their downstream proliferations. She sees her patient 
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With regard to health care research, the topics selected for investigation will need to fall 
within the area of intersection of the gaze and health care. The EBM doctor will look for 
problems suitable for investigation (which assumes funding) through RCT or observational 
study. Typically this will involve holding one or more variables constant while altering one 
or more other variables. Obviously, this assumes that such variables can be isolated and 
dealt with. But there are many aspects of health care which would struggle to fit into this 
model. For example, palliative care has developed a discourse of dying. There is now a right 
way to die: quietly. Patients should realise that there comes a stage when definitive 
treatment should yield to symptomatic treatment. Patients should be actively involved in 
decisions. But some patients reject this modern discourse on dying. I am not sure that EBM 
investigates ways a team steeped in the palliative care discourse can work together to 
support this recalcitrant patient. An issue here for EBM is that the team may be divided as to 
how to proceed.  
Gillett48 gives an account of HIV/AIDS as a postmodern illness which reveals the limitations 
of biomedicine, and therefore EBM. In the West, at any rate, the illness follows a period in 
which traditional values were challenged. This means that some men formed sexual 
relationships with other men. Other people injected drugs intravenously. These choices 
confronted the power of biology, in that some people developed HIV/AIDS. Despite 
extensive research, the (biomedical) treatment for this condition is only partly effective. 
Sufferers were forced together to try to deal with prevention and education and to support 
each other in grief. This group of people, accustomed to challenging the social hierarchy, 
developed partnerships with their health providers, negotiating treatment. Doctors and 
sufferers had to face the question of whether to tell the partner that the patient had tested 
positive. Ethical questions arose over testing people for the virus. Although I have referred 
to the West, the condition spread extensively in the third world. In Africa, Gillett49 tells us, 
some men enjoyed their sex with or without the preparedness of the woman. Women often 
have little education, political power, or rights within the marriage. This all facilitated the 
spread of infection among women, and therefore among men and children. An ethical issue 
arose over research into this condition. Largely led by Western organisations, any such 
research in third world countries was bedevilled by the fact that those who took part in the 
research were unlikely to be able to afford its benefits. In one study, some desperate 
research subjects managed to decipher the code in the RCT and break protocol by handing 
around the active moiety. The point I am making is that there is a (disease) space in which 
culture and biomedicine meet. With Gillett,50 I submit that much of what I have described is 
poorly handled by EBM, whose gaze is restricted―EBM is blind to certain aspects of the 
problem that is human disease and therefore it may be blind to critical determinants that 
will make a real difference to the suffering caused. Then with Foucault, I draw attention to 
the dominance of the narrow EBM discourse and to the association of knowledge and 
power. The western biomedical gaze constructed our solutions in terms of pharmaceutical 
remedies rather than in terms of socio-political change, revealing the hegemony of the 
biomedical, pathological anatomy gaze.  
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The medical gaze has been said to discriminate against some patients. Such issues as social 
class, gender, race and whether the patient is paying, have received comment. The medical 
gaze struggles with comorbidity, and with poorly defined problems and language 
problems. The medical gaze also struggles with the fact that the modern equivalent of the 
Hippocratic airs and spaces is to widen our gaze to the socio-culturo-politico-historical 
contexts of disease. As stated above, this last struggle has implications for patients with 
AIDS, for example.  
The gaze surely includes the higher valuation which doctors place on signs as distinct from 
symptoms. This is described by Foucault,51who explains how numerous chest diseases can 
be heralded by such symptoms as cough and shortness of breath. However, early in the 
nineteenth century, Laennec focused on examination of the chest. He found that, in a few 
patients, the voice was transmitted surprisingly well to a small area of the chest wall. He 
called this clinical sign “pectoriloquy”, and made the (epistemological) decision that this, 
rather than the symptoms, would establish the diagnosis (of Pulmonary Tuberculosis). To 
this day doctors prioritise signs (and particularly images and the results of laboratory 
investigations with their attached figures) over symptoms if they point to different 
diagnoses. In passing I note the very interesting point that Laennec made an epistemological 
leap. However, the point of this paragraph is simply to flesh in Foucault's medical gaze with 
more detail.  
2.2.6 EBM rhetoric 
EBM exaggerates the importance of its "gold standard" evidence in the EBM gaze. During 
the (PICO) conceptual excursion, the doctor needs look back at her patient and assess the 
patient's suitability for this research-based intervention. EBM leaders have, in 2008, 
provided detailed guidance on this. There is a complex issue regarding the judgment as to 
whether the patient is suitable for the intervention, the alternative, and even the outcome 
proposed. The doctor must know something of the patient, her attitudes, values, 
preferences, and perhaps even her social situation. With increasing emphasis on the 
business aspect of medicine and also the scientific aspect and the computer, this detailed 
understanding of the patient is declining in comparison to what it was in the time when 
most people lived in a country district and saw one doctor over many years. The 
knowledge of the patient, who is reified, is incomplete and inaccurate. Whatever 
assessment the doctor makes, the knowledge of the patient is fallible and not based on an 
RCT. The knowledge of the patient is different in kind from the RCT knowledge. This surely 
limits the entire EBM discursive practice which projects the image that it is based on the 
results of clinical studies. Even so, as stated by numerous authors, the gap between the 
group data and the individual's suitability cannot be reduced beyond a certain, unknown, 
distance. The actual susceptibility of the patient for the researched intervention cannot be 
precisely known. If the clinical doctor follows the study results and invokes the intervention 
for her patient, we can, at best, hope and believe that that the intervention will be helpful. 
Regrettably, if the patient improves, we still do not actually know whether the intervention 
caused the improvement, or was coincidental.  
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2.2.7 The docile body 
Foucault's gaze has been problematised. The trouble is that the patient does not look back! 
(This has been called “the docile body”, and does not square with phenomenology.) There is 
an air of dominance here. My comments on the sufferers from AIDS are a suitable antidote. I 
represent these patients as active in the medical relationship.  
Bloor and McIntosh noted that the subjects of the surveying therapeutic gaze responded in 
various ways, including direct rejection and attack on the value and legitimacy of the health 
worker's52 attentions, non-cooperation, silence, escape, avoidance, and most-common of all, 
concealment.53  
In my work as a Police Medical Officer, I need permission to examine every patient in police 
custody. Sometimes this is not granted, even when the patient asked for a doctor, and I have 
travelled 22 kilometers during the night. In my third year I was challenged as to whether I 
was a Police Medical Officer (as I had stated) or “just a doctor off the street”. I always have a 
constable with me, so questions about the intake of drugs and aclohol, intended to help me 
assess the state of the brain, receive a variety of responses. Recently, in obtaining a history as 
to how the patient gained an incised wound in front of his patella tendon, I was given 
completely different accounts by the patient and constable. These police patients, then, 
sometimes show up one limitation of the medical gaze.  
3. The medical /EBM gaze meets the smooth space of the doctor-patient 
consultation which includes the patient and her problems 
I now bring the EBM gaze, which includes the results of epidemiological research, 
conducted on large groups of experimental subjects, into the smooth space of the patient. 
However, the reticulated knowedge of the EBM gaze is a poor fit for the smooth space of the 
patient. As the reticulated gaze arrives in smooth space, it leaves gaps between the laminae 
of the framework. Thus it fails to deal adequately with the smooth space of the patient. 
Consider the wild suffering and wellness that escapes medical surveillance because its flows 
of energy are not easily categorized into the diagnoses and tests that yield currency for EBM.  
EBM has forced us to develop our understanding of the application of evidence derived 
from large groups of experimental subjects to the individual patient and so has addressed 
one of its most frequently cited problems. “The inferential leap necessary for treating an 
individual based on aggregate findings is mostly assumed away”.54 But in an RCT, some 
patients are excluded, subjects actually take their medication, the treatment period is likely 
to be short and closely monitored in comparison with future widespread use of the 
treatment, and the control condition often uses placebo treatment, not a realistic option for 
the “nomadic” clinician.55 The end points of the research may differ from the outcomes of 
interest to the doctor and/or patient, a problem not always captured in terms of internal 
versus external validity.56 The theory which the RCT provides evidence for is therefore not 
                                                 
52 Strictly speaking, this quote refers to British health visitors calling on mothers, not actually to doctors.  
53 Lupton 1997, p. 104. 
54 Tanenbaum 1999, p. 757. 
55 Worrall 2010.  
56 Bluhm 2010.  
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the theory that the trialled treatment will, overall, be beneficial for the next patient. 
Therefore the relationship between group research (in striated space) and clinical care (in 
smooth or nomadic space) is not self-evident despite voices to the contrary.57 
The vexed issue of how apply the findings from population research to the individual 
patient is partly clarified by attention to patient characteristics (including age, severity of 
disease, comorbidity, ethnicity, and compliance with treatment regimens), healthcare 
system characteristics (skills of treating doctors, treatment or test availability, monitoring) 
and outcome characteristics (do study outcomes matter to the present doctor/patient dyad, 
surrogate endpoints, such as bone density rather than fractures, and so on).58 The clinical 
doctor treating the individual patient on the basis of population research needs to notice the 
number needed to treat figure “for a group of individuals resembling their patient”,59 and to 
carefully look into relative risks and absolute risks as they exist for the unselected people 
who walk into the clinic rather than the select group in whom study effects are seen. What is 
more, even though subgroup analyses reflect “patient diversity in risk for disease, 
responsiveness to treatment, vulnerability to adverse effects, and utility for different 
outcomes”,60 subgroups of one are not part of that kind of science even though they are the 
norm in the nomadic space of real world clinical medicine. When we add ethical 
considerations of patient choice and the acceptability of treatment to the mix61 it is no 
wonder that results produced in a striated world do not apply at the contested margins of 
striation where nomadic knowledge charts its paths through smooth spaces of unstructured 
and sometimes chaotic experience.62  
EBM does not tell us how to mix and match the five warrants that plausibly should attend 
clinical decision-making. (These are: the results of clinical research, pathophysiological 
reasoning, clinical experience, patient preferences and actions, and system factors {such as 
the availability of a test or treatment.}) Differences in ontology, methodology, epistemology 
and ethicality criss cross the field.63 Firstly, there is an ontological difference between 
pathophysiology and system factors. For example, while pathophysiology may be anchored 
in the biology of antibacterials, system factors may be anchored in health economics such 
that a general practitioner is not allowed to prescribe certain drugs. The difference in these 
two warrants is ontological in that they belong to different orders of reality. Second, an 
epistemological difference exists between clinical experience and the results of an RCT – one 
depends on judgments of similarity and difference between particular instances of illness 
(the last spinal empyema and this one) and the other on the adequacy of inclusion and 
application criteria relating particular cases to a general category (this pneumonia as an 
                                                 
57 Silva & Wyer 2009.  
58 Bassler, Busse, Karanicolas & Guyatt 2008. 
59 Bassler, Busse, Karanicolas & Guyatt 2008, p. 2.  
60 Bassler, Karanicolas, Busse & Guyatt 2008, p. 1.  
61 Bassler, Karanicolas, Busse & Guyatt 2008.  
62 I must admit that the frequent emphasis in my work on the chaotic nature of clinical practice is 
perhaps excessive, and intended to contrast with EBM. I am aware that Descartes and many other great 
thinkers have been struck by orderliness in the universe, and its susceptibility to mathematical 
modeling. And there was some structure in the clinical consultation before EBM. For example,the 
results of pathophysiological experiments have guided doctors for a very long time.  
63 Kerridge 2010.  
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The vexed issue of how apply the findings from population research to the individual 
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and outcome characteristics (do study outcomes matter to the present doctor/patient dyad, 
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more, even though subgroup analyses reflect “patient diversity in risk for disease, 
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instance of bacterial infection). Thirdly, there is a difference between patient preferences and 
and the clinical experience of the doctor as in the choice for abortion and the doctor’s 
judgment that it will turn out badly for the woman concerned. There is a major ethical 
component in the way the decision is arrived at in that the patient chooses and the doctor 
can only advise on the basis of experience. Somehow these two warrants must be combined 
and how to do so is unclear.  
We can draw two conclusions from this analysis of the difficulty in combining warrants for 
decision. One is that there is an epistemological crisis in medicine, since we now realise that 
we do not know how to amalgamate five streams of very different kinds of knowledge. The 
second is that we no longer know what (in real life) EBM is: 100 different doctors may 
combine the multiple warrants for decision in different ways and in this task of integrating 
the warrants, no schema has been agreed or even proposed.  
I now direct more attention to the difficulty of combining the five warrants for decision.  I 
actually simplify the problem by selecting just two of the five warrants. The problem then 
simplifies to: how to combine the result of epidemiological research with clinical experience. (I allow 
myself to wander a little between clinical experience and clinical intuition).  Note that EBM 
uses the term "integrate" for the warrants for decision.  
Deleuze and Guattari64 provide an analysis of the impasse. (Note that there is a difference 
between clinical experience and clinical expertise.) Consider clinical research results and 
clinical expertise and recall the 200265 model of decision making whereby clinical expertise 
brokers the possibly conflicting claims of research evidence, patient preferences and actions, 
and clinical state and circumstances. The EBM desire to bring the results of clinical research 
into clinical decision making can be viewed as an attempt to striate smooth space—the 
epidemiological evidence is used to reticulate the smooth space of clinical experience/intuition 
and patient management.66 
Smooth space and striated space—nomad space and sedentary space—the space in which the war 
machine develops and the space instituted by the state apparatus--are not of the same nature. No 
sooner do we note a simple opposition between the two kinds of space than we must indicate a 
much more complex difference by virtue of the successive terms of the oppositions fail to coincide 
entirely. And no sooner have we done that than we must remind ourselves that the two spaces in 
fact exist only in mixture: smooth space is constantly being translated, traversed into a striated 
space; striated space is constantly being reversed, returned to a smooth space. In the first case, 
one organises even the desert; in the second, the desert gains and grows; and the two can happen 
simultaneously. But the de facto mixes do not preclude a de jure, or abstract, distinction between 
the two spaces. That there is such a distinction accounts for the fact that the two spaces do not 
communicate with each other in the same way: it is the de jure distinction that determines the 
forms assumed by a given de facto mix and the direction or meaning of the mix (is a smooth 
space captured, enveloped by a striated space or does a striated space dissolve into a smooth 
space, allow a smooth space to develop?). This raises a number of simultaneous questions: the 
simple oppositions between the two spaces; the complex differences; the de facto mixes, and the 
passages from one to another; the principles of the mixture, which are not at all symmetrical, 
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sometimes causing a passage from smooth to striated, sometimes from striated to smooth, 
according to entirely different movements.67  
If this is an accurate analysis, then it follows that rational integration eludes us with regard 
to the desire of EBM to resolve the conflict between the results of clinical research and 
clinical experiences/intuition.68 
There is another way of seeing why we cannot rationally reticulate smooth space and 
develop a method to overcome the difference because in the multiplicities we deal with in 
human life a kind of tacit knowledge, similar to clinical intuition/expertise, is indispensable. 
We have on numerous occasions encountered all kinds of differences between two types of 
multiplicities: metric and non-metric; extensive and qualitative; centred and acentred; 
arborescent and rhizomatic; numerical and flat; dimensional and directional; of masses and of 
packs; of magnitude and of distance; of breaks and of frequency; striated and smooth.69  
While it is possible to create rules to deal with entities that are part of the same order, it is 
not rationally possible to reticulate or divide up a commodity which is heterogeneous and 
intensive. Take pain. Although doctors ask patients to rate pain on a scale of ten, we cannot 
move from there to arguing that if a treatment leads a patient to change the rating of the 
pain intensity from 10 to five, the pain (as an orderly variable) has been halved. There are 
many areas of medicine not amenable to rational metrication and biostatistics because they 
are intrinsically relational rather than objectively fixed.  
In the last few paragraphs I argue that there is no rational way to merge the results of 
epidemiological research with clinical intuition. I heralded an epistemological crisis in 
medicine, though I am not the first to do this. So what are doctors doing? The method of 
mixing these disparate inputs lies not in any codified system. They are joined through 
implicit, not explicit, knowledge, as is learned by a house surgeon from her senior. The 
judgments involved are learned by the less experienced doctor. Thus the epistemological 
crisis moves into the field of tacit knowledge. A lengthy and detailed explanation, which 
draws on Wittgenstein and Kuhn, of the way in which all codifiable knowledge rests in a sea 
of implicit knowledge is developed by Tim Thornton70 who argues that both scientific 
research results and clinical expertise rest, in fact, on tacit knowledge. Whatever codified 
knowledge is to be used, judgement is required as to which codified knowledge and whether 
and when to use it.  For example, judgment is required in selecting a theory to apply to 
several diverse scientific problems. Thornton points out that the best and fullest accounts of 
EBM make this clear, but EBM does lend itself to distortion in which evidence-based 
medicine quickly slips into codified knowledge, paying little attention to the backgound use 
of judgement or implicit knowledge. The devil is in the detail as to the wise use of the term 
"based".  
If Deleuze and Guattari71 are right, a method for reticulating decision-making warrants into 
evidential form is bound to fail72 in that new forms of evidence would suffer under the 
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tyranny of data,73 and the whole approach of reticulating the warrants for decision into 
evidential form ignores the argument that the inputs cannot be construed as evidence. The 
attempt itself is a totalising tendency suited to a striated domain of action and not nomadic 
science and it marginalises the idiosyncratic aspects of patients, doctors, and their 
interaction so that “the movement challenges professionalism by disputing what and how 
physicians know, and especially by marginalising what one physician can know about one 
patient”.74 This encounter-based knowledge is smooth or nomadic and does not have a 
settled scientific home.   
The assertions of EBM, focused on the importance of clinical research, falter because 
medicine is at the intersection of several sciences and even of diverse scholarly disciplines 
each with its own mode of knowing. For example, the humanities, such as anthropology and 
history, emphasize qualitative evidence and argument. Ethics draws heavily on rational 
thought and the critical examination of claims to good practice. Therefore placing evidence 
from epidemiology and biostatistics in the dominant position for clinical understanding is 
hegemonic.75 Post-structuralist writers interweave “evidence” with issues arising when one 
takes note of power and regimes of truth. Misak,76 for instance, explains that narrative 
evidence can provide insight into what it is like to be sick, or to receive investigation and/or 
treatment that is likely to escape RCTs. She gives detailed comment on how we all assess 
what we are told and incorporate it into our stories and provides a framework for a still 
better assessment of the multiplicity and richness of clinical phenomena. 
4. Reflections on science in medicine 
EBM attempts to put medicine on a more scientific footing, using clinical epidemiology. As 
is well-known, the early protagonists were concerned about variation in medical practice, 
cost, and the clear possiblity that even expert opinion may not square with the evidence 
derived from clinical research. One issue here is whether medicine can be classed as a 
science. The relationship between medicine and science is complex and much debated (Is 
medicine a science or an art? EBM protagonists have said that they will help provide the art 
of medicine with a scientific basis.). I take the view that medicine draws on a number of 
disciplines, including physiology, ethics, law, epidemiology and biostatistics, anthropology 
and so on.  I have positioned my work to be alert to any tendency of epidemiology and 
biostatistics to dictate its rules of evidence to the whole of medicine. In this regard, I note 
that De Caro and Macarthur77 introduce a volume which explains the difficulties scientific 
naturalism has in dealing with a number of issues which occur in medicine. For example, 
scientific naturalism, “where causes are thought of as mind-independent”78 is under strain 
when it attempts to provide convincing accounts of intentional states, human freedom and 
personal identity, of patients, doctors and researchers. Scientific naturalism provides us with 
an account of objects placed in a world-as-studied-by-science. These objects can even 
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include meaning, motivation and values. However, De Caro and Macarthur79 allude to a 
chapter by Huw Price, which draws attention to the “metaphysically substantial conceptions 
of reference and truth” supporting this object world. These authors note an asymmetry in 
this naturalism: it is heavy on the object but light on the subject. Explaining this, De Caro 
and Macarthur draw attention to the negligible attention paid to use of linguistic terms and 
expressions. This subject naturalism is strangely omitted. There is also their tendency to 
accept a fundamentally foundational and exclusively true and well-ordered scheme of 
knowledge with a unitary structure of justification and principles of validity and worth. 
I consider that epidemiology and biostatistics exemplify scientific naturalism and cannot 
cope adequately with some aspects (such as intentional states, freedom, personal identity) of 
the lives of patients. From here it is a short step (via psycho-neuro-humero-immunology) to 
denying epidemiology and biostatistics supreme authority in medicine. This is an example 
of my application of philosophy to EBM. I hope this approach savours more of providing a 
viewpoint than the authority of philosophy. In any event, I am comforted by the last 
sentence in De Caro and Macarthur’s “Introduction”,80 ending...” the distinction between 
science and philosophy is one that is constantly being negotiated.”  
In further consideration of what authority science has in medicine I now provide an answer 
to the question I asked two paragraphs back: Is medicine a science or an art? Montgomery, in 
her book, "How doctors think",81 tells us it is neither: it is a practice. By now I have argued 
that medicine is a practice which draws on science. If this is right we need be circumspect 
regarding any claim which science may make as to its authority, epistemically, in medicine. 
This matter has been dealt with extensively by many authors such as Miles, Loughlin and 
Polychronis. Rather than reiterate their viewpoints, I will limit myself to post--structuralist 
comment. According to Foucault, knowledge and power are inseparable. And from the 
point of view of Deleuze and Guattari, now that EBM has been so extensively problematised 
at the conceptual level by the above-mentioned authors, we are not in a position to anoint 
this approach to medicine as "the truth".  In fact post-structuralist thinkers allow a range of 
pathways to knowledge, including the provision of knowledge by one doctor about one 
patient. Even patients can conrtibute knowledge. To what extent is the patient's pain 
reduced by the treatment? Heidegger, admittedly not a post-structuralist philosopher, tells 
us that being cannot be investigated as if it were an entity, using "positive" sciences like 
biology. Rather being has the struture of meaning, and is best investigated 
phenomenologically. It seems to me that pain is nearer to being than to an entity.  
5. Conclusion 
Much of what I have written has been written before. I beleive that the cutting edge of my 
own contribution lies in the following points. The EBM process starts in smooth space, 
proceeds into codified knowledge, and returns to try to striate or organise smooth space. I 
have highlighted the rapid distancing from the patient involved in the PICO question and I 
look forward to providing an existential/phenomenological account of this in a later paper 
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on Heidegger. As the doctor assesses the suitability of the patient for the intervention she 
hopefully takes account of detailed advice provided by EBM leaders in 2008. Even so, I 
suggest that the more we focus on science, on business and on the computer, the more we 
move away from the relationship of yesteryear when a doctor, ideally, knew her patient. 
When all has been said and done, the knowledge which the doctor has of her patient's 
suitability for the intervention is of a different kind from the much-vaunted knowledge 
derived from clinical research. I take the view that this provides EBM with a scarcely-
acknowedged soft underbelly.  
I have drawn on the writings of Kerridge and Deleuze and Guattari to argue that the 
warrants for decision are heterogenous with reagrd to ontology, methodology, ethicality 
and epistemology and that they cannot be integrated, rationally. I have presented the process 
as warrants for decision being mixed through tacit knowledge, often learned from a senior 
doctor. I have presented clinical research as an example of striated space and clinical 
experience as an example of partly smooth space (intuition). Deleuze and Guattari explain 
that it is not possible to integrate smooth space and striated space. Not rationally. Thornton 
moves the issue into tacit knowledge.  
I consider that EBM has scarcely noticed that it has partly constructed the (guidelined) 
doctor, the patient (consortium of variables) and the (research-infiltrated) consultation 
space. And it has scarcely noticed the meta-epistemological issue that it has set itself up to 
determine what constitutes medical knowledge and that it assumes the the visble and 
articulable are isomorphic. It has given no account of nomadic science and works with the 
belief that smooth space should be striated and that it can be striated. Never mind infinity, 
the smallest deviation and the space between the laminating parallel lines. EBM seems 
unaware that we know more than we can descibe (this relates to the way in which tacit 
knowledge extends beyond the explicit knowledge in which EBM trades) and that whatever 
does not get into the medical/EBM/gaze is not a candidate for knowledge/research.  
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1. Introduction 
In many ways, physicians and surgeons practice in a manner reminiscent of individual care 
provided in the late nineteenth century. The patient presents with a complaint or condition, 
the physician queries the patient, gathers physical evidence from examination and other 
measures, performs a mental exercise that arrives  
first at an answer of what the problem is, then what caused the problem then a solution 
(treatment) is selected from a menu of options. Though the patient presents with a problem, 
the approach to solving the problem was entirely driven by the education and training of 
the clinician. In earlier times, diagnoses and treatment were often lacking, and the role of the 
clinician became one of educator or comforter rather than healer. 
In the early part of the 21st century more is expected of those physicians providing 
diagnostic and treatment services. There is a greater understanding of physiology and 
pathological process affecting human health, and there is a greater array of treatments for 
injuries and conditions. Among the contemporary patient expectations are 1) the physician 
is actively listening and placing the wants and needs of the patient above all else, 2) the 
healthcare provider is delivering the most effective means of arriving at an accurate 
diagnosis then providing the most appropriate care and 3) does the expected outcome of 
treatment meet the needs of the patient while remaining affordable. These new rules of 
engagement are woven into the framework of evidence-based medicine (EBM).  
2. Patient centered care 
EBM is patient centered, that is the patient is the center of the decision process starting with 
choice of diagnostic procedures, then the selection of treatment and is the evaluator of the 
success of treatment. Outcomes that matter to patients also matter to physicians and can be 
characterized as Patient Oriented Evidence that Matters (POEM). Reduction of pain, 
improved function, improved quality of life, reduced mortality, and reasonable cost are the 
cornerstone of value added to the lives of individuals who seek treatment. This might seem 
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commonsensical and physicians traditionally think that the 19th century way of providing 
care has been meeting the needs outlined above. In the United States and other countries 
with advanced medical knowledge systems, the evidence is mounting that the needs of 
patients are not addressed in a patient centered way, nor are outcomes as good as 
physicians believe.  
The fundamental process of Evidence Based-Medicine (EBM) consists of five-steps: 1) 
developing a question using the populations-intervention-comparison-outcome (PICO) 
format, 2) finding research that may answer the question, 3) evaluating the research for 
validity, impact, and applicability, 4) applying the information to clinical decision making, 
and 5) periodically evaluating one’s outcomes after implementation and performance of the 
previous four steps.5 The development of the question to be answered is patient centered 
and the EBM process focuses on issues that matter to the patient. This is a labor intense 
process that involves finding several sources of evidence, analyzing, evaluating and then 
making the product understandable by the patient. 
The introduction of EBM shifted the decision making to the patient while having the 
physician analyze the patient within the context of evidence that is relevant to that patient 
and their condition. After the analysis, the diagnosis is expressed in a relativistic way 
using likelihood or probability to the patient in a way he or she can understand. Offering 
treatment is more of a menu with expected outcomes and possible unwanted outcomes 
freely discussed with the patient. The treatment options are based upon the highest order 
of evidence available, and when possible treatment guidelines based upon best evidence 
is given as the most reliable means to predict outcome. At times there will be good 
evidence to cite in the discussions with the patient, other times there will be a paucity of 
good evidence and the patient’s decision may reflect the lack of evidence, relying more on 
expert opinion. 
One reason physicians and surgeons rely on textbooks and content experts is the time factor. 
It is very easy and quick to call a colleague for an opinion or formally consult a colleague for 
either input on evaluation or treatment- or to assume care of a challenging patient problem. 
When clinicians do spend their time searching for answers to questions or problems, the 
easiest sources are textbooks, review articles, audio reproductions of lectures and 
information provided by pharmaceutical and implant companies. Again, easy location of 
didactic information consumes less time and energy than a thorough search and analysis of 
possibly relevant, possibly useful information. 
Clinicians develop idiosyncratic ways of evaluating, communicating and interacting with 
their patients- often a direct reflection of residency/fellowship training. One tactic is not 
providing answers to patient’s questions or questions of care, probably due to a 
combination of factors- lack of time and little knowledge. Many feel that by reading current 
literature and attending CME courses that they are indeed keeping up with meaningful 
change and offering their patients the best practice based upon the best current knowledge. 
The clinician’s sense of security by maintaining exposure to relevant topics in the literature 
is a culture of habit- reading familiar journal articles, reliance on consultants, compliance 
with local customs or referral patterns and reliance on quick sources of information- 
textbooks, review articles, electronic media, colleagues etc. While these sources may be of 
great value, there is a high probability that they are out of date or biased. One of the most 
ingrained biases in all medical literature is the highly selective patient population described 
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in texts and manuscripts- often the idealized patient in a study is not very similar to the 
patient in the doctor’s practice, or the real world patient has multiple problems while the 
textbook discusses only one problem at a time.  
Decision-making is another key element of evidence based medicine. There is the continual 
need to remind ourselves that patient care is about patients making decisions that affect 
outcome. The earlier notion of shared decision making has now shifted with the EBM 
paradigm to patient-centered decision making. The physician is once again a ‘doctor’- from 
the Latin ‘teacher’. 
3. Sources of evidence 
There are three main sources of medical information that can be used in generating 
evidence. First is primary sources material. This is the collection of original publications that 
answer questions about patient care. Next are the review articles, textbooks, synopses and 
curriculum of courses that are the first attempt to synthesize evidence with opinions. Most 
of the teaching at the Medical School level is in this second level, as are the popular texts 
and review courses. Third is the assimilation of best evidence via systematic reviews, meta-
analysis and generation of evaluation or treatment guidelines.  
The first level of primary source is the substrate that is entered into the evidence production 
cycle. The production cycle creates evidence in response to a clinical need, refines the results 
of investigations to craft an answer to the question raised by the clinical need. Once meaning 
is added to the data gathered, this evidence is now disseminated via publications or 
presentations, the evidence is put into practice and lastly the evidence is evaluated to 
determine if further evidence is needed to better solve the original need. The role of 
generating evidence is fundamental, however, the need for dissemination and implementation 
become almost as important if the evidence is to be used to improve quality of care.  
The second level of information is the synthesis of opinions and creation of literature that 
informs clinicians about what is available. This group includes review articles, textbooks, 
online texts and review lectures. As a source of evidence, this second level is highly variable 
in that expert opinion may supersede the synthesis of the best evidence, and other bias may 
creep into the review product. The third level is the combination of best evidence with 
critical analysis provided by experts in methods of providing statistical support for best 
evidence. These are the systematic reviews of evidence and meta-analysis. Studies that 
combine first level evidence into stronger support statements, or non-support statements of 
diagnostic and treatment evidence. 
Medical knowledge is stratified in a pyramidal formula created by Bloom in the 1950s (see 
figure 1). Recall or remembering is the entry level of knowledge with understanding and 
applying the next two levels that are necessary in medical practice. Most clinicians operate 
mostly in the first three levels of knowledge and rely on sources than can analyze, evaluate 
and create the understanding and application for improving medical knowledge. This 
taxonomy of learning is similar to the creation of best evidence and application to patient care. 
The importance again of disseminating the evidence is essential for improving quality of 
care, and later on an evaluation of care after implementation is needed to determine if more 
and better evidence is still needed. 
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4. Information mastery  
EBM has created several concepts and principles that are embodied in “a hierarchy of 
evidence and that conclusions related to evidence from controlled experiments are accorded 
 
(University of Texas, Arlington, Center for Learning accessed via Google, 10/21.2011) 
Fig. 1. 
greater credibility than conclusions grounded in other sorts of evidence.” In this hierarchy 
there is a (unproven) belief by advocates of EBM that randomized control trials- the highest 
level of evidence- should trump evidence from non-randomized trials and case-comparison 
studies. The lowest levels of evidence consist of case series and expert opinion. Though 
logical, there remains a great deal of reluctance on the part of practicing physicians to 
abandon their comfort zone in the reliance on expert opinion and studies that do not use 
comparative cohorts of patients. And the unaddressed problem of relevance, that is most 
studies do not include the complexity seen in most ‘real world’ patients. 
5. The usefulness of evidence 
With the advent of new and better evidence have come guidelines based upon evidence. 
Having guidelines is a shortcut for doctors who can follow key elements of evidence-based 
practice without having to do extensive literature research and analyses. This is one of the 
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fundamental principles of information mastery- the usefulness principle, expressed as an 
equation: 
Usefulness = Relevance x Validity/ Work 
Where relevance is the similarity of the real world patient to that portrayed in the guideline 
and general applicability of the evidence, validity is the scientific truthfulness of the 
information and work is the amount of time spent finding the answer to a question in clinical 
diagnosis or treatment. Validity is of prime importance with relevance a close second.  
Simply stated, the Usefulness Equation is a form of Occam’s Razor- finding the simplest 
solution to a problem with the important features of the process being 1) likelihood of 
success and 2) ease of access to the information needed to make judgments and decisions. 
This is not a quantitative equation but gives a sense of the relationship between the key 
elements of best evidence. 
Learning mastery is a means of educating students in a linear fashion. Students are taught 
basics or fundamentals, and then they are shown how to apply process to the fundamentals to 
solve problems and create higher cognitive functioning. An example is learning numbers and 
then learning to make sentences with numbers- i.e. equations- applying addition, subtraction 
etc. Similar to learning mastery is information mastery. A process in which adult learners are 
instructed in basic functions about finding information that is used to solve problems and 
answer questions. An example is using the Internet to search for the best treatment of a 40-
year-old woman who smokes, has a BMI of 34 and presents with pneumonia. With the patient 
care issue, the best use of the internet is not to have a search engine deliver thousands of 
journal articles that would take countless hours and a great deal of analytic skill to synthesize a 
treatment. The Internet can now provide rapid access to treatment guidelines, protocols and 
algorithm based upon high level of evidence that will produce good outcomes at reasonable 
cost, if the patient agrees with the recommended treatment.  
With the advent of information technology and the availability of sources of reliable 
evidence vetted by experts in the EBM it is now feasible to instruct clinicians in where to 
find and how to implement usable best evidence. Rather than frustrate busy practitioners 
with the laborious process of generating their own best evidence, the time is best spent 
gathering evidence and EBM guidelines. 
Slawson and Shaugnessy (2003) have created and tested a curriculum to teach the principles 
of information management. The curriculum has three levels:  
 Level 1 is for clinicians who can use the concepts to make better patient-care decision; 
 Level 2 is for teachers and writers who teach clinicians the curriculum and provide 
evidence-based reviews of original research; and 
 Level 3 is for researchers who are adept at conducting decision analysis, meta-analysis, 
and other techniques of synthesizing raw research information into useable clinical 
information. 
6. Locating information from available sources 
Finding the information at the point of care (just in time) is at the core of how the 
application of evidence-based medicine can transform the practice of medicine in ways that 
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4. Information mastery  
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(University of Texas, Arlington, Center for Learning accessed via Google, 10/21.2011) 
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Finding the information at the point of care (just in time) is at the core of how the 
application of evidence-based medicine can transform the practice of medicine in ways that 
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save time, cost, suffering and lives. The combination of clinical and laboratory diagnosis 
with the technology to bring validated treatment plans into use makes for less reliance on 
the doctor’s memory or experience. Given the current focus on patient safety and reducing 
medical diagnostic and treatment errors, there is great advantage to putting systems-based 
solutions in place that override the individual decision making of physicians. With 
evidence-based medicine, there is no need for doctors to memorize and catalogue volumes 
of information ‘just in case’ they need it. There now exists ‘just in time’ information that is 
processed into usable guidelines that inform and educate the patient while providing a 
more reliable process that protects patient safety and delivers better outcomes.  
There are two ‘tools’ in information mastery that apply to ‘just in time’ application of 
evidence at the point of care. First are hunting tools, second are foraging tools (figure 2). 
A high-quality foraging tool employs a transparent process that: 
1. filters out disease-oriented research and presents only patient-oriented research outcomes, 
2. demonstrates that a validity assessment has been performed using appropriate criteria, 
3. assigns levels of evidence, based on appropriate validity criteria, to individual studies,  
4. provides specific recommendations, when feasible, on how to apply the information, 
placing it into clinical context, 
5. comprehensively reviews the literature for a specific specialty or discipline, and 
6. coordinates with a high-quality hunting tool. 
A high-quality hunting tool employs a transparent process that: 
1. uses a specific, explicit method for comprehensively searching the literature to find 
relevant and valid information, 
2. provides key recommendations supported by patient oriented outcomes when possible, 
and, when not, specified as preliminary when supported only by disease-oriented outcomes, 
3. assigns levels of evidence+ or strength of recommendation# to key recommendations 
using approved criteria,  
4. coordinates with a reliable foraging tool. 
(Ebell, 2003) 
Fig. 2. Criteria for High-Quality Hunting and Foraging Tools 
Hunting tools are information resources that have already organized the literature-based 
information by relevance, having synthesized the validity into a product that can be easily 
(quickly) accessed by electronic search media. There is a simple rating system for the 
combined validity and relevance called the Strength of Recommendation Taxonomy (SORT). 
The importance of a combined system such as SORT is that it meets the conditions of the 
Usefulness Equation- it is easy to locate (low work) and has high relevance and validity. An 
additional quality that is of value in a hunting tool is the transparency displayed. The issues 
surrounding transparency include the description of the process used in the generation of 
evidence as well as conflicts of interest with stakeholders in the results of the evidence. 
Though many physicians are capable of their interpretation and analysis of medical 
literature, including relevance and validity, it is time consuming and impractical to do this 
on a regular basis. Once again the Usefulness Equation discourages intensive searching or 
analytics because of the work involved. Perhaps such analysis and discovery is useful for 
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clinical research but is unwieldy for patient care. The ideal source for best evidence should 
be independent of bias, thoroughly searches the literature, expertly assesses the validity and 
then summarizes the content in a concise, readable outline for the reader. 
In addition to hunting tools that zoom-in on the relevance and validity, are the second major 
type of location tools- foraging. These are sources that have valid information that helps the 
clinician keep current. Newer patient-oriented evidence may be published but unless the 
clinician knows of the existence of such newer knowledge, the physician does not know that 
there is a need to change practice. The incorporation of foraging tools into clinical does not 
require point of care application but is part of the background work that should be done by 
those assuming patient care responsibility. As with the hunting tools, these foraging tools 
are transparent, explaining methods, criteria for entry and exclusion and outlining conflicts 
of interest among stakeholders. The habitual use of a foraging tool prompts the clinician of 
patient oriented evidence that will keep practice current; however some review of the 
relevance and validity of these sources is needed before adopting recommendations. Unlike 
hunting tools, the practitioner is not looking for clinical pathways or immediate answers to 
patient care questions. 
Relevance is the patient-centered aspect of EBM. The evidence that helps with patients 
making decisions is identifying patient-oriented evidence that matters (POEM). This POEM 
matters to the clinician as well and is what physicians and surgeons should be searching for 
and present to their patients for consumption prior to decisions. 
Three questions that help assess the evidence as POEM: 
5. Did the study or guideline evaluate an outcome, and is the outcome one that patients 
care about? 
6. Did the study or guideline evaluate a condition, disease or issue that is congruent with 
patients in your practice? 
7. If the evidence is true, would the discovery of that truth require you to incorporate this 
finding into your practice? 
Validity is the most scientifically and intellectually challenging element of evidence based 
medicine. Analysis and assessment of information that is considered evidence is difficult 
and time consuming. For those without the background needed to dissect methodology, 
statistical plans, bias, accuracy and error- it is most difficult to arrive at a judgment about 
the validity of any medical research. And if the outcome is a disease status or a surrogate 
endpoint for what matters to most patients, it is an even more difficult challenge. Having 
reliable hunting and foraging tools brings the world of evidence back into the realm of 
patient care for the majority of clinicians who do not have the training, inclination or time to 
apply scientific rigor to patient care information. Again, some level of assessment of the 
relevance is needed in conjunction with validity in order to satisfy the Usefulness Equation. 
Information that is not valid is not useful, and information that is not relevant is not useful. 
If the amount of work to find evidence is excessive, the clinician will not consistently put 
that amount of effort into the process. Other sources of information become the default 
search engine- textbooks, review articles etc. 
Value in healthcare is currently defined as an equation: 
Value = Quality/ Cost 
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save time, cost, suffering and lives. The combination of clinical and laboratory diagnosis 
with the technology to bring validated treatment plans into use makes for less reliance on 
the doctor’s memory or experience. Given the current focus on patient safety and reducing 
medical diagnostic and treatment errors, there is great advantage to putting systems-based 
solutions in place that override the individual decision making of physicians. With 
evidence-based medicine, there is no need for doctors to memorize and catalogue volumes 
of information ‘just in case’ they need it. There now exists ‘just in time’ information that is 
processed into usable guidelines that inform and educate the patient while providing a 
more reliable process that protects patient safety and delivers better outcomes.  
There are two ‘tools’ in information mastery that apply to ‘just in time’ application of 
evidence at the point of care. First are hunting tools, second are foraging tools (figure 2). 
A high-quality foraging tool employs a transparent process that: 
1. filters out disease-oriented research and presents only patient-oriented research outcomes, 
2. demonstrates that a validity assessment has been performed using appropriate criteria, 
3. assigns levels of evidence, based on appropriate validity criteria, to individual studies,  
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and, when not, specified as preliminary when supported only by disease-oriented outcomes, 
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(quickly) accessed by electronic search media. There is a simple rating system for the 
combined validity and relevance called the Strength of Recommendation Taxonomy (SORT). 
The importance of a combined system such as SORT is that it meets the conditions of the 
Usefulness Equation- it is easy to locate (low work) and has high relevance and validity. An 
additional quality that is of value in a hunting tool is the transparency displayed. The issues 
surrounding transparency include the description of the process used in the generation of 
evidence as well as conflicts of interest with stakeholders in the results of the evidence. 
Though many physicians are capable of their interpretation and analysis of medical 
literature, including relevance and validity, it is time consuming and impractical to do this 
on a regular basis. Once again the Usefulness Equation discourages intensive searching or 
analytics because of the work involved. Perhaps such analysis and discovery is useful for 
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clinical research but is unwieldy for patient care. The ideal source for best evidence should 
be independent of bias, thoroughly searches the literature, expertly assesses the validity and 
then summarizes the content in a concise, readable outline for the reader. 
In addition to hunting tools that zoom-in on the relevance and validity, are the second major 
type of location tools- foraging. These are sources that have valid information that helps the 
clinician keep current. Newer patient-oriented evidence may be published but unless the 
clinician knows of the existence of such newer knowledge, the physician does not know that 
there is a need to change practice. The incorporation of foraging tools into clinical does not 
require point of care application but is part of the background work that should be done by 
those assuming patient care responsibility. As with the hunting tools, these foraging tools 
are transparent, explaining methods, criteria for entry and exclusion and outlining conflicts 
of interest among stakeholders. The habitual use of a foraging tool prompts the clinician of 
patient oriented evidence that will keep practice current; however some review of the 
relevance and validity of these sources is needed before adopting recommendations. Unlike 
hunting tools, the practitioner is not looking for clinical pathways or immediate answers to 
patient care questions. 
Relevance is the patient-centered aspect of EBM. The evidence that helps with patients 
making decisions is identifying patient-oriented evidence that matters (POEM). This POEM 
matters to the clinician as well and is what physicians and surgeons should be searching for 
and present to their patients for consumption prior to decisions. 
Three questions that help assess the evidence as POEM: 
5. Did the study or guideline evaluate an outcome, and is the outcome one that patients 
care about? 
6. Did the study or guideline evaluate a condition, disease or issue that is congruent with 
patients in your practice? 
7. If the evidence is true, would the discovery of that truth require you to incorporate this 
finding into your practice? 
Validity is the most scientifically and intellectually challenging element of evidence based 
medicine. Analysis and assessment of information that is considered evidence is difficult 
and time consuming. For those without the background needed to dissect methodology, 
statistical plans, bias, accuracy and error- it is most difficult to arrive at a judgment about 
the validity of any medical research. And if the outcome is a disease status or a surrogate 
endpoint for what matters to most patients, it is an even more difficult challenge. Having 
reliable hunting and foraging tools brings the world of evidence back into the realm of 
patient care for the majority of clinicians who do not have the training, inclination or time to 
apply scientific rigor to patient care information. Again, some level of assessment of the 
relevance is needed in conjunction with validity in order to satisfy the Usefulness Equation. 
Information that is not valid is not useful, and information that is not relevant is not useful. 
If the amount of work to find evidence is excessive, the clinician will not consistently put 
that amount of effort into the process. Other sources of information become the default 
search engine- textbooks, review articles etc. 
Value in healthcare is currently defined as an equation: 
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Evidence Based Medicine – Closer to Patients or Scientists? 86
Quality is the desired outcome of treatment while cost is monetary amount needed to 
provide treatment. Cost includes the added expense of treating complications, errors and 
poor results, plus the loss in earnings and savings required to pay for services. Providing 
improved quality increases value, as does decreasing cost. The potential for EBM and 
guidelines is the improvement in quality- by bringing the delivery of an outcome that is 
closer to the expectation of the patient the quality metric improves. There is evidence now 
that improved quality, by reducing unwanted outcomes and complications, will reduce cost. 
Thus a more robust increase in value is created if both the numerator and the denominator 
of the Value Equation can be properly affected. 
7. Summary 
A great deal has been written and taught about patient-centered decision making and patient 
centered care. The shift from expert opinion and experience-based learning toward best 
evidence and clinical practice guidelines is a shift in our medical learning and practice. Critical 
evaluation of patient care requires a metric that is based on outcome, which in turn requires 
reflection by the physician on how well the diagnoses and treatments are working in a given 
patient population. There is value to learning from one’s practice- that is now considered a 
core competency in residency training in the United States. The improvement in patient 
outcomes that is expected with newer medical knowledge is, in itself, a delivery system of 
evidence to the point of care. Familiarity with sources of best evidence and practice guidelines 
is a reasonable next step to improve upon historical performance of physicians and surgeons. 
Reducing errors & complications, improving compliance with best practice, lowering costs, 
meeting patient expectations are lofty goals that require a newer way of problem solving than 
that of the past century. Tools exist for finding best evidence quickly and content experts have 
already done the heavy lifting by gathering and analyzing the primary sources, creating 
tertiary sources of good evidence. Though high-level evidence does not yet exist in many areas 
of clinical practice, there is ample evidence that could be put into practice now. Using available 
information sources and experience, information mastery facilitates putting that which is 
better into practice and will create evidence-based, patient centered care. 
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1. Introduction 
Information Prescription (IPs) is provision of specific evidence based health information to a 
specific individual/patient to help him/her understand, manage and control the ill health. 
Most of the time it is defined as prescription of right information to right person at right time 
(Kemper-Mettler, 2002a). Maybe this definition is the simplest way for describing a powerful 
complex process. To borderline the right person at right time and offer the right information at 
right time in practice is really huge work. Information prescription pledge active participation 
of patient in healthcare process. It promises that information intervention may boost the 
healthcare outcomes, reduce the medical errors and undertake the patients’ right. But we need 
to clearly illustrate it in our practice. How information therapy and information prescription 
can boost health care, what is the differences between patient education and information 
prescription? How a piece of evidence based information can be given to a patient who should 
make decision about her\his health in an emergency condition? Is it really possible in practice? 
The philosophy of Ix and prescription of information to patient is perfect. It brings patient in 
the field and gives a colorful sense to patient centered healthcare. What is significant in this 
process is that every environment has its own norms, condition, beliefs, communication style 
and language, social and cultural features that influence in practicing Information therapy (Ix). 
IIt is essential to put information therapy into practice to find out an applicable model for a 
specific environment. Through this pilot model, appropriate protocols and guidelines can be 
developed to reach the best practice. Fulfillment of IPs relies on, at least, three components i.e. 
Information Technology (IT), Patients Preference and Physicians Interest. IT manifestations 
like Internet, social networking tools, mobile phone/computer facilities are widely available 
for patients and physicians equally, in developed countries. In such IT based environment 
patients are either seeking health information or have access to the net to communicate with 
their physicians, receive IPs, search for health information and share their story and 
information with their networks. In consequence, Information Prescriptions is now part of 
healthcare system of developed counties like US and UK.  
2. Our current status where Ix and IP to be practiced 
In Iran, as a sample of a developing country, almost 100% of patients demand for information 
prescription and information therapy service offered by hospital or the physician who offer 
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healthcare services to them (Gavgani, 2011). Fortunately 97% of clinical specialists believe 
that patients have right to information therapy services and information prescription need 
to be given to patients as part of their healthcare service (Gavgani,2010-2011). Access to the 
internet is available for individuals and professionals through ADSL and Dial UP services. The 
speed is limited to 64MBPS, 128 mbps higher for individual and professional. According to 
NetIndex the average download speed in Iran is 0.48mbps and higher in ranking the 
downloading speed of countries Iran ranks 167th among 168 countries (AsrIran,2011). Not 
all people afford high speed and unlimited internet access. The majority of ordinary internet 
users utilize 64 and 128 mbps speed internet access. All people do not have a computer to 
connect to the Internet, not all physicians uses computer with web in their office. Patients in 
Iran prefer to receive information therapy services in print format and most preferably in 
person from their health providers rather than Internet and library. However, mobile phone 
is also one of the most used devices by people for communication and transferring 
information therefore it also is a preferable device for delivering IPs to patients in Iran. 
Patients demand for information about diseases, treatments and medications (Gavgani, 
2011). According to the above mentioned facts we had to adopt information therapy 
standards and guidelines to generate and develop an information therapy model applicable 
to our present situation with specific barriers that we face. We decided practice Information 
Therapy and Information Prescription for a limited subject area as a pilot project to find out 
the potentials, barriers, and driver forces in a model applicable for our social and cultural 
condition.  
The main Objective of this project was provision of IPs for patients with cardiovascular 
problems, hospitalized in Shahid Madani Cardiology Hospital (Tabriz-Iran)from November 
2011 to February 2011 ,during four months . It also aimed to detect the barriers and 
requirements for filling IPs in non-wired condition and reach to a sustainable and applicable 
model for fulfillment of IPs in developing and non-wired countries. 
3. Preparing data base for information therapy and information prescription  
Cardiovascular system and cardiac diseases includes a broad subject area especially  
it doubles when the other diseases interconnect with them. To identify the  
information services coverage we limited our service area to only coronary artery diseases 
(CAD). At first we extracted MeSH tree term map for CAD from MeSH data base 
(http://www.ncbi.nlm.nih.gov/mesh) [Figure1]. It enabled us to manage our information 
retrieval and storing model.  
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Fig. 1. Relation between CAD and other subjects according to MeSH 
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According to the MeSH the broader terms /subjects for CAD can be recognized in coronary 
diseases, myocardial Ischemia, among heart disease. It also can be related to 
Arteriosclerosis, Arterial Occlusive Diseases and cardiovascular diseases. Therefore we 
prepared evidence based patient information for all the above mentioned three categories. 
Figure 2 presents tree numbers and entry terms in MeSH data base. 
 
Fig. 2. Coronary Disease in MeSH tree 
We extracted information from accurate resources including Cochrane library 
(www.cochrane.org), Medline Plus (www.nlm.nih.gov/medlineplus), MD Consult 
(www.mdconsult.com), RxList (www.rxlist.com/), Kaiser permanent 
(www.kaiserpermanente.org), Mayo Clinic (www.mayoclinic.com) and Pubmed clinical 
queries (http://www.ncbi.nlm.nih.gov/pubmed/clinical). According to Iranian nations 
cultural and religious background we also extracted description of a healthy heart from 
Holy Quran (http://www.parquran.com) and religious sources to use as standard for 
patient. We categorized information into three 1) Disease related health information: 
included information about diseases most of the time background information about 
Myocardial Infarction (MI), Myocardial Ischemia, Blood Pressure, Diabetics and in 
association with MI , Kidney Failure in relation with MI and so on. 2) Diagnostic 
information like Angiography. 3) Information for intervention which itself divided into 
two subcategories surgery, plus subcategories i.e. before and after operation, Angioplasty, 
CABG; and drug intervention such as Warfarin, Plavix, Aspirin, interaction and side 
effects of drugs. Our information prescriptions for after operational  
healthcare control and management of diseases was a little bit different information 
according to cultural and religious background of society. There are rich sources of 
Islamic rules in Quran (www.parsquran.com) and hadiths (saying) 
(http://www.tebyan.net/index.aspx?pid=65874; ) for sexual relationship, mental health and 
nutrition therefore unlimited relationships and alcohol were not cause and concern for 
these society. Instead concerns around performing prayer, sympathy and being deep 
imaginative in sorrowful incidents with religious root were negotiable. We prepared 
information on when to start exercise and sexual relationship, what kind of exercise and heavy 
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works they can or can’t do, how important is taking medicine on time and in a regular style for 
their recovery and disease control. We also included the side effects of eating much and bad 
eating style, time of and number of taking meal per day, some foods and activities according to 
Islamic rules and Quran. After extracting and collecting data we added value to information 
according to library science rules (Gavgani, 2009; 2011). Information translated into Persian , 
simplified and made readable with 6 and 7 grade. Then We used dicsern 
(www.dicsern.org.uk) questionnaire's criteria to build the structure of IPs and also Ix 
standards using Ix standards (Kemper-Mettler, 2002b). Finally, we stored information in 
simple database.  
4. Practice of Information Prescription (IPs) services 
We asked specialists whether they would like to practice information therapy and evidence 
based information prescription in a team work with information specialists. Two 
cardiologists accepted to work with us in information therapy and to prescribe information 
for their patients. Then we joined to the ward round as a team member, we noted down the 
problems while cardiologists were taking history, explaining the case to their assistants 
(residents). Physicians according to the hospitals traditional method used to give brief oral 
information to patients during the visit and history taking. But in this project despite of the 
traditional model cardiologists ordered personalized information for each case that is called 
information prescription when needed. It means that all information were not applicable for 
all patients in the ICU. For example a 36 year married man who had been operated with 
stent placement , and had drug addiction, smoking cigarette was prescribed information 
about Angioplasty, stent placement, drug, smoke and exercise. We prepared the information 
from the small database that we had made ready already, personalized it and submitted to 
the cardiologist, he approved information and one of the assistants offered information to 
the patient and explained it once orally to patient. Patient requested instruction for sexual 
relationship information. That is ordered again by assistant to our information team. We 
again extracted and personalized it and gave to specialist to approve or reject it.  
The other case was a 60 year old woman with 90kg weight who was accepted with heart 
attack and arrhythmia. She was also in inset of diabetics. She was prescribed information 
about pacemaker batteries, diet and lowering the weight, being alerted about airtime, sugar 
and LDL , HDL level, the risk of being diabetic and its relation with MI and heart attack. 
During taking history she said she can never go on diet because she is crazy of delicious 
foods with oil and sweets. We offered her extra information about Islamic instructions on 
eating style, quantity and time of taking food. Especially we stressed on the Islamic 
recommendation on “stop eating before you feel full”.  
A common model we used in our information prescription and information therapy service 
scenario is documented in a flowchart [Figure 3]. However it is significant to note that the 
process can be practiced with some differences according to the type of disease and patient’s 
moment in care.  
In some cases the only recommendation to patient is to repeat/to follow the previous 
instructions in such situation there would not be IP order therefore process will end with no 
need IP as shown in figure 3. 
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Fig. 3. The process of IP service in this project (flowchart) 
5. Result 
About 1500 patients with coronary Artery Disease (CAD) accepted in Shahid Madani 
Hospital during the months October to February 2010. The prescription were given only to 
those who candidate for state placement and were in professional relation with our two 
cardiologists. Total number of patients received IPs was 95. The average age of patients was 
37.5. The youngest age was 34 and the oldest was 75. Major topics of IPs related to the 
Coronary Artery Disease (CAD) classified into four main categories including: diagnosis, 
treatment, surgery, medicine (Table 3).  
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Fig. 3. The process of IP service in this project (flowchart) 
5. Result 
About 1500 patients with coronary Artery Disease (CAD) accepted in Shahid Madani 
Hospital during the months October to February 2010. The prescription were given only to 
those who candidate for state placement and were in professional relation with our two 
cardiologists. Total number of patients received IPs was 95. The average age of patients was 
37.5. The youngest age was 34 and the oldest was 75. Major topics of IPs related to the 
Coronary Artery Disease (CAD) classified into four main categories including: diagnosis, 
treatment, surgery, medicine (Table 3).  
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Table 3. category of prescription given to the patients with CAD 
The causes of CAD can be affected by different factors such as atherosclerosis, heart attack 
(angina), arrhythmia, sudden cardiac arrest (SCA), heart failure, diabetes , high blood 
pressure, high blood cholesterol. But in this study we excluded the causes and only included 
IPs related to the four above mentioned main categories, plus a category named “General” 
about CAD and other topics. The subcategory “other” includes information which was offered 
to patients by doctor’s demand for specific cases or patients’ request such as high blood 
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*we separated the category of medicines from treatment and divided the category of treatment into PCI 
and TCI . Indeed, this study has taken place in heat surgery department not internal heart disease. 
Therefore, the two above mentioned medicines are only medications that usually are prescribed for 
patients after heart surgery. About other medications like infection control medicine we did not have IP 
order. 
Table 4. Information offered for patients through their IP order 
 
Evidence Based Information Prescription (IPs) in Developing Countries 95 
CAD, Angioplasty and Stent are topics that were prescribed by doctor to all of the 95 
patients, that undergone surgery (PCI: angioplasty and stent placement). In addition to the 
main information on the diseases and intervention totally Majority of topics offered to the 
patients in this study were about surgery (27.5% ), treatment ( 25%), General topics related 
to CAD and other information on ( 24.6%). The lowest percentage of topics prescribed for 
patients was about diagnosis techniques (8.9% ), and after that about medicines (14% ). 
6. Drivers and barriers 
Influencing factors were categorized into two groups: drivers and barriers. Some of the 
factors can act dual functionally in other word their presence helps the progress of process 
and their absence cut down and create difficulty for service. In such cases border line may 
be drown case vise. 
6.1 Drivers  
6.1.1 Patients’ preference and demand for Information 
6.1.2 Physician’s interest and belief on providing IPs to patients 
6.1.3 Number of Information specialist who are interested in Filling information prescriptions 
6.1.4 Availability of more than 80% of demanded information 
6.2 Barriers 
6.2.1. Time: Time is the most critical component of information Therapy service . Ideally 
there should not be time gap between oral information that a physician gives to a patient 
and the information prescription which is Filled for patient. In the most preferred situation 
IP would better to be given to patient at the 10-15 minute visit time. IP also can be given 
along with the medications and Rx.  
6.2.2. Integrated health information system (HIS): In an integrated HIS all the components of 
databases are coded, for example: ICD10 is used for coding diseases, NDC for drug, CPT for 
diagnostic tests and NLM for information. Coding enables the flow and circulation of 
information easy, fast and secure thought the system. In this project lack of such integrated 
system was crucial.  
6.2.3 Confidence: confidence between health providers and patient is a two edge factor 
either driver or barrier for Ix and IPs.  
6.2.4 Place: An identified place with at least 2 computer systems , internet connection, 
printer (color and or back and with) to receive, prepare and deliver prescriptions on time 
6.2.5 ICT applications: Low speed internet connection is a critical barrier for successful Ix 
and IP services.  
6.2.6 Mobile Technology: Mobile computer and mobile phone facilitate availability and 
accessibility of information. A mobile phone with printer can create shift in IPs service in 
ward round. Patient in developing countries use mobile phone more than web and they 
demand for mobile phone information delivery more than web or email delivery (Vishwa 
M., Gavgan V.Z, 2009).  
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6.2.7 Database: Database of patient information is critical driver for Ix and IP services. 
Without having reliable information accessible, IP services will be time consuming process. 
6.2.8 Patients’s portal: Patient portal makes information available either from outside 
sources or from patient interactions. 
6.2.9 Organizational support: Without organizational support , coordination and 
management it is impossible to practice Ix and IP in countries with centralized government 
and health system. We had limitation to take part in ward round or have access to patients’ 
data because clinical librarianship concept does not practice formally in Iran. 
6.2.10 Multimedia format: Availability of information in multimedia format is effective and 
efficient tool in understanding, learning and practicing prescribed information. 
6.2.11 Literacy : Rural population are almost illiterate and it can be considered barrier if 
information supposed to be given in print format. Having information stored in different 
formats like audio and or audiovisual files can be used/offered in along with IP for better 
understanding.  
6.2.12 Budget: Allocating money is also helpful in different aspects. It can be used in Critical 
situation that IPs team may face in providing and offering the service more effectively. 
6.2.13 Confidentiality: Confidentiality is vital at least in patients-doctor relationship. Patient 
should be given guarantee that their health, mental and physical data is kept secure and will 
be used only for better health care. In some cases patients were worried about why should 
they are asking for specific questions and why should they are offered with specific 
information.  
6.2.14 Communication style: In hospital setting clinicians give information about diseases 
and medications to patients orally. In conscious assent also it is usual to briefly explain the 
probable side effects, non effect and harms of intervention especially for surgery. But it is 
believed that the communication style, stress and pressure on words and procedures may 
effect in preference of patients (Nabhan A ,2011). Written information is documented and 
does not stress on type of intervention directly or indirectly.  
7. Conclusion 
The main Objective of this project was provision of IPs for patients with cardiovascular 
problems. The project successfully was conducted and the process of execution illustrated 
using flowchart. The other objective of study was finding drivers and barriers for IPs in Iran 
as a sample of developing country with lack of required facilities like electronic health 
record (EHR) and patient information services. The study found that despite of patients’ 
preference and interest in receiving IPs, there are limitations for fulfillment of IPs in 
developing countries like Iran. Access to the Internet, electronic and integrated health 
records, patient information portals, availability of computer for individuals, health and 
computer literacy, are inconsistent throughout country. Therefore, it is essential to adopt 
both traditional paper based system and Information technology along with emerging IT 
based tools to ensure sustainability of IPs. The most significant barrier for Ix and IP service 
we faced in this project was cultural change and attitude of stakeholders including 
physicians, health providers and health consumers. Although physicians and nurses accept 
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the theory of Ix and IP service and believe that patient has right to information and right 
information at right time to be made available for them. In practice they feel uncomfortable 
with it. Some of the health providers think that giving information to patients may create 
more and unnecessary jobs for health providers. Next to this issues the technical problems 
can be categorized in three including: 1) Time 2) Health information Technology and system 
3) Training. Physicians time to accomplish IPs affected by many interconnected factors. One 
of the factors can be availability ICT and HIS. The last, HIS, is itself a big issue. Without HIS 
and patient information database/system it is very difficult for physicians to prescribe 
information even if they are appetite to empower their patients and get their feedbacks for 
shared decision making. Therefore; it can be said that at time, the biggest barrier to 
accomplish IPs in non wired and non-English language countries like Iran is lack of Patient 
Information system in vernacular languages like Persian. At least a patient information 
database is a significant factor to store, retrieve and personalize patient information in 
vernacular language at the moment of care. To overcome the time barrier on the side of 
physicians it is essential to consider the IPs as a essential component of physicians-patient 
communication in any visit .Physicians and residents need to be trained in prescription of 
information to their patients and other allied health providers like nurses also need to be 
trained to recognize the importance of IP s and its differences with the longstanding patient 
education in their profession. This study suggests that, to practice Ix and IPs successfully it 
is essential to create a framework in healthcare system in which every stakeholder and every 
particle of system including physician, nurse, informationist, social workers and patient 
look at health care promotion as a continual quality improvement goal. Patient care and 
information prescription need to be accepted as a best practice to empower patient. 
Protocols and guideline to be developed and made available for health providers and other 
stakeholders to enable them practiced Ix and IPs based of their own specific environment 
according to the facilities, barriers, cultural and ideological issues.  
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in Obstetrics and Gynecology 
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1. Introduction 
Evidence-based medicine (EBM) is the process of systematically reviewing, appraising and 
using clinical research findings to aid the delivery of optimum clinical care to patients 
(Rosenberg and Donald, 1995). It is considered a new trend in both teaching medicine and 
supporting the clinical decisive process, answering the clinical questions. The basis of the 
evidence-based medicine comprises of analysing and interpreting current and reliable 
medical publications concerning certain subject (Laudański and Pierzyński., 2000).  
Evidence-based practice is “a process of care that takes the patient and his or her preferences 
and actions, the clinical setting including the resources available, and current and applicable 
scientific evidence, and knits the three together using the clinical expertise and training of 
the health-care providers.” (Haynes et al., 2002).  
Thus, EBP as illustrated in Figure (1) is the integration of clinical expertise, patient values, and 
the best research evidence into the decision making process for patient care. Clinical expertise 
refers to the clinician's cumulated experience, education and clinical skills. The patient 
brings to the encounter his or her own personal and unique concerns, expectations, and 
values. The best evidence is usually found in clinically relevant research that has been 
conducted using sound methodology (Sackett et al., 2000). 
Despite its ancient origins, evidence based medicine remains a relatively young discipline 
whose positive impacts are just beginning to be validated, and it will continue to evolve 
(Bennett et al., 1987; Shin et al., 1993). 
The aim of this chapter is to explore different aspects of evidence based medicine including 
background on its development, motives towards changing our attitudes in practice and 
how can evidence be extracted. The chapter will also highlight the major role of evidence 
based medicine in changing attitudes towards evidence based practice which ensures safety 
and efficiency of the health service provided, in the field of obstetrics and gynecology; a 
domain that has greatly participated in the establishment of evidence based medicine and 
evidence based practice. Many examples on how evidence based medicine has changed 
attitudes in practice will be displayed to demonstrate and emphasize this role. 
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Fig. 1. Evidence Based Practice (EBP) 
2. Why changing attitudes in practice 
Although clinical research is consistently producing new findings that may contribute to 
effective and efficient patient care, the findings of such research will not change population 
outcomes unless health services and health care professionals adopt them in practice 
(Grimshaw et al., 2001). 
However, the enormous volume of information that is published in an ever-increasing 
number of available medical journals constitute a major obstacle and a real challenge to 
obtaining reliable evidence for clinical practice from research. Over half a million papers on 
gynecology, infertility, pregnancy and obstetrics are published each year. To sift through 
these MEDLINE records, let alone the full papers that may be relevant, to identify those 
which should form the basis of clinical practice is an overwhelming and nearly impossible 
task. How, then, can busy clinicians have easy access to, and identify, the most appropriate 
information on which to base their clinical decisions? (Dodd and Crowther, 2006). 
The contribution of evidence-based medicine to improved patient outcomes in general 
practice is incontestable. Evidence based practice promotes practices that have better 
outcomes and are scientifically proven to be effective. It aims to eliminate unsound or risky 
practices, thus improving quality of care, providing best service to the patient and 
promoting patient safety.  
Actually, evidence based practice is one step toward making sure that each patient gets the 
best service possible. Furthermore, it helps physicians to keep knowledge up to date and 
supplements clinical judgment; very vital benefit especially in the light of the rapidly 
growing literature and medical advances. 
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3. Evidence based and experience oriented practice  
Clinical medicine is currently in transition from experience-oriented practice to an evidence-
based one which requires the best available evidence that answers our clinical questions for 
better safety and efficacy. However, there is a balance, and even tension, between evidence 
and clinical expertise: 
"Without clinical expertise, practice risks becoming tyrannized by external evidence, for 
even excellent external evidence may be inapplicable to or inappropriate for an individual 
patient. Without current best external evidence, practice risks becoming rapidly out of date, 
to the detriment of patients." Good doctors use both individual clinical expertise and the 
best available external evidence, and neither alone is enough (Sackett et al., 1996). 
Evidence based medicine helps clinicians to integrate the best external clinical evidence 
from systematic research with individual clinical expertise to make effective decisions about 
patient treatment and care. 
Best available external clinical evidence means clinically relevant research, often from the basic 
sciences of medicine, but especially from patient centred clinical research into the accuracy and 
precision of diagnostic tests, the power of prognostic markers, and the efficacy and safety of 
therapeutic, rehabilitative, and preventive regimens.  
External clinical evidence can inform, but can never replace, individual clinical expertise, and 
it is this expertise that decides whether the external evidence applies to the individual patient 
at all and, if so, how it should be integrated into a clinical decision (Sackett et al., 1996).  
4. How can evidence be extracted? 
The best evidence is usually found in clinically relevant research that has been conducted 
using sound methodology (Sackett et al., 2000). EBM is not restricted to randomized trials 
and meta-analyses. Actually, it involves tracking down the best external evidence with 
which to answer our clinical questions.  
Thus, to find out about the accuracy of a diagnostic test, we need to find proper cross-
sectional studies of patients clinically suspected of harboring the relevant disorder, not a 
randomized trial while for a question about prognosis, we need proper follow-up studies (i.e. 
prospective cohort studies) of patients assembled at a uniform, early point in the clinical 
course of their disease. And, sometimes, the evidence we need will come from the basic 
sciences, such as genetics or immunology. 
It is when asking questions about therapy that we should try to avoid the non-experimental 
approaches, because these routinely lead to false-positive conclusions about efficacy. 
Because the randomized trial, and especially the systematic review of several randomized 
trials, is so much more likely to inform us and so much less likely to mislead us, it has 
become the "gold standard" for judging whether a treatment does more good than harm 
(Sackett et al., 1996). 
5. Development of evidence based practice in obstetrics 
Although the term ‘evidence-based medicine’ was first used by Gordon Guyatt of McMaster 
University, Canada, in 1990, (Guyatt and Rennie, 2002) the development of evidence-based 
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practice in obstetrics began in the early 1970s. Archie Cochrane, in his now well-known 
writings (Cochrane, 1972), awarded the ‘wooden spoon’ to obstetricians for having made the 
poorest use of randomized controlled trials, and having widely incorporated changes into 
clinical practice without appropriate evaluation(Cochrane, 1972).  
Such observation inspired Iain Chalmers in 1974 to start the enormous task of collecting all 
randomized controlled trials related to the field of perinatal medicine. More than 3000 trials 
conducted between 1940 and 1984 were identified. This collection was first published in 
1985 as the Oxford Database of Perinatal Trials (ODPT) (Chlamers et al., 1986). In 1989, the 
first comprehensive synthesis of evidence for pregnancy care, entitled "Effective Care in 
Pregnancy and Childbirth" (ECPC), was published; it included systematic reviews of the 
identified randomized trials (Enkin et al., 1989).  
This two-volume book was condensed into the paperback "A Guide to Effective Care in 
Pregnancy and Childbirth (GECPC)" summarizing the available evidence on the effects of 
pregnancy care, and categorizing care practices into those with evidence of known benefit, 
those of uncertain benefit, and those of known harm (Enkin et al., 1989). All of these early 
pregnancy and childbirth initiatives were important forerunners to the Cochrane 
Collaboration (The Cochrane Library, 2005). 
6. Examples for how evidence based medicine changed practices in 
obstetrics and gynecology 
We will be displaying in the coming section many practical examples elaborating the great 
noticeable role of evidence based medicine in shifting the practices in obstetrics and 
gynecology towards better safety and higher efficacy and in eliminating risky unsafe 
practices. Evidence based medicine has changed attitudes towards interventions, 
therapeutics and diagnostics.  
6.1 Changing attitudes towards interventions (evidence based interventions)  
What matters in health care is identifying and using interventions that have been shown by 
strong research evidence to achieve the best outcomes within available resources for 
everyone (Fletcher and Lancet, 1999). Examples for such interventions will be discussed. 
6.1.1 The term breech trial 
Among most issues in the field of obstetrics that have been very controversial is the breech 
delivery. Approximately 4% of all infants are in breech presentation. Delivery in this 
position is more difficult, with increased risk of complications to the fetus such as umbilical 
cord prolapse, hypoxia, and fetal injury. 
Despite increased risks, breech deliveries are usually accomplished without complications 
and without the need for ‘expert assistance’ from an experienced, trained clinician or 
midwife. However, in the event that expert assistance is needed but not obtained, 
permanent damage can occur during breech births because of the lack of appropriate and 
well-timed actions by the birth attendant. 
Historically, vaginal breech deliveries were considered the norm until 1959, when routine 
cesarean delivery was shown to reduce perinatal mortality and morbidity (Wright, 1959). 
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While there was a general belief that planned cesarean delivery was better than planned 
vaginal delivery for breech deliveries, evidence was inconclusive because most studies were 
observational, two small RCTs showed no difference, and evidence suggested that 
improved neonatal outcomes might occur at the expense of poorer maternal outcomes. 
The Term Breech trial, a multi-center trial across 121 centers in 26 countries randomizing 
2088 women to ‘planned cesarean delivery’ or ‘planned vaginal’ deliveries (1997 – 2000). The 
trial found during interim analyses that cesarean delivery was associated with a reduced 
risk of perinatal morbidity and mortality. The term breech trial had an immediate dramatic 
impact on the management of term breech deliveries with policies changed in accordance 
with the trials findings. Rapid change in clinical practice occurred in many locations, 
although not universally, as some desired more evidence and others were reticent to accept 
the trials results as conclusive (Hannah et al., 2000). 
Several comparison studies showed alteration of clinical practice via examining rates of 
vaginal breech delivery versus cesarean delivery in various countries (e.g., New Zealand, 
Australia) (Kaushik and Gudgeon, 2003). 
6.1.2 Examples of other obstetrical interventions 
There was widespread variation in clinical practice in areas such as the role of external 
cephalic version (ECV) for breech presentation (effective in reducing the need for caesarean 
delivery), the use of prophylactic antibiotics at caesarean delivery (effective in reducing 
maternal puerperal sepsis), the use of antenatal corticosteroids for fetal lung maturation 
(effective in reducing the risk of neonatal respiratory disease and mortality in infants born 
preterm), the use of vacuum-assisted vaginal births (effective in reducing maternal vaginal 
and perineal trauma), and selective versus routine use of episiotomy (effective in reducing 
maternal perineal trauma).  
The systematic reviews first published in Effective Care in Pregnancy and Childbirth 
(ECPC) and The Oxford Database of Perinatal Trials (ODPT), and by the Cochrane 
Collaboration Pregnancy and Childbirth review group, summarized the best available 
evidence at the time, indicating benefit for all of these interventions. For some of these 
interventions, clinical practice has indeed changed.  
Prenatal corticosteroids are now widely prescribed for women at risk of preterm birth, with 
82% of mothers of infants born at less than 34 weeks’ gestation admitted to the neonatal 
intensive care unit in Australia, having been administered corticosteroids prior to birth 
(Donoghue et al., 2002). The uptake of ECV for breech presentation at term has been less 
successful, with only 67% of obstetricians surveyed in Australia and New Zealand offering 
ECV (Phipps et al., 2003). 
6.1.3 The obstetrical outcomes after conservative treatment of intraepithelial 
neoplasia or early invasive lesions 
With the establishment of effective screening programmes for cancer cervix, women are 
more commonly diagnosed early with preinvasive lesions and microinvasive cervical 
cancers which make younger women with such lesions candidate for conservative treatment 
for the sake of preservation of the potential for childbearing.  
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However, proper counseling of those young women on the effect of such conservative 
treatment on the obstetrical outcome has been problematic and inadequate till the 
emergence of an important meta-analysis performed by Kyrgiou et al in 2006 in which the 
authors have investigated the obstetric outcomes in women who underwent excisional 
procedures in the cervix (Kyrgiou et al., 2006). 
In this meta-anlaysis, a total of 27 studies were included. The authors exhibited that cold 
knife cervical conisation was significantly associated with preterm delivery, low birth 
weight and cesarean delivery; similarly Large Loop Excision of the Transformation Zone 
(LLETZ) was associated with preterm delivery, low birth weight and premature rupture of 
the membranes. Similar but marginally non-significant adverse effects were recorded for 
laser conisation. But the investigators did not detect significantly increased risks for 
obstetric outcomes after laser ablation. 
It was concluded that all the excisional procedures used to treat cervical intraepithelial 
neoplasia present similar pregnancy-related morbidity without apparent neonatal 
morbidity. This study changed the future attitude of gynecologists  towards women with 
abnormal cervical lesions and alerted the physicians to be more cautious for future 
treatment options. This study also provided clinicians with evidence base to counsel women 
appropriately (Kyrgiou et al., 2006). 
6.1.4 Preimplantation genetic screening for aneuploidies in IVF/ICSI 
Despite the great advances that have taken place in the field of in vitro fertilization (IVF) 
since its introduction in 1978 with the achievement of considerable success rates in almost 
all causes of infertility, still many women fail to become pregnant in spite of repeated 
transfers of apparently morphologically normal embryos.  
Among the highly accused causes for this repeated failure is the inherent abnormal 
chromosomal make-up of the embryos (i.e. embryonic aneuploidy) (Wilton, 2002). Other 
causes responsible for the pregnancy failure are the poor endometrial receptivity and the 
inefficiency of the embryo transfer techniques (Mansour and Aboulghar, 2002).  
Many of the chromosome abnormalities observed in human embryos will cause the embryos 
to die early in development, sometimes even before implantation, or before term pregnancy 
can be reached. 
Patient populations with certain characteristics (e.g. advanced maternal age, recurrent 
implantation failure , repeated miscarriages, patients undergoing testicular sperm extraction 
(TESE) and intracytoplasmic sperm injection (ICSI) have been considered at higher risk of 
producing aneuploid embryos (Kahraman et al., 2004; Munne et al., 2004; Gianaroli et al., 
2005) which would die around the time of implantation and therefore result in no 
established pregnancy (Munne et al., 2003; Caglar et al., 2005). 
In recent years, these observations of significant incidences of aneuploidy in early human 
embryos has led to the expansion of preimplantation genetic diagnosis techniques for 
aneuploidies (PGD-AS) to patients who are considered to have a poor prognosis of reaching 
a full-term pregnancy (Sermon et al., 2005). 
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Embryo morphology alone cannot be used to predict euploidy since many good quality 
embryos have been found to be aneuploid (Delhanty et al., 1997; Harper et al., 1995; Magli et 
al., 2001), thus genetic diagnosis is required to detect aneuploid embryos. 
Two main techniques namely; fluorescent in situ hybridization (FISH) for multiple 
chromosomes and polymerase chain reaction (PCR), are used to document a high frequency 
of chromosomal errors and aneuploidy in human preimplantation embryos. These 
techniques enable the selection of chromosomally normal embryos that are more likely to 
implant.  
PGD-AS is commonly also known as preimplantation genetic screening (PGS), with both 
terms used interchangeably. PGS needs to be differentiated from preimplantation genetic 
diagnosis (PGD). While the technology used in both techniques is almost identical, PGS and 
PGD differ mainly in their indications. PGD aims to prevent the birth of affected children in 
couples with a high risk of transmitting specific genetic disorders, whether numerical or 
structural in nature. PGS, on the other hand, aims to improve pregnancy rates in infertile 
couples undergoing IVF/ICSI treatment, and who do not have any chromosomal aberrations. 
PGS allows the detection of aneuploidy before the step of embryo transfer. Aneuploid 
embryos could be screened out and only euploid ones transferred, thus theoretically 
increasing the chance of pregnancy and reducing the chance of miscarriage. 
A recent systematic review and meta-analysis by Abou-Setta et al., in 2011 aimed to 
evaluate whether PGS can improve the clinical outcomes of IVF/ICSI compared with no 
intervention. There was no significant difference in live birth rates following PGS compared 
with no PGS (R.R = 0.79, 95% CI: 0.54 to 1.15; p = 0.22; I2 = 65.74%, 95% uCI: 10.51% to 
86.89%) (Figure 2). As well, there was no significant difference in clinical pregnancy rate 
following PGS compared with no PGS (R.R = 0.89, 95% CI: 0.67 to 1.17; p = 0.40; I2 = 62.00%, 
95% uCI: 1.70% to 76.66%) (Figure 3). 
 
Fig. 2. Forest plot of comparison: PGS vs Control Live birth rate 
The results of this systematic review showed that until today, there was no enough evidence 
in the literature to give a conclusive decision on the value of PGS for patients undergoing 
IVF/ICSI. Currently with the evidence at hand, PGS seems to have no impact on improving 
live birth rate (Figure 2) and the clinical pregnancy rate (Figure 3) in patients undergoing 
IVF/ICSI. In fact, many of the trials were not completed and were stopped early because of 
the ineffectiveness of the intervention (Abou-setta et al., 2011).  
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6.2 Changing attitudes towards therapeutics (evidence based therapeutics)  
The advances in therapeutics are tremendous with many novel drugs and therapies 
manufactured and developed every day with the emergence of new strategies and 
mechanisms of actions making the selection of the best effective therapy a difficult and 
challenging task. Evaluation of the superiority of a particular therapy based on a single trial 
is inadequate and deficient. Hence, for evaluation to be better and adequate, it should be 
served by a comprehensive and systematic review of all existing data sets. We will display 
examples for some therapeutics that have been evaluated in an evidence based approach, 
resulting in changing attitudes towards their use. 
6.2.1 Hormone Replacement Therapy: WHI study 
Hormone replacement therapy, (HRT) involves the replacement of the depleted hormone 
levels in menopausal women by the administration of synthetic estrogen with or without 
progestogen with the aim to alleviate symptoms of menopause.  
Despite the potential health benefits that were expected from the use of HRT, many risks 
and complications have been associated with its use. Although observational studies 
suggested protective effects on heart disease (Stampfer et al., 1991), osteoporosis (Lindsay et 
al., 1976), and even Alzheimer's disease (Henderson et al., 1994), recent clinical trials have 
questioned some of these benefits. Till now, the debate regarding the risk-benefit ratio of 
hormone replacement therapy has not been completely resolved. 
However, in July 2002, the Women’s Health Initiative (WHI), - a large, multicentric clinical 
trial by the National Heart, Lung and Blood Institute (NHLBI) and other units of National 
Institute of Health (NIH) – reported that hormone replacement therapy actually posed more 
health risks than benefits (Rossouw et al., 2002).  
This was the turning point in HRT, as the number of health hazards attributed to HRT 
grew, practitioners discontinued routine prescriptions for this once a time very popular and 
rampant treatment modality and HRT use substantially decreased in the general population 
(Dorval et al., 2007, Hersh et al., 2004, Majumdar et al., 2004). 
Changing Attitudes in Obstetrics and Gynecology – 
How Evidence Based Medicine is Changing Our Practice? 
 
107 
The results of this study provide the best evidence available at present on HRT for 
prevention of heart disease, and indicate that combined HRT is not indicated for this 
purpose in the studied population, thus contradicting the reported beneficial effects of HRT 
on coronary heart disease (CHD) in previous observational studies (Rossouw et al., 2002). 
6.2.2 Inudction of ovulation in patients with polycystic ovary syndrome  
Polycystic ovary syndrome has an estimated prevalence of 4-8 % in reproductive-aged 
women (Knochenhauer et al., 1998; Asuncion et al., 2000). It is the most common cause of 
oligoanovulatory infertility (Hull, 1987). Ovulation in these cases has been suggested to be 
induced by the use of clomiphene citrate or insulin sensitizer or combination of both. 
Metformin as an insulin sensitizer improves peripheral insulin sensitivity by decreasing 
glucose production by the liver and increasing the sensitivity of target tissues to insulin. 
Metformin was also found to reduce levels of androgens in both lean and obese women, 
leading to increased rates of spontaneous ovulation (Batukan et al., 2001; Haas et al., 2003; 
Essah et al., 2006). 
It has been demonstrated by a number of studies that up to 40 % of anovulatory women 
with polycystic ovary syndrome will ovulate, and many will achieve pregnancy with 
metformin alone (Diamanti-Kandarakis et al., 1998; Neveu et al., 2007). 
Despite the postulated effectiveness of metformin in induction of ovulation in cases with 
polycystic ovary syndrome, randomised controlled trials conducted by Moll et al., 2006 and 
Legro et al., 2007 didn’t support these expectations.  
Moll et al., 2006 performed a randomised double blind clinical trial to compare the effect of 
clomiphene citrate plus metformin and clomiphene citrate plus placebo on induction of 
ovulation in women with newly diagnosed polycystic ovary syndrome. The authors 
recruited 228 women with polycystic ovary syndrome, of those, 111 women were allocated 
to clomiphene citrate plus metformin (metformin group) and 114 women were allocated to 
clomiphene citrate plus placebo (placebo group).  
The results of the study showed that the ovulation rate in the metformin group was 64% 
compared with 72% in the placebo group, a non-significant difference (risk difference − 8%, 
95% confidence interval − 20% to 4%). Hence, the authors concluded that metformin is not 
an effective addition to clomiphene citrate as the primary method of inducing ovulation in 
women with polycystic ovary syndrome. 
The above conclusion was also emphasized by another study performed by Legro et al. in 2007 
who conducted a randomized prospective study involving 626 infertile women with 
polycystic ovary syndrome. In this study, the authors found live-birth rates with clomiphene 
citrate alone were higher (22.5 %) than with metformin alone (7.2 %) (Legro et al., 2007).  
6.2.3 Metformin in prevention of ovarian hyperstimulation syndrome  
Ovarian hyperstimulation syndrome (OHSS) is considered to be the most serious 
complication of superovulation in IVF-embryo transfer. The syndrome can vary in 
presentation from mild to severe life threatening disease. Severe manifestations of OHSS 
may include massive fluid shifts, hemoconcentration or renal and liver dysfunction. The 
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syndrome may be ultimately complicated by thromboembolic events and adult respiratory 
distress syndrome (Rizk and Aboulghar, 1999).  
Several strategies have been suggested to prevent such life threatening complication of 
ovulation induction. Among the suggested strategies is the administration of metformin. A 
meta-analysis has indicated that the administration of metformin significantly prevents 
OHSS development in patients with polycystic ovary syndrome, a high risk group (Costello 
et al., 2006).  
The mechanism of action of metformin is not completely clear, but both reduction of ovarian 
reserve, as demonstrated by the reduction of anti-Müllerian hormone (AMH) values 
(Piltonen et al., 2005), and a reduced insulin dependent VEGF production (Tang et al., 2006), 
have been suggested. 
6.2.4 Changing attitudes in ovarian stimulation towards patient's safety  
Gonadotropin-releasing hormone agonists (GnRHa) were introduced in ovarian stimulation 
for IVF to suppress the premature surge of luteinizing hormone (LH).  
Various protocols have been suggested for controlled ovarian hyperstimulation in assisted 
reproduction, however, the long agonist protocol have been the standard protocol because 
of the associated increase in pregnancy rates.  
In this long agonist protocol, GnRHa is started either in the mid-luteal phase or in the early 
follicular phase of the preceding cycle and continued until pituitary desensitization has been 
achieved; usually after 2–3 weeks, at which point gonadotropin administration will be 
started (Al-Inany and Aboulghar, 2003).  
However, despite the increased pregnancy rates, the use of the GnRHa long protocols has 
been concurrently associated with an increase in the incidence of ovarian hyperstimulation 
syndrome (Rizk and Smitz, 1992).   
The fear from such serious and potentially life threatening complications has motivated 
researchers to study other alternative protocols that would achieve better safety with at least 
equivalent results, thus improving the outcome of IVF. Gonadotropin-releasing hormone 
antagonists have emerged as an alternative treatment for preventing premature LH surges 
during controlled ovarian hyperstimulation (Al-Inany et al., 2011). 
GnRH agonist and antagonist exert their effects through different mechanisms of action. 
GnRH agonists act by downregulation of pituitary GnRH receptors and desensitization of 
the gonadotropic cells, while GnRH antagonists act by directly and rapidly inhibiting 
gonadotropin release within several hours through competitive binding to pituitary GnRH 
receptors. This mechanism of action is dependent on the equilibrium between endogenous 
GnRH and the applied antagonist and is highly dose dependent in contrast to the agonists 
(Felberbaum et al., 1995).  
The competitive blockade of the receptors by GnRH antagonists results in immediate arrest 
of gonadotropin secretion; therefore, they can be given after starting gonadotropin 
administration. This will lead to dramatic reduction in the duration of treatment cycle as 
well as avoiding flare up and estrogen deprivation symptoms associated with GnRHa-
induced downregulation. 
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Cochrane reviews comparing GnRH antagonist to the more widely used long GnRH agonist 
protocols were published successively, with the first review published in 2001 (Al-Inany and 
Aboulghar, 2001), that was later updated in 2006 (Al-Inany et al., 2006) and recently updated 
again in 2011 (Al-Inany et al., 2011). The last updated review focused on patient-oriented 
value mainly safety and ongoing pregnancy/live birth rate.  
The earlier two versions of that review showed lower efficacy for GnRH antagonists while 
the most recent one showed lower pregnancy in antagonist but did not reach statistically 
significant level.  
According to the most recent review, nine trials reported live birth rates in 1515 women. 
There was no significant difference in live birth rates following GnRH antagonist compared 
with GnRH agonist (OR = 0.86, 95% CI = 0.69 to 1.08; p = 0.20; I2 = 0.00%, 95% CI = 0.00% to 
31.62%) (Figure 3).  
However, more importantly, there were a statistically highly significant lower incidence of 
OHSS in the GnRH antagonist group (Twenty-nine randomized controlled trials reported 
ovarian hyperstimulation rates in 5417 women, R.D = -0.03, 95% CI = -0.05 to -0.02; p < 
0.00001; I2 = 67,68%, 95% CI = 52.50% to 78.02%) (See Figure 4).  
Thus, there was a significant difference favouring GnRH antagonist compared with GnRH 
agonist. The incidence was reduced by 50% in antagonist group (1.91 vs 3.74%). The 
corresponding number needed to harm was 25 (95% CI: 19–36) with an absolute risk 
reduction of 4% (95% CI: 2.79–5.13).  
This means that for every 25 women undergoing downregulation by agonist, one more case 
of severe OHSS may be expected. In addition, the cancellation rate owing to high risk to 
develop OHSS was significantly higher in GnRHa group. This means that the difference 
would be highly significant if cancellation was not done (Al-Inany et al., 2011). 
6.2.5 For intrauterine insemination (IUI) timing: Which is the best; human chorionic 
gonadotropin administration or monitoring of LH surge?  
Kosmas et al., 2007 conducted a systematic review and meta-anlaysis to find out whether the 
timing of intrauterine insemination by the administration of hCG achieves better results 
than the monitoring of LH surge.  
Seven studies with 2,623 patients were involved in this meta-analysis, in which 1,461 
patients received hCG, and 1,162 had LH surge detection. When all studies were 
combined, patients who received hCG before IUI demonstrated lower clinical-pregnancy 
rates than did women who had IUI after spontaneous ovulation (odds ratio, 0.74; 95% 
confidence interval, 0.57–0.961).  
In subgroup analysis of studies that considered ovulatory dysfunction to be the infertility 
reason, the results favored women who received hCG. In contrast, across studies that 
reported male factor as the infertility reason, as well as across studies including women with 
unexplained infertility, results appeared to favor the LH surge detection approach. 
However, none of those subgroup analyses reached statistical significance (Kosmas et al., 
2007).  
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6.3 Changing attitudes towards diagnostics (evidence based diagnosis)  
Evidence-based medicine has progressively developed as the standard approach for many 
diagnostic procedures. With the increasing varieties of investigating and diagnostic tools, 
evidence based medicine allows for the selection of the best diagnostic approach that would 
achieve the most reliable diagnosis with the least possible expenses, thus avoiding other less 
accurate and unnecessary diagnostic methods.  
6.3.1 Anti-Müllerian hormone  
Anti-Müllerian hormone (AMH) has become the ‘molecule of the moment’ in the field of 
Reproductive Endocrinology. Indeed, it is valuable as a means of increasing understanding 
of ovarian pathophysiology and for guiding clinical management across a broad range of 
conditions. 
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In a cross-sectional study by La Marca et al., 2010, AMH was measured in 277 healthy 
females (aged 18–50 years) by commercial enzyme-linked immunosorbent assay. Serum 
AMH concentrations show a progressive decline with female ageing. The age-related 
changes in AMH were best fitted by a polynomial function. Mean AMH concentrations 
were not modified by past use of oral contraceptive and were independent of parity of 
women. Age-specific normative values for circulating AMH concentration were established. 
AMH concentrations seem to be independent of the reproductive history of the patient (La 
Marca et al., 2010). 
AMH plays a basic role as a prognostic marker in women undergoing ovarian stimulation 
protocols and can predict an excessive response to ovarian stimulation (Broer et al., 2010). 
7. Conclusions  
Evidence Based Medicine is currently changing our daily practice in obstetrics and 
gynecology towards achieving better health to women and mothers all over the world. The 
best evidence can be extracted from clinically relevant research that answers a clinical 
question using sound methodology.  
Our paradigms in the fields of diagnosis, interventions and therapeutics have exhibited 
some of the progress that has been performed throughout the last years. There is an 
increasing necessity for systematically reviewing, appraising and using clinical research 
findings to shift our practice towards an evidence based one. Evidence-based practice 
requires a clear view of the evidence combined with wise integration of this information 
with other knowledge and experience in clinical decision making. 
Evidence based medicine has been adopted, alongside health economics, and has been 
promoted as the gold standard tool for advancement and provision of health services in 
obstetrics and gynecology. Thus, a keen and sincere physician should be seeking evidence 
based medicine and integrating evidence based practice to deliver a higher level of health 
service to his patients.  
In a domain full of controversies as that of the obstetrics and gynecology, it is crucial to 
consider what the evidence says and exert every effort to integrate this evidence into 
practice as this will be the surest way that a patient will receive safe and effective up to date 
health service.  
Drawing examples on evidence based medicine is endless and can not be fulfilled 
completely in this context however, we aimed to draw the light on the role of evidence 
based medicine in changing attitudes in our routine daily practice by demonstrating some 
important examples that would emphasize that role.  
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promoted as the gold standard tool for advancement and provision of health services in 
obstetrics and gynecology. Thus, a keen and sincere physician should be seeking evidence 
based medicine and integrating evidence based practice to deliver a higher level of health 
service to his patients.  
In a domain full of controversies as that of the obstetrics and gynecology, it is crucial to 
consider what the evidence says and exert every effort to integrate this evidence into 
practice as this will be the surest way that a patient will receive safe and effective up to date 
health service.  
Drawing examples on evidence based medicine is endless and can not be fulfilled 
completely in this context however, we aimed to draw the light on the role of evidence 
based medicine in changing attitudes in our routine daily practice by demonstrating some 
important examples that would emphasize that role.  
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1. Introduction 
The Papanicolou screen (“Pap smear”) was developed in 1928 by Dr. George Papanicolaou 
for the identification of cervical cancers. It became widely known after his publication in 
1941 and widely used in clinical practice in the 1950s; it is now the most commonly 
performed cancer screening test world-wide (1). This has been one of the most successful 
cancer screening techniques in modern medicine, and in the United States rates of cervical 
cancer have decreased by almost 80% since the 1950s (2,3). Pap smear screening has been 
widely embraced by physicians and women alike, and is considered a critical part of the 
routine health care of women. However, up to 20% of American women do not receive 
regular Pap smears, and in developing countries without the complex resources required to 
process and read Pap specimens, screening remains a challenge (4). Among women with 
cervical cancer in the U.S., at least 60% did not have appropriate Pap surveillance prior to 
their diagnoses (5). 
In the decades since the initial development of the Pap smear, our understanding of the 
pathophysiology of cervical cancer has evolved considerably. The occurrence of pre-
malignant cervical lesions, now referred to as cervical dysplasia, was recognized as early at 
the 1940s (6). During the 1970s and 1980s, the human Papilloma virus (HPV) was identified 
within cervical lesions (7, 8). As early as 1976, Dr. Harald zur Hausen and colleagues 
postulated a role for the HPV in cervical oncogenesis, and his subsequent work isolating 
oncogenic HPV strains and elucidating the oncogenic process earned him the Nobel Prize in 
Medicine in 2008 (9-11).  
The discoveries of premalignant cervical lesions and the role of HPV in cervical dysplasias 
and cancers have also enabled physicians to gradually refine the use of Pap smear screening. 
As a result, the number of women who need Pap smears, and the frequency at which they 
are recommended, has changed significantly over the last several years. However, 
dissemination of the newest guidelines has been met with some resistance both from 
women and their physicians.  
In this article, we will review these advancements and the current evidence about the 
modern use of Pap smears and HPV screening, the evidence leading to the new 
recommendations and some barriers to their full implementation. 
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2. Fundamentals of screening for disease 
Screening can be defined as the effort to identify asymptomatic disease or disease precursors 
through examinations or tests applied rapidly to an appropriate segment of the population. 
Screening tests delineate patients who appear well and have a disease from those who do 
not have a disease. Numerous examples of screening tests exist in clinical practice as a part 
of primary or secondary prevention, including blood pressure measurements, serum 
cholesterol measurements, pap tests, and colonoscopy. Importantly, screening tests are not 
intended to be diagnostic. A positive screening test requires follow-up and commitment to 
further investigation.  
A successful and appropriate screening test depends on numerous criteria, which cluster in 
to three general categories delineated by Katz: disease-specific criteria, test-specific criteria, 
and society or system-criteria (Table 1) (12). All of the factors listed in Table 1 impact the 
potential benefits of screening programs both to individual patients and populations. 
Disease screening would be unjustified if the burden of disease is insignificant or if 
treatment outcomes are no different between asymptomatic cases diagnosed at an early 
stage and symptomatic cases diagnosed at later stage. If an effective treatment for a disease 
is not available, screening and early detection confers no benefit to patients. Disease 
prevalence, discussed in detail below, is integral to screening programs as screening for 
extremely rare conditions would not be cost-effective or accurate given that false-positive 
tests may outnumber true-positive results. The screening test itself must be convenient, 
acceptable, safe, and cost-effective for patients. An ideal screening test should take only a  
 
Disease-specific 
 Condition must have significant burden on health (morbidity, mortality, suffering) 
 Disease detectable in asymptomatic state 
 Natural history of disease modifiable with treatment 
 Early, effective treatment available 
 Appropriate prevalence: not too rare or too common 
Test-specific 
 Highly sensitive to reliably identify disease cases 
 Highly specific to minimize false positives 
 Cost-effective 
 Test is safe, convenient, and acceptable to patients 
Society/System-specific 
 Confirmatory, diagnostic testing readily available for screen positive 
 Effective treatment readily available for confirmed cases 
 Screening program cost-effective for population 
Adapted from Katz DL, Fundamentals of screening: the art and science of looking for trouble, Sage 
Publications, London, 2001 (reference 12).  
Table 1. Characteristics of an Appropriate Screening Test 
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few minutes to perform, require minimal preparation by the patient, and be inexpensive. 
Additionally, given that screening programs require a significant commitment of resources, 
they should be cost-effective and confer benefit on a population or societal level. As 
described further in this chapter, screening for cervical cancer exemplifies an ideal screening 
test by meeting all of the aforementioned criteria. 
Importantly, a successful screening program is dependent upon the various characteristics 
of the screening test, and an understanding of these principals is fundamental to providers 
and public health officials. Sensitivity and specificity are characteristics inherent to a test 
and are independent of disease prevalence. Sensitivity is the probability that if the disease is 
present, the test is positive. Mathematically, the numerator is the number of subjects with a 
disease who have a positive test and the denominator is the total number of subjects with a 
disease. A test with high sensitivity effectively identifies subjects with disease and 
infrequently misses true cases (low false negative rate). Specificity is the probability that if a 
disease is absent, the test is negative. Mathematically, the numerator is the number of 
subjects without a disease who also have a negative test, and the denominator is the total 
number of subjects without disease. Tests with high specificity infrequently identify subjects 
as having disease when they do not (low false positive rate). Given that screening tests must 
identify disease in asymptomatic patients where the prevalence is usually low (even in high 
risk groups), a good screening test must have high sensitivity as to not miss the few cases of 
disease present. Additionally, the sensitivity must remain high in the early stages of disease. 
A test that demonstrates high sensitivity only in late-stage disease, where treatment may be 
less effective, will not provide clinical utility. Good screening tests should also have high 
specificity to reduce the number of false positive results which require follow-up evaluation 
or intervention.  
The calculation of sensitivity and specificity for screening tests are determined in a manner 
similar to that of diagnostic tests, however one major difference deserves mention. The 
sensitivity and specificity of diagnostic tests are based on comparisons between the test 
results and a different test (the reference or “gold standard”). For a screening test, the “gold 
standard” for detecting disease includes both another test and a period of follow-up. 
Additional testing is routinely administered to those who have positive screening tests for 
confirmation (differentiation of true and false-positive results). However, a period of follow-
up is necessary for all negative results to differentiate subjects with true and false-negative 
tests. This characteristic is particularly important in cancer screening, where cancers 
discovered during the period of follow-up (interval cancers) occur. Choosing the 
appropriate duration of follow-up may impact the sensitivity and specificity of the test, 
which overestimates sensitivity if the follow-up period is too short and underestimates 
sensitivity if the follow-up period is too long. (13) 
Positive and negative predictive values (PPV, NPV) also represent important characteristics 
of screening tests. PPV represents the probability that a subject with a positive test has a 
disease. The numerator is the number of subjects with disease who have a positive test and 
the denominator is the number of subjects with a positive test. Conversely, NPV represents 
the probability that subject with a negative test does not have disease. The numerator is the 
number of subjects without disease who have a negative test and the denominator is the 
number of subjects with a negative test. The predictive values depend on disease prevalence 
within a population. For a test with a given sensitivity and specificity, as prevalence rises 
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few minutes to perform, require minimal preparation by the patient, and be inexpensive. 
Additionally, given that screening programs require a significant commitment of resources, 
they should be cost-effective and confer benefit on a population or societal level. As 
described further in this chapter, screening for cervical cancer exemplifies an ideal screening 
test by meeting all of the aforementioned criteria. 
Importantly, a successful screening program is dependent upon the various characteristics 
of the screening test, and an understanding of these principals is fundamental to providers 
and public health officials. Sensitivity and specificity are characteristics inherent to a test 
and are independent of disease prevalence. Sensitivity is the probability that if the disease is 
present, the test is positive. Mathematically, the numerator is the number of subjects with a 
disease who have a positive test and the denominator is the total number of subjects with a 
disease. A test with high sensitivity effectively identifies subjects with disease and 
infrequently misses true cases (low false negative rate). Specificity is the probability that if a 
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number of subjects without disease. Tests with high specificity infrequently identify subjects 
as having disease when they do not (low false positive rate). Given that screening tests must 
identify disease in asymptomatic patients where the prevalence is usually low (even in high 
risk groups), a good screening test must have high sensitivity as to not miss the few cases of 
disease present. Additionally, the sensitivity must remain high in the early stages of disease. 
A test that demonstrates high sensitivity only in late-stage disease, where treatment may be 
less effective, will not provide clinical utility. Good screening tests should also have high 
specificity to reduce the number of false positive results which require follow-up evaluation 
or intervention.  
The calculation of sensitivity and specificity for screening tests are determined in a manner 
similar to that of diagnostic tests, however one major difference deserves mention. The 
sensitivity and specificity of diagnostic tests are based on comparisons between the test 
results and a different test (the reference or “gold standard”). For a screening test, the “gold 
standard” for detecting disease includes both another test and a period of follow-up. 
Additional testing is routinely administered to those who have positive screening tests for 
confirmation (differentiation of true and false-positive results). However, a period of follow-
up is necessary for all negative results to differentiate subjects with true and false-negative 
tests. This characteristic is particularly important in cancer screening, where cancers 
discovered during the period of follow-up (interval cancers) occur. Choosing the 
appropriate duration of follow-up may impact the sensitivity and specificity of the test, 
which overestimates sensitivity if the follow-up period is too short and underestimates 
sensitivity if the follow-up period is too long. (13) 
Positive and negative predictive values (PPV, NPV) also represent important characteristics 
of screening tests. PPV represents the probability that a subject with a positive test has a 
disease. The numerator is the number of subjects with disease who have a positive test and 
the denominator is the number of subjects with a positive test. Conversely, NPV represents 
the probability that subject with a negative test does not have disease. The numerator is the 
number of subjects without disease who have a negative test and the denominator is the 
number of subjects with a negative test. The predictive values depend on disease prevalence 
within a population. For a test with a given sensitivity and specificity, as prevalence rises 
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the PPV of a test increases and the NPV decreases. Conversely, as prevalence falls, the PPV 
decreases and the NPV increases. This observation has important implications for screening 
tests, where the disease prevalence is generally low. Therefore, most screening tests have 
low PPV and high NPV (despite high sensitivity and specificity). Clinically, this implies that 
providers offering screening tests to their patients must accept the fact that many patients 
will screen positive and not truly have disease; however, these patients still require follow-
up evaluation and testing.  
3. Biases and pitfalls of screening programs 
Instinctively, screening for disease has apparent benefits. However, given that no test in 
medicine is perfect, widespread adoption of screening tests prior proving their benefit can 
become problematic. Therefore, prior to implementing population-wide screening 
programs, a test should be subject to careful study. Similar to any intervention in medicine, 
the most rigorous means of establishing the efficacy of a treatment or intervention is with a 
randomized controlled trial. However, many years and large numbers of patients are 
required to establish the efficacy of a preventative intervention or screening test. For 
example, a study demonstrating that early treatment of colorectal cancer detected by disease 
screening reduced cancer-related mortality by one-third required 45,000 subjects and 13 
years of follow-up surveillance (14). Therefore, a case series describing screening programs 
or a “clinical impressions” of the impact of screening do not suffice to establish efficacy.  
Rigorous study is necessary to avoid biases specific to the study of screening programs. One 
such bias, lead-time bias, occurs when discovering a disease in an early stage with screening 
does not impact mortality rates or outcomes relative to discovering the disease later when it 
would typically present with symptoms. Discovering the disease early may appear 
beneficial by increasing “survival time”. However, in reality, early detection only serves to 
advance diagnosis, thereby increasing the duration of time a patient has a disease. A patient 
living with disease for a longer period of time may be subject to more frequent examinations 
and tests as well as increased anxiety from a longer time with knowledge of disease.  
Another type of bias present in screening programs is length-time bias. Length-time bias is a 
type of selection bias that occurs when outcomes appear better in a screened population of 
subjects due to the fact that diseases with a favorable prognosis are more readily discovered 
with screening. This phenomenon is exemplified by cancer screening, where slow-growing 
lesions are diagnosed more readily than rapidly-growing lesions due to a longer pre-clinical, 
asymptomatic period. Given that slow-growing tumors generally have a better prognosis 
than rapidly-growing tumors, screening programs generally discover slow-growing tumors 
with inherently more favorable prognoses. Therefore, while mortality rates for cancers 
discovered through screening may be more favorable, screening is not truly protective in 
this setting.  
Lastly, compliance bias can occur in studying the efficacy of screening programs. 
Compliance, the degree to which patients follow or adhere to medical advice, may impact 
studies of disease screening as compliant patients tend to have better prognoses 
independent of screening. For example, studies that compare disease outcomes between 
subjects who volunteer for screening and those that do not may demonstrate improved 
outcome, however this improvement may be secondary to higher compliance amongst 
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volunteers rather than any benefit conferred by the screening program. Therefore, to 
effectively evaluate the impact of any screening test or program, randomized trials with 
concurrent screening and control groups must be conducted to minimize the introduction of 
length-time and compliance bias. By following studied populations with mortality rates, 
rather than survival rates, lead-time bias can be avoided.  
Screening programs also have the potential to produce significant adverse effects in a 
screened population, which highlights another critical reason to rigorously study screening 
tests prior to their widespread application. Adverse effects range from discomfort produced 
from the test itself to false-positive test results to overdiagnosis. In effective screening 
programs, false-positive results account for a minority of all test results. However, false-
positive results can still have a substantial impact on a large number of patients by 
producing anxiety and the discomfort and cost of additional follow-up tests. Given that 
screening tests are often repeated in intervals, each repeat screen is subject to further false-
positive results. Additionally, the negative impact of overdiagnosis cannot be overstated. 
While the underlying presumption in cancer screening is that earlier detection translates 
into improved outcomes, recent evidence has challenged this thesis. In a recent editorial, 
Welch reviewed the impact of a 10-year course of screening mammography on 2500 women 
in the US at age 50 (15). While one breast cancer-related death would be prevented by 
mammography, up to 1000 women will have at least one false-positive result and 
approximately half will undergo a breast biopsy. Additionally, breast cancer will be 
overdiagnosed in 5-15 women who will be treated “needlessly” with surgery, 
chemotherapy, radiation, or a combination thereof. Therefore, even excellent screening tests 
are not without pitfalls.  
Screening for cervical cancer exemplifies a good screening test by satisfying the 
aforementioned criteria described by Katz (Table 1). Cervical cancer is appropriately 
prevalent and has a significant disease-related morbidity and mortality. The natural history 
of the disease, from HPV infection to carcinoma, has been clearly established. A 
premalignant window for intervention exists such that treatment significantly decreases 
disease burden. Follow-up testing with colposcopy is generally available and effective at 
detecting premaligant lesions. Excision procedures reliably treat premalignant lesions and 
prevent progression to cancer. When utilized for screening, Pap smears have acceptable test 
characteristics. While reports of sensitivity and specificity vary significantly between 
studies, a meta-analysis demonstrated sensitivity as high as 86% and specificity as high as 
100% (16). Additionally, negative predictive values have been demonstrated to be higher 
than 95% (17). As such, Pap screening remains one of the most significant and successful 
screening tests in the history of modern medicine. The remainder of this chapter provides 
and evidence-based assessment of Pap and HPV screening with a discussion current 
recommendations and controversies. 
4. History of Pap screening and impact of screening on cervical cancer 
incidence and mortality 
Dr. George Papanicolaou, a physician and scientist trained in Greece in the early 1900s, 
immigrated to the United States in 1913 seeking greater opportunities in medicine and 
research (Figure 1). He became acquainted with T.H. Morgan, a well-known zoologist who 
had already read and cited Papanicolaou’s doctoral thesis in a publication. Mr. Morgan 
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Adapted from Vilos G. Dr. George Papanicolaou and the Birth of the Pap Test. Obstetrical & 
Gynecological Survey. 54(8):481-483, August 1999. 
Fig. 1. Dr. George Papanicolaou 
recommended Papanicolaou for a part time position as a technician in the pathology 
department at New York Hospital. His scientific mind impressed the department and 
shortly thereafter he was appointed as an assistant professor in the anatomy department at 
Cornell Medical School. His research on the chromosomal basis of gender differentiation in 
guinea pigs led to the discovery that exfoliated cells from the vagina could predict the 
timing of ovulation. In his initial experiments, he used a small nasal speculum to obtain the 
sample and then plated slides for microscopy, noting “an impressive wealth of diverse cell 
forms and a sequence of distinctive cytologic pattern” (21). With this observation, he 
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hypothesized that an analogous pattern could be appreciated in humans. Concomitantly, he 
began to obtain samples from his wife for further study, which represented the birth of the 
Pap smear. Shortly thereafter, he initiated the systematic study of exfoliated vaginal cells in 
women working at New York Hospital. In February 1295, he encountered a woman with an 
undiagnosed carcinoma of the cervix. The slide produced from her sample was recognized 
as cancer, and he then understood the implications of his methods on the diagnosis of 
cervical cancer. He confirmed his findings by recruiting other women with known 
cervical cancers and characterizing their cervicovaginal samples. He presented his test 
and findings at the Third Race Betterment Conference in Battle Creek, Michigan in 
January of 1928 (22).  
Papanicolaou’s 1928 presentation was greeted with skepticism by pathologists at the time as 
they felt biopsy should remain the gold standard diagnostic modality. Unfortunately, ten 
additional years of research was required before the Pap test was evaluated rigorously as a 
potential diagnostic tool. Finally, in 1939, at the urging of his department chair, 
Papanicolaou and fellow gynecologic pathologist Herbert F. Traut initiated a clinical trial of 
the Pap test. Vaginal samples were collected from all women admitted to the obstetric and 
gynecologic services at New York Hospital. They published their findings in the American 
Journal of Obstetrics and Gynecology in 1941, which detailed the differences between normal 
and malignant cells of the cervix. In this landmark publication, Papanicolaou proposed his 
technique as a simple, inexpensive means to test large numbers of women and diagnose 
cancer at an earlier stage which would be more amenable to treatment (1).  
Shortly after the publication of this manuscript, his technique started to gain more 
widespread acceptance including the support of the National Cancer Institute and the 
American Cancer Society (ACS). In 1948, the ACS held the first interdisciplinary conference 
to promote the “Pap” test (23). In the late 1940s and early 1950s, community-based projects 
were undertaken to explore the feasibility and acceptance of screening large proportions of 
the population as well as to evaluate the impact of screening on cancer incidence and 
mortality. Screening programs in Ohio, Tennessee, and Kentucky all demonstrated increases 
in the detection of carcinoma in situ and decreases in the incidence of invasive carcinoma. 
For example, in the study from Kentucky, over 90% of the female population in the greater 
Louisville area was screened at least once during an 11 year period and the rate of cervical 
cancer declined by 32% (24-26).  
With local and regional programs demonstrating benefit, the ACS promoted a national 
effort and campaign for screening. In 1957, the ACS initiated a campaign for annual, 
universal screening called the “Uterine Cancer Year”. The American College of Obstetricians 
and Gynecologists followed with recommendations for cervical cytologic screening in their 
first and second editions of the Manual of Standards in Obstetric-Gynecologic Practice, 
published in 1959 and 1965 respectively (27). At that point, the framework was in place for 
the incorporation of Pap screening into standard gynecologic practice.  
The aforementioned community-based evaluations established that cervical cytologic 
screening was acceptable to large populations of women. Importantly, these evaluations 
also demonstrated a consistent decrease in cervical cancer incidence and mortality in each 
community where screening was introduced. Interestingly, however, no randomized clinical 
trials of cervical cytology assessment with Pap screening have been performed to date. 
 
Evidence Based Medicine – Closer to Patients or Scientists? 122 
 
Adapted from Vilos G. Dr. George Papanicolaou and the Birth of the Pap Test. Obstetrical & 
Gynecological Survey. 54(8):481-483, August 1999. 
Fig. 1. Dr. George Papanicolaou 
recommended Papanicolaou for a part time position as a technician in the pathology 
department at New York Hospital. His scientific mind impressed the department and 
shortly thereafter he was appointed as an assistant professor in the anatomy department at 
Cornell Medical School. His research on the chromosomal basis of gender differentiation in 
guinea pigs led to the discovery that exfoliated cells from the vagina could predict the 
timing of ovulation. In his initial experiments, he used a small nasal speculum to obtain the 
sample and then plated slides for microscopy, noting “an impressive wealth of diverse cell 
forms and a sequence of distinctive cytologic pattern” (21). With this observation, he 
 
Evidence-Based Cervical Cancer Screening: The Modern Evolution of the Pap Smear 123 
hypothesized that an analogous pattern could be appreciated in humans. Concomitantly, he 
began to obtain samples from his wife for further study, which represented the birth of the 
Pap smear. Shortly thereafter, he initiated the systematic study of exfoliated vaginal cells in 
women working at New York Hospital. In February 1295, he encountered a woman with an 
undiagnosed carcinoma of the cervix. The slide produced from her sample was recognized 
as cancer, and he then understood the implications of his methods on the diagnosis of 
cervical cancer. He confirmed his findings by recruiting other women with known 
cervical cancers and characterizing their cervicovaginal samples. He presented his test 
and findings at the Third Race Betterment Conference in Battle Creek, Michigan in 
January of 1928 (22).  
Papanicolaou’s 1928 presentation was greeted with skepticism by pathologists at the time as 
they felt biopsy should remain the gold standard diagnostic modality. Unfortunately, ten 
additional years of research was required before the Pap test was evaluated rigorously as a 
potential diagnostic tool. Finally, in 1939, at the urging of his department chair, 
Papanicolaou and fellow gynecologic pathologist Herbert F. Traut initiated a clinical trial of 
the Pap test. Vaginal samples were collected from all women admitted to the obstetric and 
gynecologic services at New York Hospital. They published their findings in the American 
Journal of Obstetrics and Gynecology in 1941, which detailed the differences between normal 
and malignant cells of the cervix. In this landmark publication, Papanicolaou proposed his 
technique as a simple, inexpensive means to test large numbers of women and diagnose 
cancer at an earlier stage which would be more amenable to treatment (1).  
Shortly after the publication of this manuscript, his technique started to gain more 
widespread acceptance including the support of the National Cancer Institute and the 
American Cancer Society (ACS). In 1948, the ACS held the first interdisciplinary conference 
to promote the “Pap” test (23). In the late 1940s and early 1950s, community-based projects 
were undertaken to explore the feasibility and acceptance of screening large proportions of 
the population as well as to evaluate the impact of screening on cancer incidence and 
mortality. Screening programs in Ohio, Tennessee, and Kentucky all demonstrated increases 
in the detection of carcinoma in situ and decreases in the incidence of invasive carcinoma. 
For example, in the study from Kentucky, over 90% of the female population in the greater 
Louisville area was screened at least once during an 11 year period and the rate of cervical 
cancer declined by 32% (24-26).  
With local and regional programs demonstrating benefit, the ACS promoted a national 
effort and campaign for screening. In 1957, the ACS initiated a campaign for annual, 
universal screening called the “Uterine Cancer Year”. The American College of Obstetricians 
and Gynecologists followed with recommendations for cervical cytologic screening in their 
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Therefore, while a true causal relationship may never be formally established, a consistent 
association of screening with a reduction in cervical cancer burden provides convincing 
evidence of the impact of the Pap test.  
The international epidemiology of cervical cancer further supports a direct correlation 
between screening programs and decreased cancer incidence and mortality. Prior to the 
widespread adoption of screening programs in developed countries, incidence rates of 
cervical cancer were similar to those found in developing countries today (28). Currently, 
however, marked disparities exist between the incidence of cervical cancer as well as 
cervical cancer-related mortality between the developed and developing world (Figure 2). 
Due to widespread implementation of cervical cancer screening programs in the developed 
world, cervical cancer has become one of the least common malignancies impacting women. 
In the United States in 2007, approximately 12,000 women were diagnosed with cervical 
cancer and 4000 died from the disease. Additionally, as noted by the NCI Surveillance 
Epidemiology and End Results (SEER) data, the incidence and mortality rate for cervical 
cancer continues to decline at 2.6% per year and 0.6% per year respectively (data available 
through 2008) (29, 30). Worldwide, however, the incidence of cervical cancer is 
approximately 500,000 cases per year with over 250,000 cancer-related deaths (31). 
According to the World Health Organization, over 80% of cervical cancer-related deaths 
occur in the developing world, and the lack of access to screening and prevention programs 
represents the primary reason for the enormous disparity between resource-rich and 
resource-poor nations  (32). Additionally, even in countries with adequate screening programs, 
poor women suffer a disproportionate share of the burden of disease, with incidence rates  
 
Adapted from: Sankaranarayanan R, Ferlay J. Worldwide burden of gyaecological cancer: the size of the 
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approximately two-fold higher than more affluent women (28). Cervical cancer does not 
make the list of the ten most incident or lethal cancers in the United States. However, 
cervical cancer remains the second leading cause of cancer-related female mortality 
worldwide (29, 32). It is therefore a substantial public health challenge despite the presence 
of an effective screening test. Moving forward, resources must be allocated for the 
development of comprehensive screening programs as well as HPV vaccination programs in 
the developing world. 
5. HPV as the causative agent for cervical cancer 
Human Papilloma viruses (HPV) were first identified in cervical cancer cells in 1947 by 
Pund et al, who noted “koilocytic changes” in cervical tissues (6). Subsequently, multiple 
investigators have elucidated that infection with HPV is the critical factor in cervical 
oncogenesis (7-11). There are over 120 strains of HPV, and approximately 30 strains affect 
the anogenital region (33). These are classified as either “low risk” or “high risk” HPV 
subtypes. Low risk HPV subtypes include 6, 11, 40, 42 and 43 and are associated with genital 
warts, but not significantly associated with cervical cancer. High risk HPV subtypes include 
16, 18, 31, 33, 35, 39, 45, 51, 52, 56 and 58; these are associated with cervical dysplasia and 
cancer. HPV 16 accounts for approximately half of squamous cervical cancers, HPV 18 for 
another 10-15%, and 31, 33, 35, 52 and 58 about 2-5% each. Overall, between 95-100% of 
squamous cervical cancers are HPV-related (34, 35). 
HPV is a family of double-stranded, circular DNA viruses. The genome codes for two 
oncogenic proteins, E6 and E7, that interfere with control of host cell replication. The E6 
protein binds to the tumor suppressor gene, p53, and inactivates it. The E7 protein binds to 
the Rb tumor suppressor gene which results in loss of apoptosis and cell-cycle control. This 
leads to unchecked replication of infected cells, and shedding of the virus which can be 
passed on to new hosts. Episomal replication can lead to destabilization of host genome and 
aneuploidy, which in turn may promote integration of the HPV genome in fragile areas of 
the host DNA. Integration of HPV DNA into the host cell DNA is associated with cervical 
dysplasias and cancer. 
HPV is transmitted by sexual contact, and in fact is the most common sexually transmitted 
infection in the world. Population-based studies have found that the lifetime prevalence of 
HPV infection is 50-80% (35). The estimated attack rate after contact with an HPV-infected 
partner is 66% (34). However, over 75% of HPV infections are asymptomatic, and are 
cleared by the host immune system within 6-24 months without clinical sequelae (34, 36-39). 
Most of these infections are not evident to the patient and are never detected before they are 
cleared. For patients with HPV that is clinically detected, approximately 70% will 
demonstrate viral clearance within one year, and 90% within two years. Importantly, it is 
persistent infection with high risk HPV that is associated with progressive cervical dysplasias 
and cervical cancer. 
Screening for cervical cancer consists of cytologic screening—the Pap smear—either alone or 
in conjunction with HPV testing. In the following sections we will review screening 
strategies and the current recommendations for the use of both Pap smears and the available 
HPV tests.  
 
Evidence Based Medicine – Closer to Patients or Scientists? 124 
Therefore, while a true causal relationship may never be formally established, a consistent 
association of screening with a reduction in cervical cancer burden provides convincing 
evidence of the impact of the Pap test.  
The international epidemiology of cervical cancer further supports a direct correlation 
between screening programs and decreased cancer incidence and mortality. Prior to the 
widespread adoption of screening programs in developed countries, incidence rates of 
cervical cancer were similar to those found in developing countries today (28). Currently, 
however, marked disparities exist between the incidence of cervical cancer as well as 
cervical cancer-related mortality between the developed and developing world (Figure 2). 
Due to widespread implementation of cervical cancer screening programs in the developed 
world, cervical cancer has become one of the least common malignancies impacting women. 
In the United States in 2007, approximately 12,000 women were diagnosed with cervical 
cancer and 4000 died from the disease. Additionally, as noted by the NCI Surveillance 
Epidemiology and End Results (SEER) data, the incidence and mortality rate for cervical 
cancer continues to decline at 2.6% per year and 0.6% per year respectively (data available 
through 2008) (29, 30). Worldwide, however, the incidence of cervical cancer is 
approximately 500,000 cases per year with over 250,000 cancer-related deaths (31). 
According to the World Health Organization, over 80% of cervical cancer-related deaths 
occur in the developing world, and the lack of access to screening and prevention programs 
represents the primary reason for the enormous disparity between resource-rich and 
resource-poor nations  (32). Additionally, even in countries with adequate screening programs, 
poor women suffer a disproportionate share of the burden of disease, with incidence rates  
 
Adapted from: Sankaranarayanan R, Ferlay J. Worldwide burden of gyaecological cancer: the size of the 
problem. Best Pract Res Clinc Obstet Gynaecol. 2006;20:207-225. 
Fig. 2. Age-standardized incidence rates of cervical cancer per 100,000 women 
 
Evidence-Based Cervical Cancer Screening: The Modern Evolution of the Pap Smear 125 
approximately two-fold higher than more affluent women (28). Cervical cancer does not 
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of an effective screening test. Moving forward, resources must be allocated for the 
development of comprehensive screening programs as well as HPV vaccination programs in 
the developing world. 
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investigators have elucidated that infection with HPV is the critical factor in cervical 
oncogenesis (7-11). There are over 120 strains of HPV, and approximately 30 strains affect 
the anogenital region (33). These are classified as either “low risk” or “high risk” HPV 
subtypes. Low risk HPV subtypes include 6, 11, 40, 42 and 43 and are associated with genital 
warts, but not significantly associated with cervical cancer. High risk HPV subtypes include 
16, 18, 31, 33, 35, 39, 45, 51, 52, 56 and 58; these are associated with cervical dysplasia and 
cancer. HPV 16 accounts for approximately half of squamous cervical cancers, HPV 18 for 
another 10-15%, and 31, 33, 35, 52 and 58 about 2-5% each. Overall, between 95-100% of 
squamous cervical cancers are HPV-related (34, 35). 
HPV is a family of double-stranded, circular DNA viruses. The genome codes for two 
oncogenic proteins, E6 and E7, that interfere with control of host cell replication. The E6 
protein binds to the tumor suppressor gene, p53, and inactivates it. The E7 protein binds to 
the Rb tumor suppressor gene which results in loss of apoptosis and cell-cycle control. This 
leads to unchecked replication of infected cells, and shedding of the virus which can be 
passed on to new hosts. Episomal replication can lead to destabilization of host genome and 
aneuploidy, which in turn may promote integration of the HPV genome in fragile areas of 
the host DNA. Integration of HPV DNA into the host cell DNA is associated with cervical 
dysplasias and cancer. 
HPV is transmitted by sexual contact, and in fact is the most common sexually transmitted 
infection in the world. Population-based studies have found that the lifetime prevalence of 
HPV infection is 50-80% (35). The estimated attack rate after contact with an HPV-infected 
partner is 66% (34). However, over 75% of HPV infections are asymptomatic, and are 
cleared by the host immune system within 6-24 months without clinical sequelae (34, 36-39). 
Most of these infections are not evident to the patient and are never detected before they are 
cleared. For patients with HPV that is clinically detected, approximately 70% will 
demonstrate viral clearance within one year, and 90% within two years. Importantly, it is 
persistent infection with high risk HPV that is associated with progressive cervical dysplasias 
and cervical cancer. 
Screening for cervical cancer consists of cytologic screening—the Pap smear—either alone or 
in conjunction with HPV testing. In the following sections we will review screening 
strategies and the current recommendations for the use of both Pap smears and the available 
HPV tests.  
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6. Pap smear screening strategies 
Pap smear screening has been considered an integral part of well-woman care for over 50 
years, and both physicians and women have incorporated it into their annual routines. 
Because of the recognition that sexual debut put women at risk for HPV, older guidelines 
recommended starting Pap smear screening at coitarche, or by age 18 if coitarche had not 
occurred. Pap smears were performed annually throughout a woman’s life, without a 
recommended terminus. A better understanding of the epidemiology and time course of 
HPV infection has allowed these long-standing recommendations to be gradually modified, 
in order to minimize unnecessary testing.  
6.1 Adolescents and young women 
When considering younger women, two points are important to bear in mind. The first is 
that the interval between HPV infection and a clinically detectable cervical dysplasia is 
months to several years. The second is that HPV is highly prevalent (up to 80%) and usually 
transient (without clinical sequelae) (34, 36, 39, 40). Understanding the time course initially 
led to an updated recommendation that women should start Pap smear screening three 
years after coitarche or by age 21. However, a finer understanding of both points together 
implies that detection of minor abnormalities in very young women is probably clinically 
irrelevant, because they nearly always resolve. Only 1 of 1000 women diagnosed with 
cervical cancer in the United States are under the age of 21, or approximately 10-12 women 
per year nationwide (41). Thus, current guidelines from the multiple American College of 
Obstetrics and Gynecology (ACOG) have been simplified to recommend initiation of Pap 
smear screening at age 21, regardless of the timing of sexual debut (40). 
Between the ages of 21 and 29, two different possible screening strategies are recommended. 
Currently, ACOG recommend biennial screening for these women. The American Society 
for Colposcopy and Cervical Pathology (ASCCP), ACS and the United States Preventative 
Services Task Force (USPSTF) have recently released draft consensus guidelines which 
recommend Pap smear screening every 3 years in this age group (40, 42, 43). 
6.2 Adult women 
Starting at age 30, the recommended interval for Pap smear screening can be extended, 
assuming several criteria are met. First, healthy women who have reached age 30 and have 
had three prior consecutive normal Pap smears can then extend their Pap screening interval 
to every three years. Second, women who have a normal Pap smear and a negative high risk 
HPV test can then be screened every three years (see additional information in “HPV 
Screening Strategies”, below). Women in either group are unlikely to develop a clinically 
significant dysplasia during the two unscreened years, and the resultant decrease in 
unnecessary Pap smears should translate into a significant savings to the health care system 
(40, 42). 
There are several important caveats to extended interval screening. First, it is key that 
women are educated about the rationale for extended interval screening, and that they 
understand that their “annual exam” consists of more than their Pap smear. Women should 
be encouraged to have a regular physical examination even in the years when a Pap is not 
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indicated. Second, there are a number of exclusion criteria for extended interval screening. 
Women with a history of moderate to severe cervical dysplasia (grades 2 or 3) are not 
eligible for this extended interval; they should continue annual Pap smears for at least 
twenty years after treatment. Other women who should continue to have annual screening 
include women exposed to diethylstilbesterol (DES), women on immunosuppressant 
medication, and women living with HIV/AIDS. Women who have a history of cervical 
cancer must continue to be screened with Pap smears indefinitely. In contrast, women who 
have undergone hysterectomy (with removal of the cervix) for reasons other than cervical 
dysplasia or cervical cancer do not need any further Pap smears postoperatively. 
Pap smear screening can be stopped between the ages of 65 or 70, depending on the source 
of the guidelines: ACOG recommends cessation between 65 and 70, and the 
ASCCP/ACS/USPSTF draft guidelines recommend cessation of Pap testing by age 70. 
Termination of Pap smear screening also requires that women meet the exclusion criteria 
noted above—that at least 20 years have passed since a moderate or severe cervical 
dysplasia, and no significant immunosuppression. Importantly, while the peak incidence of 
cervical cancer among Caucasian women is in the 40s, it is in the 70s for Hispanic and Asian 
women, and increases throughout the lifespan for African American women. Therefore, it is 
important that prior history and screening be taken into account prior to discontinuing Pap 
smears (40). 
Women often have some anxiety about stopping Pap smears, as they may fear that a cancer 
will be missed, or that their physicians are “abandoning” important screening practices 
simply because they are “too old.” It is helpful to explain that the Pap smear screens only for 
cervical cancer, and that they will still have annual gynecologic exams to screen for ovarian 
cancer and other pathology. 
7. HPV screening strategies 
Screening tests for HPV have been available since 1999. Tests exist for both low risk and 
high risk HPV; however, since low risk HPV is not associated with carciongenesis, there are 
currently no clinical indications for low risk HPV testing. Some authors have even called for 
the low risk test to be removed from the market, as it does not appear to add any clinically 
useful information, and may contribute to confusion among clinicians about how and when 
to screen for HPV (44, 45). For high risk HPV subtypes, there are three currently available 
and FDA-approved tests; the best studied of these is Hybrid Capture, and further data are 
needed to assess the reliability of newer tests (46). 
7.1 Reflex HPV testing for ASC-US Paps 
Clinically, several strategies for using HPV tests have been employed. The first and most 
prevalent use of the HPV test is for the evaluation of a non-diagnostic Pap smear. 
Approximately 4% of Pap smears will result in a reading of “atypical squamous cells of 
undetermined significance,” or ASC-US (47). These Paps may represent a wide spectrum of 
problems: non-specific inflammation, dysplasia of any severity, cervical cancer, or simply 
artifact. Further evaluation is therefore warranted; in 20-60% of women with an ASC-US 
Pap smear, dysplasia is present. The American Society for Colposcopy and Cervical 
Pathology (ASCCP) offers three management strategies: a repeat Pap smear in six months, 
 
Evidence Based Medicine – Closer to Patients or Scientists? 126 
6. Pap smear screening strategies 
Pap smear screening has been considered an integral part of well-woman care for over 50 
years, and both physicians and women have incorporated it into their annual routines. 
Because of the recognition that sexual debut put women at risk for HPV, older guidelines 
recommended starting Pap smear screening at coitarche, or by age 18 if coitarche had not 
occurred. Pap smears were performed annually throughout a woman’s life, without a 
recommended terminus. A better understanding of the epidemiology and time course of 
HPV infection has allowed these long-standing recommendations to be gradually modified, 
in order to minimize unnecessary testing.  
6.1 Adolescents and young women 
When considering younger women, two points are important to bear in mind. The first is 
that the interval between HPV infection and a clinically detectable cervical dysplasia is 
months to several years. The second is that HPV is highly prevalent (up to 80%) and usually 
transient (without clinical sequelae) (34, 36, 39, 40). Understanding the time course initially 
led to an updated recommendation that women should start Pap smear screening three 
years after coitarche or by age 21. However, a finer understanding of both points together 
implies that detection of minor abnormalities in very young women is probably clinically 
irrelevant, because they nearly always resolve. Only 1 of 1000 women diagnosed with 
cervical cancer in the United States are under the age of 21, or approximately 10-12 women 
per year nationwide (41). Thus, current guidelines from the multiple American College of 
Obstetrics and Gynecology (ACOG) have been simplified to recommend initiation of Pap 
smear screening at age 21, regardless of the timing of sexual debut (40). 
Between the ages of 21 and 29, two different possible screening strategies are recommended. 
Currently, ACOG recommend biennial screening for these women. The American Society 
for Colposcopy and Cervical Pathology (ASCCP), ACS and the United States Preventative 
Services Task Force (USPSTF) have recently released draft consensus guidelines which 
recommend Pap smear screening every 3 years in this age group (40, 42, 43). 
6.2 Adult women 
Starting at age 30, the recommended interval for Pap smear screening can be extended, 
assuming several criteria are met. First, healthy women who have reached age 30 and have 
had three prior consecutive normal Pap smears can then extend their Pap screening interval 
to every three years. Second, women who have a normal Pap smear and a negative high risk 
HPV test can then be screened every three years (see additional information in “HPV 
Screening Strategies”, below). Women in either group are unlikely to develop a clinically 
significant dysplasia during the two unscreened years, and the resultant decrease in 
unnecessary Pap smears should translate into a significant savings to the health care system 
(40, 42). 
There are several important caveats to extended interval screening. First, it is key that 
women are educated about the rationale for extended interval screening, and that they 
understand that their “annual exam” consists of more than their Pap smear. Women should 
be encouraged to have a regular physical examination even in the years when a Pap is not 
 
Evidence-Based Cervical Cancer Screening: The Modern Evolution of the Pap Smear 127 
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an immediate colposcopic examination of the cervix, or HPV testing. If an HPV test is 
performed and is negative, the Pap is considered normal, and the woman can simply have a 
Pap in one year. If HPV testing is positive, then the suspicion for dysplasia is higher and 
colposcopy is recommended (48). Thus in the setting of ASC-US, a negative HPV test will 
reassure those women at low risk for dysplasia and allow them to avoid unnecessary 
procedures, and a positive HPV test will ensure that women at higher risk for dysplasia are 
rapidly evaluated. For clinicians using liquid-based cytology, the HPV test can be done on 
the same sample as the Pap smear, thus obviating the need for the patient to return for a 
second exam if ASC-US is found. 
7.2 Automatic HPV testing 
The other testing strategy is “automatic” HPV testing (rather than reflexively in response to 
the cytologic result), and is appropriate for women over the age of 30. It is important that 
women under 30 years of age not undergo routine or automatic HPV screening, as the 
prevalence of HPV among younger women is very high, and most of these infections are 
transient and without consequence. Among women over 30, however, transient HPV 
infections are less common, and the HPV test has a higher positive predictive value for 
cervical dysplasia (48). 
When a woman over 30 has a cytologically normal Pap smear and a negative high risk HPV 
test, she is considered very low risk for cervical dysplasia and cancer, and should thereafter 
receive Pap smears only every three years (40, 48). Even if a woman acquires an HPV infection 
during that three year interval, the long incubation time between HPV acquisition and 
development of significant dysplasia means that her next Pap smear should still detect any 
new dysplasia in its early stages. 
When a woman over 30 has a cytologically normal Pap smear and a positive high risk HPV 
test, current guidelines recommend repeating both tests in 12 months, as it is only persistent 
HPV infection that leads to dysplasia. If at 12 months the HPV test is persistently positive, or 
if a cytologic abnormality has developed in that interval, then colposcopy is recommended 
(48). 
8. HPV vaccination 
There are currently two commercially available prophylactic vaccines against HPV: a 
quadrivalent vaccine against strains 6, 11, 16, and 18, and a bivalent vaccine against 16 and 
18. Neither vaccine has been studied long enough nor in a large enough number of women 
to demonstrate a reduction in cervical cancer among vaccines. However, both vaccines have 
demonstrated excellent immunogenicity against the targeted HPV strains, and have shown 
efficacy at reducing the surrogate endpoints of grade 2 and grade 3 cervical dysplasia (49-
51). It is anticipated that high uptake of the vaccine will reduce the number of women 
requiring colposcopy and subsequent extirpative procedures, and ultimately reduce cervical 
cancer rates. However, several caveats must be added. 
First, as vaccination protects against only two oncogenic strains, women remain vulnerable 
to other (non-vaccine) HPV strains, and therefore remain at some risk for cervical dysplasia 
and cancer. Both vaccines induce some cross-protection against non-vaccine strains, though 
this is far from perfect. Therefore, vaccinated women should continue to undergo Pap 
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smears at the interval appropriate for their age and health status—the vaccine does not 
abrogate the need for Pap smears (40). 
Second, availability and uptake of the vaccine has thus far been low for a variety of reasons. 
At present, approximately 37% of eligible girls in the United States have been vaccinated 
against HPV (52). There have been multiple barriers to its widespread adoption. These 
include parental uncertainty about the importance and timing of vaccinating young girls for 
a sexually transmitted disease, expense of the vaccine series, and even political posturing 
over the vaccine, to name a few. With widespread adoption, vaccination against HPV 16 and 
18 has the potential to eliminate up to two thirds of cervical cancer worldwide (53). The 
highest burden of HPV disease and cervical cancer clearly lies in developing nations 
without easy access to cervical cancer screening. At present, the cost of the vaccine is such 
that it is not available to the populations most in need. 
9. Barriers to adoption of evidence-based Pap smear screening 
While the current Pap smear screening guidelines have been widely publicized and received 
considerable attention in the lay press when released, there remains ongoing evidence of 
Pap smear over-use by clinicians (44, 45, 54). There are a number of barriers to physician 
compliance with evidence-based treatment protocols. These include lack of awareness of the 
guidelines, lack of “buy-in” to the new recommendations, and inertia. In addition, patient 
expectations for an annual Pap smear may drive some Pap overuse, as it may be easier to 
accede to the patient’s request than to spend limited visit time explaining HPV and the 
rationale for the new screening intervals. However, Pap smears performed too frequently or 
too early and HPV tests performed at inappropriate ages or intervals represent a significant 
cost to the health care system. Furthermore, there is the potential for patient harm when Pap 
smears are not performed according to current standards. For example, the diagnosis of 
HPV or a low grade dysplasia in an 18 year old woman may cause her real emotional 
distress, may result in her subjection to additional procedures such as colposcopies and 
biopsies, and possibly extirpative procedures. However, the 18 year old is likely to simply 
clear her HPV infection without intervention. By age 21, when her first Pap smear is due, 
one of two things will occur—she will have cleared her HPV, and her Pap smear will be 
normal, or she will have persistent dysplasia, in which case she merits further evaluation. 
The probability that she will have a cervical cancer is, as noted above, vanishingly small 
(41). 
10. Areas of controversy and uncertainty 
10.1 HPV triage: molecular screening for cervical cancer 
As demonstrated in a large international study, the prevalence of HPV among documented 
cervical cancers was over 99%, which represents the largest attributable fraction ever 
identified for a cause of cancer (55). Therefore, significant interest exists in utilizing HPV 
testing as a primary screening modality. Several large clinical studies have been conducted 
to evaluate the efficacy of primary HPV screening and/or cotesting with conventional 
cytology. The Canadian Cervical Cancer Screening Trial evaluated the test characteristics of 
HPV testing with conventional cytology in 10, 154 women aged 30-69 who underwent both 
tests. Consistent with prior studies, the sensitivity of HPV testing for the detection of CIN 2 
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HPV infection that leads to dysplasia. If at 12 months the HPV test is persistently positive, or 
if a cytologic abnormality has developed in that interval, then colposcopy is recommended 
(48). 
8. HPV vaccination 
There are currently two commercially available prophylactic vaccines against HPV: a 
quadrivalent vaccine against strains 6, 11, 16, and 18, and a bivalent vaccine against 16 and 
18. Neither vaccine has been studied long enough nor in a large enough number of women 
to demonstrate a reduction in cervical cancer among vaccines. However, both vaccines have 
demonstrated excellent immunogenicity against the targeted HPV strains, and have shown 
efficacy at reducing the surrogate endpoints of grade 2 and grade 3 cervical dysplasia (49-
51). It is anticipated that high uptake of the vaccine will reduce the number of women 
requiring colposcopy and subsequent extirpative procedures, and ultimately reduce cervical 
cancer rates. However, several caveats must be added. 
First, as vaccination protects against only two oncogenic strains, women remain vulnerable 
to other (non-vaccine) HPV strains, and therefore remain at some risk for cervical dysplasia 
and cancer. Both vaccines induce some cross-protection against non-vaccine strains, though 
this is far from perfect. Therefore, vaccinated women should continue to undergo Pap 
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smears at the interval appropriate for their age and health status—the vaccine does not 
abrogate the need for Pap smears (40). 
Second, availability and uptake of the vaccine has thus far been low for a variety of reasons. 
At present, approximately 37% of eligible girls in the United States have been vaccinated 
against HPV (52). There have been multiple barriers to its widespread adoption. These 
include parental uncertainty about the importance and timing of vaccinating young girls for 
a sexually transmitted disease, expense of the vaccine series, and even political posturing 
over the vaccine, to name a few. With widespread adoption, vaccination against HPV 16 and 
18 has the potential to eliminate up to two thirds of cervical cancer worldwide (53). The 
highest burden of HPV disease and cervical cancer clearly lies in developing nations 
without easy access to cervical cancer screening. At present, the cost of the vaccine is such 
that it is not available to the populations most in need. 
9. Barriers to adoption of evidence-based Pap smear screening 
While the current Pap smear screening guidelines have been widely publicized and received 
considerable attention in the lay press when released, there remains ongoing evidence of 
Pap smear over-use by clinicians (44, 45, 54). There are a number of barriers to physician 
compliance with evidence-based treatment protocols. These include lack of awareness of the 
guidelines, lack of “buy-in” to the new recommendations, and inertia. In addition, patient 
expectations for an annual Pap smear may drive some Pap overuse, as it may be easier to 
accede to the patient’s request than to spend limited visit time explaining HPV and the 
rationale for the new screening intervals. However, Pap smears performed too frequently or 
too early and HPV tests performed at inappropriate ages or intervals represent a significant 
cost to the health care system. Furthermore, there is the potential for patient harm when Pap 
smears are not performed according to current standards. For example, the diagnosis of 
HPV or a low grade dysplasia in an 18 year old woman may cause her real emotional 
distress, may result in her subjection to additional procedures such as colposcopies and 
biopsies, and possibly extirpative procedures. However, the 18 year old is likely to simply 
clear her HPV infection without intervention. By age 21, when her first Pap smear is due, 
one of two things will occur—she will have cleared her HPV, and her Pap smear will be 
normal, or she will have persistent dysplasia, in which case she merits further evaluation. 
The probability that she will have a cervical cancer is, as noted above, vanishingly small 
(41). 
10. Areas of controversy and uncertainty 
10.1 HPV triage: molecular screening for cervical cancer 
As demonstrated in a large international study, the prevalence of HPV among documented 
cervical cancers was over 99%, which represents the largest attributable fraction ever 
identified for a cause of cancer (55). Therefore, significant interest exists in utilizing HPV 
testing as a primary screening modality. Several large clinical studies have been conducted 
to evaluate the efficacy of primary HPV screening and/or cotesting with conventional 
cytology. The Canadian Cervical Cancer Screening Trial evaluated the test characteristics of 
HPV testing with conventional cytology in 10, 154 women aged 30-69 who underwent both 
tests. Consistent with prior studies, the sensitivity of HPV testing for the detection of CIN 2 
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or greater was significantly higher than that of conventional cytology (96.4% versus 55.4%) 
and the specificity was lower (94.1% versus 96.8%) (27, 56, 57).  
A population-based screening study in Amsterdam randomly assigned approximately 
17,000 women to either cytology/HPV co-testing or cytology alone at an initial screen. These 
women were then followed with cytology/HPV co-testing at 5 years (the standard screening 
interval in the Netherlands). Results of CIN 3 or worse were detected in 70% more women 
in the group undergoing cytology/HPV co-testing at initial screening, and women in this 
group were less likely to have CIN3 or worse detected at the five year follow-up screening 
test. Overall, the number of cases of CIN3 lesions or cancers did not differ between trial 
arms, suggesting that initial co-testing may detect significant lesions earlier but not any 
more effectively than conventional cytologic screening (58). Similar results were obtained in 
a large study conducted in England (59).  
A recent randomized controlled trial from Italy that evaluated conventional cytology 
compared with HPV DNA testing in over 47,000 women provides additional information 
regarding the efficacy of HPV screening as a primary modality (60). In this study, initial 
screening with HPV DNA testing reduced the number of invasive cervical cancers 
discovered at a second round of screening (0 cases with HPV screening, 9 cases with 
conventional cytology). Additionally, women screened with HPV testing were noted to have 
an excess number of cases of CIN 2 or greater over the two rounds of screening. Therefore, 
this study represents the first evidence that primary screening with HPV testing decreases 
the incidence of cervical cancer with earlier detection. However, HPV testing also leads to 
the overdiagnosis of women with CIN 2 or worse lesions that would have spontaneously 
regressed without treatment.  
Lastly, a long-term prospective cohort study of over 330,000 women in a Northern California 
health-maintenance organization has provided interesting new data on the safety and efficacy 
of cytology/HPV cotesting. This study demonstrated that patients with an initial negative 
HPV test demonstrated an extremely low risk of CIN3 or worse over the subsequent 5 years. 
The risk was practically equal for those with negative and ASCUS cytologies and a negative 
initial HPV test. Notably, the cumulative 5-year risk of cancer was lower in those with negative 
HPV tests compared with negative cytology at the initial screen (3.8 per 100,000 compared 
with 7.5 per 100,000). The authors concluded that a single negative HPV test is sufficiently 
reassuring against a 5-year risk of cancer. They also advocated for a triage strategy of primary 
HPV testing with positive results undergoing triage by cytology (54).  
While findings from these (and many other) studies vary in magnitude, consistent 
observations are noteworthy. Compared with cytology, HPV testing offers a highly 
reproducible, objective outcome that is easily monitored. Compared with cytology alone, 
HPV testing is more sensitive, less specific, and has a higher negative predictive value (27, 
56, 57). The lower sensitivity relative to conventional cytology is significant in that with 
primary HPV screening, significantly more women would be recommended for unnecessary 
colposcopies for transient HPV infections, which would consume substantial health care 
resources. This phenomenon is particularly true for women under age 30, who have the 
highest incidence of HPV infection and the lowest rates of cervical cancer. The addition of 
HPV testing to conventional cytology may result in the earlier diagnosis of high grade 
lesions or cancer and may reduce the incidence of caner (evidence from one clinical trial), 
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however a mortality benefit has not been demonstrated to date. Thus, additional study 
regarding the optimal screening strategy is required.  
10.2 Visual inspection with acetic acid and “Screen and Treat” programs 
Historically, visual inspection of the cervix without magnification was the initial screening 
test for cervical cancer. Introduced by Schiller in the 1930s, the test was initially performed 
by applying Lugol’s iodine to the cervix (61). The test was rapidly replaced by Pap testing, 
which demonstrated improved specificity. However, visual inspection of the cervix, after 
the application of either acetic acid or Lugol’s solution, remains a mainstay of cervical 
cancer screening in resource-poor settings given that the technique requires little equipment, 
provides rapid results, and is economical.  
A substantial body of literature exists supporting the efficacy of visual inspection techniques 
and “screen and treat” protocols. Regarding test characteristics, observational studies have 
evaluated the sensitivity and specificity of visual inspection, which were noted to be 79% 
and 85% respectively in a meta-analysis of 11 of the higher quality studies (62). The efficacy 
of visual inspection as a part of “screen and treat” programs has also been evaluated in a 
number of studies. A large randomized controlled trial in India that evaluated over 80,000 
women assigned to either triage with visual inspection followed by cryotherapy or excision 
versus standard therapy (health education). The visual inspection protocol decreased 
cervical cancer incidence and mortality (63). Additionally, a large randomized trial from 
South Africa evaluated the efficacy of two distinct screen and treat protocols in 6500 
previously unscreened women. All women in the trial were screened with visual inspection, 
HPV testing, and cytology and were then randomized to one of three treatment arms: 
cryotherapy for positive HPV test, cryotherapy for positive visual inspection, or delayed 
evaluation (follow-up at 6 months). At the 6 and 12 month follow-up colposcopic 
evaluations, significantly fewer women were noted to have CIN 2 or worse in the HPV and 
visual inspections groups compared with conventional cytology (64).  
Therefore, while conventional screening programs remain the backbone of cervical cancer 
prevention, visual inspection and screen and treat protocols provide options for women in 
low-resource settings where screening programs remain unavailable. These protocols 
provide opportunities for efficient, safe, and effective treatment of women and eliminate any 
potential problems related to communication barriers and non-compliance with follow-up. 
Additional research and resources must be directed toward the evaluation and 
implementation of effective screening and treatment protocols in low-resource settings.  
10.3 Conventional Pap screening versus liquid-based cytology 
With “conventional” Pap screening, cells obtained from the cervix are transferred directly to 
a glass slide with fixation by either ethyl alcohol or other spray fixative. Liquid-based 
cytology refers to the technology whereby cervical cells are suspended in a liquid transport 
medium and then displayed on a glass slide in the laboratory. Liquid-based cytology 
improves specimen adequacy by minimizing artifact, such as inflammation, non-cellular 
debris, and epithelial cell clumping, which may obscure interpretation of the smear. 
However, while the uniform cell layer from liquid-based cytology allows for easier 
interpretation, pathologists and cytotechnologists cannot use the additional information 
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or greater was significantly higher than that of conventional cytology (96.4% versus 55.4%) 
and the specificity was lower (94.1% versus 96.8%) (27, 56, 57).  
A population-based screening study in Amsterdam randomly assigned approximately 
17,000 women to either cytology/HPV co-testing or cytology alone at an initial screen. These 
women were then followed with cytology/HPV co-testing at 5 years (the standard screening 
interval in the Netherlands). Results of CIN 3 or worse were detected in 70% more women 
in the group undergoing cytology/HPV co-testing at initial screening, and women in this 
group were less likely to have CIN3 or worse detected at the five year follow-up screening 
test. Overall, the number of cases of CIN3 lesions or cancers did not differ between trial 
arms, suggesting that initial co-testing may detect significant lesions earlier but not any 
more effectively than conventional cytologic screening (58). Similar results were obtained in 
a large study conducted in England (59).  
A recent randomized controlled trial from Italy that evaluated conventional cytology 
compared with HPV DNA testing in over 47,000 women provides additional information 
regarding the efficacy of HPV screening as a primary modality (60). In this study, initial 
screening with HPV DNA testing reduced the number of invasive cervical cancers 
discovered at a second round of screening (0 cases with HPV screening, 9 cases with 
conventional cytology). Additionally, women screened with HPV testing were noted to have 
an excess number of cases of CIN 2 or greater over the two rounds of screening. Therefore, 
this study represents the first evidence that primary screening with HPV testing decreases 
the incidence of cervical cancer with earlier detection. However, HPV testing also leads to 
the overdiagnosis of women with CIN 2 or worse lesions that would have spontaneously 
regressed without treatment.  
Lastly, a long-term prospective cohort study of over 330,000 women in a Northern California 
health-maintenance organization has provided interesting new data on the safety and efficacy 
of cytology/HPV cotesting. This study demonstrated that patients with an initial negative 
HPV test demonstrated an extremely low risk of CIN3 or worse over the subsequent 5 years. 
The risk was practically equal for those with negative and ASCUS cytologies and a negative 
initial HPV test. Notably, the cumulative 5-year risk of cancer was lower in those with negative 
HPV tests compared with negative cytology at the initial screen (3.8 per 100,000 compared 
with 7.5 per 100,000). The authors concluded that a single negative HPV test is sufficiently 
reassuring against a 5-year risk of cancer. They also advocated for a triage strategy of primary 
HPV testing with positive results undergoing triage by cytology (54).  
While findings from these (and many other) studies vary in magnitude, consistent 
observations are noteworthy. Compared with cytology, HPV testing offers a highly 
reproducible, objective outcome that is easily monitored. Compared with cytology alone, 
HPV testing is more sensitive, less specific, and has a higher negative predictive value (27, 
56, 57). The lower sensitivity relative to conventional cytology is significant in that with 
primary HPV screening, significantly more women would be recommended for unnecessary 
colposcopies for transient HPV infections, which would consume substantial health care 
resources. This phenomenon is particularly true for women under age 30, who have the 
highest incidence of HPV infection and the lowest rates of cervical cancer. The addition of 
HPV testing to conventional cytology may result in the earlier diagnosis of high grade 
lesions or cancer and may reduce the incidence of caner (evidence from one clinical trial), 
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however a mortality benefit has not been demonstrated to date. Thus, additional study 
regarding the optimal screening strategy is required.  
10.2 Visual inspection with acetic acid and “Screen and Treat” programs 
Historically, visual inspection of the cervix without magnification was the initial screening 
test for cervical cancer. Introduced by Schiller in the 1930s, the test was initially performed 
by applying Lugol’s iodine to the cervix (61). The test was rapidly replaced by Pap testing, 
which demonstrated improved specificity. However, visual inspection of the cervix, after 
the application of either acetic acid or Lugol’s solution, remains a mainstay of cervical 
cancer screening in resource-poor settings given that the technique requires little equipment, 
provides rapid results, and is economical.  
A substantial body of literature exists supporting the efficacy of visual inspection techniques 
and “screen and treat” protocols. Regarding test characteristics, observational studies have 
evaluated the sensitivity and specificity of visual inspection, which were noted to be 79% 
and 85% respectively in a meta-analysis of 11 of the higher quality studies (62). The efficacy 
of visual inspection as a part of “screen and treat” programs has also been evaluated in a 
number of studies. A large randomized controlled trial in India that evaluated over 80,000 
women assigned to either triage with visual inspection followed by cryotherapy or excision 
versus standard therapy (health education). The visual inspection protocol decreased 
cervical cancer incidence and mortality (63). Additionally, a large randomized trial from 
South Africa evaluated the efficacy of two distinct screen and treat protocols in 6500 
previously unscreened women. All women in the trial were screened with visual inspection, 
HPV testing, and cytology and were then randomized to one of three treatment arms: 
cryotherapy for positive HPV test, cryotherapy for positive visual inspection, or delayed 
evaluation (follow-up at 6 months). At the 6 and 12 month follow-up colposcopic 
evaluations, significantly fewer women were noted to have CIN 2 or worse in the HPV and 
visual inspections groups compared with conventional cytology (64).  
Therefore, while conventional screening programs remain the backbone of cervical cancer 
prevention, visual inspection and screen and treat protocols provide options for women in 
low-resource settings where screening programs remain unavailable. These protocols 
provide opportunities for efficient, safe, and effective treatment of women and eliminate any 
potential problems related to communication barriers and non-compliance with follow-up. 
Additional research and resources must be directed toward the evaluation and 
implementation of effective screening and treatment protocols in low-resource settings.  
10.3 Conventional Pap screening versus liquid-based cytology 
With “conventional” Pap screening, cells obtained from the cervix are transferred directly to 
a glass slide with fixation by either ethyl alcohol or other spray fixative. Liquid-based 
cytology refers to the technology whereby cervical cells are suspended in a liquid transport 
medium and then displayed on a glass slide in the laboratory. Liquid-based cytology 
improves specimen adequacy by minimizing artifact, such as inflammation, non-cellular 
debris, and epithelial cell clumping, which may obscure interpretation of the smear. 
However, while the uniform cell layer from liquid-based cytology allows for easier 
interpretation, pathologists and cytotechnologists cannot use the additional information 
 
Evidence Based Medicine – Closer to Patients or Scientists? 132 
provided by background inflammation as clues facilitating diagnosis. In addition, large 
systematic review challenged the clinical relevance of this difference in adequacy by failing 
to discover a difference in the number of unsatisfactory slides (65). One significant 
advantage conferred by liquid-based cytology is the ability to collect reflex HPV testing, 
which otherwise must be obtained by a separate sample in systems using conventional 
cytology.  
At the time liquid-based cytology was developed, the test was marketed as a more sensitive 
screening test than conventional cytology which was supported by early studies with clear 
methodological inadequacies (66-69). Recent studies have challenged this notion, and to 
date, the question remains largely unanswered (20, 70, 71). A systematic review of 56 
published studies that included over 1 million slides recently addressed the current 
literature on this subject (19). Regarding study design, no studies were noted to be “ideal” 
but five were considered to be of high-quality. The authors concluded that liquid-based 
cytology offered no improvement over conventional cytology for the detection of high-
grade lesions. Other systematic and independent reviews have reported similar findings (18, 
72). Observational data suggest that liquid-based samples may improve the detection of 
glandular lesions (73-75). 
Arguably, the liquid-based Pap screening test is not a “better” test than conventional 
cytology. However, despite the increased cost, the liquid-based screen offers advantages 
that will maintain its use in developed countries, particularly the United States. In the 2006 
screening guidelines, the American Society for Colposcopy and Cervical Pathology endorses 
reflex HPV testing as the preferred triage strategy for an ASCUS Pap result, which is 
supported by data from a large, well-designed clinical trial (37, 76). Therefore, given the ease 
of HPV testing with liquid-based samples and the current available infrastructure, the 
return of conventional cytology to the US is unlikely. However, should primary HPV 
screening with reflex cytology for positive results be adopted in the future, liquid based 
screening may become a less cost effective strategy given that the number of samples will 
decline. Importantly, the aforementioned studies support the use of conventional cytology 
as a safe, effective, and cost-effective screening strategy in settings with limited resources. 
11. Conclusions 
 The Pap smear is the single most successful cancer screening tool in modern medicine. 
 Cervical cancer is due to persistent infection with high-risk, oncogenic HPV strains. 
 Even in women with documented high-grade dysplasia (CIN 2 or greater), a long 
premalignant window exists which allows for purposeful intervention and prevention 
of progression to malignancy. 
 As a result, newer screening recommendations have decreased screening intervals to 
maximize the benefit of screening and decrease unnecessary interventions 
 As our understanding of HPV increases, Pap smear screening intervals continue to 
decline and triage strategies may change. It is imperative that practitioners remain 
informed of evidence-based guidelines.  
 Despite the availability of screening and preventative strategies, the majority of the 
cervical cancer disease burden is in the developing world. Inequalities in the availability 
of screening are a substantial public health challenge. 
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 Universal vaccination against HPV has the potential to substantially reduce the cervical 
cancer disease burden worldwide, however cost and other barrier currently limited the 
widespread adoption of this strategy. 
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provided by background inflammation as clues facilitating diagnosis. In addition, large 
systematic review challenged the clinical relevance of this difference in adequacy by failing 
to discover a difference in the number of unsatisfactory slides (65). One significant 
advantage conferred by liquid-based cytology is the ability to collect reflex HPV testing, 
which otherwise must be obtained by a separate sample in systems using conventional 
cytology.  
At the time liquid-based cytology was developed, the test was marketed as a more sensitive 
screening test than conventional cytology which was supported by early studies with clear 
methodological inadequacies (66-69). Recent studies have challenged this notion, and to 
date, the question remains largely unanswered (20, 70, 71). A systematic review of 56 
published studies that included over 1 million slides recently addressed the current 
literature on this subject (19). Regarding study design, no studies were noted to be “ideal” 
but five were considered to be of high-quality. The authors concluded that liquid-based 
cytology offered no improvement over conventional cytology for the detection of high-
grade lesions. Other systematic and independent reviews have reported similar findings (18, 
72). Observational data suggest that liquid-based samples may improve the detection of 
glandular lesions (73-75). 
Arguably, the liquid-based Pap screening test is not a “better” test than conventional 
cytology. However, despite the increased cost, the liquid-based screen offers advantages 
that will maintain its use in developed countries, particularly the United States. In the 2006 
screening guidelines, the American Society for Colposcopy and Cervical Pathology endorses 
reflex HPV testing as the preferred triage strategy for an ASCUS Pap result, which is 
supported by data from a large, well-designed clinical trial (37, 76). Therefore, given the ease 
of HPV testing with liquid-based samples and the current available infrastructure, the 
return of conventional cytology to the US is unlikely. However, should primary HPV 
screening with reflex cytology for positive results be adopted in the future, liquid based 
screening may become a less cost effective strategy given that the number of samples will 
decline. Importantly, the aforementioned studies support the use of conventional cytology 
as a safe, effective, and cost-effective screening strategy in settings with limited resources. 
11. Conclusions 
 The Pap smear is the single most successful cancer screening tool in modern medicine. 
 Cervical cancer is due to persistent infection with high-risk, oncogenic HPV strains. 
 Even in women with documented high-grade dysplasia (CIN 2 or greater), a long 
premalignant window exists which allows for purposeful intervention and prevention 
of progression to malignancy. 
 As a result, newer screening recommendations have decreased screening intervals to 
maximize the benefit of screening and decrease unnecessary interventions 
 As our understanding of HPV increases, Pap smear screening intervals continue to 
decline and triage strategies may change. It is imperative that practitioners remain 
informed of evidence-based guidelines.  
 Despite the availability of screening and preventative strategies, the majority of the 
cervical cancer disease burden is in the developing world. Inequalities in the availability 
of screening are a substantial public health challenge. 
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Have we succumbed to a new tyranny in medicine—evidence-based medicine? With 
apologies to my former professor, Dr. David Sackett! but has the randomized controlled trial 
(RCT) become a new idol? Indeed, EBM has been satirized as a new religion.1 At the risk of 
not being ‘politically correct”,2 I would argue that evidence-based medicine (EBM) can be 
abused and substituted for sound clinical judgment. The exponents of the new paradigm we 
call evidence-based medicine recognized this: “Thus, knowing the tools of evidence-based 
practice is necessary but not sufficient for delivering the highest quality of patient care. In 
addition to clinical expertise, the clinician requires compassion, sensitive listening skills, and 
broad perspectives from the humanities and social sciences.”3 Evidence-based medicine, 
when properly understood and applied, improves patient outcomes but it is often 
misunderstood and used inappropriately.4 It is important to recognize the limitations of 
EBM as well as its benefits in the care of our patients. Strauss and McAlister point out some 
of the limitations of EBM5: “ shortage of coherent, consistent scientific evidence, difficulties 
in applying evidence to the care of individual patients, barriers to the practice of high-
quality medicine, limited time and resources, paucity of evidence that evidence-based 
medicine works.” One common example that many community generalists would share 
around the concept of ‘barriers to the practice of high-quality medicine’ is the issue of a lack 
of resources for the appropriate care of one’s patient. For example, there is an unacceptable 
waiting time for a child you suspect of having autism to see a child psychiatrist to confirm 
the diagnosis and enable the family to obtain publicly funded resources for early 
intervention. This is equally true for other psychiatric disorders. Indeed, the wait time for 
many subspecialties in pediatrics is often in the order of many months.  
Evidence-based medicine is an offshoot of the philosophical movement known as scientific 
positivism. Scientific positivism is a particular philosophy, which states that only that which 
is scientifically verifiable is true. The critique of scientific positivism is that its central 
premise is itself not scientifically verifiable but must be accepted as a sort of first principle or 
axiom. Similarly, the principle of evidence-based medicine must be itself accepted as an 
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axiom of the system. This can be seen if we frame the following question, ‘what is the 
evidence that evidence-based medicine improves patient outcomes?’ In fact, there is no such 
evidence since such a trial would be extremely difficult and unethical to do. “Evidence-
based medicine, like other models of care, has limitations …efforts need to be directed 
toward … conducting studies to test whether and how evidence-based medicine affects 
processes of care and patient outcomes.”6  
Let me clearly state that my comments are not to be taken as an excuse to return to magical 
thinking or charlatanism. The outstanding achievements of modern medicine have been 
accomplished through the rigorous application of the scientific method in developing 
evidence-based guidelines. Patient outcomes have certainly improved with the application 
of these treatments. We are also aware of therapeutic disasters when the principles of 
controlled observations and rigorous research designs are not observed. (eg tying off the 
internal mammary arteries in the treatment for angina pectoris7).  
Having said this, there is an a priori reason why we should not substitute evidence-based 
medicine for a more holistic approach and that is quite simply that the evidence is never 
complete. This is a fundamental feature of the scientific method and it is applicable in all the 
sciences. Recently, for example, the most fundamental aspect of Einstein’s theory of special 
relativity, the fixed speed of light (299,792,458 m/sec) has been challenged by experiments 
at OPERA which demonstrated that neutrinos travel slightly faster than the speed of light.8 
If this finding is duplicated by other laboratories, then our understanding of the 
fundamental features of space-time will need to be revised. Until this announcement, it was 
unthinkable that Einstein’s constant was not true since his theory of special relativity made 
many predictions subsequently validated by observation. However, this latest challenge to 
Einstein should not surprise us because the basic hermeneutic underlying the scientific 
method depends on theories validated by observations; as the observations change through 
more and more sophisticated technological advances, the theories need to be modified. 
Physicists have yet to achieve the unifying theory which combines Einstein’s theory of 
special relativity and quantum mechanics which at present are incompatible. Evidence-
based medicine is based on the scientific method and it is subject to the same caveats as 
physics and cosmology. Theoretically, the evidence base will continue to unfold ad infinitum 
since there is no principle which enables us to know that the end of the evidence has been 
reached and there can be no further evidence. We can only act in the concrete world of sick 
patients with the evidence at hand, as best as it, knowing that perhaps further evidence will 
prove us wrong. 
A recent discussion in the New England Journal of Medicine highlights this problem and 
introduces a new dynamic.9 The authors relate the case of a 13 year-old girl with lupus 
erythematosus with nephritic syndrome, antiphospholipid antibodies and pancreatitis. They 
site the difficulty of knowing whether or not to anticoagulate this patient since there is no 
data in the pediatric literature on this question. There would also be the danger of inducing 
bleeding. A survey of other pediatric rheumatologists did not produce a consensus. Since 
there were no RCT’s on this question, the authors state that they turned to their hospital’s 
EMR database and within the space of a few hours obtained their experience over the 
previous five years to arrive at an ‘electronic cohort’. Through this retrospective analysis 
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they opted to treat their patient with anticoagulants. This was not a RCT of anticoagulants 
versus no anticoagulants in a selected group of patients with SLE but physicians using their 
judgment based on past experience. “Did we make the correct decision for our patient? 
Thrombosis did not develop, and the patient did not have any sequelae related to her 
anticoagulation; truthfully, though, we may never really know. We will, however, know 
that we made the decision on the basis of the best data available—acting…in the light of 
experience guided by intelligence.”10  
There is always the possibility of newer evidence that will invalidate a particular diagnosis, 
therapeutic choice or diagnostic test. Newer diagnostic tools inevitably result in a greater 
understanding of pathophysiology, e.g. the explosion of molecular genetics. Often, there is 
no definitive RCT in the literature to help one with a clinical decision. Sometimes the results 
of a Cochrane summary, i.e the evaluation of available RCT’s regarding a particular 
question, are contradictory or inconclusive.11 One could also argue that the ‘gold standard’ 
RCT is best used when a clearly defined therapy is being tested i.e. drug A vs drug B in a 
well-defined group of patients. This may be the case in a secondary or tertiary care center 
but is not the case in primary care where multiple pathologies may be at work in a broader 
group of patients. An RCT may not be the most useful tool when evaluating problems in 
primary care where there is a less highly selected group of patients with a single defined 
etiology. 12 The outcome measure used in an RCT may be inappropriate as in the case of 
rosiglitazone where the primary outcome measure was the lowering of glycated 
hemoglobin. The clinical trials leading up to the release of this drug on the markets focused 
on an outcome that may not be relevant (glycemic control ) and ignored important side 
effects, assuming that a reduction in glycated hemoglobin translates into improved patient 
outcome. Indeed the side effects (weight gain, edema, and changes in lipids) detected 
during the clinical trials may well be more important with regard to outcome than glycemic 
control. Nissen and Wolski in fact showed that rosiglitazone increases the risks of 
myocardial infarction, despite improved glycemic control. 13  
Recently, Ioannidis has argued cogently that much published research is eventually shown 
to be false. This results from the attempts to achieve a conclusive result based on a single 
study assessed statistically using a p value of <.05. “A finding from a well-conducted, 
adequately powered randomized controlled trial starting with a 50% pre-study chance that 
the intervention is effective is eventually true about 85% of the time. …Conversely, a meta-
analytic finding from inconclusive studies where pooling is used to “correct” the low power 
of single studies, is probably false if R<1:3. Research findings from underpowered, early-
phase clinical trials would be true about one in four times, or even less frequently if bias is 
present.”14 There is also a darker side to the quest for evidence-based guidelines when vital 
evidence is withheld from the public domain, or falsified, invalidating the ‘evidence’ upon 
which a particular therapy is recommended. An example of this occurred with the clinical 
trials of a new iron-chelator, deferiprone. Apotex, the pharmaceutical firm developing the 
new drug, would not allow the publication of negative data. While researching a new iron-
chelating agent, deferiprone, for Apotex, Nancy Olivieri of the Hospital for Sick Children in 
Toronto, uncovered data indicating that the drug would not provide long-term control of 
iron overload in patients with thalassemia major and worsened hepatic fibrosis. The 
pharmaceutical firm funding her research, Apotex, would not allow her to publish the data 
 
Evidence Based Medicine – Closer to Patients or Scientists? 
 
140 
axiom of the system. This can be seen if we frame the following question, ‘what is the 
evidence that evidence-based medicine improves patient outcomes?’ In fact, there is no such 
evidence since such a trial would be extremely difficult and unethical to do. “Evidence-
based medicine, like other models of care, has limitations …efforts need to be directed 
toward … conducting studies to test whether and how evidence-based medicine affects 
processes of care and patient outcomes.”6  
Let me clearly state that my comments are not to be taken as an excuse to return to magical 
thinking or charlatanism. The outstanding achievements of modern medicine have been 
accomplished through the rigorous application of the scientific method in developing 
evidence-based guidelines. Patient outcomes have certainly improved with the application 
of these treatments. We are also aware of therapeutic disasters when the principles of 
controlled observations and rigorous research designs are not observed. (eg tying off the 
internal mammary arteries in the treatment for angina pectoris7).  
Having said this, there is an a priori reason why we should not substitute evidence-based 
medicine for a more holistic approach and that is quite simply that the evidence is never 
complete. This is a fundamental feature of the scientific method and it is applicable in all the 
sciences. Recently, for example, the most fundamental aspect of Einstein’s theory of special 
relativity, the fixed speed of light (299,792,458 m/sec) has been challenged by experiments 
at OPERA which demonstrated that neutrinos travel slightly faster than the speed of light.8 
If this finding is duplicated by other laboratories, then our understanding of the 
fundamental features of space-time will need to be revised. Until this announcement, it was 
unthinkable that Einstein’s constant was not true since his theory of special relativity made 
many predictions subsequently validated by observation. However, this latest challenge to 
Einstein should not surprise us because the basic hermeneutic underlying the scientific 
method depends on theories validated by observations; as the observations change through 
more and more sophisticated technological advances, the theories need to be modified. 
Physicists have yet to achieve the unifying theory which combines Einstein’s theory of 
special relativity and quantum mechanics which at present are incompatible. Evidence-
based medicine is based on the scientific method and it is subject to the same caveats as 
physics and cosmology. Theoretically, the evidence base will continue to unfold ad infinitum 
since there is no principle which enables us to know that the end of the evidence has been 
reached and there can be no further evidence. We can only act in the concrete world of sick 
patients with the evidence at hand, as best as it, knowing that perhaps further evidence will 
prove us wrong. 
A recent discussion in the New England Journal of Medicine highlights this problem and 
introduces a new dynamic.9 The authors relate the case of a 13 year-old girl with lupus 
erythematosus with nephritic syndrome, antiphospholipid antibodies and pancreatitis. They 
site the difficulty of knowing whether or not to anticoagulate this patient since there is no 
data in the pediatric literature on this question. There would also be the danger of inducing 
bleeding. A survey of other pediatric rheumatologists did not produce a consensus. Since 
there were no RCT’s on this question, the authors state that they turned to their hospital’s 
EMR database and within the space of a few hours obtained their experience over the 
previous five years to arrive at an ‘electronic cohort’. Through this retrospective analysis 
 
Evidence-Based Medicine – Perspectives of a Community-Based Pediatrician 
 
141 
they opted to treat their patient with anticoagulants. This was not a RCT of anticoagulants 
versus no anticoagulants in a selected group of patients with SLE but physicians using their 
judgment based on past experience. “Did we make the correct decision for our patient? 
Thrombosis did not develop, and the patient did not have any sequelae related to her 
anticoagulation; truthfully, though, we may never really know. We will, however, know 
that we made the decision on the basis of the best data available—acting…in the light of 
experience guided by intelligence.”10  
There is always the possibility of newer evidence that will invalidate a particular diagnosis, 
therapeutic choice or diagnostic test. Newer diagnostic tools inevitably result in a greater 
understanding of pathophysiology, e.g. the explosion of molecular genetics. Often, there is 
no definitive RCT in the literature to help one with a clinical decision. Sometimes the results 
of a Cochrane summary, i.e the evaluation of available RCT’s regarding a particular 
question, are contradictory or inconclusive.11 One could also argue that the ‘gold standard’ 
RCT is best used when a clearly defined therapy is being tested i.e. drug A vs drug B in a 
well-defined group of patients. This may be the case in a secondary or tertiary care center 
but is not the case in primary care where multiple pathologies may be at work in a broader 
group of patients. An RCT may not be the most useful tool when evaluating problems in 
primary care where there is a less highly selected group of patients with a single defined 
etiology. 12 The outcome measure used in an RCT may be inappropriate as in the case of 
rosiglitazone where the primary outcome measure was the lowering of glycated 
hemoglobin. The clinical trials leading up to the release of this drug on the markets focused 
on an outcome that may not be relevant (glycemic control ) and ignored important side 
effects, assuming that a reduction in glycated hemoglobin translates into improved patient 
outcome. Indeed the side effects (weight gain, edema, and changes in lipids) detected 
during the clinical trials may well be more important with regard to outcome than glycemic 
control. Nissen and Wolski in fact showed that rosiglitazone increases the risks of 
myocardial infarction, despite improved glycemic control. 13  
Recently, Ioannidis has argued cogently that much published research is eventually shown 
to be false. This results from the attempts to achieve a conclusive result based on a single 
study assessed statistically using a p value of <.05. “A finding from a well-conducted, 
adequately powered randomized controlled trial starting with a 50% pre-study chance that 
the intervention is effective is eventually true about 85% of the time. …Conversely, a meta-
analytic finding from inconclusive studies where pooling is used to “correct” the low power 
of single studies, is probably false if R<1:3. Research findings from underpowered, early-
phase clinical trials would be true about one in four times, or even less frequently if bias is 
present.”14 There is also a darker side to the quest for evidence-based guidelines when vital 
evidence is withheld from the public domain, or falsified, invalidating the ‘evidence’ upon 
which a particular therapy is recommended. An example of this occurred with the clinical 
trials of a new iron-chelator, deferiprone. Apotex, the pharmaceutical firm developing the 
new drug, would not allow the publication of negative data. While researching a new iron-
chelating agent, deferiprone, for Apotex, Nancy Olivieri of the Hospital for Sick Children in 
Toronto, uncovered data indicating that the drug would not provide long-term control of 
iron overload in patients with thalassemia major and worsened hepatic fibrosis. The 
pharmaceutical firm funding her research, Apotex, would not allow her to publish the data 
 
Evidence Based Medicine – Closer to Patients or Scientists? 
 
142 
because of a research contract. Dr. Olivieri published the data regardless 15and a major 
controversy regarding academic freedom ensued at great personal cost to Dr. Olivieri.16 
Another example is that of the COX-2 inhibitors. In the enthusiasm to release a new drug, 
rofecoxib, a COX-2 inhibitor, Bombardier et al17 overlooked an important cardiovascular 
side effect in a subgroup of patients even though the drug showed promise in the group of 
patients for which the clinical trial was designed, those with rheumatoid arthritis. 
Subsequent analysis of the data indicating a substantial risk for cardiovascular events in 
patients taking the drug, resulted in the withdrawal of rofecoxib(Vioxx) from the market. . 
This has recently led to the institution of a registry for all RCT’s; any researcher who wishes 
to publish in any of the major medical journals will now have to insure that their RCT is 
registered in the public domain, with all data both positive and negative available.18  
There is also the moral issue of using data from trials conducted unethically as in the 
infamous Tuskegee Syphilis study in which 399 poor black sharecroppers were denied 
effective treatment so that researchers could follow the natural history of syphilis.19Similar 
comments can be made about the Nazi doctors and the use of eponyms such as 
Hallervorden-Spatz syndrome, honouring a pathologist, Hallervorden, who actively 
participated in the Nazi euthanasia program in order to obtain specimens of human brains 
for his research.20  
Evidence can be published in recognized medical journals that is false because it has been 
unethically manipulated to justify a particular conclusion. Such was the case of the 
unjustified link between MMR immunization and autism published in The Lancet by Dr. 
Andrew Wakefield.21 This publication was not only wrong but the data was manipulated as 
was shown by Brian Deer’s exposé published in the British Medical Journal in 2011.22 
Wakefield postulated that 12 children had a ‘new syndrome’ of enterocolitis and regressive 
autism. In fact, 3/12 patients did not have regressive autism. 5/12 had a previous diagnosis 
of developmental problems long before receiving MMR vaccine and the symptoms of 
autism occurred months after the MMR was given and not within days. The study was 
further biased by the fact that the patients were recruited by known anti-MMR campaigners. 
Furthermore Dr. Wakefield stood to make financial gain through litigation by suing the 
pharmaceutical firms manufacturing the vaccine if his ‘research’ was generally accepted. 
The Lancet subsequently retracted the article in 2010 after untold damage had been done.23 
The false link between MMR and autism has caused needless worry to parents and along 
with other factors has led to a decline in herd immunity to measles with resultant increase in 
the number of cases in the developed world, where previously measles had almost been 
eliminated. As of October 2011, 26,074 cases of measles have been reported in European 
member states, with 14,000 cases in France alone. This has resulted in 7288 hospitalizations 
and 9 deaths.24 Thus, while evidence-based practice is desirable, it is not always possible 
because of contamination of the evidence by either incomplete or changing evidence, and 
unethical manipulation of evidence. Because of these failures, evidence-based medicine 
cannot always lead to the healing and relief from suffering that our patients seek. 
Paradoxically, they turn to complementary and alternative medicine (CAM) which often has 
less of an evidence base than traditional medicine. 
A further issue is that conclusions drawn from RCT’s are based on a statistical assessment of 
the participants in the clinical trial but you must apply the conclusion to your particular 
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patient. The danger is that your particular patient may not be similar to the patients in the 
clinical trial. This is especially a problem when trying to apply the results of a study, which 
has been done in a secondary or tertiary care center. The patients enrolled in such a trial 
may be quite different than the patients seen in a community practice. At any given clinical 
encounter, the physician does not have all the information needed to make an evidence-
based decision. For example, every individual patient has a particular pharmacogenetic 
profile, which is largely unknown. Another major problem in pediatrics is, of course, that 
most drugs are ‘orphans’ i.e. there is no good information derived from studies in pediatrics 
and so we ‘extrapolate’ from adult studies. It is good to remind oneself that ‘extrapolation’ 
means that we are outside the principle of evidence-based medicine—we are extrapolating 
or going beyond the evidence on an assumption. The assumption is that what holds true for 
adult patients will hold true for pediatric patients. Of course, the ‘assumption’ is not 
evidence-based! Moreover, we now know that this assumption is often untrue. 
Consequently, evidence-based principles sometimes ‘break down’ in the concrete world in 
which individual physicians must act.  
The renowned mediaeval philosopher/theologian Thomas Aquinas made a distinction, 
derived from Aristotle, between the speculative and practical intellect. The speculative 
intellect is the locus of analytical, theoretical thinking and this is the home of evidence-based 
medicine. The practical intellect, however, is the locus of applying evidence-based medicine 
to the practice of medicine: the specific judgment (having taken into account the evidence 
and the particulars of this patient before me) that the physician makes in determining the 
appropriateness of a particular treatment. The practical intellect is the final common 
pathway leading to a particular judgment for a particular patient. Let us take an example. A 
9 year old girl is brought to your office at 5:00 PM on a Friday afternoon complaining of an 
earache. You correctly diagnose an otitis media. Evidence-based medicine would suggest 
that the correct course is not to prescribe an antibiotic but rather to prescribe analgesics and 
re-examine the patient 48 hours later; if no resolution, then it is appropriate to prescribe an 
antibiotic. But other considerations may override the principles of evidence-based medicine: 
the mother may not be able to come back for a re-examination or the family is about to catch 
a plane for a holiday etc. Thus, a more holistic approach is mandated and the principle of 
evidence-based medicine breaks down. There is always a certain unpredictability in our 
encounters with patients. 
Let us take another example. There are many excellent pediatric hospitals that care for 
patients with cystic fibrosis. A recent article in The New Yorker describes how all of them 
follow the same evidence-based guidelines for the treatment of cystic fibrosis and yet if one 
examines their results, they are distributed along a bell curve; most of the hospitals were 
only average in their results and one hospital stood out: the Babies and Children’s Hospital 
in Cleveland where a respirologist named LeRoy Matthews had established a program for 
the treatment of cystic fibrosis in 1957. When national mortality rates for cystic fibrosis in 
the best centers was around 20%, Matthews claimed that his mortality rate was less than 2%. 
What was the difference? The difference turned out to be innovation and constantly 
challenging the evidence-based guidelines which record past experience.25 We must remain 
focused on our patients and challenge ourselves to do better, to go beyond the evidence-
based guidelines in order to excel, thereby constantly improving the guidelines themselves.  
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A recent essay in the New England Journal of Medicine entitled, The New Language of 
Medicine argues that we are in danger of losing the notion that physicians are healers. We 
now refer to ourselves as ‘providers’ who have a ‘product’ to sell and our patients are now 
‘consumers’ buying this product. “Beyond introducing new words, the movement toward 
industrializing and standardizing all of medicine (rather than just safety and emergency 
protocols) has caused certain terms that were critical to our medical education to all but 
disappear. ‘Clinical judgment’, for instance, is a phrase that has fallen into disgrace, replaced 
by ‘evidence-based practice’, the practice of medicine based on scientific data. But evidence 
is not new; throughout our medical education beginning more than three decades ago, we 
regularly examined the scientific evidence for our clinical practices. On rounds or in clinical 
conferences, doctors debated the design and results of numerous research studies. But the 
exercise of clinical judgment, which permitted assessment of those data and the application 
of study results to an individual patient, was seen as the acme of professional practice.”26 
In conclusion, there have always been two streams in medicine: the Hippocratic and 
Aesculapian. Evidence-based medicine and guidelines belong to the Hippocratic stream. 
The Aesculapian stream emphasizes healing and the importance of the psychological and 
spiritual aspects involved in healing. Because physicians do not always take this into 
account, many patients turn to complementary medicine for relief of their symptoms. 
Modern 21st Century medicine needs to be reminded of both the Hippocratic and the 
Aesculapian heritage in its long and renowned history. A good physician must take a 
holistic approach in any clinical encounter with a suffering human being. Evidence-based 
medicine must never be abandoned but it must be incorporated into the practical intellect along 
with the particular concrete aspects of this patient in order to make an appropriate and 
efficacious therapeutic decision. The cornerstones of caring for our patients and practicing 
good medicine are the encounter with the patient through our history and physical 
examination. We then combine this with the principles of evidence-based medicine, 
recognizing its hermeneutic weakness, to arrive at the best possible outcome for our patient. 
It is then that evidence-based medicine becomes “’ebullience-based medicine,’ a lively, 
enthusiastic, continually joyful expression of our good fortune at having the privilege to be 
able to care for and advocate for children.”27 
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1. Introduction 
1.1 Non-specific low back pain in western countries 
Low back pain (LBP) is an extremely common problem which most people in industrialized 
countries experience at some point in their lives. The prevalence of LBP in the USA ranges 
from 8% to 56% (Manchikanti, 2000). Estimation of the one-year incidence of a first-ever 
episode of LBP ranges between 6.3% and 15.4%, while estimation of the one-year incidence 
of any episode of LBP ranges between 1.5% and 36%. Studies have found the incidence of 
LBP is highest in the third decade, and overall prevalence increases with age up to the 60-65 
year age group, and then gradually declines. Many environmental and personal factors 
influence the onset and course of LBP. In addition to age, commonly reported risk factors 
include low educational status, stress, anxiety, depression, professional dissatisfaction, low 
levels of social support in the workplace and whole-body vibration activities. LBP has an 
enormous impact on individuals, families, communities, governments and businesses 
throughout the world (Hoy et al, 2010), and associated costs are estimated at between 
between $20 billion and $50 billion per year (Nachemson, 1992). 
Non-specific low back pain (NS-LBP) represents about 85% of LBP patients seen in primary 
care (Deyo and Phillips, 1996), and the vast majority of LBP patients seen by physical 
therapists are classified under this label. This classification process differentiates between 
specific spinal pathology, nerve root pain and simple or NS-LBP (Waddell, 2004). Patients 
suffering from NS-LBP who are not improving may benefit from referral for spinal 
manipulation provided by a trained spinal care specialist such as a physical therapist, 
chiropractor, osteopathic physician or physician who specializes in musculoskeletal medicine 
(NGC-7704, 2009). No evidence was found to support recommending regular manipulative 
treatment for the prevention of LBP (NGC-7704, 2009). High-quality evidence suggests that 
there is no clinically relevant difference between the efficacy of spinal manipulative therapy 
(SMT) and other interventions for reducing pain and improving function in patients with 
chronic NS-LBP. Determining cost-effectiveness of care is of high priority (Rubinstein et al, 
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2011). Risk of serious complications after spinal manipulation is low (estimated risk: cauda 
equina syndrome, less than one in one million). Current guidelines contraindicate 
manipulation on people with severe or progressive neurological deficit (NGC-7704, 2009).  
1.2 Osteopathy and osteopathic medicine  
In the USA, osteopathic physicians are licensed to practise the full scope of medicine. In 
Europe, Australia and New-Zealand, osteopaths are first-contact practitioners trained in 
private or academic institutions with Bachelors or Masters degree levels, and they are 
allowed to provide only osteopathic manipulative treatment (OMT) (WHO Benchmarks, 
2010). OMT is one of the numerous treatment approaches within manual and manipulative 
therapies for the management of a variety of musculoskeletal and non-musculoskeletal 
conditions. A wide range of manual techniques described in the Authorized Osteopathic 
Thesaurus (AOT) (Authorized Osteopathic Thesaurus, 2009) are used for the treatment of 
somatic dysfunction (SD). A SD is a functional disturbance of the musculoskeletal system 
tissues and related vascular and neurological components (Rumney, 1975). Osteopathic care 
relies on four tenets: (1) the body is a unit; the person is a unit of body, mind, and spirit, (2) 
the body is capable of self-regulation, self-healing, and health maintenance, (3) structure and 
function are reciprocally interrelated and (4) rational treatment is based upon an 
understanding of the basic principles of body unity, self-regulation, and the 
interrelationship of structure and function (Rogers et al, 2002).  
The distinguishing features of osteopathic care described in the scientific literature seem to 
be the concept of SD, the OMT and the four basic tenets of osteopathic therapeutic principles 
(WHO Benchmarks, 2010). Although these concepts were proposed mainly for educational 
purposes, they appear to be central in osteopathic practice, and are currently challenged by 
evidence-informed osteopathy (Fryer, 2008). 
The SD is a pathological entity referenced in the International Classifications of Diseases 
(ICD) 10 and has a political use as a tool distinctive from other manual therapies (Zegarra-
Parodi, 2010). This concept relies however on biomechanical and neurophysiological 
theories that are partially supported in clinical practice. It is recommended to osteopathic 
physicians to use OMT for NS-LBP caused by musculoskeletal conditions, i.e. to treat SD 
related to LBP (NGC-7504, 2009).  
OMT is a distinctive therapeutic modality which significantly decreases LBP with an effect 
size of -0.30 (CI 95% = [-0.47;-0.13]). The level of pain reduction is greater than expected 
from placebo effects alone and persists for at least three months (Licciardone et al, 2005a).  
1.3 Purpose  
The purpose of this chapter is to describe current clinical and scientific evidence regarding 
the concept of somatic dysfunction associated with non-specific low back pain for 
osteopathic manipulative diagnosis and treatment. This clinical concept will be analyzed in 
the light of evidence-based medicine.  
2. Methods 
A systematic literature search was conducted in July 2011 to identify published papers 
examining osteopathic manipulative diagnosis and treatment of NS-LBP patients. The 
EBM in Clinical Practice: Implementation in Osteopathic  
Diagnosis and Manipulative Treatment for Non-Specific Low Back Pain Patients 
 
149 
research included studies from 1975 onwards, i.e. since SD was first defined by Rumney. 
The databases searched were Medline, CINAHL and the Cochrane library. The search terms 
were as follows: key term - “somatic dysfunction”, “low back pain”, “osteopathic 
manipulative treatment” or “OMT” “osteopathic diagnosis”. The key terms were searched 
for in the title, abstract and keywords. Studies were included if they were written in English 
or French. The reference lists of retrieved studies were scanned to identify additional 
relevant papers.  
3. Results 
3.1 Osteopathic diagnosis: The somatic dysfunction concept 
3.1.1 Historical aspects 
Littlejohn, one of the pioneers of osteopathy, developed the concept of physiological 
disturbance associated with mechanical strain from the bony structures in 1903. He 
suggested that a properly functioning nervous system was a key element to maintain health 
and recover from disease. Burns then began to study physiological effects following 
manipulations at the Kirksville College of Osteopathic Medicine (KCOM) in the early 20th 
century. She mapped the effects produced by osteopathic lesions - manipulable lesions 
described by osteopaths - at different spinal segments, and found a close correspondence in 
the pattern produced in experiments on animals and the clinical patterns observed in herself 
and her colleagues (Allan, 1986). Experimental studies suggested the involvement of the 
parasympathetic and the sympathetic pathways in the genesis of the osteopathic lesion 
through viscerosomatic reflexes (Burns, 1948). Denslow and Korr (Denslow, 1993; Korr, 
1997) from KCOM led the first experimental studies on the human body to lend support to a 
model providing a neurological explanation for the origin and maintenance of the 
osteopathic lesion. They observed paraspinal muscle hyperexcitability associated with two 
misaligned vertebrae and alteration of sympathetic nervous system activity through 
sudomotricity studies. Some musculoskeletal symptoms quickly improved with 
manipulation: the nervous system is the only system that can operate almost 
instantaneously and may therefore be the mechanism behind the effects seen following 
manipulation. They developed the “facilitated segment” concept (Korr, 1979): an injured 
somatic or visceral structure produces discordant afferent impulses creating what is now 
described as a sensitization of the dorsal horn. The osteopathic lesion was initially described 
according to its characteristic features: altered range and quality of joint movement, altered 
tissue texture in the surrounding tissues, and sometimes apparent asymmetry of one 
vertebra compared to the others (Korr, 1947). 
Rumney, from the KCOM, wrote the first paper describing the concept of SD (Rumney, 
1975). Three major components of disease had been identified: visceral, psychic and somatic. 
He focused on the somatic component. He thought that the osteopathic profession had 
misled other health professions about what osteopathy was, by introducing the adjective 
“osteopathic” to terms, as in “osteopathic lesion” or “osteopathic pathology”, creating 
difficulties communicating with other scientific groups. Inaccurate concepts used by early 
osteopaths for manipulations such as the “bone out of place” were then replaced by 
concepts focusing more on the physiopathological consequences of biomechanical 
impairments as scientific knowledge increased within the osteopathic profession. The SD 
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Rumney, from the KCOM, wrote the first paper describing the concept of SD (Rumney, 
1975). Three major components of disease had been identified: visceral, psychic and somatic. 
He focused on the somatic component. He thought that the osteopathic profession had 
misled other health professions about what osteopathy was, by introducing the adjective 
“osteopathic” to terms, as in “osteopathic lesion” or “osteopathic pathology”, creating 
difficulties communicating with other scientific groups. Inaccurate concepts used by early 
osteopaths for manipulations such as the “bone out of place” were then replaced by 
concepts focusing more on the physiopathological consequences of biomechanical 
impairments as scientific knowledge increased within the osteopathic profession. The SD 
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was therefore defined as “an area of impaired function of related components of the 
musculoskeletal system (muscle, bone, fascia and ligament) and its associated or related parts in the 
vascular, lymphatic, and nervous systems”. Three important criteria for manual diagnosis were 
described: tissue changes, hyperalgesia and motion changes. This diagnosis is based on 
different signs in order to lead to a precise treatment, making specific adjustments. This 
concept was a shift from previous theories, which held that a global approach was sufficient 
to be effective. 
In 1990 Van Buskirk, an American osteopath, came up with a model to support the SD 
pathogenesis (Van Buskirk, 1990). This model focused on nociceptors, as they were the only 
described sensory receptors which could generate muscle hypertonia, autonomic arousal, 
and consequent loco-regional circulatory impairments commonly associated with SD. Van 
Buskirk’s SD model brought together three previous models based on: changes in nervous 
system activity, in connective tissue and in local circulation. Nervous system activity 
changes associated with SD corresponded to an increase of sympathetic outflow caused by 
localized excessive nociceptive information from visceral or somatic structures. Maintaining 
excessive nociceptive input would be detrimental to the normal function of the organ 
involved, and immune function would theoretically be diminished. These afferents would 
also produce reflex muscle contraction by axon reflex and sympathetic vasodilatation effects 
which would engorge the affected muscles and produce a restriction of motion. Over time, 
the muscle would become fibrotic and if stretched or strained again, nociceptors would be 
activated once again. 
3.1.2 Physiological studies 
Fryer, from Victoria University, Australia, recently revisited the SD neurophysiological 
theories with modern equipment (Fryer, 1999; Fryer, 2003), focusing on paraspinal tissue 
texture changes detected with palpation associated with electromyographic (EMG) data. A 
literature review has shown that the concept of reactive muscle contraction associated with 
intervertebral dysfunction seems plausible (Fryer et al, 2004a). The deep paraspinal muscle 
inhibition observed during dynamic and static activities was used as a theoretical 
framework for a possible relationship between dysfunctional muscle activity and tissue 
texture change findings with SD. However abnormal paraspinal tissues detected with 
palpation were associated with increased and/or decreased muscle activity (Fryer et al, 
2004b). They then tried to find a possible relationship between an abnormal paraspinal 
muscle palpation and local sensitivity measured using an algometer. They observed that 
paraspinal sites identified as having abnormal tissue texture and tenderness diagnosed by 
palpation, had significantly lower mean pressure pain threshold than other sites 
immediately surrounding the abnormal region (Fryer et al, 2004c). These results tend to 
corroborate common palpation findings diagnosed by osteopathic practitioners. Increased 
motor activity might be a contributing factor to tissue changes detected with palpation 
(Fryer et al, 2006). 
Fryer pursued his studies at the Andrew Taylor Still Research Institute (ATSRI) in Kirksville 
where Korr and Denslow had worked 60 years before. Principal biases, i.e. thinner 
intramuscular wires, proper statistical analysis and limited cohort size, were corrected. Recent 
studies concluded that there was no evidence of distinguishing EMG activity in the deep 
thoracic paraspinal musculature at sites identified as abnormal to palpation under resting 
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conditions, compared to sites identified as normal (Fryer et al, 2010a). They suggested that 
other factors than muscle activity, such as tissue fluid and inflammatory mediators, could be 
responsible for the apparent abnormality of these tissues during palpation. 
3.2 Osteopathic palpatory findings in LBP patients 
The SD concept underlies the diagnosis and the treatment in osteopathic medicine in clinical 
guidelines. In the USA, the National Guideline Clearinghouse (NGC) recommended that 
OMT be utilized by osteopathic physicians to treat SD associated with NS-LBP (NGC-7504, 
2009). This recommendation has a 1a level of evidence (the highest level) and is based on the 
results of a systematic review of randomized controlled trials (Licciardone et al, 2005a).  
Fundamental requirements for a diagnostic test to be recommended to clinicians are its 
accuracy and its reliability (Bossuyt et al, 2003). Over recent years, evidence-based medicine 
has challenged osteopathic practicioners to favor proven reliable palpatory tests when 
diagnosing patients’ conditions. Determining the accuracy and reliability of diagnostic tests 
used in osteopathy is therefore a high priority (Lucas and Bogduk, 2010). For that purpose, 
the ATSRI tried to investigate the interobserver reliability of common osteopathic palpatory 
tests used to evaluate the lumbar spine (Degenhardt et al, 2005). Three practitioners 
performed common palpatory tests for the clinical findings associated with SD: tenderness, 
tissue texture changes, vertebral positional asymmetry, and motion asymmetry in subjects. 
The procedure was repeated and the results were re-evaluated after consensus training had 
been completed by the examiners. This study showed that the initial evaluation of 
interobserver reliability for the four tests was poor to fair (kappa ranged from -0.02 to 0.34). 
Acceptable kappa values for clinical tests were achieved after consensus training only for 
tissue texture and tenderness, but the tenderness test was the only test that had a good 
kappa value (k=0.68). 
The lack of reliable tests in manual medicine is common as there is no gold standard except 
for pain. Acceptable reliability in diagnosing SD could however be achieved with 
appropriate and regular training in clinical studies and then be recommended to clinicians. 
Snider et al. (2008) investigated the incidence and severity of SD of four lumbar vertebral 
segments (L1-L4) in subjects with chronic NS-LBP. They included 16 subjects with chronic 
LBP and 47 subjects without chronic LBP. Subjects’ four lumbar vertebral segments (L1-L4) 
were evaluated. From 15 palpatory tests taught at KCOM, the four that achieved greatest 
inter-examiner reliability in the Degenhardt et al. study (2005) were included in a specific 
training protocol designed to promote consensus between examiners. The two groups 
showed significantly different severity of SD, determined from tissue texture changes 
(p=0.006) and static rotational asymmetry (p=0.008). Severity was found to be greater for the 
chronic LBP group than for the non-LBP group. Significant differences were observed in the 
incidence of vertebrae testing positive for resistance to anterior springing (p<0.001) and 
tenderness (p=0.002), with both occurring more frequently in the chronic LBP group than in 
the non-LBP group. Furthermore, the severity of SD as determined with resistance to 
anterior springing (p<0.001) and tenderness (p=0.001) was also significantly different 
between the two groups, with the chronic LBP group again showing greater severity than 
the non-LBP group. NS-LBP patients have more severe SD compared to asymptomatic 
patients and clinicians usually associate these clinical findings with symptoms to shape 
specific OMT for each patient. Snider et al. (2010) investigated the association of lumbar SD 
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conditions, compared to sites identified as normal (Fryer et al, 2010a). They suggested that 
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2009). This recommendation has a 1a level of evidence (the highest level) and is based on the 
results of a systematic review of randomized controlled trials (Licciardone et al, 2005a).  
Fundamental requirements for a diagnostic test to be recommended to clinicians are its 
accuracy and its reliability (Bossuyt et al, 2003). Over recent years, evidence-based medicine 
has challenged osteopathic practicioners to favor proven reliable palpatory tests when 
diagnosing patients’ conditions. Determining the accuracy and reliability of diagnostic tests 
used in osteopathy is therefore a high priority (Lucas and Bogduk, 2010). For that purpose, 
the ATSRI tried to investigate the interobserver reliability of common osteopathic palpatory 
tests used to evaluate the lumbar spine (Degenhardt et al, 2005). Three practitioners 
performed common palpatory tests for the clinical findings associated with SD: tenderness, 
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Acceptable kappa values for clinical tests were achieved after consensus training only for 
tissue texture and tenderness, but the tenderness test was the only test that had a good 
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The lack of reliable tests in manual medicine is common as there is no gold standard except 
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Snider et al. (2008) investigated the incidence and severity of SD of four lumbar vertebral 
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were evaluated. From 15 palpatory tests taught at KCOM, the four that achieved greatest 
inter-examiner reliability in the Degenhardt et al. study (2005) were included in a specific 
training protocol designed to promote consensus between examiners. The two groups 
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(p=0.006) and static rotational asymmetry (p=0.008). Severity was found to be greater for the 
chronic LBP group than for the non-LBP group. Significant differences were observed in the 
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as assessed with palpation with bone mineral density (BMD) among LBP and healthy patients. 
They observed that lumbar segments with palpated rotational asymmetry had higher mean 
BMD T scores than lumbar segments with no asymmetry (p=0.002). Lumbar segments with 
anterior motion restriction had higher mean BMD T scores than lumbar segments with no 
motion restriction (p=0.03). LBP patients demonstrated higher regional mean lumbar BMD T 
scores than those without LBP (p<0.001). These results suggest an association of objective 
lumbar vertebral BMD variation to palpatory findings associated with SD. 
Although patients describe the same symptoms, OMT is test-dependent and then specific 
according to SD incidence and severity, and the association made with symptoms by the 
practitioner. Pain provocation tests are currently described as the most reliable, and soft 
tissue paraspinal palpatory diagnostic tests and landmarks as not reliable. Practitioners 
should therefore combine their own experience with current data to select specific tests in 
order to achieve a precise SD diagnosis. 
3.3 Osteopathic Manipulative Treatment for LBP patients 
It has now been established that SD can be treated by OMT (Fryer, 1999) and several studies 
describe the benefits of OMT in the treatment of LBP (Licciardone et al, 2005a). However 
even if scientific evidence supporting the effectiveness of OMT has emerged, there is still a 
lack of scientific evidence to describe the psycho-physiological mechanisms underlying 
these treatments (Evans, 2002). 
The main explanations for the effects of manual techniques are based on data from human 
and animal studies, and recent models rely on neurophysiology (Pickar, 2002; Skyba et al, 
2003). Manipulation-induced hypoalgesia has been demonstrated in studies with human 
subjects (Sterling et al, 2001). Skyba et al. (2003) demonstrated in an experimental study on 
rats, that the antihyperalgesia produced by joint manipulation appears to involve 
descending inhibitory mechanisms which utilize serotonin and norepinephrine. Pickar 
(2002) explained that spinal manipulation impacts proprioceptive primary afferent neurons 
from paraspinal tissues, paraspinal tissues. He suggested that this can affect pain 
processing, possibly by altering the central facilitated state of the spinal cord, the motor 
control system, and through somato-somatic reflex and somato-visceral reflex. Several 
studies have shown a relationship between spinal manipulation and response of the 
autonomic nervous system (ANS): spinal manipulation induced a sympathetic response that 
was measured by the modification of skin conductance or the α-amylase-activity (Sterling et 
al, 2001; Henderson et al, 2010) and OMT produced vagal response (Henley et al, 2008). 
Several studies (Sherman et al, 2004; Andersson et al, 1999; Licciardone et al, 2003) describe 
OMT’s beneficial effects on symptoms of chronic pain patients. For NS-LBP patients in 
particular, Degenhardt et al (2007) observed a decrease in pain blood markers associated 
with a decreased level of stress described by patients 24 hours after receiving OMT.  
3.4 Osteopathic diagnosis and Osteopathic Manipulative Treatment records in a 
clinical setting 
Despite the SD’s ICD classification (ICD-10, 2007), the SD nomenclature is not universally 
used: a 2010 study of the UK osteopathic profession revealed multiple terms used to 
describe this palpatory diagnosis of “somatic dysfunction”, including “restriction”, “naming 
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by anatomical aetiology”, “dysfunction”, “facet lock”, “motion restriction” and more than 12 
other names (Fryer, 2010b). Despite the lack of uniform terminology for the SD, the Louisa 
Burns Osteopathic Research Committee of the American Academy of Osteopathy 
standardized the palpatory diagnosis of SD by developing and validating the Outpatient 
Osteopathic Subjective Objective Assessment Plan Note Form Series (OOSNF). These data 
records sheets are standardized and used to objectively measure and record the diagnosis 
and treatment of SD during patient encounters (Sleszynski et al, 1999). Two systematic 
reviews (Sefnger et al, 2004; Stochkendahl et al, 2006) recommended that clinicians should 
not base their diagnosis on a single clinical examination such as palpation, but rather on a 
range of tests and findings (Brunse al, 2010). The SD diagnosis is not used in a pain and 
movement model as in manual medicine for example, but includes other previously 
described clinical findings. Its four diagnostic criteria are commonly represented in the 
osteopathic literature by the acronym TART: (T) tissue texture abnormality: effusions, laxity, 
stability, tone; (A) asymmetry: crepitation, defects, masses, misalignment; (R) restriction of 
motion: contracture and (T) tenderness: pain (Outpatient Osteopathic SOAP Note Form, 
2002; Authorized Osteopathic Thesaurus, 2009). 
The OOSNF musculoskeletal table is used to collect data on the musculoskeletal evaluation 
of 13 anatomic regions: head, cervical, upper thoracic (T1–T4), midthoracic (T5–T9), lower 
thoracic (T10–T12), lumbar, sacrum/pelvis, pelvis/innominate, lower extremities (left and 
right), upper extremities (left and right), and ribs. For each of the patient's anatomic regions, 
the osteopathic practitioner evaluates the severity of SD. The scoring criteria for levels of SD 
are as follows: (0 – None): no SD present or background levels of SD only, (1 – Mild): more 
than background levels of SD, minor TART elements present, (2 – Moderate): obvious TART 
elements, which may or may not be overtly symptomatic, with significant restriction of 
motion and/or tenderness elements present and (3 – Severe): key SD with significant 
symptomatology, including restriction of motion and/or tenderness elements that “stand 
out” with minimal search or provocation (Sleszynski et al, 1999). 
Johnson and Kurtz (2003) classified OMT in three categories: (1) direct techniques which 
engage the restrictive barrier: articulatory, High-Velocity Low-Amplitude Thrust (HVLAT), 
muscle energy, soft tissue, (2) indirect techniques applied away from the restrictive barrier: 
counterstain, cranial, facilitated positional release, functional, fascial ligamentous release, 
and (3) direct-indirect techniques: myofascial/integrated neuromuscular release, lymphatic. 
The OMT modalities used to treat the SD evaluated in correlation with the patient chief 
complaint and the perception of how the SD in each region responded to OMT immediately 
after treatment are reported. The scoring criteria for responses after OMT are either: (R) 
Resolved: the SD is completely resolved without evidence of it ever having been present, (I) 
Improved: the SD is improved but not completely resolved, (U) Unchanged: the SD is 
unchanged or the same after treatment as it was before treatment, (W) Worse: the SD is 
worse or aggravated immediately after treatment. In the final section, the osteopathic 
practitioner details new medications, exercises he wishes the patient to carry out and 
nutritional, food or diet recommendations (Outpatient Osteopathic SOAP Note Form, 2002). 
Members of the profession should consider the long-term value of this widely accessible 
database which will facilitate descriptive and clinical osteopathic studies (Sleszynski and 
Glonek, 2005). These tools, which have been used in published research are necessary for the 
osteopathic profession’s future, as governments and paying third-parties require more 
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evidence to justify treatment reimbursement. The profession has the opportunity to provide 
data to describe, explain, and support OMT’s effectiveness for musculoskeletal and non-
musculoskeletal conditions.  
3.5 Osteopathic management of LBP patients: Patient-practitioner interaction 
The emphasis in treating patients who have NS-LBP is on improving function, decreasing 
peripheral nociception and central facilitation, and empowering individuals to move 
forward in resuming their normal daily life activities (Kuchera, 2005). 
A growing number of chronic pain patients are consulting complementary and alternative 
medicine (CAM) practitioners owing to dissatisfaction with mainstream medicine. (Kuchera, 
2007) Patients appreciate having an individual answer to their symptoms, and an 
understandable explanation. As diagnosis in osteopathic medicine is not based only on pain, 
patients presenting the same symptoms may not receive the same treatment. Each osteopathic 
practitioner designs a specific treatment according to the patient’s expectations and his/her 
osteopathic diagnosis, i.e. the SDs relating to the NS-LBP. The test-dependant OMT for SD 
may focus on various local, spinal and supra-spinal theoretical outcomes determining 
technique choices and goals. OMT is chosen and adapted after obtaining patients’ consent, and 
treatment strategies depend on the patient’s ability to face the treatment’s homeostatic 
response and the main underlying pathophysiological mechanism (Kuchera, 2007). 
Lifestyle and habits, including ergonomics, are crucial points to take into consideration as 
they may be provoking or sustaining factors for SD, and can challenge treatment results or 
even prevent amelioration. Patient history should therefore encompass these aspects and 
look carefully for possible personal or occupational biomechanical stressors. Such 
information could be included in a specific patient education programme in order to avoid 
dysfunctional strain patterns leading to recurrent symptoms. 
According to Kuchera (2007), physical examination of chronic pain patients by osteopathic 
practitioners should not be limited to searching for pain generators, as chronic pain is often 
associated with anxiety, depression and a reduction in the quality of life. Chronic pain shifts 
pain activity from the sensory cortex to the anterior cingulate gyrus, leading patients to 
describe their suffering rather than the location of their pain. Osteopathic practitioners use 
patient communication about social, family and emotional impact of illness rather than 
focusing on pain (Carey et al, 2003) and provide health and diet advice (Kuchera, 2007).  
An American study showed that the length of consultation was longer for osteopathic 
physicians compared to allopathic physicians: 20 minutes versus 15 minutes on average 
(p<0.01) (Sun et al, 2004). This feature may have a positive therapeutic influence on the 
perception and understanding of pain by the patient, which is described as a possible 
psychosocial risk factor for transition from acute to chronic pain (Penney, 2010). Quality of 
care and patient satisfaction with osteopathic practitioners could be attributed to 
communication and empathy (Pincus et al, 2000).  
4. Discussion 
4.1 Osteopathic diagnosis for LBP patients 
The International Association for the Study of Pain (IASP) describes two main models to 
explain LBP’s physiopathological mechanisms: the End-Organ Dysfunction Model (EODM) 
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and the Altered Nervous System Processing Models (ANSPM) (Pain, Clinical Updates: Low 
Back Pain, 2010). Both models are for educational and treatment purposes; it is supposed 
that treatment is more effective if it targets specific physiopathological mechanisms. The 
EODM supports the theory that nociceptive stimuli are caused by lumbar spine pathologies 
such as injuries, degenerative changes or repetitive strain injuries. However LBP does not 
always correlate with lumbar spine pathologies diagnosed by MRI scans or pain 
provocation/palliation techniques. It is proposed in the ANSPM that perception of sensory 
information is altered. This alteration might be due to physiological changes within the 
nervous system with an increased susceptibility to pain due to psychological vulnerabilities, 
such as depression or anxiety. In daily practice, practitioners reported that patients suffering 
from LBP are predisposed to reporting additional chronic pain syndromes. Researchers 
have discovered that sensory neurons, usually silent in healthy patients, may become 
reorganized and generate spontaneous action potentials leading to a rewiring of the central 
nervous system in chronic pain conditions. However symptoms described by LBP patients 
cannot be explained with a single model but rather with a combination of EODM and 
ANSPM with variation for each patient. It is interesting to observe that the clinical concept 
of SD combines these two approaches, i.e. a biomechanical strain from somatic and visceral 
structures which is associated with altered reflexive neurological responses from the 
involved anatomical area to the spinal cord. 
SD diagnosed among NS-LBP patients may be causative, reflexive, reactive or perpetuating, 
or a mix of these. Models for SD are controversial and rely on biomechanics (Triano, 2001) 
and neurophysiological reflexes (Van Buskirk, 1990; Pickar, 2002; Howell and Willard, 2005). 
Data from scientific literature about mechanical and neurophysiological modifications 
observed in LBP patients may also be interpreted by osteopathic practitioners using the SD 
concept, but this does not give a scientific validation of this concept. Here are two examples 
of results from EMG and ulstrasonography studies on LBP patients where the results could 
be “osteopathically” interpreted, i.e. focusing not only on local physiopathological changes 
but also looking at possible interactions with other anatomical areas according to their 
biomechanical and neurophysiological functions. Some of these physiopathological changes 
could also be associated with palpatory findings by experienced practitioners and be 
interpreted using the concept of SD to improve osteopathic diagnosis.  
In a comparative study, Van Dieën et al. (2003) revisited conflicting evidence on the 
modified activity of trunk muscles in NS-LBP patients. The main theory was based on a 
pain-spasm-pain model where it was considered that pain was generating muscle activity 
which in turn caused pain. This model was supported by EMG activity found during motor 
tasks: increased activity of antagonist muscles, decreased activity of agonist muscles, and no 
increased activity in static posture. However Van Dieën et al. highlighted that previous 
studies demonstrated disparate results caused by methodological flaws especially in the 
normalization of EMG data. After improving the standardization of the EMG baseline, they 
measured the activities of agonist and antagonist trunk muscles during trunk motions in 
healthy and LBP patients. EMG ratios between lumbar and thoracic erector spinae were 
calculated and they observed that trunk muscle use in patients with LBP was greater than in 
healthy control subjects. They suggested a trunk muscle strategy aiming to increase spinal 
stability in LBP patients.  
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evidence to justify treatment reimbursement. The profession has the opportunity to provide 
data to describe, explain, and support OMT’s effectiveness for musculoskeletal and non-
musculoskeletal conditions.  
3.5 Osteopathic management of LBP patients: Patient-practitioner interaction 
The emphasis in treating patients who have NS-LBP is on improving function, decreasing 
peripheral nociception and central facilitation, and empowering individuals to move 
forward in resuming their normal daily life activities (Kuchera, 2005). 
A growing number of chronic pain patients are consulting complementary and alternative 
medicine (CAM) practitioners owing to dissatisfaction with mainstream medicine. (Kuchera, 
2007) Patients appreciate having an individual answer to their symptoms, and an 
understandable explanation. As diagnosis in osteopathic medicine is not based only on pain, 
patients presenting the same symptoms may not receive the same treatment. Each osteopathic 
practitioner designs a specific treatment according to the patient’s expectations and his/her 
osteopathic diagnosis, i.e. the SDs relating to the NS-LBP. The test-dependant OMT for SD 
may focus on various local, spinal and supra-spinal theoretical outcomes determining 
technique choices and goals. OMT is chosen and adapted after obtaining patients’ consent, and 
treatment strategies depend on the patient’s ability to face the treatment’s homeostatic 
response and the main underlying pathophysiological mechanism (Kuchera, 2007). 
Lifestyle and habits, including ergonomics, are crucial points to take into consideration as 
they may be provoking or sustaining factors for SD, and can challenge treatment results or 
even prevent amelioration. Patient history should therefore encompass these aspects and 
look carefully for possible personal or occupational biomechanical stressors. Such 
information could be included in a specific patient education programme in order to avoid 
dysfunctional strain patterns leading to recurrent symptoms. 
According to Kuchera (2007), physical examination of chronic pain patients by osteopathic 
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associated with anxiety, depression and a reduction in the quality of life. Chronic pain shifts 
pain activity from the sensory cortex to the anterior cingulate gyrus, leading patients to 
describe their suffering rather than the location of their pain. Osteopathic practitioners use 
patient communication about social, family and emotional impact of illness rather than 
focusing on pain (Carey et al, 2003) and provide health and diet advice (Kuchera, 2007).  
An American study showed that the length of consultation was longer for osteopathic 
physicians compared to allopathic physicians: 20 minutes versus 15 minutes on average 
(p<0.01) (Sun et al, 2004). This feature may have a positive therapeutic influence on the 
perception and understanding of pain by the patient, which is described as a possible 
psychosocial risk factor for transition from acute to chronic pain (Penney, 2010). Quality of 
care and patient satisfaction with osteopathic practitioners could be attributed to 
communication and empathy (Pincus et al, 2000).  
4. Discussion 
4.1 Osteopathic diagnosis for LBP patients 
The International Association for the Study of Pain (IASP) describes two main models to 
explain LBP’s physiopathological mechanisms: the End-Organ Dysfunction Model (EODM) 
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and the Altered Nervous System Processing Models (ANSPM) (Pain, Clinical Updates: Low 
Back Pain, 2010). Both models are for educational and treatment purposes; it is supposed 
that treatment is more effective if it targets specific physiopathological mechanisms. The 
EODM supports the theory that nociceptive stimuli are caused by lumbar spine pathologies 
such as injuries, degenerative changes or repetitive strain injuries. However LBP does not 
always correlate with lumbar spine pathologies diagnosed by MRI scans or pain 
provocation/palliation techniques. It is proposed in the ANSPM that perception of sensory 
information is altered. This alteration might be due to physiological changes within the 
nervous system with an increased susceptibility to pain due to psychological vulnerabilities, 
such as depression or anxiety. In daily practice, practitioners reported that patients suffering 
from LBP are predisposed to reporting additional chronic pain syndromes. Researchers 
have discovered that sensory neurons, usually silent in healthy patients, may become 
reorganized and generate spontaneous action potentials leading to a rewiring of the central 
nervous system in chronic pain conditions. However symptoms described by LBP patients 
cannot be explained with a single model but rather with a combination of EODM and 
ANSPM with variation for each patient. It is interesting to observe that the clinical concept 
of SD combines these two approaches, i.e. a biomechanical strain from somatic and visceral 
structures which is associated with altered reflexive neurological responses from the 
involved anatomical area to the spinal cord. 
SD diagnosed among NS-LBP patients may be causative, reflexive, reactive or perpetuating, 
or a mix of these. Models for SD are controversial and rely on biomechanics (Triano, 2001) 
and neurophysiological reflexes (Van Buskirk, 1990; Pickar, 2002; Howell and Willard, 2005). 
Data from scientific literature about mechanical and neurophysiological modifications 
observed in LBP patients may also be interpreted by osteopathic practitioners using the SD 
concept, but this does not give a scientific validation of this concept. Here are two examples 
of results from EMG and ulstrasonography studies on LBP patients where the results could 
be “osteopathically” interpreted, i.e. focusing not only on local physiopathological changes 
but also looking at possible interactions with other anatomical areas according to their 
biomechanical and neurophysiological functions. Some of these physiopathological changes 
could also be associated with palpatory findings by experienced practitioners and be 
interpreted using the concept of SD to improve osteopathic diagnosis.  
In a comparative study, Van Dieën et al. (2003) revisited conflicting evidence on the 
modified activity of trunk muscles in NS-LBP patients. The main theory was based on a 
pain-spasm-pain model where it was considered that pain was generating muscle activity 
which in turn caused pain. This model was supported by EMG activity found during motor 
tasks: increased activity of antagonist muscles, decreased activity of agonist muscles, and no 
increased activity in static posture. However Van Dieën et al. highlighted that previous 
studies demonstrated disparate results caused by methodological flaws especially in the 
normalization of EMG data. After improving the standardization of the EMG baseline, they 
measured the activities of agonist and antagonist trunk muscles during trunk motions in 
healthy and LBP patients. EMG ratios between lumbar and thoracic erector spinae were 
calculated and they observed that trunk muscle use in patients with LBP was greater than in 
healthy control subjects. They suggested a trunk muscle strategy aiming to increase spinal 
stability in LBP patients.  
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It has been hypothesized that the connective tissues forming the fascial planes of the back 
play a role in the pathogenesis of chronic LBP. In a randomized trial, Langevin et al. (2009) 
observed that LBP patients had, on average, 25% greater perimuscular connective tissue 
thickness than did subjects without LBP. According to these authors, increased thickness 
and disorganization of connective tissue layers due to inflammation, fatty infiltration, 
fibrosis and adhesions may impair the normal relative movement of connective tissue 
planes, increase tissue stiffness, decrease range of motion and predispose to further injury. 
Disorganized connective tissue layers may also cause pain due to trapping of sensory nerve 
fibres through the collagen matrix. 
4.2 Osteopathic Manipulative Treatment for LBP patients: Implications for treatment 
Licciardone, Brimhall and King from the Osteopathic Research Center (ORC) carried out a 
systematic review and meta-analysis of randomised clinical trials on OMT for LBP 
(Licciardone et al 2005a). The effects of SMT on LBP patients were already reported in the 
literature but no data was available to evaluate the specific OMT on that patient population. 
Spinal manipulations and mobilizations are effective in adults for acute, subacute LBP and 
for chronic LBP (Bronfort et al, 2010).  
Eight OMT studies versus control treatments were included in their meta-analysis. They 
were conducted between 1973 and 2001 in the USA and the UK. They met good 
methodology quality criteria. The methodological quality of four of the OMT trials was 
independently confirmed in a recent systematic review which included a best evidence 
synthesis incorporating eight explicit quality criteria, including similarity of baseline 
characteristics of subjects or reporting of adjusted outcomes; concealment of treatment 
allocation; blinding of subjects; blinding of providers or other control for attention bias; 
blinded or unbiased outcomes assessment; subject dropouts being reported and accounted 
for in the analysis; missing data being reported and accounted for in the analysis; and 
intention-to-treat analysis or absence of differential co-interventions between groups in 
studies with full compliance. 
Two out of the three authors reviewed the articles independently, and conflicting data were 
resolved by consensus. Effect size computed with Cohen's d statistic was used to report all 
trial results. Effect size is the measure of the strength of the relationship between two 
variables in a statistical population. The negative effect found size represented a greater 
decrease in pain among OMT subjects relative to control treatment subjects.  
This meta-analysis included 525 subjects with LBP from the 8 eligible trials. Pain 
associated with OMT was very significantly reduced. Analysis was performed with a 
best-case and a worse-case scenario. Both supported the efficacy of OMT for LBP, and 
showed an improved reduction in pain with OMT in comparison with placebo control or 
active treatment, though the worst-case scenario was not found to be statistically 
significant. LBP symptoms treated with OMT were significantly reduced in the short-term 
(effect size, -0.28; 95% CI, -0.51 to -0.06; p = 0.01), medium-term (effect size, -0.33; 95% CI, -
0.51 to -0.15; p < 0.001), and long-term (effect size, -0.40; 95% CI, -0.74 to -0.05; p = 0.03) 
follow-up periods. Overall results showed a statistically significant reduction in LBP in 
patients treated with OMT. Stratified meta-analyses were performed to control for 
moderator variables, and this showed that OMT significantly reduced low back pain 
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versus active treatment / placebo control and versus no treatment control. OMT might act 
as a substitute for, or decrease the use of, medication known to carry risks of substantial 
side-effects. Contrary to the USA, osteopaths in the UK are not licensed physicians. Effect 
sizes observed in the UK study were comparable to those found in the USA studies 
suggesting that the results reflected accurately the effects of OMT and not other elements 
of low back care. 
Systematic imaging prior to OMT is not part of professional guidelines, but its absence may 
limit the differential diagnosis process, and prohibit the use of some potentially iatrogenic 
OMT. The most serious adverse effects of manual techniques are vertebral artery 
dissections following cervical manipulations (Vogel, 2010). A systematic review of the 
literature on the side effects of manual therapies (Carnes et al, 2010) concluded that severe 
side effects were low but half of patients described post-manipulative transient mild to 
moderate side effects. Patients treated by final year students in a clinical center integrated 
in a UK osteopathic school were surveyed about the main side-effects experienced after 
OMT (Rajendran et al, 2009). Patients consulted primarily for LBP (33%) and neck pain 
(20%). Local pain (24.3%), local stiffness (18,3%), and an increase in the pain that 
motivated the consultation (11.8%) were the most common side-effects reported. They 
were felt up to two days after the consultation but 96% of these manifestations were 
considered by the patients as mild or moderate.  
The numbers of OMT sessions for LBP patients reported varies in the literature (Licciardone 
et al, 2005a): treatment protocols included from 4 to 10 sessions lasting from 15 to 45 
minutes over a period of one to six months. The authors did not reference or justify their 
choices for the protocol which were mainly based on experts’ opinions. However, the format 
most consistent with current clinical practice would be around 6 to 8 sessions with a 
frequency of one session every 2 weeks over a period of 3 to 4 months.  
Sloan and Walsh (2010) demonstrated how the language used by practitioners could affect 
patients’ pain perception and outcomes among LBP patients. Mechanical explanations 
about patients’ conditions were associated with better outcomes than degenerative ones. 
Placebo responses are often described pejoratively and interpreted as something 
administered to patients which cannot be controlled, but the patient’s response is 
nonetheless a positive one. Nocebo responses may result from words used by 
practitioners while talking with their patients to describe their conditions. Practitioners 
should keep in mind the possible iatrogenic effects of their vocabulary, and should use 
simple and neutral words in order to give patients an explanation that makes sense to 
them. As with all other healthcare practitioners, the placebo response could therefore be 
enhanced, and depends mainly on how osteopathic practitioners describe their 
understanding of the symptoms. This affects patients’ beliefs about prognosis and 
attitudes towards treatment and self-care (Abbey, 2011). 
4.3 Osteopathic Manipulative Treatment for LBP patients: Implications for training 
Palpation teaching presents specific challenges. Four main issues have been described in 
the scientific literature surrounding manual therapies, and should be addressed to 
improve palpation teaching: hand positioning, amount and direction of force and 
interpretation of tissue response (Degenhardt, 2009). Educators in osteopathy train 
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It has been hypothesized that the connective tissues forming the fascial planes of the back 
play a role in the pathogenesis of chronic LBP. In a randomized trial, Langevin et al. (2009) 
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thickness than did subjects without LBP. According to these authors, increased thickness 
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(Licciardone et al 2005a). The effects of SMT on LBP patients were already reported in the 
literature but no data was available to evaluate the specific OMT on that patient population. 
Spinal manipulations and mobilizations are effective in adults for acute, subacute LBP and 
for chronic LBP (Bronfort et al, 2010).  
Eight OMT studies versus control treatments were included in their meta-analysis. They 
were conducted between 1973 and 2001 in the USA and the UK. They met good 
methodology quality criteria. The methodological quality of four of the OMT trials was 
independently confirmed in a recent systematic review which included a best evidence 
synthesis incorporating eight explicit quality criteria, including similarity of baseline 
characteristics of subjects or reporting of adjusted outcomes; concealment of treatment 
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blinded or unbiased outcomes assessment; subject dropouts being reported and accounted 
for in the analysis; missing data being reported and accounted for in the analysis; and 
intention-to-treat analysis or absence of differential co-interventions between groups in 
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Two out of the three authors reviewed the articles independently, and conflicting data were 
resolved by consensus. Effect size computed with Cohen's d statistic was used to report all 
trial results. Effect size is the measure of the strength of the relationship between two 
variables in a statistical population. The negative effect found size represented a greater 
decrease in pain among OMT subjects relative to control treatment subjects.  
This meta-analysis included 525 subjects with LBP from the 8 eligible trials. Pain 
associated with OMT was very significantly reduced. Analysis was performed with a 
best-case and a worse-case scenario. Both supported the efficacy of OMT for LBP, and 
showed an improved reduction in pain with OMT in comparison with placebo control or 
active treatment, though the worst-case scenario was not found to be statistically 
significant. LBP symptoms treated with OMT were significantly reduced in the short-term 
(effect size, -0.28; 95% CI, -0.51 to -0.06; p = 0.01), medium-term (effect size, -0.33; 95% CI, -
0.51 to -0.15; p < 0.001), and long-term (effect size, -0.40; 95% CI, -0.74 to -0.05; p = 0.03) 
follow-up periods. Overall results showed a statistically significant reduction in LBP in 
patients treated with OMT. Stratified meta-analyses were performed to control for 
moderator variables, and this showed that OMT significantly reduced low back pain 
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versus active treatment / placebo control and versus no treatment control. OMT might act 
as a substitute for, or decrease the use of, medication known to carry risks of substantial 
side-effects. Contrary to the USA, osteopaths in the UK are not licensed physicians. Effect 
sizes observed in the UK study were comparable to those found in the USA studies 
suggesting that the results reflected accurately the effects of OMT and not other elements 
of low back care. 
Systematic imaging prior to OMT is not part of professional guidelines, but its absence may 
limit the differential diagnosis process, and prohibit the use of some potentially iatrogenic 
OMT. The most serious adverse effects of manual techniques are vertebral artery 
dissections following cervical manipulations (Vogel, 2010). A systematic review of the 
literature on the side effects of manual therapies (Carnes et al, 2010) concluded that severe 
side effects were low but half of patients described post-manipulative transient mild to 
moderate side effects. Patients treated by final year students in a clinical center integrated 
in a UK osteopathic school were surveyed about the main side-effects experienced after 
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(20%). Local pain (24.3%), local stiffness (18,3%), and an increase in the pain that 
motivated the consultation (11.8%) were the most common side-effects reported. They 
were felt up to two days after the consultation but 96% of these manifestations were 
considered by the patients as mild or moderate.  
The numbers of OMT sessions for LBP patients reported varies in the literature (Licciardone 
et al, 2005a): treatment protocols included from 4 to 10 sessions lasting from 15 to 45 
minutes over a period of one to six months. The authors did not reference or justify their 
choices for the protocol which were mainly based on experts’ opinions. However, the format 
most consistent with current clinical practice would be around 6 to 8 sessions with a 
frequency of one session every 2 weeks over a period of 3 to 4 months.  
Sloan and Walsh (2010) demonstrated how the language used by practitioners could affect 
patients’ pain perception and outcomes among LBP patients. Mechanical explanations 
about patients’ conditions were associated with better outcomes than degenerative ones. 
Placebo responses are often described pejoratively and interpreted as something 
administered to patients which cannot be controlled, but the patient’s response is 
nonetheless a positive one. Nocebo responses may result from words used by 
practitioners while talking with their patients to describe their conditions. Practitioners 
should keep in mind the possible iatrogenic effects of their vocabulary, and should use 
simple and neutral words in order to give patients an explanation that makes sense to 
them. As with all other healthcare practitioners, the placebo response could therefore be 
enhanced, and depends mainly on how osteopathic practitioners describe their 
understanding of the symptoms. This affects patients’ beliefs about prognosis and 
attitudes towards treatment and self-care (Abbey, 2011). 
4.3 Osteopathic Manipulative Treatment for LBP patients: Implications for training 
Palpation teaching presents specific challenges. Four main issues have been described in 
the scientific literature surrounding manual therapies, and should be addressed to 
improve palpation teaching: hand positioning, amount and direction of force and 
interpretation of tissue response (Degenhardt, 2009). Educators in osteopathy train 
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students to perform techniques and to adapt them according to patient needs in a clinical 
context, to describe relative and absolute contraindications, and to describe expected 
outcomes. The typical lecturing process is to teach OMT every year from the first year, 
gradually teaching more complicated and refined methods to develop students’ skills 
(Standard 2000: Standard of proficiency March 1999. General Osteopathic Council 
(GOsC), 2000).  
Osteopathic training within universities now includes a sound background to the 
biomechanical and neurophysiological aspects of OMT. Theoretical models of action are 
currently shifting away from a classical mechanistic view to a systemic view, incorporating 
data from recent publications. Different models of practice in osteopathy have been 
described: biomechanical, neurological, respiratory/circulatory, behavioral/psychological 
and bioenergetic models (WHO Benchmarks, 2010). They differ regarding the application of 
forces and comprehension of the body’s response to mechanical and psychological stresses. 
Palpatory findings associated with SD may vary according to the theoretical model, and this 
may create cognitive conflicts (Johsua and Dupin, 1993). Diversity of concepts requiring 
different cognitive and manual approaches may be a source of confusion for students. Some 
osteopathic education centres have therefore prioritized SD and OMT theoretical and 
practical training according to their scientific levels of evidence. Manipulation and 
mobilization were therefore prioritized probably because they are better supported by 
current evidence. This is probably because these direct OMTs are similar to techniques 
performed and studied by other professionals (Lederman, 2005). Direct OMTs use mainly 
biomechanical (Triano, 2001) and neurophysiological models (Van Buskirk, 1990; Pickar, 
2002; Howell and Willard, 2005). 
Clinimetrics is the practice of assessing or describing symptoms, signs and laboratory 
findings by means of scales, indices and other quantitative instruments (Feinstein, 1987). 
It is clinically important to focus on this during training in order to train future 
professionals to make appropriate decisions about patient management, based on the best 
level of evidence available. A clinical measurement instrument, such as a test, should 
ideally be valid (it should measure what it is intended to measure), be reliable, i.e. 
reproducible (the instrument score should remain stable when there has been no change 
in the performance), be responsive to change over time, and be precise enough to measure 
the minimal clinically important change (MIC), defined by Jaeschke et al (2009) as the 
smallest difference in score in the domain of interest which patients perceive as beneficial, 
and which would mandate, in the absence of troublesome side effects and excessive cost, 
a change in the patient’s management. These challenging aspects have been assessed for 
osteopathy osteopathy. As with as with other manual therapies, not having gold 
standards to evaluate tests with to assess their validity is a problem (Lucas and Bogduk, 
2011). Studies assessing diagnostic reliability should be standardized, and under ideal 
conditions conditions, have certain variables controlled, the most important being that the 
examiners should be blinded to other examiners’ findings for inter-examiner reliability 
studies. The application and interpretation of the test should be appropriate and there 
should be enough time between repeated measurements to avoid altering results. 
Osteopathic educators should prioritize the contents of their training programmes 
according to the tests’ performances. Tests should also be, as stated above, valid, 
responsive to change over time, such as before and after treatment, and precise enough to 
measure the MIC. Insufficient performance of tests in the detection of MIC may cause a 
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type-2 error in RCTs; no difference is observed during the study when in reality there is a 
difference between groups (Lucas and Bogduk, 2011). Students should also be aware of 
such limitations of studies during critical appraisal of published literature in the manual 
therapies field.  
4.4 Evidence-oriented osteopathy 
EBM has been defined by Sackett et al. (1996) as “the conscientious, explicit, and judicious 
use of current best evidence in making decisions about the care of individual patients”. 
Incorporation of EBM in daily practice for clinicians is a challenging issue, especially for 
manual therapists therapists, owing to the lack of reliable and valid tests excepting, the pain 
reproduction tests. Evidence based medicine cannot however be “cookbook” medicine 
because each patient is a unique individual with different medical needs (ATSU, Evidence 
Based Medicine, 2011). For example, the main pathophysiological mechanisms underlying a 
patient’s symptoms or injury might be evaluated through case history: sclerotomal tissue pain 
described as “deep, dull, or toothache-like”, and myotomal pain that is difficult to localise and 
is described as “crampy” or “stiff” (Kuchera, 2007). Discussing the generalizability of 
published data also requires critical appraisal skills that are common to all other healthcare 
professionals, and osteopathic practitioners should ask themselves if results from research are 
applicable specifically to their patients. Interpretation of such studies has, however, several 
limitations. The main one is that osteopathy should be considered as a complex intervention 
(Sturmberg and Martin, 2008), and needs to be evaluated using specific methodological tools 
which are different for pharmacological interventions.  
A scope of practice for osteopathic practitioners is about to be published in Europe 
(European Federation of Osteopaths (EFO), The Scope of Osteopathic Practice in Europe, 
2011). Osteopaths themselves have defined the indication for OMT as the presence of SD 
that is clinically significant. The SD concept may however be perceived as perverted by part 
of the profession when used as a tool to categorize their patients, rather than a tool to 
diagnose and treat them (Johnson and Kurtz, 2003). This concept has caused the profession 
to lose part of its monistic vision (Lee, 2005), by implying a direct link between SD and 
symptoms and diseases, which in reality corresponds to a biomedical model (Leigh, 1994)  
The concept of SD is clinically relevant, particularly in its association with LBP and its 
prevalence in a clinical setting (Licciardone et al, 2005b) but a clear distinction should be 
made between clinical evidence and scientific evidence for the concept of SD. SD is more 
prevalent in subjects with chronic LBP than in subjects without chronic LBP (Snider et al, 
2008), and specific OMT is provided on a test-dependent basis for each patient. Patient 
agreement should also be obtained, and patient values and expectations for the outcome of 
the OMT should be acknowledged. Although OMT for the treatment of SD associated with 
LBP is now included in clinical guidelines in the USA, osteopathic practitioners should 
understand that successful clinical outcomes do not validate this concept. Data from existing 
clinical, descriptive and physiological studies with strong methodology could only support 
some of the most common assertions within the osteopathic profession. 
As for all other disciplines, osteopathic curricula should rely on the best available evidence, 
and challenges are arising concerning some osteopathic concepts due to conflicting current 
evidence (Fryer, 2008). A balance between clinical findings and scientific evidence in 
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students to perform techniques and to adapt them according to patient needs in a clinical 
context, to describe relative and absolute contraindications, and to describe expected 
outcomes. The typical lecturing process is to teach OMT every year from the first year, 
gradually teaching more complicated and refined methods to develop students’ skills 
(Standard 2000: Standard of proficiency March 1999. General Osteopathic Council 
(GOsC), 2000).  
Osteopathic training within universities now includes a sound background to the 
biomechanical and neurophysiological aspects of OMT. Theoretical models of action are 
currently shifting away from a classical mechanistic view to a systemic view, incorporating 
data from recent publications. Different models of practice in osteopathy have been 
described: biomechanical, neurological, respiratory/circulatory, behavioral/psychological 
and bioenergetic models (WHO Benchmarks, 2010). They differ regarding the application of 
forces and comprehension of the body’s response to mechanical and psychological stresses. 
Palpatory findings associated with SD may vary according to the theoretical model, and this 
may create cognitive conflicts (Johsua and Dupin, 1993). Diversity of concepts requiring 
different cognitive and manual approaches may be a source of confusion for students. Some 
osteopathic education centres have therefore prioritized SD and OMT theoretical and 
practical training according to their scientific levels of evidence. Manipulation and 
mobilization were therefore prioritized probably because they are better supported by 
current evidence. This is probably because these direct OMTs are similar to techniques 
performed and studied by other professionals (Lederman, 2005). Direct OMTs use mainly 
biomechanical (Triano, 2001) and neurophysiological models (Van Buskirk, 1990; Pickar, 
2002; Howell and Willard, 2005). 
Clinimetrics is the practice of assessing or describing symptoms, signs and laboratory 
findings by means of scales, indices and other quantitative instruments (Feinstein, 1987). 
It is clinically important to focus on this during training in order to train future 
professionals to make appropriate decisions about patient management, based on the best 
level of evidence available. A clinical measurement instrument, such as a test, should 
ideally be valid (it should measure what it is intended to measure), be reliable, i.e. 
reproducible (the instrument score should remain stable when there has been no change 
in the performance), be responsive to change over time, and be precise enough to measure 
the minimal clinically important change (MIC), defined by Jaeschke et al (2009) as the 
smallest difference in score in the domain of interest which patients perceive as beneficial, 
and which would mandate, in the absence of troublesome side effects and excessive cost, 
a change in the patient’s management. These challenging aspects have been assessed for 
osteopathy osteopathy. As with as with other manual therapies, not having gold 
standards to evaluate tests with to assess their validity is a problem (Lucas and Bogduk, 
2011). Studies assessing diagnostic reliability should be standardized, and under ideal 
conditions conditions, have certain variables controlled, the most important being that the 
examiners should be blinded to other examiners’ findings for inter-examiner reliability 
studies. The application and interpretation of the test should be appropriate and there 
should be enough time between repeated measurements to avoid altering results. 
Osteopathic educators should prioritize the contents of their training programmes 
according to the tests’ performances. Tests should also be, as stated above, valid, 
responsive to change over time, such as before and after treatment, and precise enough to 
measure the MIC. Insufficient performance of tests in the detection of MIC may cause a 
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type-2 error in RCTs; no difference is observed during the study when in reality there is a 
difference between groups (Lucas and Bogduk, 2011). Students should also be aware of 
such limitations of studies during critical appraisal of published literature in the manual 
therapies field.  
4.4 Evidence-oriented osteopathy 
EBM has been defined by Sackett et al. (1996) as “the conscientious, explicit, and judicious 
use of current best evidence in making decisions about the care of individual patients”. 
Incorporation of EBM in daily practice for clinicians is a challenging issue, especially for 
manual therapists therapists, owing to the lack of reliable and valid tests excepting, the pain 
reproduction tests. Evidence based medicine cannot however be “cookbook” medicine 
because each patient is a unique individual with different medical needs (ATSU, Evidence 
Based Medicine, 2011). For example, the main pathophysiological mechanisms underlying a 
patient’s symptoms or injury might be evaluated through case history: sclerotomal tissue pain 
described as “deep, dull, or toothache-like”, and myotomal pain that is difficult to localise and 
is described as “crampy” or “stiff” (Kuchera, 2007). Discussing the generalizability of 
published data also requires critical appraisal skills that are common to all other healthcare 
professionals, and osteopathic practitioners should ask themselves if results from research are 
applicable specifically to their patients. Interpretation of such studies has, however, several 
limitations. The main one is that osteopathy should be considered as a complex intervention 
(Sturmberg and Martin, 2008), and needs to be evaluated using specific methodological tools 
which are different for pharmacological interventions.  
A scope of practice for osteopathic practitioners is about to be published in Europe 
(European Federation of Osteopaths (EFO), The Scope of Osteopathic Practice in Europe, 
2011). Osteopaths themselves have defined the indication for OMT as the presence of SD 
that is clinically significant. The SD concept may however be perceived as perverted by part 
of the profession when used as a tool to categorize their patients, rather than a tool to 
diagnose and treat them (Johnson and Kurtz, 2003). This concept has caused the profession 
to lose part of its monistic vision (Lee, 2005), by implying a direct link between SD and 
symptoms and diseases, which in reality corresponds to a biomedical model (Leigh, 1994)  
The concept of SD is clinically relevant, particularly in its association with LBP and its 
prevalence in a clinical setting (Licciardone et al, 2005b) but a clear distinction should be 
made between clinical evidence and scientific evidence for the concept of SD. SD is more 
prevalent in subjects with chronic LBP than in subjects without chronic LBP (Snider et al, 
2008), and specific OMT is provided on a test-dependent basis for each patient. Patient 
agreement should also be obtained, and patient values and expectations for the outcome of 
the OMT should be acknowledged. Although OMT for the treatment of SD associated with 
LBP is now included in clinical guidelines in the USA, osteopathic practitioners should 
understand that successful clinical outcomes do not validate this concept. Data from existing 
clinical, descriptive and physiological studies with strong methodology could only support 
some of the most common assertions within the osteopathic profession. 
As for all other disciplines, osteopathic curricula should rely on the best available evidence, 
and challenges are arising concerning some osteopathic concepts due to conflicting current 
evidence (Fryer, 2008). A balance between clinical findings and scientific evidence in 
 
Evidence Based Medicine – Closer to Patients or Scientists? 
 
160 
osteopathic curricula should therefore be found. Osteopathic practitioners themselves are 
able to provide critical analysis of their own clinical procedures, and are able to change them 
according to current scientific evidence (Zegarra-Parodi and Fabre, 2009). For example, 
OMT training has shifted from expert opinion-based theories (Fryette, 1954) to a more 
scientific approach (Gibbons and Tehan, 2001; McCarthy, 2001), which includes recent 
biomechanical studies on spinal coupled movement (Bogduk and Mercer, 2000; Herzog, 
2000). Hartmann’s minimum leverage techniques concept (Hartmann, 1996) fits with current 
biomechanical understanding, its main educational objective relying on obtaining pre-
manipulative tension with combined leverage on a specific joint and therefore reducing 
amplitude of the manipulation. Systematically training osteopathic students to find evidence 
for clinical decisions relative to individual patient needs may be relevant in order to improve 
their appraisal skills, and use them in a clinical setting once they become professional. This is a 
long term process. The osteopathic profession has moved from an empirical body of practice to 
a regulated profession included in different healthcare systems. 
Osteopathic medicine is a relatively young profession compared to allopathic medicine, and 
the lack of scientific studies to support common clinical procedures is currently being 
addressed, especially in the USA and in the UK; countries where osteopathy was first 
regulated and where dedicated research institutions now exist: ATSRI and ORC in the USA 
and the National Council for Osteopathic Research (NCOR) in the UK. The situation is not 
improved by the fact that there is no regulation or official research facilities in many 
countries. 
5. Conclusion 
There is a growing body of clinical evidence to support the use of the concept of SD during 
osteopathic diagnosis and manipulative treatment for NS-LBP patients. Interpretation of 
osteopathic palpatory findings is central to the creation of a treatment plan, and the choice 
of OMT. The concept of SD is also fundamental for osteopathic educators to transmit their 
experience. This concept is however being challenged owing to the relative lack of scientific 
evidence, and the current demands from academic and governmental institutions. 
Successful outcomes in a clinical setting with the use of the SD concept do not equal a 
validation of this concept. It needs to be re-evaluated in the light of evidence-oriented 
osteopathy. The SD is currently a clinically descriptive concept rather than one with 
supporting scientific evidence. The published clinical and experimental data should 
nevertheless be presented and taught, so that osteopathic practitioners can provide OMT 
based on the best available levels of evidence. 
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Evidence-based medicine (EBM) was introduced to the best benefit of the patient. 
It has transformed the pathophysiological approach to the outcome approach of 
today’s treatments. Disease-oriented to patient-oriented medicine. And, for some, 
daily medical practice from patient oriented to case oriented medicine. Evidence has 
changed the paternalistic way of medical practice. And gave room to patients, who 
show a tendency towards partnership. Although EBM has introduced a different 
way of thinking in the day to day medical practice, there is plenty of space for 
implementation and improvement. This book is meant to provoke the thinker towards 
the unlimited borders of caring for the patient.
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